id	sid	tid	token	lemma	pos
aji-33	1	1	_	_	PUNCT
aji-33	2	1	_	_	PUNCT
aji-33	3	1	_	_	PUNCT
aji-33	4	1	_	_	PUNCT
aji-33	5	1	_	_	PUNCT
aji-33	6	1	_	_	PUNCT
aji-33	7	1	_	_	PUNCT
aji-33	8	1	_	_	PUNCT
aji-33	9	1	_	_	PUNCT
aji-33	10	1	_	_	PUNCT
aji-33	11	1	_	_	PUNCT
aji-33	12	1	_	_	PUNCT
aji-33	13	1	_	_	PUNCT
aji-33	14	1	_	_	PUNCT
aji-33	15	1	_	_	PUNCT
aji-33	16	1	_	_	PUNCT
aji-33	17	1	_	_	PUNCT
aji-33	18	1	_	_	PUNCT
aji-33	19	1	_	_	PUNCT
aji-33	20	1	_	_	PUNCT
aji-33	21	1	_	_	PUNCT
aji-33	22	1	_	_	PUNCT
aji-33	23	1	_	_	PUNCT
aji-33	24	1	_	_	PUNCT
aji-33	25	1	_	_	PUNCT
aji-33	26	1	_	_	PUNCT
aji-33	27	1	_	_	PUNCT
aji-33	28	1	_	_	PUNCT
aji-33	29	1	_	_	PUNCT
aji-33	30	1	_	_	PUNCT
aji-33	31	1	_	_	PUNCT
aji-33	32	1	_	_	PUNCT
aji-33	33	1	_	_	PUNCT
aji-33	34	1	_	_	PUNCT
aji-33	35	1	_	_	PUNCT
aji-33	36	1	_	_	PUNCT
aji-33	37	1	_	_	PUNCT
aji-33	38	1	_	_	PUNCT
aji-33	39	1	_	_	PUNCT
aji-33	40	1	_	_	PUNCT
aji-33	41	1	_	_	PUNCT
aji-33	42	1	_	_	PUNCT
aji-33	43	1	_	_	PUNCT
aji-33	44	1	_	_	PUNCT
aji-33	45	1	_	_	PUNCT
aji-33	46	1	_	_	PUNCT
aji-33	47	1	_	_	PUNCT
aji-33	48	1	_	_	PUNCT
aji-33	49	1	_	_	PUNCT
aji-33	50	1	_	_	PUNCT
aji-33	51	1	_	_	PUNCT
aji-33	52	1	_	_	PUNCT
aji-33	53	1	_	_	PUNCT
aji-33	54	1	_	_	PUNCT
aji-33	55	1	_	_	PUNCT
aji-33	56	1	_	_	PUNCT
aji-33	57	1	_	_	PUNCT
aji-33	58	1	_	_	PUNCT
aji-33	59	1	_	_	PUNCT
aji-33	60	1	_	_	PUNCT
aji-33	61	1	_	_	PUNCT
aji-33	62	1	_	_	PUNCT
aji-33	63	1	_	_	PUNCT
aji-33	64	1	_	_	PUNCT
aji-33	65	1	_	_	PUNCT
aji-33	66	1	_	_	PUNCT
aji-33	67	1	_	_	PUNCT
aji-33	68	1	_	_	PUNCT
aji-33	69	1	_	_	PUNCT
aji-33	70	1	_	_	PUNCT
aji-33	71	1	_	_	PUNCT
aji-33	72	1	_	_	PUNCT
aji-33	73	1	_	_	PUNCT
aji-33	74	1	_	_	PUNCT
aji-33	75	1	_	_	PUNCT
aji-33	76	1	_	_	PUNCT
aji-33	77	1	_	_	PUNCT
aji-33	78	1	_	_	PUNCT
aji-33	79	1	_	_	PUNCT
aji-33	80	1	_	_	PUNCT
aji-33	81	1	_	_	PUNCT
aji-33	82	1	_	_	PUNCT
aji-33	83	1	_	_	PUNCT
aji-33	84	1	_	_	PUNCT
aji-33	85	1	_	_	PUNCT
aji-33	86	1	_	_	PUNCT
aji-33	87	1	_	_	PUNCT
aji-33	88	1	_	_	PUNCT
aji-33	89	1	_	_	PUNCT
aji-33	90	1	_	_	PUNCT
aji-33	91	1	_	_	PUNCT
aji-33	92	1	_	_	PUNCT
aji-33	93	1	_	_	PUNCT
aji-33	94	1	_	_	PUNCT
aji-33	95	1	_	_	PUNCT
aji-33	96	1	_	_	PUNCT
aji-33	97	1	_	_	PUNCT
aji-33	98	1	_	_	PUNCT
aji-33	99	1	_	_	PUNCT
aji-33	100	1	_	_	PUNCT
aji-33	101	1	_	_	PUNCT
aji-33	102	1	*	*	PUNCT
aji-33	102	2	corresponding	correspond	VERB
aji-33	102	3	author	author	NOUN
aji-33	102	4	:	:	PUNCT
aji-33	102	5	e	e	NOUN
aji-33	102	6	-	-	NOUN
aji-33	102	7	mail	mail	NOUN
aji-33	102	8	:	:	PUNCT
aji-33	102	9	drasv@ymail.com	drasv@ymail.com	PROPN
aji-33	102	10	;	;	PUNCT
aji-33	102	11	asian	asian	ADJ
aji-33	102	12	journal	journal	NOUN
aji-33	102	13	of	of	ADP
aji-33	102	14	immunology	immunology	NOUN
aji-33	102	15	3(1	3(1	NUM
aji-33	102	16	):	):	PUNCT
aji-33	102	17	233	233	NUM
aji-33	102	18	-	-	SYM
aji-33	102	19	252	252	NUM
aji-33	102	20	,	,	PUNCT
aji-33	102	21	2020	2020	NUM
aji-33	102	22	;	;	PUNCT
aji-33	102	23	article	article	NOUN
aji-33	102	24	no.aji.58422	no.aji.58422	PROPN
aji-33	102	25	acute	acute	PROPN
aji-33	102	26	immune	immune	ADJ
aji-33	102	27	mediated	mediate	VERB
aji-33	102	28	lung	lung	NOUN
aji-33	102	29	injury	injury	NOUN
aji-33	102	30	in	in	ADP
aji-33	102	31	covid	covid	PROPN
aji-33	102	32	19	19	NUM
aji-33	102	33	:	:	PUNCT
aji-33	102	34	a	a	DET
aji-33	102	35	review	review	NOUN
aji-33	102	36	a.	a.	NOUN
aji-33	102	37	s.	s.	PROPN
aji-33	103	1	v.	v.	ADP
aji-33	103	2	prasad1	prasad1	PROPN
aji-33	103	3	*	*	PROPN
aji-33	103	4	1	1	NUM
aji-33	103	5	department	department	NOUN
aji-33	103	6	of	of	ADP
aji-33	103	7	internal	internal	ADJ
aji-33	103	8	medicine	medicine	NOUN
aji-33	103	9	,	,	PUNCT
aji-33	103	10	gandhi	gandhi	PROPN
aji-33	103	11	institute	institute	PROPN
aji-33	103	12	of	of	ADP
aji-33	103	13	technology	technology	PROPN
aji-33	103	14	and	and	CCONJ
aji-33	103	15	management	management	NOUN
aji-33	103	16	,	,	PUNCT
aji-33	103	17	rishikonda	rishikonda	PROPN
aji-33	103	18	,	,	PUNCT
aji-33	103	19	visakhapatnam	visakhapatnam	PROPN
aji-33	103	20	,	,	PUNCT
aji-33	103	21	india	india	PROPN
aji-33	103	22	.	.	PUNCT
aji-33	104	1	author	author	PROPN
aji-33	104	2	’s	’s	PART
aji-33	104	3	contribution	contribution	NOUN
aji-33	104	4	the	the	DET
aji-33	104	5	sole	sole	ADJ
aji-33	104	6	author	author	NOUN
aji-33	104	7	designed	design	VERB
aji-33	104	8	,	,	PUNCT
aji-33	104	9	analysed	analyse	VERB
aji-33	104	10	,	,	PUNCT
aji-33	104	11	interpreted	interpret	VERB
aji-33	104	12	and	and	CCONJ
aji-33	104	13	prepared	prepare	VERB
aji-33	104	14	the	the	DET
aji-33	104	15	manuscript	manuscript	NOUN
aji-33	104	16	.	.	PUNCT
aji-33	105	1	article	article	NOUN
aji-33	105	2	information	information	PROPN
aji-33	105	3	editor(s	editor(s	PROPN
aji-33	105	4	):	):	PUNCT
aji-33	105	5	(	(	PUNCT
aji-33	105	6	1	1	X
aji-33	105	7	)	)	PUNCT
aji-33	105	8	dr	dr	PROPN
aji-33	105	9	.	.	PROPN
aji-33	105	10	cynthia	cynthia	PROPN
aji-33	105	11	aracely	aracely	ADV
aji-33	105	12	alvizo	alvizo	VERB
aji-33	105	13	báez	báez	ADJ
aji-33	105	14	,	,	PUNCT
aji-33	105	15	autonomous	autonomous	ADJ
aji-33	105	16	university	university	PROPN
aji-33	105	17	of	of	ADP
aji-33	105	18	nuevo	nuevo	PROPN
aji-33	105	19	leon	leon	PROPN
aji-33	105	20	,	,	PUNCT
aji-33	105	21	mexico	mexico	PROPN
aji-33	105	22	.	.	PUNCT
aji-33	106	1	reviewers	reviewer	NOUN
aji-33	106	2	:	:	PUNCT
aji-33	106	3	(	(	PUNCT
aji-33	106	4	1	1	X
aji-33	106	5	)	)	PUNCT
aji-33	106	6	ritika	ritika	X
aji-33	106	7	gupta	gupta	PROPN
aji-33	106	8	,	,	PUNCT
aji-33	106	9	india	india	PROPN
aji-33	106	10	.	.	PUNCT
aji-33	107	1	(	(	PUNCT
aji-33	107	2	2	2	X
aji-33	107	3	)	)	PUNCT
aji-33	107	4	abioye	abioye	NOUN
aji-33	107	5	,	,	PUNCT
aji-33	107	6	adesoye	adesoye	NOUN
aji-33	107	7	idowu	idowu	NOUN
aji-33	107	8	,	,	PUNCT
aji-33	107	9	university	university	NOUN
aji-33	107	10	of	of	ADP
aji-33	107	11	ilorin	ilorin	PROPN
aji-33	107	12	,	,	PUNCT
aji-33	107	13	nigeria	nigeria	PROPN
aji-33	107	14	.	.	PUNCT
aji-33	108	1	complete	complete	ADJ
aji-33	108	2	peer	peer	NOUN
aji-33	108	3	review	review	NOUN
aji-33	108	4	history	history	NOUN
aji-33	108	5	:	:	PUNCT
aji-33	108	6	http://www.sdiarticle4.com/review-history/58422	http://www.sdiarticle4.com/review-history/58422	AUX
aji-33	108	7	received	receive	VERB
aji-33	108	8	01	01	NUM
aji-33	108	9	june	june	PROPN
aji-33	108	10	2020	2020	NUM
aji-33	108	11	accepted	accept	VERB
aji-33	108	12	16	16	NUM
aji-33	108	13	june	june	PROPN
aji-33	108	14	2020	2020	NUM
aji-33	108	15	published	publish	VERB
aji-33	108	16	23	23	NUM
aji-33	108	17	june	june	PROPN
aji-33	108	18	2020	2020	NUM
aji-33	108	19	abstract	abstract	ADV
aji-33	108	20	there	there	PRON
aji-33	108	21	are	be	VERB
aji-33	108	22	many	many	ADJ
aji-33	108	23	gaps	gap	NOUN
aji-33	108	24	in	in	ADP
aji-33	108	25	our	our	PRON
aji-33	108	26	present	present	ADJ
aji-33	108	27	understanding	understanding	NOUN
aji-33	108	28	of	of	ADP
aji-33	108	29	the	the	PRON
aji-33	108	30	of	of	ADP
aji-33	108	31	the	the	DET
aji-33	108	32	sars	sars	PROPN
aji-33	108	33	cov	cov	PROPN
aji-33	108	34	2	2	NUM
aji-33	108	35	related	relate	VERB
aji-33	108	36	matters	matter	NOUN
aji-33	108	37	like	like	ADP
aji-33	108	38	its	its	PRON
aji-33	108	39	pamps,(pathogen	pamps,(pathogen	PROPN
aji-33	108	40	associated	associate	VERB
aji-33	108	41	molecular	molecular	ADJ
aji-33	108	42	patterns),antigenic	patterns),antigenic	ADJ
aji-33	108	43	profile	profile	NOUN
aji-33	108	44	,	,	PUNCT
aji-33	108	45	immune	immune	ADJ
aji-33	108	46	evasive	evasive	ADJ
aji-33	108	47	mechanisms	mechanism	NOUN
aji-33	108	48	and	and	CCONJ
aji-33	108	49	also	also	ADV
aji-33	108	50	other	other	ADJ
aji-33	108	51	host	host	NOUN
aji-33	108	52	related	relate	VERB
aji-33	108	53	matters	matter	NOUN
aji-33	108	54	,	,	PUNCT
aji-33	108	55	like	like	ADP
aji-33	108	56	prr	prr	NOUN
aji-33	108	57	s(pattern	s(pattern	ADJ
aji-33	108	58	recognizing	recognize	VERB
aji-33	108	59	receptors	receptor	NOUN
aji-33	108	60	)	)	PUNCT
aji-33	108	61	and	and	CCONJ
aji-33	108	62	the	the	DET
aji-33	108	63	deranged	derange	VERB
aji-33	108	64	host	host	NOUN
aji-33	108	65	defense	defense	NOUN
aji-33	108	66	mechanisms	mechanism	NOUN
aji-33	108	67	,	,	PUNCT
aji-33	108	68	that	that	PRON
aji-33	108	69	cause	cause	VERB
aji-33	108	70	self	self	NOUN
aji-33	108	71	-	-	PUNCT
aji-33	108	72	damage	damage	NOUN
aji-33	108	73	.	.	PUNCT
aji-33	109	1	these	these	DET
aji-33	109	2	constraints	constraint	NOUN
aji-33	109	3	come	come	VERB
aji-33	109	4	in	in	ADP
aji-33	109	5	way	way	NOUN
aji-33	109	6	of	of	ADP
aji-33	109	7	accurately	accurately	ADV
aji-33	109	8	delineating	delineate	VERB
aji-33	109	9	the	the	DET
aji-33	109	10	pathogenesis	pathogenesis	NOUN
aji-33	109	11	of	of	ADP
aji-33	109	12	covid19	covid19	NOUN
aji-33	109	13	lung	lung	NOUN
aji-33	109	14	disease	disease	NOUN
aji-33	109	15	.	.	PUNCT
aji-33	110	1	hence	hence	ADV
aji-33	110	2	is	be	AUX
aji-33	110	3	the	the	DET
aji-33	110	4	speculative	speculative	ADJ
aji-33	110	5	nature	nature	NOUN
aji-33	110	6	of	of	ADP
aji-33	110	7	any	any	DET
aji-33	110	8	concept	concept	NOUN
aji-33	110	9	trying	try	VERB
aji-33	110	10	to	to	PART
aji-33	110	11	explain	explain	VERB
aji-33	110	12	the	the	DET
aji-33	110	13	same	same	ADJ
aji-33	110	14	.	.	PUNCT
aji-33	111	1	an	an	DET
aji-33	111	2	integrated	integrate	VERB
aji-33	111	3	approach	approach	NOUN
aji-33	111	4	is	be	AUX
aji-33	111	5	embarked	embark	VERB
aji-33	111	6	upon	upon	SCONJ
aji-33	111	7	,	,	PUNCT
aji-33	111	8	taking	take	VERB
aji-33	111	9	into	into	ADP
aji-33	111	10	account	account	NOUN
aji-33	111	11	the	the	DET
aji-33	111	12	known	know	VERB
aji-33	111	13	clinical	clinical	ADJ
aji-33	111	14	,	,	PUNCT
aji-33	111	15	radiological	radiological	ADJ
aji-33	111	16	,	,	PUNCT
aji-33	111	17	laboratory	laboratory	NOUN
aji-33	111	18	,	,	PUNCT
aji-33	111	19	and	and	CCONJ
aji-33	111	20	autopsy	autopsy	ADJ
aji-33	111	21	findings	finding	NOUN
aji-33	111	22	,	,	PUNCT
aji-33	111	23	in	in	ADP
aji-33	111	24	search	search	NOUN
aji-33	111	25	of	of	ADP
aji-33	111	26	clues	clue	NOUN
aji-33	111	27	that	that	PRON
aji-33	111	28	may	may	AUX
aji-33	111	29	suggest	suggest	VERB
aji-33	111	30	a	a	DET
aji-33	111	31	possible	possible	ADJ
aji-33	111	32	mechanism	mechanism	NOUN
aji-33	111	33	,	,	PUNCT
aji-33	111	34	that	that	PRON
aji-33	111	35	explains	explain	VERB
aji-33	111	36	the	the	DET
aji-33	111	37	underlying	underlie	VERB
aji-33	111	38	lung	lung	NOUN
aji-33	111	39	damage	damage	NOUN
aji-33	111	40	in	in	ADP
aji-33	111	41	covid	covid	PROPN
aji-33	111	42	19	19	NUM
aji-33	111	43	.	.	PUNCT
aji-33	112	1	it	it	PRON
aji-33	112	2	is	be	AUX
aji-33	112	3	seen	see	VERB
aji-33	112	4	that	that	SCONJ
aji-33	112	5	no	no	DET
aji-33	112	6	single	single	ADJ
aji-33	112	7	mechanism	mechanism	NOUN
aji-33	112	8	or	or	CCONJ
aji-33	112	9	syndrome	syndrome	NOUN
aji-33	112	10	could	could	AUX
aji-33	112	11	explain	explain	VERB
aji-33	112	12	fully	fully	ADV
aji-33	112	13	the	the	DET
aji-33	112	14	pathology	pathology	NOUN
aji-33	112	15	and	and	CCONJ
aji-33	112	16	pathogenesis	pathogenesis	NOUN
aji-33	112	17	of	of	ADP
aji-33	112	18	lung	lung	NOUN
aji-33	112	19	damage	damage	NOUN
aji-33	112	20	in	in	ADP
aji-33	112	21	covid19	covid19	NOUN
aji-33	112	22	.	.	PUNCT
aji-33	113	1	hence	hence	ADV
aji-33	113	2	,	,	PUNCT
aji-33	113	3	multiple	multiple	ADJ
aji-33	113	4	mechanisms	mechanism	NOUN
aji-33	113	5	consistent	consistent	ADJ
aji-33	113	6	with	with	ADP
aji-33	113	7	each	each	DET
aji-33	113	8	known	know	VERB
aji-33	113	9	facet	facet	NOUN
aji-33	113	10	of	of	ADP
aji-33	113	11	the	the	DET
aji-33	113	12	pathology	pathology	NOUN
aji-33	113	13	are	be	AUX
aji-33	113	14	explored	explore	VERB
aji-33	113	15	.	.	PUNCT
aji-33	114	1	thus	thus	ADV
aji-33	114	2	the	the	DET
aji-33	114	3	inflammatory	inflammatory	ADJ
aji-33	114	4	damage	damage	NOUN
aji-33	114	5	of	of	ADP
aji-33	114	6	the	the	DET
aji-33	114	7	alveolar	alveolar	ADJ
aji-33	114	8	tissue	tissue	NOUN
aji-33	114	9	is	be	AUX
aji-33	114	10	sought	seek	VERB
aji-33	114	11	to	to	PART
aji-33	114	12	be	be	AUX
aji-33	114	13	explained	explain	VERB
aji-33	114	14	by	by	ADP
aji-33	114	15	the3	the3	NOUN
aji-33	114	16	complement	complement	NOUN
aji-33	114	17	activation	activation	NOUN
aji-33	114	18	pathways	pathway	NOUN
aji-33	114	19	i.e.	i.e.	X
aji-33	114	20	the	the	DET
aji-33	114	21	alternative	alternative	ADJ
aji-33	114	22	pathway	pathway	NOUN
aji-33	114	23	,	,	PUNCT
aji-33	114	24	the	the	DET
aji-33	114	25	mbl	mbl	PROPN
aji-33	114	26	/	/	SYM
aji-33	114	27	lectin	lectin	NOUN
aji-33	114	28	pathway/	pathway/	NUM
aji-33	114	29	and	and	CCONJ
aji-33	114	30	tissue	tissue	NOUN
aji-33	114	31	factor	factor	NOUN
aji-33	114	32	/	/	SYM
aji-33	114	33	extrinsic	extrinsic	ADJ
aji-33	114	34	pathway(of	pathway(of	NOUN
aji-33	114	35	the	the	DET
aji-33	114	36	classical	classical	ADJ
aji-33	114	37	complement	complement	NOUN
aji-33	114	38	activation	activation	NOUN
aji-33	114	39	)	)	PUNCT
aji-33	114	40	,	,	PUNCT
aji-33	114	41	the	the	DET
aji-33	114	42	contact	contact	NOUN
aji-33	114	43	cascade	cascade	NOUN
aji-33	114	44	involving	involve	VERB
aji-33	114	45	the	the	DET
aji-33	114	46	kallikrein	kallikrein	NOUN
aji-33	114	47	-	-	PUNCT
aji-33	114	48	kinin	kinin	ADJ
aji-33	114	49	pathway	pathway	NOUN
aji-33	114	50	,	,	PUNCT
aji-33	114	51	and	and	CCONJ
aji-33	114	52	the	the	DET
aji-33	114	53	cytokine	cytokine	NOUN
aji-33	114	54	mediated	mediate	VERB
aji-33	114	55	pro	pro	ADJ
aji-33	114	56	and	and	CCONJ
aji-33	114	57	anti	anti	ADJ
aji-33	114	58	inflammatory	inflammatory	ADJ
aji-33	114	59	mechanisms	mechanism	NOUN
aji-33	114	60	.	.	PUNCT
aji-33	115	1	the	the	DET
aji-33	115	2	vascular	vascular	ADJ
aji-33	115	3	pathology	pathology	NOUN
aji-33	115	4	like	like	ADP
aji-33	115	5	hemorrhages	hemorrhage	NOUN
aji-33	115	6	and	and	CCONJ
aji-33	115	7	small	small	ADJ
aji-33	115	8	blood	blood	NOUN
aji-33	115	9	vessel	vessel	NOUN
aji-33	115	10	micro	micro	NOUN
aji-33	115	11	-	-	NOUN
aji-33	115	12	thrombi	thrombi	NOUN
aji-33	115	13	as	as	SCONJ
aji-33	115	14	observed	observe	VERB
aji-33	115	15	at	at	ADP
aji-33	115	16	autopsy	autopsy	ADJ
aji-33	115	17	,	,	PUNCT
aji-33	115	18	are	be	AUX
aji-33	115	19	viewed	view	VERB
aji-33	115	20	from	from	ADP
aji-33	115	21	the	the	DET
aji-33	115	22	point	point	NOUN
aji-33	115	23	of	of	ADP
aji-33	115	24	view	view	NOUN
aji-33	115	25	of	of	ADP
aji-33	115	26	simple	simple	ADJ
aji-33	115	27	activation	activation	NOUN
aji-33	115	28	of	of	ADP
aji-33	115	29	the	the	DET
aji-33	115	30	coagulation	coagulation	NOUN
aji-33	115	31	cascade	cascade	NOUN
aji-33	115	32	to	to	ADP
aji-33	115	33	small	small	ADJ
aji-33	115	34	vessel	vessel	NOUN
aji-33	115	35	vasculitis	vasculitis	PROPN
aji-33	115	36	(	(	PUNCT
aji-33	115	37	leucocytoclastic	leucocytoclastic	ADJ
aji-33	115	38	vasculitis	vasculitis	PROPN
aji-33	115	39	)	)	PUNCT
aji-33	115	40	and	and	CCONJ
aji-33	115	41	coagulative	coagulative	NOUN
aji-33	115	42	micro	micro	ADJ
aji-33	115	43	angiopathy	angiopathy	ADJ
aji-33	115	44	.	.	PUNCT
aji-33	116	1	besides	besides	SCONJ
aji-33	116	2	,	,	PUNCT
aji-33	116	3	the	the	DET
aji-33	116	4	role	role	NOUN
aji-33	116	5	of	of	ADP
aji-33	116	6	tm	tm	NOUN
aji-33	116	7	-	-	ADJ
aji-33	116	8	pc	pc	NOUN
aji-33	116	9	-	-	PUNCT
aji-33	116	10	epcr	epcr	ADJ
aji-33	116	11	system	system	NOUN
aji-33	116	12	(	(	PUNCT
aji-33	116	13	thrombomodulin	thrombomodulin	NOUN
aji-33	116	14	-	-	PUNCT
aji-33	116	15	protein	protein	NOUN
aji-33	116	16	c	c	NOUN
aji-33	116	17	-	-	PUNCT
aji-33	116	18	epcr	epcr	ADJ
aji-33	116	19	system	system	NOUN
aji-33	116	20	)	)	PUNCT
aji-33	116	21	is	be	AUX
aji-33	116	22	explored	explore	VERB
aji-33	116	23	.	.	PUNCT
aji-33	117	1	the	the	DET
aji-33	117	2	points	point	NOUN
aji-33	117	3	in	in	ADP
aji-33	117	4	favour	favour	NOUN
aji-33	117	5	and	and	CCONJ
aji-33	117	6	against	against	ADP
aji-33	117	7	of	of	ADP
aji-33	117	8	each	each	PRON
aji-33	117	9	of	of	ADP
aji-33	117	10	the	the	DET
aji-33	117	11	above	above	ADJ
aji-33	117	12	are	be	AUX
aji-33	117	13	discussed.the	discussed.the	DET
aji-33	117	14	central	central	ADJ
aji-33	117	15	role	role	NOUN
aji-33	117	16	played	play	VERB
aji-33	117	17	by	by	ADP
aji-33	117	18	the	the	DET
aji-33	117	19	macrophage	macrophage	ADJ
aji-33	117	20	polymorphism	polymorphism	NOUN
aji-33	117	21	is	be	AUX
aji-33	117	22	focused	focus	VERB
aji-33	117	23	in	in	ADP
aji-33	117	24	the	the	DET
aji-33	117	25	context	context	NOUN
aji-33	117	26	of	of	ADP
aji-33	117	27	the	the	DET
aji-33	117	28	simultaneous	simultaneous	ADJ
aji-33	117	29	presence	presence	NOUN
aji-33	117	30	of	of	ADP
aji-33	117	31	review	review	NOUN
aji-33	117	32	article	article	NOUN
aji-33	117	33	prasad	prasad	PROPN
aji-33	117	34	;	;	PUNCT
aji-33	117	35	aji	aji	NOUN
aji-33	117	36	,	,	PUNCT
aji-33	117	37	3(1	3(1	NUM
aji-33	117	38	):	):	PUNCT
aji-33	117	39	233	233	NUM
aji-33	117	40	-	-	SYM
aji-33	117	41	252	252	NUM
aji-33	117	42	,	,	PUNCT
aji-33	117	43	2020	2020	NUM
aji-33	117	44	;	;	PUNCT
aji-33	117	45	article	article	NOUN
aji-33	117	46	no.aji.58422	no.aji.58422	NOUN
aji-33	117	47	234	234	NUM
aji-33	117	48	active	active	ADJ
aji-33	117	49	inflammation	inflammation	NOUN
aji-33	117	50	in	in	ADP
aji-33	117	51	the	the	DET
aji-33	117	52	lung	lung	NOUN
aji-33	117	53	tissue	tissue	NOUN
aji-33	117	54	and	and	CCONJ
aji-33	117	55	the	the	DET
aji-33	117	56	interstetium	interstetium	NOUN
aji-33	117	57	and	and	CCONJ
aji-33	117	58	healing	healing	NOUN
aji-33	117	59	by	by	ADP
aji-33	117	60	interstitial	interstitial	ADJ
aji-33	117	61	fibrosis	fibrosis	NOUN
aji-33	117	62	,	,	PUNCT
aji-33	117	63	seen	see	VERB
aji-33	117	64	in	in	ADP
aji-33	117	65	the	the	DET
aji-33	117	66	lungs	lung	NOUN
aji-33	117	67	of	of	ADP
aji-33	117	68	covid	covid	NOUN
aji-33	117	69	19	19	NUM
aji-33	117	70	patients	patient	NOUN
aji-33	117	71	.	.	PUNCT
aji-33	118	1	the	the	DET
aji-33	118	2	role	role	NOUN
aji-33	118	3	played	play	VERB
aji-33	118	4	by	by	ADP
aji-33	118	5	the	the	DET
aji-33	118	6	other	other	ADJ
aji-33	118	7	humoral	humoral	ADJ
aji-33	118	8	and	and	CCONJ
aji-33	118	9	cellular	cellular	ADJ
aji-33	118	10	elements	element	NOUN
aji-33	118	11	of	of	ADP
aji-33	118	12	both	both	CCONJ
aji-33	118	13	innate	innate	ADJ
aji-33	118	14	and	and	CCONJ
aji-33	118	15	adaptive	adaptive	ADJ
aji-33	118	16	immunity	immunity	NOUN
aji-33	118	17	is	be	AUX
aji-33	118	18	briefly	briefly	ADV
aji-33	118	19	reviewed	review	VERB
aji-33	118	20	.	.	PUNCT
aji-33	119	1	the	the	DET
aji-33	119	2	uniqueness	uniqueness	NOUN
aji-33	119	3	and	and	CCONJ
aji-33	119	4	diversified	diversified	ADJ
aji-33	119	5	features	feature	NOUN
aji-33	119	6	of	of	ADP
aji-33	119	7	covid	covid	PROPN
aji-33	119	8	19	19	NUM
aji-33	119	9	lung	lung	NOUN
aji-33	119	10	pathology	pathology	NOUN
aji-33	119	11	,	,	PUNCT
aji-33	119	12	suggests	suggest	VERB
aji-33	119	13	two	two	NUM
aji-33	119	14	things	thing	NOUN
aji-33	119	15	that	that	PRON
aji-33	119	16	the	the	DET
aji-33	119	17	immune	immune	ADJ
aji-33	119	18	mediated	mediate	VERB
aji-33	119	19	damage	damage	NOUN
aji-33	119	20	seems	seem	VERB
aji-33	119	21	more	more	ADV
aji-33	119	22	probable	probable	ADJ
aji-33	119	23	than	than	SCONJ
aji-33	119	24	could	could	AUX
aji-33	119	25	be	be	AUX
aji-33	119	26	explained	explain	VERB
aji-33	119	27	by	by	ADP
aji-33	119	28	the	the	DET
aji-33	119	29	viral	viral	ADJ
aji-33	119	30	infectivity	infectivity	NOUN
aji-33	119	31	and	and	CCONJ
aji-33	119	32	that	that	SCONJ
aji-33	119	33	the	the	DET
aji-33	119	34	pathology	pathology	NOUN
aji-33	119	35	seems	seem	VERB
aji-33	119	36	to	to	PART
aji-33	119	37	stem	stem	VERB
aji-33	119	38	from	from	ADP
aji-33	119	39	a	a	DET
aji-33	119	40	mixture	mixture	NOUN
aji-33	119	41	of	of	ADP
aji-33	119	42	different	different	ADJ
aji-33	119	43	underlying	underlying	ADJ
aji-33	119	44	and	and	CCONJ
aji-33	119	45	overlapping	overlap	VERB
aji-33	119	46	syndromes	syndrome	NOUN
aji-33	119	47	.	.	PUNCT
aji-33	120	1	hence	hence	ADV
aji-33	120	2	,	,	PUNCT
aji-33	120	3	the	the	DET
aji-33	120	4	author	author	NOUN
aji-33	120	5	prefers	prefer	VERB
aji-33	120	6	to	to	PART
aji-33	120	7	call	call	VERB
aji-33	120	8	all	all	DET
aji-33	120	9	the	the	DET
aji-33	120	10	covid	covid	PROPN
aji-33	120	11	19	19	NUM
aji-33	120	12	related	relate	VERB
aji-33	120	13	features	feature	NOUN
aji-33	120	14	of	of	ADP
aji-33	120	15	lung	lung	NOUN
aji-33	120	16	pathology	pathology	NOUN
aji-33	120	17	as	as	ADP
aji-33	120	18	“	"	PUNCT
aji-33	120	19	acute	acute	ADJ
aji-33	120	20	immune	immune	ADJ
aji-33	120	21	mediated	mediate	VERB
aji-33	120	22	lung	lung	NOUN
aji-33	120	23	injury	injury	NOUN
aji-33	120	24	"	"	PUNCT
aji-33	120	25	.	.	PUNCT
aji-33	121	1	(	(	PUNCT
aji-33	121	2	aili	aili	NOUN
aji-33	121	3	)	)	PUNCT
aji-33	121	4	than	than	ADP
aji-33	121	5	trying	try	VERB
aji-33	121	6	to	to	PART
aji-33	121	7	bunch	bunch	VERB
aji-33	121	8	them	they	PRON
aji-33	121	9	under	under	ADP
aji-33	121	10	a	a	DET
aji-33	121	11	single	single	ADJ
aji-33	121	12	syndrome	syndrome	NOUN
aji-33	121	13	.	.	PUNCT
aji-33	122	1	keywords	keyword	NOUN
aji-33	122	2	:	:	PUNCT
aji-33	122	3	pathogen	pathogen	VERB
aji-33	122	4	associated	associated	ADJ
aji-33	122	5	proteins	protein	NOUN
aji-33	122	6	(	(	PUNCT
aji-33	122	7	pamps	pamp	NOUN
aji-33	122	8	)	)	PUNCT
aji-33	122	9	;	;	PUNCT
aji-33	122	10	pathogen	pathogen	VERB
aji-33	122	11	recognizing	recognize	VERB
aji-33	122	12	receptors	receptor	NOUN
aji-33	122	13	(	(	PUNCT
aji-33	122	14	prrs	prr	NOUN
aji-33	122	15	)	)	PUNCT
aji-33	122	16	complement	complement	NOUN
aji-33	122	17	;	;	PUNCT
aji-33	122	18	cytokines	cytokine	NOUN
aji-33	122	19	;	;	PUNCT
aji-33	122	20	phagocytosis	phagocytosis	NOUN
aji-33	122	21	;	;	PUNCT
aji-33	122	22	antibody	antibody	NOUN
aji-33	122	23	;	;	PUNCT
aji-33	122	24	ards	ard	NOUN
aji-33	122	25	;	;	PUNCT
aji-33	122	26	immune	immune	ADJ
aji-33	122	27	evasion	evasion	NOUN
aji-33	122	28	;	;	PUNCT
aji-33	122	29	capillaritis	capillaritis	PROPN
aji-33	122	30	;	;	PUNCT
aji-33	122	31	microangiopathy	microangiopathy	ADJ
aji-33	122	32	.	.	PUNCT
aji-33	123	1	1	1	X
aji-33	123	2	.	.	X
aji-33	123	3	introduction	introduction	NOUN
aji-33	123	4	the	the	DET
aji-33	123	5	lung	lung	NOUN
aji-33	123	6	pathology	pathology	NOUN
aji-33	123	7	and	and	CCONJ
aji-33	123	8	pathogenesis	pathogenesis	NOUN
aji-33	123	9	of	of	ADP
aji-33	123	10	covid	covid	PROPN
aji-33	123	11	19	19	NUM
aji-33	123	12	,	,	PUNCT
aji-33	123	13	is	be	AUX
aji-33	123	14	elusive	elusive	ADJ
aji-33	123	15	and	and	CCONJ
aji-33	123	16	hence	hence	ADV
aji-33	123	17	remained	remain	VERB
aji-33	123	18	speculative	speculative	ADJ
aji-33	123	19	,	,	PUNCT
aji-33	123	20	till	till	SCONJ
aji-33	123	21	date	date	NOUN
aji-33	123	22	.	.	PUNCT
aji-33	124	1	described	describe	VERB
aji-33	124	2	originally	originally	ADV
aji-33	124	3	as	as	ADP
aji-33	124	4	a	a	DET
aji-33	124	5	‘	'	PUNCT
aji-33	124	6	pneumonialike	pneumonialike	ADJ
aji-33	124	7	’	'	PUNCT
aji-33	124	8	condition	condition	NOUN
aji-33	124	9	,	,	PUNCT
aji-33	124	10	similar	similar	ADJ
aji-33	124	11	to	to	ADP
aji-33	124	12	one	one	NUM
aji-33	124	13	caused	cause	VERB
aji-33	124	14	by	by	ADP
aji-33	124	15	sars	sar	NOUN
aji-33	124	16	cov	cov	PROPN
aji-33	124	17	1	1	NUM
aji-33	124	18	(	(	PUNCT
aji-33	124	19	2003	2003	NUM
aji-33	124	20	)	)	PUNCT
aji-33	124	21	and	and	CCONJ
aji-33	124	22	mers	mers	PROPN
aji-33	124	23	cov	cov	PROPN
aji-33	124	24	,	,	PUNCT
aji-33	124	25	(	(	PUNCT
aji-33	124	26	2011	2011	NUM
aji-33	124	27	)	)	PUNCT
aji-33	124	28	,	,	PUNCT
aji-33	124	29	which	which	PRON
aji-33	124	30	are	be	AUX
aji-33	124	31	members	member	NOUN
aji-33	124	32	of	of	ADP
aji-33	124	33	the	the	DET
aji-33	124	34	same	same	ADJ
aji-33	124	35	family	family	NOUN
aji-33	124	36	of	of	ADP
aji-33	124	37	corona	corona	PROPN
aji-33	124	38	virus	virus	NOUN
aji-33	124	39	.	.	PUNCT
aji-33	125	1	the	the	DET
aji-33	125	2	former	former	ADJ
aji-33	125	3	was	be	AUX
aji-33	125	4	less	less	ADV
aji-33	125	5	severe	severe	ADJ
aji-33	125	6	but	but	CCONJ
aji-33	125	7	caused	cause	VERB
aji-33	125	8	pandemic	pandemic	ADJ
aji-33	125	9	and	and	CCONJ
aji-33	125	10	the	the	DET
aji-33	125	11	later	later	NOUN
aji-33	125	12	was	be	AUX
aji-33	125	13	34	34	NUM
aji-33	125	14	%	%	NOUN
aji-33	125	15	more	more	ADV
aji-33	125	16	severe	severe	ADJ
aji-33	125	17	,	,	PUNCT
aji-33	125	18	mortality	mortality	NOUN
aji-33	125	19	-	-	PUNCT
aji-33	125	20	wise	wise	ADJ
aji-33	125	21	,	,	PUNCT
aji-33	125	22	but	but	CCONJ
aji-33	125	23	remained	remain	VERB
aji-33	125	24	confined	confine	VERB
aji-33	125	25	to	to	ADP
aji-33	125	26	middle	middle	PROPN
aji-33	125	27	east	east	PROPN
aji-33	125	28	mostly	mostly	ADV
aji-33	125	29	.	.	PUNCT
aji-33	126	1	the	the	DET
aji-33	126	2	covid	covid	PROPN
aji-33	126	3	19	19	NUM
aji-33	126	4	,	,	PUNCT
aji-33	126	5	thus	thus	ADV
aji-33	126	6	resembled	resemble	VERB
aji-33	126	7	more	more	ADJ
aji-33	126	8	of	of	ADP
aji-33	126	9	sars	sars	PROPN
aji-33	126	10	1	1	NUM
aji-33	126	11	and	and	CCONJ
aji-33	126	12	hence	hence	ADV
aji-33	126	13	the	the	DET
aji-33	126	14	virus	virus	NOUN
aji-33	126	15	is	be	AUX
aji-33	126	16	named	name	VERB
aji-33	126	17	sars	sar	NOUN
aji-33	126	18	cov	cov	PROPN
aji-33	126	19	2	2	NUM
aji-33	126	20	.	.	PUNCT
aji-33	127	1	in	in	ADP
aji-33	127	2	due	due	ADJ
aji-33	127	3	course	course	NOUN
aji-33	127	4	of	of	ADP
aji-33	127	5	time	time	NOUN
aji-33	127	6	,	,	PUNCT
aji-33	127	7	the	the	DET
aji-33	127	8	postscript	postscript	NOUN
aji-33	127	9	,	,	PUNCT
aji-33	127	10	‘	'	PUNCT
aji-33	127	11	like	like	INTJ
aji-33	127	12	’	'	PUNCT
aji-33	127	13	is	be	AUX
aji-33	127	14	dropped	drop	VERB
aji-33	127	15	and	and	CCONJ
aji-33	127	16	the	the	DET
aji-33	127	17	syndrome	syndrome	NOUN
aji-33	127	18	has	have	AUX
aji-33	127	19	come	come	VERB
aji-33	127	20	to	to	PART
aji-33	127	21	be	be	AUX
aji-33	127	22	called	call	VERB
aji-33	127	23	‘	'	PUNCT
aji-33	127	24	covid	covid	PROPN
aji-33	127	25	19	19	NUM
aji-33	127	26	pneumonia	pneumonia	NOUN
aji-33	127	27	’	'	PUNCT
aji-33	127	28	,	,	PUNCT
aji-33	127	29	contrary	contrary	ADV
aji-33	127	30	to	to	ADP
aji-33	127	31	the	the	DET
aji-33	127	32	facts	fact	NOUN
aji-33	127	33	.	.	PUNCT
aji-33	128	1	the	the	DET
aji-33	128	2	opinions	opinion	NOUN
aji-33	128	3	as	as	ADP
aji-33	128	4	to	to	ADP
aji-33	128	5	the	the	DET
aji-33	128	6	cause	cause	NOUN
aji-33	128	7	of	of	ADP
aji-33	128	8	covid	covid	PROPN
aji-33	128	9	19	19	NUM
aji-33	128	10	induced	induced	ADJ
aji-33	128	11	lung	lung	NOUN
aji-33	128	12	damage	damage	NOUN
aji-33	128	13	varied	varied	ADJ
aji-33	128	14	from	from	ADP
aji-33	128	15	ards	ard	NOUN
aji-33	128	16	,	,	PUNCT
aji-33	128	17	shlh	shlh	NOUN
aji-33	128	18	(	(	PUNCT
aji-33	128	19	secondary	secondary	ADJ
aji-33	128	20	hemophagocytic	hemophagocytic	ADJ
aji-33	128	21	lymphohistiocytosis	lymphohistiocytosis	NOUN
aji-33	128	22	)	)	PUNCT
aji-33	128	23	and	and	CCONJ
aji-33	128	24	cytokine	cytokine	VERB
aji-33	128	25	storm	storm	NOUN
aji-33	128	26	from	from	ADP
aji-33	128	27	the	the	DET
aji-33	128	28	clinical	clinical	ADJ
aji-33	128	29	point	point	NOUN
aji-33	128	30	of	of	ADP
aji-33	128	31	view	view	NOUN
aji-33	128	32	and	and	CCONJ
aji-33	128	33	‘	'	PUNCT
aji-33	128	34	interstitial	interstitial	ADJ
aji-33	128	35	pneumonia	pneumonia	NOUN
aji-33	128	36	’	'	PUNCT
aji-33	128	37	from	from	ADP
aji-33	128	38	radiological	radiological	ADJ
aji-33	128	39	point	point	NOUN
aji-33	128	40	of	of	ADP
aji-33	128	41	view	view	NOUN
aji-33	128	42	.	.	PUNCT
aji-33	129	1	the	the	DET
aji-33	129	2	autopsy	autopsy	ADJ
aji-33	129	3	findings	finding	NOUN
aji-33	129	4	raise	raise	VERB
aji-33	129	5	suspicion	suspicion	NOUN
aji-33	129	6	of	of	ADP
aji-33	129	7	capillarites	capillarite	NOUN
aji-33	129	8	(	(	PUNCT
aji-33	129	9	small	small	ADJ
aji-33	129	10	blood	blood	NOUN
aji-33	129	11	vessel	vessel	NOUN
aji-33	129	12	vasculitis	vasculitis	PROPN
aji-33	129	13	)	)	PUNCT
aji-33	129	14	to	to	PART
aji-33	129	15	coagulative	coagulative	VERB
aji-33	129	16	microangiopathy	microangiopathy	PROPN
aji-33	129	17	.	.	PUNCT
aji-33	130	1	it	it	PRON
aji-33	130	2	is	be	AUX
aji-33	130	3	felt	feel	VERB
aji-33	130	4	that	that	SCONJ
aji-33	130	5	the	the	DET
aji-33	130	6	clinical	clinical	ADJ
aji-33	130	7	as	as	ADV
aji-33	130	8	well	well	ADV
aji-33	130	9	as	as	ADP
aji-33	130	10	laboratory	laboratory	NOUN
aji-33	130	11	,	,	PUNCT
aji-33	130	12	radiological	radiological	ADJ
aji-33	130	13	and	and	CCONJ
aji-33	130	14	autopsy	autopsy	ADJ
aji-33	130	15	data	datum	NOUN
aji-33	130	16	if	if	SCONJ
aji-33	130	17	taken	take	VERB
aji-33	130	18	together	together	ADV
aji-33	130	19	sheds	shed	VERB
aji-33	130	20	some	some	DET
aji-33	130	21	light	light	NOUN
aji-33	130	22	as	as	ADP
aji-33	130	23	to	to	ADP
aji-33	130	24	the	the	DET
aji-33	130	25	exact	exact	ADJ
aji-33	130	26	lung	lung	NOUN
aji-33	130	27	pathology	pathology	NOUN
aji-33	130	28	and	and	CCONJ
aji-33	130	29	pathogenesis	pathogenesis	NOUN
aji-33	130	30	of	of	ADP
aji-33	130	31	covid	covid	PROPN
aji-33	130	32	19	19	NUM
aji-33	130	33	lung	lung	NOUN
aji-33	130	34	disease	disease	NOUN
aji-33	130	35	.	.	PUNCT
aji-33	131	1	hence	hence	ADV
aji-33	131	2	these	these	DET
aji-33	131	3	aspects	aspect	NOUN
aji-33	131	4	are	be	AUX
aji-33	131	5	briefly	briefly	ADV
aji-33	131	6	reviewed	review	VERB
aji-33	131	7	in	in	ADP
aji-33	131	8	search	search	NOUN
aji-33	131	9	of	of	ADP
aji-33	131	10	clues	clue	NOUN
aji-33	131	11	to	to	ADP
aji-33	131	12	the	the	DET
aji-33	131	13	lung	lung	NOUN
aji-33	131	14	pathology	pathology	PROPN
aji-33	131	15	/	/	SYM
aji-33	131	16	pathogenesis	pathogenesis	NOUN
aji-33	131	17	of	of	ADP
aji-33	131	18	covid	covid	PROPN
aji-33	131	19	19	19	NUM
aji-33	131	20	.	.	NOUN
aji-33	131	21	2	2	NUM
aji-33	131	22	.	.	X
aji-33	131	23	clinical	clinical	ADJ
aji-33	131	24	data	datum	NOUN
aji-33	131	25	2.1	2.1	NUM
aji-33	131	26	pneumonialike	pneumonialike	NOUN
aji-33	131	27	condition	condition	NOUN
aji-33	131	28	of	of	ADP
aji-33	131	29	covid	covid	PROPN
aji-33	131	30	19	19	NUM
aji-33	131	31	vs	vs	ADP
aji-33	131	32	ards	ards	PROPN
aji-33	131	33	li	li	PROPN
aji-33	131	34	,	,	PUNCT
aji-33	131	35	x.	x.	PROPN
aji-33	131	36	,	,	PUNCT
aji-33	131	37	ma	ma	PROPN
aji-33	131	38	,	,	PUNCT
aji-33	131	39	x	x	PUNCT
aji-33	132	1	[	[	X
aji-33	132	2	1	1	NUM
aji-33	132	3	]	]	PUNCT
aji-33	132	4	has	have	AUX
aji-33	132	5	elaborately	elaborately	ADV
aji-33	132	6	discussed	discuss	VERB
aji-33	132	7	the	the	DET
aji-33	132	8	matter	matter	NOUN
aji-33	132	9	and	and	CCONJ
aji-33	132	10	could	could	AUX
aji-33	132	11	make	make	VERB
aji-33	132	12	out	out	ADP
aji-33	132	13	some	some	DET
aji-33	132	14	differences	difference	NOUN
aji-33	132	15	between	between	ADP
aji-33	132	16	the	the	DET
aji-33	132	17	two	two	NUM
aji-33	132	18	conditions	condition	NOUN
aji-33	132	19	.	.	PUNCT
aji-33	133	1	peter	peter	PROPN
aji-33	133	2	g	g	PROPN
aji-33	133	3	gibson	gibson	PROPN
aji-33	133	4	et	et	PROPN
aji-33	133	5	al	al	PROPN
aji-33	133	6	.	.	PROPN
aji-33	133	7	2020	2020	NUM
aji-33	133	8	)	)	PUNCT
aji-33	134	1	[	[	X
aji-33	134	2	2	2	X
aji-33	134	3	]	]	AUX
aji-33	134	4	have	have	VERB
aji-33	134	5	to	to	PART
aji-33	134	6	say	say	VERB
aji-33	134	7	"	"	PUNCT
aji-33	134	8	we	we	PRON
aji-33	134	9	are	be	AUX
aji-33	134	10	familiar	familiar	ADJ
aji-33	134	11	with	with	ADP
aji-33	134	12	ards	ard	NOUN
aji-33	134	13	,	,	PUNCT
aji-33	134	14	however	however	ADV
aji-33	134	15	when	when	SCONJ
aji-33	134	16	it	it	PRON
aji-33	134	17	occurs	occur	VERB
aji-33	134	18	as	as	ADP
aji-33	134	19	part	part	NOUN
aji-33	134	20	of	of	ADP
aji-33	134	21	covid-19	covid-19	PROPN
aji-33	134	22	,	,	PUNCT
aji-33	134	23	it	it	PRON
aji-33	134	24	has	have	VERB
aji-33	134	25	different	different	ADJ
aji-33	134	26	features	feature	NOUN
aji-33	134	27	and	and	CCONJ
aji-33	134	28	there	there	PRON
aji-33	134	29	remain	remain	VERB
aji-33	134	30	,	,	PUNCT
aji-33	134	31	unanswered	unanswered	ADJ
aji-33	134	32	questions	question	NOUN
aji-33	134	33	"	"	PUNCT
aji-33	134	34	.	.	PUNCT
aji-33	135	1	wu	wu	PROPN
aji-33	135	2	c	c	PROPN
aji-33	135	3	,	,	PUNCT
aji-33	135	4	chen	chen	PROPN
aji-33	135	5	x	x	PROPN
aji-33	135	6	,	,	PUNCT
aji-33	135	7	cai	cai	PROPN
aji-33	135	8	y	y	PROPN
aji-33	135	9	,	,	PUNCT
aji-33	135	10	xia	xia	PROPN
aji-33	135	11	j	j	PROPN
aji-33	135	12	,	,	PUNCT
aji-33	135	13	zhou	zhou	PROPN
aji-33	135	14	x	x	PROPN
aji-33	135	15	,	,	PUNCT
aji-33	135	16	xu	xu	PROPN
aji-33	135	17	s	s	PART
aji-33	135	18	(	(	PUNCT
aji-33	135	19	2020	2020	NUM
aji-33	135	20	)	)	PUNCT
aji-33	135	21	suggest	suggest	VERB
aji-33	135	22	that	that	SCONJ
aji-33	135	23	among	among	ADP
aji-33	135	24	the	the	DET
aji-33	135	25	patients	patient	NOUN
aji-33	135	26	affected	affect	VERB
aji-33	135	27	,	,	PUNCT
aji-33	135	28	the	the	DET
aji-33	135	29	pneumonia	pneumonia	NOUN
aji-33	135	30	-	-	PUNCT
aji-33	135	31	like	like	ADJ
aji-33	135	32	process	process	NOUN
aji-33	135	33	of	of	ADP
aji-33	135	34	covid	covid	PROPN
aji-33	135	35	19	19	NUM
aji-33	135	36	.	.	PUNCT
aji-33	136	1	unto	unto	ADP
aji-33	136	2	20	20	NUM
aji-33	136	3	%	%	NOUN
aji-33	136	4	only	only	ADV
aji-33	136	5	develop	develop	VERB
aji-33	136	6	pneumonia	pneumonia	NOUN
aji-33	136	7	of	of	ADP
aji-33	136	8	which	which	PRON
aji-33	136	9	,	,	PUNCT
aji-33	136	10	about	about	ADV
aji-33	136	11	3	3	NUM
aji-33	136	12	to	to	PART
aji-33	136	13	4	4	NUM
aji-33	136	14	%	%	NOUN
aji-33	136	15	develop	develop	VERB
aji-33	136	16	severe	severe	ADJ
aji-33	136	17	form	form	NOUN
aji-33	136	18	necessitating	necessitate	VERB
aji-33	136	19	ventilator	ventilator	NOUN
aji-33	136	20	support	support	NOUN
aji-33	136	21	.	.	PUNCT
aji-33	137	1	~50	~50	PUNCT
aji-33	137	2	%	%	X
aji-33	137	3	develop	develop	VERB
aji-33	137	4	hypoxemia	hypoxemia	NOUN
aji-33	137	5	by	by	ADP
aji-33	137	6	day	day	NOUN
aji-33	137	7	8	8	NUM
aji-33	137	8	.	.	PUNCT
aji-33	138	1	severe	severe	ADJ
aji-33	138	2	illness	illness	NOUN
aji-33	138	3	and	and	CCONJ
aji-33	138	4	cytokine	cytokine	ADJ
aji-33	138	5	release	release	NOUN
aji-33	138	6	syndrome	syndrome	NOUN
aji-33	138	7	appear	appear	VERB
aji-33	138	8	to	to	PART
aji-33	138	9	develop	develop	VERB
aji-33	138	10	mostly	mostly	ADV
aji-33	138	11	within	within	ADP
aji-33	138	12	5–10	5–10	ADJ
aji-33	138	13	days	day	NOUN
aji-33	138	14	after	after	ADP
aji-33	138	15	the	the	DET
aji-33	138	16	onset	onset	NOUN
aji-33	138	17	of	of	ADP
aji-33	138	18	symptoms	symptom	NOUN
aji-33	138	19	in	in	ADP
aji-33	138	20	susceptible	susceptible	ADJ
aji-33	138	21	patients	patient	NOUN
aji-33	138	22	.	.	PUNCT
aji-33	139	1	ardslike	ardslike	ADP
aji-33	139	2	clinical	clinical	ADJ
aji-33	139	3	picture	picture	NOUN
aji-33	139	4	is	be	AUX
aji-33	139	5	suggested	suggest	VERB
aji-33	139	6	to	to	PART
aji-33	139	7	develop	develop	VERB
aji-33	139	8	in	in	ADP
aji-33	139	9	42	42	NUM
aji-33	139	10	%	%	NOUN
aji-33	139	11	of	of	ADP
aji-33	139	12	patients	patient	NOUN
aji-33	139	13	presenting	present	VERB
aji-33	139	14	with	with	ADP
aji-33	139	15	covid-19	covid-19	PROPN
aji-33	139	16	pneumonia	pneumonia	NOUN
aji-33	139	17	,	,	PUNCT
aji-33	139	18	and	and	CCONJ
aji-33	139	19	61	61	NUM
aji-33	139	20	-	-	SYM
aji-33	139	21	81	81	NUM
aji-33	139	22	%	%	NOUN
aji-33	139	23	of	of	ADP
aji-33	139	24	those	those	PRON
aji-33	139	25	requiring	require	VERB
aji-33	139	26	icu	icu	PROPN
aji-33	139	27	care	care	NOUN
aji-33	140	1	[	[	X
aji-33	140	2	3	3	NUM
aji-33	140	3	]	]	PUNCT
aji-33	140	4	.	.	PUNCT
aji-33	141	1	puah	puah	PROPN
aji-33	141	2	sh	sh	PROPN
aji-33	141	3	et	et	PROPN
aji-33	141	4	al	al	PROPN
aji-33	141	5	.	.	PROPN
aji-33	141	6	report	report	NOUN
aji-33	141	7	that	that	SCONJ
aji-33	141	8	covid-19	covid-19	PROPN
aji-33	141	9	ards	ard	NOUN
aji-33	141	10	follows	follow	VERB
aji-33	141	11	a	a	DET
aji-33	141	12	predictable	predictable	ADJ
aji-33	141	13	time	time	NOUN
aji-33	141	14	course	course	NOUN
aji-33	141	15	over	over	ADP
aji-33	141	16	days	day	NOUN
aji-33	141	17	,	,	PUNCT
aji-33	141	18	with	with	ADP
aji-33	141	19	median	median	ADJ
aji-33	141	20	time	time	NOUN
aji-33	141	21	to	to	ADP
aji-33	141	22	incubation	incubation	NOUN
aji-33	141	23	period	period	NOUN
aji-33	141	24	of	of	ADP
aji-33	141	25	8.5	8.5	NUM
aji-33	141	26	days	day	NOUN
aji-33	141	27	after	after	ADP
aji-33	141	28	onset	onset	NOUN
aji-33	141	29	of	of	ADP
aji-33	141	30	symptom	symptom	NOUN
aji-33	141	31	in	in	ADP
aji-33	141	32	singaporean	singaporean	ADJ
aji-33	141	33	patients	patient	NOUN
aji-33	142	1	[	[	X
aji-33	142	2	4	4	NUM
aji-33	142	3	]	]	PUNCT
aji-33	142	4	.	.	PUNCT
aji-33	142	5	not	not	PART
aji-33	142	6	all	all	DET
aji-33	142	7	covid	covid	VERB
aji-33	142	8	19	19	NUM
aji-33	142	9	patients	patient	NOUN
aji-33	142	10	suffer	suffer	VERB
aji-33	142	11	pneumonia	pneumonia	NOUN
aji-33	142	12	like	like	ADP
aji-33	142	13	syndrome	syndrome	NOUN
aji-33	142	14	.	.	PUNCT
aji-33	143	1	even	even	ADV
aji-33	143	2	though	though	SCONJ
aji-33	143	3	ali	ali	PROPN
aji-33	143	4	of	of	ADP
aji-33	143	5	those	those	PRON
aji-33	143	6	who	who	PRON
aji-33	143	7	develop	develop	VERB
aji-33	143	8	this	this	DET
aji-33	143	9	very	very	ADV
aji-33	143	10	few	few	ADJ
aji-33	143	11	of	of	ADP
aji-33	143	12	them	they	PRON
aji-33	143	13	develop	develop	VERB
aji-33	143	14	severe	severe	ADJ
aji-33	143	15	respiratory	respiratory	ADJ
aji-33	143	16	distress	distress	NOUN
aji-33	143	17	,	,	PUNCT
aji-33	143	18	necessitating	necessitate	VERB
aji-33	143	19	ventilator	ventilator	NOUN
aji-33	143	20	support	support	NOUN
aji-33	143	21	.	.	PUNCT
aji-33	144	1	most	most	ADJ
aji-33	144	2	of	of	ADP
aji-33	144	3	them	they	PRON
aji-33	144	4	have	have	VERB
aji-33	144	5	comorbid	comorbid	NOUN
aji-33	144	6	diseases	disease	NOUN
aji-33	144	7	and	and	CCONJ
aji-33	144	8	constitute	constitute	VERB
aji-33	144	9	to	to	ADP
aji-33	144	10	the	the	DET
aji-33	144	11	2	2	NUM
aji-33	144	12	to	to	PART
aji-33	144	13	3	3	NUM
aji-33	144	14	%	%	NOUN
aji-33	144	15	mortality	mortality	NOUN
aji-33	144	16	observed	observe	VERB
aji-33	144	17	.	.	PUNCT
aji-33	145	1	the	the	DET
aji-33	145	2	autopsy	autopsy	ADJ
aji-33	145	3	findings	finding	NOUN
aji-33	145	4	which	which	PRON
aji-33	145	5	suggested	suggest	VERB
aji-33	145	6	ards	ard	NOUN
aji-33	145	7	are	be	AUX
aji-33	145	8	the	the	DET
aji-33	145	9	firm	firm	ADJ
aji-33	145	10	,	,	PUNCT
aji-33	145	11	heavy	heavy	ADJ
aji-33	145	12	lung	lung	NOUN
aji-33	145	13	filled	fill	VERB
aji-33	145	14	with	with	ADP
aji-33	145	15	fluid	fluid	NOUN
aji-33	145	16	and	and	CCONJ
aji-33	145	17	presence	presence	NOUN
aji-33	145	18	on	on	ADP
aji-33	145	19	bits	bit	NOUN
aji-33	145	20	of	of	ADP
aji-33	145	21	hyaline	hyaline	ADJ
aji-33	145	22	membrane	membrane	NOUN
aji-33	145	23	in	in	ADP
aji-33	145	24	the	the	DET
aji-33	145	25	lungs	lung	NOUN
aji-33	145	26	.	.	PUNCT
aji-33	146	1	severe	severe	ADJ
aji-33	146	2	illness	illness	NOUN
aji-33	146	3	and	and	CCONJ
aji-33	146	4	cytokine	cytokine	ADJ
aji-33	146	5	release	release	NOUN
aji-33	146	6	syndrome	syndrome	NOUN
aji-33	146	7	appear	appear	VERB
aji-33	146	8	to	to	PART
aji-33	146	9	develop	develop	VERB
aji-33	146	10	mostly	mostly	ADV
aji-33	146	11	within	within	ADP
aji-33	146	12	5–10	5–10	ADJ
aji-33	146	13	days	day	NOUN
aji-33	146	14	after	after	SCONJ
aji-33	146	15	symptom	symptom	NOUN
aji-33	146	16	onset	onset	VERB
aji-33	146	17	in	in	ADP
aji-33	146	18	susceptible	susceptible	ADJ
aji-33	146	19	patients	patient	NOUN
aji-33	146	20	.	.	PUNCT
aji-33	147	1	not	not	PART
aji-33	147	2	all	all	DET
aji-33	147	3	covid	covid	VERB
aji-33	147	4	19	19	NUM
aji-33	147	5	patients	patient	NOUN
aji-33	147	6	suffer	suffer	VERB
aji-33	147	7	pneumonia	pneumonia	NOUN
aji-33	147	8	like	like	ADP
aji-33	147	9	syndrome	syndrome	NOUN
aji-33	147	10	.	.	PUNCT
aji-33	148	1	even	even	ADV
aji-33	148	2	though	though	SCONJ
aji-33	148	3	those	those	PRON
aji-33	148	4	who	who	PRON
aji-33	148	5	develop	develop	VERB
aji-33	148	6	this	this	DET
aji-33	148	7	very	very	ADV
aji-33	148	8	few	few	ADJ
aji-33	148	9	develop	develop	VERB
aji-33	148	10	severe	severe	ADJ
aji-33	148	11	respiratory	respiratory	ADJ
aji-33	148	12	distress	distress	NOUN
aji-33	148	13	,	,	PUNCT
aji-33	148	14	necessitating	necessitate	VERB
aji-33	148	15	ventilator	ventilator	NOUN
aji-33	148	16	support	support	NOUN
aji-33	148	17	.	.	PUNCT
aji-33	149	1	most	most	ADJ
aji-33	149	2	of	of	ADP
aji-33	149	3	them	they	PRON
aji-33	149	4	have	have	VERB
aji-33	149	5	comorbid	comorbid	NOUN
aji-33	149	6	diseases	disease	NOUN
aji-33	149	7	and	and	CCONJ
aji-33	149	8	constitute	constitute	VERB
aji-33	149	9	the	the	DET
aji-33	149	10	2	2	NUM
aji-33	149	11	to	to	PART
aji-33	149	12	3	3	NUM
aji-33	149	13	%	%	NOUN
aji-33	149	14	mortality	mortality	NOUN
aji-33	149	15	observed	observe	VERB
aji-33	149	16	.	.	PUNCT
aji-33	150	1	the	the	DET
aji-33	150	2	autopsy	autopsy	ADJ
aji-33	150	3	findings	finding	NOUN
aji-33	150	4	which	which	PRON
aji-33	150	5	suggested	suggest	VERB
aji-33	150	6	ards	ard	NOUN
aji-33	150	7	are	be	AUX
aji-33	150	8	the	the	DET
aji-33	150	9	firm	firm	ADJ
aji-33	150	10	,	,	PUNCT
aji-33	150	11	heavy	heavy	ADJ
aji-33	150	12	lung	lung	NOUN
aji-33	150	13	filled	fill	VERB
aji-33	150	14	with	with	ADP
aji-33	150	15	fluid	fluid	NOUN
aji-33	150	16	and	and	CCONJ
aji-33	150	17	presence	presence	NOUN
aji-33	150	18	on	on	ADP
aji-33	150	19	bits	bit	NOUN
aji-33	150	20	of	of	ADP
aji-33	150	21	hyaline	hyaline	ADJ
aji-33	150	22	membrane	membrane	NOUN
aji-33	150	23	in	in	ADP
aji-33	150	24	the	the	DET
aji-33	150	25	lungs	lung	NOUN
aji-33	150	26	.	.	PUNCT
aji-33	151	1	peter	peter	PROPN
aji-33	151	2	g	g	PROPN
aji-33	151	3	gibson	gibson	PROPN
aji-33	151	4	et	et	PROPN
aji-33	151	5	al	al	PROPN
aji-33	151	6	opine	opine	VERB
aji-33	151	7	that	that	SCONJ
aji-33	151	8	most	most	ADJ
aji-33	151	9	of	of	ADP
aji-33	151	10	the	the	DET
aji-33	151	11	covid-19	covid-19	PROPN
aji-33	151	12	patients	patient	NOUN
aji-33	151	13	,	,	PUNCT
aji-33	151	14	meet	meet	VERB
aji-33	151	15	the	the	DET
aji-33	151	16	berlin	berlin	PROPN
aji-33	151	17	definition	definition	NOUN
aji-33	151	18	(	(	PUNCT
aji-33	151	19	2012	2012	NUM
aji-33	151	20	)	)	PUNCT
aji-33	151	21	for	for	ADP
aji-33	151	22	ards	ard	NOUN
aji-33	151	23	.	.	PUNCT
aji-33	152	1	all	all	PRON
aji-33	152	2	of	of	ADP
aji-33	152	3	them	they	PRON
aji-33	152	4	have	have	VERB
aji-33	152	5	present	present	ADJ
aji-33	152	6	with	with	ADP
aji-33	152	7	an	an	DET
aji-33	152	8	acute	acute	ADJ
aji-33	152	9	clinical	clinical	ADJ
aji-33	152	10	emergency	emergency	NOUN
aji-33	152	11	,	,	PUNCT
aji-33	152	12	with	with	ADP
aji-33	152	13	bilateral	bilateral	ADJ
aji-33	152	14	opacities	opacity	NOUN
aji-33	152	15	in	in	ADP
aji-33	152	16	the	the	DET
aji-33	152	17	lung	lung	NOUN
aji-33	152	18	imaging	imaging	NOUN
aji-33	152	19	,	,	PUNCT
aji-33	152	20	gas	gas	NOUN
aji-33	152	21	exchange	exchange	NOUN
aji-33	152	22	abnormalities	abnormality	NOUN
aji-33	152	23	,	,	PUNCT
aji-33	152	24	and	and	CCONJ
aji-33	152	25	their	their	PRON
aji-33	152	26	disease	disease	NOUN
aji-33	152	27	ca	can	AUX
aji-33	152	28	n't	not	PART
aji-33	152	29	be	be	AUX
aji-33	152	30	explained	explain	VERB
aji-33	152	31	by	by	ADP
aji-33	152	32	heart	heart	NOUN
aji-33	152	33	failure	failure	NOUN
aji-33	152	34	or	or	CCONJ
aji-33	152	35	volume	volume	NOUN
aji-33	152	36	overload	overload	NOUN
aji-33	152	37	.	.	PUNCT
aji-33	153	1	the	the	DET
aji-33	153	2	ards	ards	PROPN
aji-33	153	3	berlin	berlin	PROPN
aji-33	153	4	criteria	criterion	NOUN
aji-33	153	5	defined	define	VERB
aji-33	153	6	that	that	SCONJ
aji-33	153	7	for	for	ADP
aji-33	153	8	a	a	DET
aji-33	153	9	prasad	prasad	NOUN
aji-33	153	10	;	;	PUNCT
aji-33	153	11	aji	aji	NOUN
aji-33	153	12	,	,	PUNCT
aji-33	153	13	3(1	3(1	NUM
aji-33	153	14	):	):	PUNCT
aji-33	153	15	233	233	NUM
aji-33	153	16	-	-	SYM
aji-33	153	17	252	252	NUM
aji-33	153	18	,	,	PUNCT
aji-33	153	19	2020	2020	NUM
aji-33	153	20	;	;	PUNCT
aji-33	153	21	article	article	NOUN
aji-33	153	22	no.aji.58422	no.aji.58422	NOUN
aji-33	153	23	235	235	NUM
aji-33	153	24	patient	patient	NOUN
aji-33	153	25	to	to	PART
aji-33	153	26	be	be	AUX
aji-33	153	27	diagnosed	diagnose	VERB
aji-33	153	28	as	as	ADP
aji-33	153	29	having	have	VERB
aji-33	153	30	ards	ard	NOUN
aji-33	153	31	,	,	PUNCT
aji-33	153	32	the	the	DET
aji-33	153	33	onset	onset	NOUN
aji-33	153	34	must	must	AUX
aji-33	153	35	be	be	AUX
aji-33	153	36	within	within	ADP
aji-33	153	37	1	1	NUM
aji-33	153	38	 	 	SPACE
aji-33	153	39	week	week	NOUN
aji-33	153	40	of	of	ADP
aji-33	153	41	a	a	DET
aji-33	153	42	known	know	VERB
aji-33	153	43	clinical	clinical	ADJ
aji-33	153	44	insult	insult	NOUN
aji-33	153	45	or	or	CCONJ
aji-33	153	46	new	new	ADJ
aji-33	153	47	or	or	CCONJ
aji-33	153	48	worsening	worsen	VERB
aji-33	153	49	respiratory	respiratory	ADJ
aji-33	153	50	symptoms	symptom	NOUN
aji-33	153	51	.	.	PUNCT
aji-33	154	1	[	[	X
aji-33	154	2	5	5	NUM
aji-33	154	3	]	]	PUNCT
aji-33	154	4	,	,	PUNCT
aji-33	154	5	wang	wang	PROPN
aji-33	154	6	et	et	PROPN
aji-33	154	7	al	al	PROPN
aji-33	154	8	.	.	PUNCT
aji-33	155	1	[	[	X
aji-33	155	2	6	6	NUM
aji-33	155	3	]	]	PUNCT
aji-33	155	4	reported	report	VERB
aji-33	155	5	median	median	PROPN
aji-33	155	6	timed	time	VERB
aji-33	155	7	onset	onset	NOUN
aji-33	155	8	of	of	ADP
aji-33	155	9	ards	ard	NOUN
aji-33	155	10	,	,	PUNCT
aji-33	155	11	as	as	ADP
aji-33	155	12	8.0	8.0	NUM
aji-33	155	13	 	 	SPACE
aji-33	155	14	days	day	NOUN
aji-33	155	15	,	,	PUNCT
aji-33	155	16	zhou	zhou	PROPN
aji-33	155	17	et	et	PROPN
aji-33	155	18	al	al	PROPN
aji-33	155	19	.	.	PUNCT
aji-33	156	1	[	[	X
aji-33	156	2	7	7	X
aji-33	156	3	]	]	PUNCT
aji-33	156	4	as	as	ADP
aji-33	156	5	12	12	NUM
aji-33	156	6	 	 	SPACE
aji-33	156	7	days	day	NOUN
aji-33	156	8	.	.	PUNCT
aji-33	157	1	chen	chen	PROPN
aji-33	157	2	et	et	PROPN
aji-33	157	3	al	al	PROPN
aji-33	157	4	.	.	PUNCT
aji-33	158	1	[	[	X
aji-33	158	2	8	8	NUM
aji-33	158	3	]	]	PUNCT
aji-33	158	4	and	and	CCONJ
aji-33	158	5	guan	guan	PROPN
aji-33	158	6	et	et	PROPN
aji-33	158	7	al	al	PROPN
aji-33	158	8	.	.	PUNCT
aji-33	159	1	[	[	X
aji-33	159	2	9	9	NUM
aji-33	159	3	]	]	PUNCT
aji-33	159	4	did	do	AUX
aji-33	159	5	not	not	PART
aji-33	159	6	report	report	VERB
aji-33	159	7	the	the	DET
aji-33	159	8	onset	onset	NOUN
aji-33	159	9	of	of	ADP
aji-33	159	10	ards	ard	NOUN
aji-33	159	11	.	.	PUNCT
aji-33	160	1	the	the	DET
aji-33	160	2	lowest	low	ADJ
aji-33	160	3	median	median	ADJ
aji-33	160	4	time	time	NOUN
aji-33	160	5	reported	report	VERB
aji-33	160	6	is	be	AUX
aji-33	160	7	4	4	NUM
aji-33	160	8	days	day	NOUN
aji-33	160	9	from	from	ADP
aji-33	160	10	the	the	DET
aji-33	160	11	onset	onset	NOUN
aji-33	160	12	of	of	ADP
aji-33	160	13	first	first	ADJ
aji-33	160	14	symptom	symptom	NOUN
aji-33	160	15	.	.	PUNCT
aji-33	161	1	the	the	DET
aji-33	161	2	main	main	ADJ
aji-33	161	3	departure	departure	NOUN
aji-33	161	4	from	from	ADP
aji-33	161	5	ards	ard	NOUN
aji-33	161	6	and	and	CCONJ
aji-33	161	7	sars	sars	PROPN
aji-33	161	8	cov2	cov2	PROPN
aji-33	161	9	pneumonia	pneumonia	NOUN
aji-33	161	10	is	be	AUX
aji-33	161	11	the	the	DET
aji-33	161	12	preserved	preserve	VERB
aji-33	161	13	lung	lung	NOUN
aji-33	161	14	compliance	compliance	NOUN
aji-33	161	15	in	in	ADP
aji-33	161	16	face	face	NOUN
aji-33	161	17	of	of	ADP
aji-33	161	18	severe	severe	ADJ
aji-33	161	19	hypoxia	hypoxia	NOUN
aji-33	161	20	,	,	PUNCT
aji-33	161	21	and	and	CCONJ
aji-33	161	22	poor	poor	ADJ
aji-33	161	23	oxygenation	oxygenation	NOUN
aji-33	161	24	without	without	ADP
aji-33	161	25	increased	increase	VERB
aji-33	161	26	work	work	NOUN
aji-33	161	27	of	of	ADP
aji-33	161	28	breathing	breathing	NOUN
aji-33	161	29	,	,	PUNCT
aji-33	161	30	which	which	PRON
aji-33	161	31	are	be	AUX
aji-33	161	32	not	not	PART
aji-33	161	33	seen	see	VERB
aji-33	161	34	in	in	ADP
aji-33	161	35	ards	ard	NOUN
aji-33	161	36	.	.	PUNCT
aji-33	162	1	it	it	PRON
aji-33	162	2	is	be	AUX
aji-33	162	3	also	also	ADV
aji-33	162	4	seen	see	VERB
aji-33	162	5	that	that	SCONJ
aji-33	162	6	ards	ard	NOUN
aji-33	162	7	developed	develop	VERB
aji-33	162	8	in	in	ADP
aji-33	162	9	some	some	DET
aji-33	162	10	covid	covid	NOUN
aji-33	162	11	19	19	NUM
aji-33	162	12	patients	patient	NOUN
aji-33	162	13	after	after	SCONJ
aji-33	162	14	they	they	PRON
aji-33	162	15	have	have	AUX
aji-33	162	16	been	be	AUX
aji-33	162	17	put	put	VERB
aji-33	162	18	on	on	ADP
aji-33	162	19	ventilator	ventilator	NOUN
aji-33	162	20	,	,	PUNCT
aji-33	162	21	sparking	spark	VERB
aji-33	162	22	speculation	speculation	NOUN
aji-33	162	23	as	as	ADP
aji-33	162	24	to	to	ADP
aji-33	162	25	whether	whether	SCONJ
aji-33	162	26	such	such	ADJ
aji-33	162	27	development	development	NOUN
aji-33	162	28	is	be	AUX
aji-33	162	29	due	due	ADJ
aji-33	162	30	to	to	ADP
aji-33	162	31	natural	natural	ADJ
aji-33	162	32	progression	progression	NOUN
aji-33	162	33	of	of	ADP
aji-33	162	34	the	the	DET
aji-33	162	35	covid	covid	PROPN
aji-33	162	36	19	19	NUM
aji-33	162	37	or	or	CCONJ
aji-33	162	38	ventilator	ventilator	NOUN
aji-33	162	39	induced	induce	VERB
aji-33	162	40	.	.	PUNCT
aji-33	163	1	robba	robba	PROPN
aji-33	163	2	c	c	NOUN
aji-33	163	3	,	,	PUNCT
aji-33	163	4	battaglini	battaglini	PROPN
aji-33	163	5	d	d	NOUN
aji-33	163	6	patroniti	patroniti	ADP
aji-33	163	7	n	n	CCONJ
aji-33	164	1	[	[	X
aji-33	164	2	10	10	NUM
aji-33	164	3	]	]	PUNCT
aji-33	164	4	et	et	PROPN
aji-33	164	5	al	al	PROPN
aji-33	164	6	.	.	PROPN
aji-33	164	7	suggested	suggest	VERB
aji-33	164	8	3	3	NUM
aji-33	164	9	phenotypes	phenotype	NOUN
aji-33	164	10	of	of	ADP
aji-33	164	11	patients	patient	NOUN
aji-33	164	12	,	,	PUNCT
aji-33	164	13	basing	base	VERB
aji-33	164	14	on	on	ADP
aji-33	164	15	their	their	PRON
aji-33	164	16	ct	ct	PROPN
aji-33	164	17	findings	finding	NOUN
aji-33	164	18	of	of	ADP
aji-33	164	19	lungs	lung	NOUN
aji-33	164	20	in	in	ADP
aji-33	164	21	covid	covid	PROPN
aji-33	164	22	19	19	NUM
aji-33	164	23	(	(	PUNCT
aji-33	164	24	discussed	discuss	VERB
aji-33	164	25	under	under	ADP
aji-33	164	26	imaging	imaging	NOUN
aji-33	164	27	features	feature	NOUN
aji-33	164	28	,	,	PUNCT
aji-33	164	29	below	below	ADV
aji-33	164	30	)	)	PUNCT
aji-33	164	31	.	.	PUNCT
aji-33	165	1	they	they	PRON
aji-33	165	2	opine	opine	VERB
aji-33	165	3	that	that	SCONJ
aji-33	165	4	not	not	PART
aji-33	165	5	all	all	DET
aji-33	165	6	cases	case	NOUN
aji-33	165	7	of	of	ADP
aji-33	165	8	covid	covid	PROPN
aji-33	165	9	lung	lung	PROPN
aji-33	165	10	involvement	involvement	NOUN
aji-33	165	11	resemble	resemble	VERB
aji-33	165	12	ards	ard	NOUN
aji-33	165	13	.	.	PUNCT
aji-33	166	1	gattinoni	gattinoni	PROPN
aji-33	166	2	et	et	PROPN
aji-33	166	3	al	al	PROPN
aji-33	166	4	.	.	PUNCT
aji-33	167	1	[	[	X
aji-33	167	2	11	11	NUM
aji-33	167	3	]	]	PUNCT
aji-33	167	4	described	describe	VERB
aji-33	167	5	two	two	NUM
aji-33	167	6	distinct	distinct	ADJ
aji-33	167	7	phenotypes	phenotype	NOUN
aji-33	167	8	,	,	PUNCT
aji-33	167	9	type	type	NOUN
aji-33	167	10	l	l	NOUN
aji-33	167	11	and	and	CCONJ
aji-33	167	12	type	type	NOUN
aji-33	167	13	h	h	NOUN
aji-33	167	14	(	(	PUNCT
aji-33	167	15	type	type	NOUN
aji-33	167	16	1	1	NUM
aji-33	167	17	and	and	CCONJ
aji-33	167	18	type	type	NOUN
aji-33	167	19	2	2	NUM
aji-33	167	20	)	)	PUNCT
aji-33	167	21	.	.	PUNCT
aji-33	168	1	type	type	NOUN
aji-33	168	2	l	l	NOUN
aji-33	168	3	disease	disease	NOUN
aji-33	168	4	,	,	PUNCT
aji-33	168	5	is	be	AUX
aji-33	168	6	characterized	characterize	VERB
aji-33	168	7	by	by	ADP
aji-33	168	8	normal	normal	ADJ
aji-33	168	9	lung	lung	NOUN
aji-33	168	10	compliance	compliance	NOUN
aji-33	168	11	and	and	CCONJ
aji-33	168	12	gas	gas	NOUN
aji-33	168	13	volume	volume	NOUN
aji-33	168	14	in	in	ADP
aji-33	168	15	the	the	DET
aji-33	168	16	presence	presence	NOUN
aji-33	168	17	of	of	ADP
aji-33	168	18	hypoxemia	hypoxemia	NOUN
aji-33	168	19	.	.	PUNCT
aji-33	169	1	these	these	DET
aji-33	169	2	patients	patient	NOUN
aji-33	169	3	may	may	AUX
aji-33	169	4	improve	improve	VERB
aji-33	169	5	,	,	PUNCT
aji-33	169	6	or	or	CCONJ
aji-33	169	7	they	they	PRON
aji-33	169	8	may	may	AUX
aji-33	169	9	worsen	worsen	VERB
aji-33	169	10	.	.	PUNCT
aji-33	170	1	about	about	ADV
aji-33	170	2	20	20	NUM
aji-33	170	3	%	%	NOUN
aji-33	170	4	to	to	PART
aji-33	170	5	30	30	NUM
aji-33	170	6	%	%	NOUN
aji-33	170	7	of	of	ADP
aji-33	170	8	patients	patient	NOUN
aji-33	170	9	had	have	VERB
aji-33	170	10	or	or	CCONJ
aji-33	170	11	evolved	evolve	VERB
aji-33	170	12	to	to	PART
aji-33	170	13	type	type	NOUN
aji-33	170	14	h	h	NOUN
aji-33	170	15	disease	disease	NOUN
aji-33	170	16	,	,	PUNCT
aji-33	170	17	characterized	characterize	VERB
aji-33	170	18	by	by	ADP
aji-33	170	19	worse	bad	ADJ
aji-33	170	20	lung	lung	NOUN
aji-33	170	21	compliance	compliance	NOUN
aji-33	170	22	and	and	CCONJ
aji-33	170	23	increased	increase	VERB
aji-33	170	24	edema	edema	NOUN
aji-33	170	25	and	and	CCONJ
aji-33	170	26	lung	lung	NOUN
aji-33	170	27	weight	weight	NOUN
aji-33	170	28	.	.	PUNCT
aji-33	171	1	"	"	PUNCT
aji-33	171	2	the	the	DET
aji-33	171	3	transition	transition	NOUN
aji-33	171	4	from	from	ADP
aji-33	171	5	type	type	NOUN
aji-33	171	6	l	l	NOUN
aji-33	171	7	to	to	PART
aji-33	171	8	type	type	NOUN
aji-33	171	9	h	h	NOUN
aji-33	171	10	may	may	AUX
aji-33	171	11	be	be	AUX
aji-33	171	12	due	due	ADJ
aji-33	171	13	to	to	ADP
aji-33	171	14	the	the	DET
aji-33	171	15	evolution	evolution	NOUN
aji-33	171	16	of	of	ADP
aji-33	171	17	the	the	DET
aji-33	171	18	covid-19	covid-19	PROPN
aji-33	171	19	pneumonia	pneumonia	NOUN
aji-33	171	20	on	on	ADP
aji-33	171	21	one	one	NUM
aji-33	171	22	hand	hand	NOUN
aji-33	171	23	and	and	CCONJ
aji-33	171	24	the	the	DET
aji-33	171	25	injury	injury	NOUN
aji-33	171	26	attributable	attributable	ADJ
aji-33	171	27	to	to	ADP
aji-33	171	28	high	high	ADJ
aji-33	171	29	-	-	PUNCT
aji-33	171	30	stress	stress	NOUN
aji-33	171	31	ventilation	ventilation	NOUN
aji-33	171	32	on	on	ADP
aji-33	171	33	the	the	DET
aji-33	171	34	other	other	ADJ
aji-33	171	35	"	"	PUNCT
aji-33	171	36	.	.	PUNCT
aji-33	172	1	sars	sar	NOUN
aji-33	172	2	of	of	ADP
aji-33	172	3	covid	covid	PROPN
aji-33	172	4	2	2	PROPN
aji-33	172	5	vs	vs	ADP
aji-33	172	6	(	(	PUNCT
aji-33	172	7	shlh)/cytokine	shlh)/cytokine	NOUN
aji-33	172	8	storm	storm	NOUN
aji-33	172	9	:	:	PUNCT
aji-33	172	10	macrophage	macrophage	ADJ
aji-33	172	11	activation	activation	NOUN
aji-33	172	12	syndrome	syndrome	NOUN
aji-33	172	13	(	(	PUNCT
aji-33	172	14	mas	mas	PROPN
aji-33	172	15	)	)	PUNCT
aji-33	172	16	,	,	PUNCT
aji-33	172	17	also	also	ADV
aji-33	172	18	known	know	VERB
aji-33	172	19	as	as	ADP
aji-33	172	20	secondary	secondary	ADJ
aji-33	172	21	haemo	haemo	NOUN
aji-33	172	22	phagocytic	phagocytic	ADJ
aji-33	172	23	lympho	lympho	X
aji-33	172	24	histocytosis	histocytosis	NOUN
aji-33	172	25	(	(	PUNCT
aji-33	172	26	shlh	shlh	NOUN
aji-33	172	27	)	)	PUNCT
aji-33	172	28	or	or	CCONJ
aji-33	172	29	cytokine	cytokine	ADJ
aji-33	172	30	storm	storm	NOUN
aji-33	172	31	is	be	AUX
aji-33	172	32	distinguished	distinguish	VERB
aji-33	172	33	by	by	ADP
aji-33	172	34	:	:	PUNCT
aji-33	172	35	1	1	NUM
aji-33	172	36	.	.	PUNCT
aji-33	172	37	absent	absent	ADJ
aji-33	172	38	haemophagocytosis	haemophagocytosis	NOUN
aji-33	172	39	2	2	NUM
aji-33	172	40	.	.	PUNCT
aji-33	173	1	lower	low	ADJ
aji-33	173	2	ferritin	ferritin	ADJ
aji-33	173	3	levels	level	NOUN
aji-33	173	4	.	.	PUNCT
aji-33	174	1	3	3	X
aji-33	174	2	.	.	X
aji-33	174	3	coagulopathy	coagulopathy	ADJ
aji-33	174	4	not	not	PART
aji-33	174	5	being	be	AUX
aji-33	174	6	due	due	ADJ
aji-33	174	7	to	to	AUX
aji-33	174	8	liver	liver	VERB
aji-33	174	9	synthesized	synthesize	VERB
aji-33	174	10	factors	factor	NOUN
aji-33	174	11	.	.	PUNCT
aji-33	175	1	4	4	X
aji-33	175	2	.	.	X
aji-33	175	3	dic	dic	PROPN
aji-33	175	4	is	be	AUX
aji-33	175	5	seen	see	VERB
aji-33	175	6	as	as	ADP
aji-33	175	7	a	a	DET
aji-33	175	8	terminal	terminal	ADJ
aji-33	175	9	event	event	NOUN
aji-33	175	10	in	in	ADP
aji-33	175	11	some	some	DET
aji-33	175	12	covid	covid	NOUN
aji-33	175	13	19	19	NUM
aji-33	175	14	patients	patient	NOUN
aji-33	175	15	only	only	ADV
aji-33	175	16	even	even	ADV
aji-33	175	17	though	though	SCONJ
aji-33	175	18	hypercytokinemia	hypercytokinemia	NOUN
aji-33	175	19	.	.	PUNCT
aji-33	176	1	2.2	2.2	NUM
aji-33	176	2	radiology	radiology	NOUN
aji-33	176	3	/	/	SYM
aji-33	176	4	imaging	imaging	NOUN
aji-33	176	5	data	datum	NOUN
aji-33	176	6	the	the	DET
aji-33	176	7	imaging	imaging	NOUN
aji-33	176	8	technics	technic	NOUN
aji-33	176	9	have	have	VERB
aji-33	176	10	high	high	ADJ
aji-33	176	11	sensitivity	sensitivity	NOUN
aji-33	176	12	of	of	ADP
aji-33	176	13	about	about	ADV
aji-33	176	14	97	97	NUM
aji-33	176	15	%	%	NOUN
aji-33	176	16	when	when	SCONJ
aji-33	176	17	tested	test	VERB
aji-33	176	18	within	within	ADP
aji-33	176	19	5	5	NUM
aji-33	176	20	days	day	NOUN
aji-33	176	21	of	of	ADP
aji-33	176	22	rt	rt	PROPN
aji-33	176	23	pcr	pcr	PROPN
aji-33	176	24	became	become	VERB
aji-33	176	25	positive	positive	ADJ
aji-33	176	26	and	and	CCONJ
aji-33	176	27	still	still	ADV
aji-33	176	28	can	can	AUX
aji-33	176	29	detect	detect	VERB
aji-33	176	30	the	the	DET
aji-33	176	31	changes	change	NOUN
aji-33	176	32	as	as	ADV
aji-33	176	33	early	early	ADV
aji-33	176	34	as	as	ADP
aji-33	176	35	3	3	NUM
aji-33	176	36	days	day	NOUN
aji-33	176	37	,	,	PUNCT
aji-33	176	38	but	but	CCONJ
aji-33	176	39	56	56	NUM
aji-33	176	40	%	%	NOUN
aji-33	176	41	are	be	AUX
aji-33	176	42	found	find	VERB
aji-33	176	43	to	to	PART
aji-33	176	44	be	be	AUX
aji-33	176	45	normal	normal	ADJ
aji-33	176	46	when	when	SCONJ
aji-33	176	47	imaged	image	VERB
aji-33	176	48	in	in	ADP
aji-33	176	49	2days	2days	NUM
aji-33	176	50	of	of	ADP
aji-33	176	51	patient	patient	NOUN
aji-33	176	52	becoming	becoming	AUX
aji-33	176	53	covid	covid	VERB
aji-33	176	54	19	19	NUM
aji-33	176	55	positive	positive	ADJ
aji-33	176	56	.	.	PUNCT
aji-33	177	1	thus	thus	ADV
aji-33	177	2	the	the	DET
aji-33	177	3	sensitivity	sensitivity	NOUN
aji-33	177	4	of	of	ADP
aji-33	177	5	imaging	image	VERB
aji-33	177	6	the	the	DET
aji-33	177	7	lungs	lung	NOUN
aji-33	177	8	in	in	ADP
aji-33	177	9	covid	covid	PROPN
aji-33	177	10	19	19	NUM
aji-33	177	11	,	,	PUNCT
aji-33	177	12	is	be	AUX
aji-33	177	13	a	a	DET
aji-33	177	14	function	function	NOUN
aji-33	177	15	of	of	ADP
aji-33	177	16	time	time	NOUN
aji-33	177	17	of	of	ADP
aji-33	177	18	doing	do	VERB
aji-33	177	19	the	the	DET
aji-33	177	20	test	test	NOUN
aji-33	177	21	.	.	PUNCT
aji-33	178	1	c.	c.	PROPN
aji-33	178	2	hani	hani	PROPN
aji-33	178	3	m.-p	m.-p	PROPN
aji-33	178	4	.	.	PUNCT
aji-33	179	1	revel	revel	VERB
aji-33	179	2	et	et	PROPN
aji-33	179	3	al	al	PROPN
aji-33	179	4	.	.	PROPN
aji-33	180	1	(	(	PUNCT
aji-33	180	2	2020	2020	NUM
aji-33	180	3	)	)	PUNCT
aji-33	180	4	extensively	extensively	ADV
aji-33	180	5	reviewed	review	VERB
aji-33	180	6	not	not	PART
aji-33	180	7	only	only	ADV
aji-33	180	8	the	the	DET
aji-33	180	9	ct	ct	PROPN
aji-33	180	10	findings	finding	NOUN
aji-33	180	11	of	of	ADP
aji-33	180	12	covid	covid	PROPN
aji-33	180	13	19	19	NUM
aji-33	180	14	,	,	PUNCT
aji-33	180	15	but	but	CCONJ
aji-33	180	16	other	other	ADJ
aji-33	180	17	causes	cause	NOUN
aji-33	180	18	of	of	ADP
aji-33	180	19	differential	differential	ADJ
aji-33	180	20	diagnosis	diagnosis	NOUN
aji-33	180	21	of	of	ADP
aji-33	180	22	the	the	DET
aji-33	180	23	typical	typical	ADJ
aji-33	180	24	ground	ground	NOUN
aji-33	180	25	glass	glass	NOUN
aji-33	180	26	shadows	shadow	NOUN
aji-33	180	27	seen	see	VERB
aji-33	180	28	in	in	ADP
aji-33	180	29	imaging	imaging	NOUN
aji-33	180	30	of	of	ADP
aji-33	180	31	covid	covid	PROPN
aji-33	180	32	19	19	NUM
aji-33	180	33	lung	lung	NOUN
aji-33	180	34	[	[	X
aji-33	180	35	12	12	NUM
aji-33	180	36	]	]	PUNCT
aji-33	180	37	.	.	PUNCT
aji-33	181	1	some	some	PRON
aji-33	181	2	of	of	ADP
aji-33	181	3	the	the	DET
aji-33	181	4	important	important	ADJ
aji-33	181	5	radiological	radiological	ADJ
aji-33	181	6	findings	finding	NOUN
aji-33	181	7	are	be	AUX
aji-33	181	8	presented	present	VERB
aji-33	181	9	below	below	ADV
aji-33	181	10	.	.	PUNCT
aji-33	182	1	for	for	ADP
aji-33	182	2	differential	differential	ADJ
aji-33	182	3	diagnosis	diagnosis	NOUN
aji-33	182	4	the	the	DET
aji-33	182	5	readers	reader	NOUN
aji-33	182	6	may	may	AUX
aji-33	182	7	refer	refer	VERB
aji-33	182	8	to	to	ADP
aji-33	182	9	the	the	DET
aji-33	182	10	reference	reference	NOUN
aji-33	182	11	suggested	suggest	VERB
aji-33	182	12	.	.	PUNCT
aji-33	183	1	1	1	X
aji-33	183	2	.	.	X
aji-33	183	3	bilateral	bilateral	ADJ
aji-33	183	4	ground	ground	NOUN
aji-33	183	5	glass	glass	NOUN
aji-33	183	6	appearance	appearance	NOUN
aji-33	183	7	which	which	PRON
aji-33	183	8	are	be	AUX
aji-33	183	9	round	round	ADJ
aji-33	183	10	in	in	ADP
aji-33	183	11	50	50	NUM
aji-33	183	12	%	%	NOUN
aji-33	183	13	cases	case	NOUN
aji-33	183	14	.	.	PUNCT
aji-33	184	1	they	they	PRON
aji-33	184	2	are	be	AUX
aji-33	184	3	called	call	VERB
aji-33	184	4	covid	covid	PROPN
aji-33	184	5	balls	ball	NOUN
aji-33	184	6	2	2	NUM
aji-33	184	7	.	.	PUNCT
aji-33	184	8	areas	area	NOUN
aji-33	184	9	of	of	ADP
aji-33	184	10	focal	focal	ADJ
aji-33	184	11	consolidation	consolidation	NOUN
aji-33	184	12	.	.	PUNCT
aji-33	185	1	3	3	X
aji-33	185	2	.	.	X
aji-33	185	3	crazy	crazy	ADJ
aji-33	185	4	paving	paving	NOUN
aji-33	185	5	pattern	pattern	NOUN
aji-33	185	6	resulting	result	VERB
aji-33	185	7	from	from	ADP
aji-33	185	8	intralobular	intralobular	ADJ
aji-33	185	9	reticulations	reticulation	NOUN
aji-33	185	10	.	.	PUNCT
aji-33	186	1	4	4	X
aji-33	186	2	.	.	X
aji-33	186	3	late	late	ADJ
aji-33	186	4	signs	sign	NOUN
aji-33	186	5	:	:	PUNCT
aji-33	186	6	signs	sign	NOUN
aji-33	186	7	suggesting	suggest	VERB
aji-33	186	8	organizing	organize	VERB
aji-33	186	9	pneumonia	pneumonia	NOUN
aji-33	186	10	.	.	PUNCT
aji-33	187	1	1	1	X
aji-33	187	2	.	.	PUNCT
aji-33	187	3	linear	linear	ADJ
aji-33	187	4	consolidations	consolidation	NOUN
aji-33	187	5	2	2	NUM
aji-33	187	6	.	.	X
aji-33	187	7	reverse	reverse	VERB
aji-33	187	8	halo	halo	NOUN
aji-33	187	9	sign	sign	NOUN
aji-33	187	10	i.e.	i.e.	X
aji-33	187	11	,	,	PUNCT
aji-33	187	12	areas	area	NOUN
aji-33	187	13	of	of	ADP
aji-33	187	14	groundglass	groundglass	PROPN
aji-33	187	15	surrounded	surround	VERB
aji-33	187	16	by	by	ADP
aji-33	187	17	peripheral	peripheral	ADJ
aji-33	187	18	consolidation	consolidation	NOUN
aji-33	187	19	.	.	PUNCT
aji-33	188	1	study	study	NOUN
aji-33	188	2	by	by	ADP
aji-33	188	3	salehi	salehi	PROPN
aji-33	188	4	et	et	PROPN
aji-33	188	5	al	al	PROPN
aji-33	188	6	.	.	PROPN
aji-33	188	7	revealed	reveal	VERB
aji-33	188	8	that	that	SCONJ
aji-33	188	9	the	the	DET
aji-33	188	10	frequencies	frequency	NOUN
aji-33	188	11	of	of	ADP
aji-33	188	12	the	the	DET
aji-33	188	13	different	different	ADJ
aji-33	188	14	ct	ct	NOUN
aji-33	188	15	abnormalities	abnormality	NOUN
aji-33	188	16	were	be	AUX
aji-33	188	17	as	as	SCONJ
aji-33	188	18	follows	follow	VERB
aji-33	188	19	:	:	PUNCT
aji-33	188	20	ggo	ggo	PROPN
aji-33	188	21	(	(	PUNCT
aji-33	188	22	central	central	ADJ
aji-33	188	23	ground	ground	NOUN
aji-33	188	24	glass	glass	NOUN
aji-33	188	25	opacity	opacity	NOUN
aji-33	188	26	)	)	PUNCT
aji-33	188	27	was	be	AUX
aji-33	188	28	observed	observe	VERB
aji-33	188	29	in	in	ADP
aji-33	188	30	88.0	88.0	NUM
aji-33	188	31	%	%	NOUN
aji-33	188	32	of	of	ADP
aji-33	188	33	patients	patient	NOUN
aji-33	188	34	,	,	PUNCT
aji-33	188	35	consolidation	consolidation	NOUN
aji-33	188	36	in	in	ADP
aji-33	188	37	31.8	31.8	NUM
aji-33	188	38	%	%	NOUN
aji-33	188	39	,	,	PUNCT
aji-33	188	40	bilateral	bilateral	ADJ
aji-33	188	41	involvement	involvement	NOUN
aji-33	188	42	in	in	ADP
aji-33	188	43	87.5	87.5	NUM
aji-33	188	44	%	%	NOUN
aji-33	188	45	and	and	CCONJ
aji-33	188	46	peripheral	peripheral	ADJ
aji-33	188	47	distribution	distribution	NOUN
aji-33	188	48	in	in	ADP
aji-33	188	49	76.0	76.0	NUM
aji-33	188	50	%	%	NOUN
aji-33	188	51	of	of	ADP
aji-33	188	52	patients	patient	NOUN
aji-33	188	53	[	[	X
aji-33	188	54	13	13	NUM
aji-33	188	55	]	]	PUNCT
aji-33	188	56	.	.	PUNCT
aji-33	189	1	guan	guan	PROPN
aji-33	189	2	cs	cs	PROPN
aji-33	189	3	,	,	PUNCT
aji-33	189	4	et	et	PROPN
aji-33	189	5	al	al	PROPN
aji-33	189	6	.	.	PROPN
aji-33	189	7	(	(	PUNCT
aji-33	189	8	2020	2020	NUM
aji-33	189	9	)	)	PUNCT
aji-33	189	10	assert	assert	VERB
aji-33	189	11	that	that	SCONJ
aji-33	189	12	“	"	PUNCT
aji-33	189	13	ground	ground	NOUN
aji-33	189	14	-	-	PUNCT
aji-33	189	15	glass	glass	NOUN
aji-33	189	16	opacities	opacity	NOUN
aji-33	189	17	may	may	AUX
aji-33	189	18	be	be	AUX
aji-33	189	19	due	due	ADJ
aji-33	189	20	to	to	ADP
aji-33	189	21	mild	mild	ADJ
aji-33	189	22	oedema	oedema	NOUN
aji-33	189	23	of	of	ADP
aji-33	189	24	the	the	DET
aji-33	189	25	alveolar	alveolar	ADJ
aji-33	189	26	septi	septi	NOUN
aji-33	189	27	,	,	PUNCT
aji-33	189	28	hyperplasia	hyperplasia	NOUN
aji-33	189	29	of	of	ADP
aji-33	189	30	the	the	DET
aji-33	189	31	interstitium	interstitium	NOUN
aji-33	189	32	,	,	PUNCT
aji-33	189	33	partial	partial	ADJ
aji-33	189	34	filling	filling	NOUN
aji-33	189	35	of	of	ADP
aji-33	189	36	airspaces	airspace	NOUN
aji-33	189	37	,	,	PUNCT
aji-33	189	38	or	or	CCONJ
aji-33	189	39	a	a	DET
aji-33	189	40	combination	combination	NOUN
aji-33	189	41	of	of	ADP
aji-33	189	42	these	these	DET
aji-33	189	43	features	feature	NOUN
aji-33	189	44	.	.	PUNCT
aji-33	190	1	besides	besides	SCONJ
aji-33	190	2	,	,	PUNCT
aji-33	190	3	the	the	DET
aji-33	190	4	crazy	crazy	ADV
aji-33	190	5	-	-	PUNCT
aji-33	190	6	paving	pave	VERB
aji-33	190	7	pattern	pattern	NOUN
aji-33	190	8	may	may	AUX
aji-33	190	9	correlate	correlate	VERB
aji-33	190	10	with	with	ADP
aji-33	190	11	hyperplasia	hyperplasia	NOUN
aji-33	190	12	of	of	ADP
aji-33	190	13	interlobular	interlobular	NOUN
aji-33	190	14	and	and	CCONJ
aji-33	190	15	intralobular	intralobular	ADJ
aji-33	190	16	interstitia	interstitia	NOUN
aji-33	190	17	”	"	PUNCT
aji-33	191	1	[	[	X
aji-33	191	2	14	14	NUM
aji-33	191	3	]	]	PUNCT
aji-33	191	4	.	.	PUNCT
aji-33	192	1	the	the	DET
aji-33	192	2	two	two	NUM
aji-33	192	3	radiological	radiological	ADJ
aji-33	192	4	features	feature	NOUN
aji-33	192	5	still	still	ADV
aji-33	192	6	alluding	allude	VERB
aji-33	192	7	explanation	explanation	NOUN
aji-33	192	8	are	be	AUX
aji-33	192	9	1	1	NUM
aji-33	192	10	.	.	NOUN
aji-33	193	1	peripheral	peripheral	ADJ
aji-33	193	2	and	and	CCONJ
aji-33	193	3	subpleural	subpleural	ADJ
aji-33	193	4	distribution	distribution	NOUN
aji-33	193	5	2	2	NUM
aji-33	193	6	.	.	PUNCT
aji-33	193	7	bilateral	bilateral	ADJ
aji-33	193	8	lower	low	ADJ
aji-33	193	9	lobe	lobe	PROPN
aji-33	193	10	involvement	involvement	NOUN
aji-33	193	11	autopsy	autopsy	ADJ
aji-33	193	12	findings	finding	NOUN
aji-33	193	13	:	:	PUNCT
aji-33	193	14	xu	xu	PROPN
aji-33	193	15	,	,	PUNCT
aji-33	193	16	l.	l.	PROPN
aji-33	193	17	shi	shi	PROPN
aji-33	193	18	,	,	PUNCT
aji-33	193	19	y.	y.	PROPN
aji-33	193	20	wang	wang	PROPN
aji-33	193	21	,	,	PUNCT
aji-33	193	22	et	et	PROPN
aji-33	193	23	al	al	PROPN
aji-33	193	24	.	.	PUNCT
aji-33	194	1	[	[	X
aji-33	194	2	15	15	NUM
aji-33	194	3	]	]	PUNCT
aji-33	194	4	described	describe	VERB
aji-33	194	5	in	in	ADP
aji-33	194	6	detail	detail	NOUN
aji-33	194	7	,	,	PUNCT
aji-33	194	8	the	the	DET
aji-33	194	9	post	post	ADJ
aji-33	194	10	-	-	ADJ
aji-33	194	11	mortem	mortem	ADJ
aji-33	194	12	findings	finding	NOUN
aji-33	194	13	of	of	ADP
aji-33	194	14	covid	covid	PROPN
aji-33	194	15	19	19	NUM
aji-33	194	16	.	.	PUNCT
aji-33	194	17	gross	gross	ADJ
aji-33	194	18	pathology	pathology	NOUN
aji-33	194	19	:	:	PUNCT
aji-33	194	20	the	the	DET
aji-33	194	21	lungs	lung	NOUN
aji-33	194	22	are	be	AUX
aji-33	194	23	firm	firm	ADJ
aji-33	194	24	and	and	CCONJ
aji-33	194	25	increased	increase	VERB
aji-33	194	26	in	in	ADP
aji-33	194	27	weight	weight	NOUN
aji-33	194	28	and	and	CCONJ
aji-33	194	29	laden	laden	ADJ
aji-33	194	30	with	with	ADP
aji-33	194	31	secretions	secretion	NOUN
aji-33	194	32	and	and	CCONJ
aji-33	194	33	exudate	exudate	VERB
aji-33	194	34	.	.	PUNCT
aji-33	195	1	both	both	CCONJ
aji-33	195	2	the	the	DET
aji-33	195	3	surface	surface	NOUN
aji-33	195	4	of	of	ADP
aji-33	195	5	lung	lung	NOUN
aji-33	195	6	and	and	CCONJ
aji-33	195	7	the	the	DET
aji-33	195	8	cut	cut	NOUN
aji-33	195	9	section	section	NOUN
aji-33	195	10	showed	show	VERB
aji-33	195	11	,	,	PUNCT
aji-33	195	12	patchy	patchy	ADJ
aji-33	195	13	areas	area	NOUN
aji-33	195	14	of	of	ADP
aji-33	195	15	haemorrhage	haemorrhage	NOUN
aji-33	195	16	.	.	PUNCT
aji-33	196	1	microscopic	microscopic	PROPN
aji-33	196	2	findings	finding	NOUN
aji-33	196	3	:	:	PUNCT
aji-33	196	4	these	these	PRON
aji-33	196	5	can	can	AUX
aji-33	196	6	be	be	AUX
aji-33	196	7	grouped	group	VERB
aji-33	196	8	as	as	ADP
aji-33	196	9	cellular	cellular	ADJ
aji-33	196	10	,	,	PUNCT
aji-33	196	11	vascular	vascular	ADJ
aji-33	196	12	and	and	CCONJ
aji-33	196	13	other	other	ADJ
aji-33	196	14	features	feature	NOUN
aji-33	196	15	.	.	PUNCT
aji-33	197	1	prasad	prasad	PROPN
aji-33	197	2	;	;	PUNCT
aji-33	197	3	aji	aji	NOUN
aji-33	197	4	,	,	PUNCT
aji-33	197	5	3(1	3(1	NUM
aji-33	197	6	):	):	PUNCT
aji-33	197	7	233	233	NUM
aji-33	197	8	-	-	SYM
aji-33	197	9	252	252	NUM
aji-33	197	10	,	,	PUNCT
aji-33	197	11	2020	2020	NUM
aji-33	197	12	;	;	PUNCT
aji-33	197	13	article	article	NOUN
aji-33	197	14	no.aji.58422	no.aji.58422	NOUN
aji-33	197	15	236	236	NUM
aji-33	197	16	the	the	DET
aji-33	197	17	cellular	cellular	ADJ
aji-33	197	18	exudate	exudate	NOUN
aji-33	197	19	consisted	consist	VERB
aji-33	197	20	of	of	ADP
aji-33	197	21	cd4	cd4	PROPN
aji-33	197	22	+	+	PROPN
aji-33	197	23	and	and	CCONJ
aji-33	197	24	cd8	cd8	PROPN
aji-33	197	25	+	+	PROPN
aji-33	197	26	lymphocytes	lymphocyte	NOUN
aji-33	197	27	in	in	ADP
aji-33	197	28	the	the	DET
aji-33	197	29	lung	lung	NOUN
aji-33	197	30	tissue	tissue	NOUN
aji-33	197	31	and	and	CCONJ
aji-33	197	32	interstetium	interstetium	NOUN
aji-33	197	33	and	and	CCONJ
aji-33	197	34	with	with	ADP
aji-33	197	35	some	some	DET
aji-33	197	36	perivascular	perivascular	ADJ
aji-33	197	37	collection	collection	NOUN
aji-33	197	38	.	.	PUNCT
aji-33	198	1	also	also	ADV
aji-33	198	2	present	present	ADJ
aji-33	198	3	are	be	AUX
aji-33	198	4	platelet	platelet	NOUN
aji-33	198	5	cells	cell	NOUN
aji-33	198	6	,	,	PUNCT
aji-33	198	7	65	65	NUM
aji-33	198	8	+	+	CCONJ
aji-33	198	9	atypical	atypical	ADJ
aji-33	198	10	megakaryocytes	megakaryocyte	NOUN
aji-33	198	11	and	and	CCONJ
aji-33	198	12	desquamated	desquamate	VERB
aji-33	198	13	type	type	NOUN
aji-33	198	14	2	2	NUM
aji-33	198	15	pneumatocytes	pneumatocyte	NOUN
aji-33	198	16	showing	show	VERB
aji-33	198	17	cytopathic	cytopathic	ADJ
aji-33	198	18	effect	effect	NOUN
aji-33	198	19	.	.	PUNCT
aji-33	199	1	neutrophils	neutrophil	NOUN
aji-33	199	2	are	be	AUX
aji-33	199	3	absent	absent	ADJ
aji-33	199	4	except	except	SCONJ
aji-33	199	5	in	in	ADP
aji-33	199	6	the	the	DET
aji-33	199	7	immunosuppressed	immunosuppressed	ADJ
aji-33	199	8	case	case	NOUN
aji-33	199	9	.	.	PUNCT
aji-33	200	1	vascular	vascular	ADJ
aji-33	200	2	features	feature	NOUN
aji-33	200	3	:	:	PUNCT
aji-33	200	4	small	small	ADJ
aji-33	200	5	blood	blood	NOUN
aji-33	200	6	vessels	vessel	NOUN
aji-33	200	7	(	(	PUNCT
aji-33	200	8	capillaries	capillary	NOUN
aji-33	200	9	)	)	PUNCT
aji-33	200	10	are	be	AUX
aji-33	200	11	found	find	VERB
aji-33	200	12	to	to	PART
aji-33	200	13	be	be	AUX
aji-33	200	14	thickened	thicken	VERB
aji-33	200	15	,	,	PUNCT
aji-33	200	16	with	with	ADP
aji-33	200	17	oedematous	oedematous	ADJ
aji-33	200	18	walls	wall	NOUN
aji-33	200	19	,	,	PUNCT
aji-33	200	20	dilated	dilate	VERB
aji-33	200	21	and	and	CCONJ
aji-33	200	22	showed	show	VERB
aji-33	200	23	increased	increase	VERB
aji-33	200	24	permeability	permeability	NOUN
aji-33	200	25	with	with	ADP
aji-33	200	26	consequent	consequent	ADJ
aji-33	200	27	seepage	seepage	NOUN
aji-33	200	28	of	of	ADP
aji-33	200	29	plasma	plasma	NOUN
aji-33	200	30	into	into	ADP
aji-33	200	31	the	the	DET
aji-33	200	32	lung	lung	NOUN
aji-33	200	33	tissue	tissue	NOUN
aji-33	200	34	.	.	PUNCT
aji-33	201	1	there	there	PRON
aji-33	201	2	is	be	VERB
aji-33	201	3	lymphocytic	lymphocytic	ADJ
aji-33	201	4	accumulation	accumulation	NOUN
aji-33	201	5	around	around	ADP
aji-33	201	6	the	the	DET
aji-33	201	7	capillaries	capillary	NOUN
aji-33	201	8	and	and	CCONJ
aji-33	201	9	micro	micro	PROPN
aji-33	201	10	throbi	throbi	PROPN
aji-33	201	11	inside	inside	ADP
aji-33	201	12	the	the	DET
aji-33	201	13	capillaries	capillary	NOUN
aji-33	201	14	.	.	PUNCT
aji-33	202	1	the	the	DET
aji-33	202	2	bigger	big	ADJ
aji-33	202	3	pulmonary	pulmonary	ADJ
aji-33	202	4	vessels	vessel	NOUN
aji-33	202	5	near	near	ADP
aji-33	202	6	hilum	hilum	NOUN
aji-33	202	7	are	be	AUX
aji-33	202	8	not	not	PART
aji-33	202	9	affected	affect	VERB
aji-33	202	10	.	.	PUNCT
aji-33	203	1	2.3	2.3	NUM
aji-33	203	2	other	other	ADJ
aji-33	203	3	autopsy	autopsy	ADJ
aji-33	203	4	findings	finding	NOUN
aji-33	203	5	1	1	NUM
aji-33	203	6	.	.	PUNCT
aji-33	203	7	focal	focal	ADJ
aji-33	203	8	presence	presence	NOUN
aji-33	203	9	of	of	ADP
aji-33	203	10	haemorrhagic	haemorrhagic	NOUN
aji-33	203	11	.	.	PUNCT
aji-33	204	1	patches	patch	NOUN
aji-33	204	2	,	,	PUNCT
aji-33	204	3	both	both	CCONJ
aji-33	204	4	in	in	ADP
aji-33	204	5	gross	gross	ADJ
aji-33	204	6	appearance	appearance	NOUN
aji-33	204	7	and	and	CCONJ
aji-33	204	8	cut	cut	VERB
aji-33	204	9	section	section	NOUN
aji-33	204	10	of	of	ADP
aji-33	204	11	lung	lung	NOUN
aji-33	204	12	.	.	PUNCT
aji-33	205	1	2	2	X
aji-33	205	2	.	.	X
aji-33	205	3	focal	focal	ADJ
aji-33	205	4	greyare	greyare	NOUN
aji-33	205	5	as	as	ADP
aji-33	205	6	of	of	ADP
aji-33	205	7	consolidation	consolidation	NOUN
aji-33	205	8	3	3	NUM
aji-33	205	9	.	.	PUNCT
aji-33	205	10	presence	presence	NOUN
aji-33	205	11	of	of	ADP
aji-33	205	12	clots	clot	NOUN
aji-33	205	13	in	in	ADP
aji-33	205	14	the	the	DET
aji-33	205	15	lung	lung	NOUN
aji-33	205	16	tissue	tissue	NOUN
aji-33	205	17	.	.	PUNCT
aji-33	206	1	4	4	X
aji-33	206	2	.	.	NUM
aji-33	206	3	scattered	scatter	VERB
aji-33	206	4	hyaline	hyaline	ADJ
aji-33	206	5	membrane	membrane	NOUN
aji-33	206	6	and	and	CCONJ
aji-33	206	7	fibrin	fibrin	NOUN
aji-33	206	8	threads	thread	NOUN
aji-33	206	9	.	.	PUNCT
aji-33	207	1	3	3	X
aji-33	207	2	.	.	X
aji-33	207	3	laboratory	laboratory	NOUN
aji-33	207	4	data	datum	NOUN
aji-33	207	5	the	the	DET
aji-33	207	6	laboratory	laboratory	NOUN
aji-33	207	7	tests	test	NOUN
aji-33	207	8	found	find	VERB
aji-33	207	9	to	to	PART
aji-33	207	10	be	be	AUX
aji-33	207	11	positive	positive	ADJ
aji-33	207	12	in	in	ADP
aji-33	207	13	covid	covid	PROPN
aji-33	207	14	19	19	NUM
aji-33	207	15	also	also	ADV
aji-33	207	16	give	give	VERB
aji-33	207	17	some	some	DET
aji-33	207	18	clues	clue	NOUN
aji-33	207	19	as	as	ADP
aji-33	207	20	to	to	ADP
aji-33	207	21	the	the	DET
aji-33	207	22	underlying	underlying	ADJ
aji-33	207	23	mechanisms	mechanism	NOUN
aji-33	207	24	involved	involve	VERB
aji-33	207	25	in	in	ADP
aji-33	207	26	the	the	DET
aji-33	207	27	pathology	pathology	NOUN
aji-33	207	28	and	and	CCONJ
aji-33	207	29	parthenogenesis	parthenogenesis	NOUN
aji-33	207	30	of	of	ADP
aji-33	207	31	covid	covid	PROPN
aji-33	207	32	19	19	NUM
aji-33	207	33	,	,	PUNCT
aji-33	207	34	if	if	SCONJ
aji-33	207	35	interpreted	interpret	VERB
aji-33	207	36	properly	properly	ADV
aji-33	207	37	.	.	PUNCT
aji-33	208	1	the	the	DET
aji-33	208	2	involvement	involvement	NOUN
aji-33	208	3	of	of	ADP
aji-33	208	4	liver	liver	NOUN
aji-33	208	5	,	,	PUNCT
aji-33	208	6	kidney	kidney	NOUN
aji-33	208	7	,	,	PUNCT
aji-33	208	8	and	and	CCONJ
aji-33	208	9	heart	heart	NOUN
aji-33	208	10	is	be	AUX
aji-33	208	11	indicated	indicate	VERB
aji-33	208	12	by	by	ADP
aji-33	208	13	the	the	DET
aji-33	208	14	increase	increase	NOUN
aji-33	208	15	in	in	ADP
aji-33	208	16	lab	lab	NOUN
aji-33	208	17	findings	finding	NOUN
aji-33	208	18	pointing	point	VERB
aji-33	208	19	in	in	ADP
aji-33	208	20	that	that	DET
aji-33	208	21	direction	direction	NOUN
aji-33	208	22	.	.	PUNCT
aji-33	209	1	probably	probably	ADV
aji-33	209	2	they	they	PRON
aji-33	209	3	represent	represent	VERB
aji-33	209	4	subclinical	subclinical	ADJ
aji-33	209	5	involvement	involvement	NOUN
aji-33	209	6	of	of	ADP
aji-33	209	7	the	the	DET
aji-33	209	8	organs	organ	NOUN
aji-33	209	9	concerned	concern	VERB
aji-33	209	10	,	,	PUNCT
aji-33	209	11	as	as	SCONJ
aji-33	209	12	overt	overt	ADJ
aji-33	209	13	manifestation	manifestation	NOUN
aji-33	209	14	of	of	ADP
aji-33	209	15	their	their	PRON
aji-33	209	16	involvement	involvement	NOUN
aji-33	209	17	is	be	AUX
aji-33	209	18	seen	see	VERB
aji-33	209	19	only	only	ADV
aji-33	209	20	in	in	ADP
aji-33	209	21	a	a	DET
aji-33	209	22	few	few	ADJ
aji-33	209	23	of	of	ADP
aji-33	209	24	the	the	DET
aji-33	209	25	patients	patient	NOUN
aji-33	209	26	and	and	CCONJ
aji-33	209	27	some	some	PRON
aji-33	209	28	in	in	ADP
aji-33	209	29	the	the	DET
aji-33	209	30	later	later	ADJ
aji-33	209	31	phase	phase	NOUN
aji-33	209	32	than	than	ADP
aji-33	209	33	earlier	early	ADJ
aji-33	209	34	phage	phage	NOUN
aji-33	209	35	of	of	ADP
aji-33	209	36	the	the	DET
aji-33	209	37	disease	disease	NOUN
aji-33	209	38	evolution	evolution	NOUN
aji-33	209	39	.	.	PUNCT
aji-33	210	1	leuko	leuko	ADJ
aji-33	210	2	-	-	PUNCT
aji-33	210	3	erythroblastic	erythroblastic	PROPN
aji-33	210	4	reaction	reaction	NOUN
aji-33	210	5	reported	report	VERB
aji-33	210	6	by	by	ADP
aji-33	210	7	some	some	PRON
aji-33	210	8	is	be	AUX
aji-33	210	9	a	a	DET
aji-33	210	10	finding	finding	NOUN
aji-33	210	11	that	that	PRON
aji-33	210	12	needs	need	VERB
aji-33	210	13	to	to	PART
aji-33	210	14	be	be	AUX
aji-33	210	15	investigated.the	investigated.the	DET
aji-33	210	16	same	same	ADJ
aji-33	210	17	is	be	AUX
aji-33	210	18	explained	explain	VERB
aji-33	210	19	as	as	ADP
aji-33	210	20	probable	probable	ADJ
aji-33	210	21	involvement	involvement	NOUN
aji-33	210	22	of	of	ADP
aji-33	210	23	bone	bone	NOUN
aji-33	210	24	marrowis	marrowis	NOUN
aji-33	210	25	the	the	DET
aji-33	210	26	increased	increase	VERB
aji-33	210	27	prothrombin	prothrombin	NOUN
aji-33	210	28	time	time	NOUN
aji-33	210	29	(	(	PUNCT
aji-33	210	30	pt	pt	NOUN
aji-33	210	31	)	)	PUNCT
aji-33	210	32	indicates	indicate	VERB
aji-33	210	33	the	the	DET
aji-33	210	34	involvement	involvement	NOUN
aji-33	210	35	of	of	ADP
aji-33	210	36	the	the	DET
aji-33	210	37	extrinsic	extrinsic	ADJ
aji-33	210	38	coagulative	coagulative	NOUN
aji-33	210	39	pathway	pathway	NOUN
aji-33	210	40	as	as	ADP
aji-33	210	41	the	the	DET
aji-33	210	42	cause	cause	NOUN
aji-33	210	43	of	of	ADP
aji-33	210	44	thrombotic	thrombotic	ADJ
aji-33	210	45	phenomena	phenomenon	NOUN
aji-33	210	46	observed	observe	VERB
aji-33	210	47	in	in	ADP
aji-33	210	48	the	the	DET
aji-33	210	49	small	small	ADJ
aji-33	210	50	blood	blood	NOUN
aji-33	210	51	vessels	vessel	NOUN
aji-33	210	52	at	at	ADP
aji-33	210	53	autopsy	autopsy	ADJ
aji-33	210	54	.	.	PUNCT
aji-33	211	1	the	the	DET
aji-33	211	2	presence	presence	NOUN
aji-33	211	3	of	of	ADP
aji-33	211	4	d	d	PROPN
aji-33	211	5	dimers	dimer	NOUN
aji-33	211	6	,	,	PUNCT
aji-33	211	7	fdp	fdp	VERB
aji-33	211	8	,	,	PUNCT
aji-33	211	9	to	to	ADP
aji-33	211	10	the	the	DET
aji-33	211	11	underlying	underlie	VERB
aji-33	211	12	thrombolytic	thrombolytic	ADJ
aji-33	211	13	(	(	PUNCT
aji-33	211	14	fibrinolytic	fibrinolytic	ADJ
aji-33	211	15	)	)	PUNCT
aji-33	211	16	process	process	NOUN
aji-33	211	17	involving	involve	VERB
aji-33	211	18	capillaries	capillary	NOUN
aji-33	211	19	of	of	ADP
aji-33	211	20	the	the	DET
aji-33	211	21	lungs	lung	NOUN
aji-33	211	22	.	.	PUNCT
aji-33	211	23	of	of	ADP
aji-33	211	24	interest	interest	NOUN
aji-33	211	25	,	,	PUNCT
aji-33	211	26	is	be	AUX
aji-33	211	27	the	the	DET
aji-33	211	28	observation	observation	NOUN
aji-33	211	29	of	of	ADP
aji-33	211	30	lymphopenia	lymphopenia	NOUN
aji-33	211	31	whereas	whereas	SCONJ
aji-33	211	32	lymphocytosis	lymphocytosis	NOUN
aji-33	211	33	is	be	AUX
aji-33	211	34	commonly	commonly	ADV
aji-33	211	35	seen	see	VERB
aji-33	211	36	in	in	ADP
aji-33	211	37	all	all	DET
aji-33	211	38	other	other	ADJ
aji-33	211	39	viral	viral	ADJ
aji-33	211	40	infections	infection	NOUN
aji-33	211	41	.	.	PUNCT
aji-33	212	1	the	the	DET
aji-33	212	2	lymphopenia	lymphopenia	NOUN
aji-33	212	3	is	be	AUX
aji-33	212	4	connected	connect	VERB
aji-33	212	5	to	to	ADP
aji-33	212	6	increased	increase	VERB
aji-33	212	7	severity	severity	NOUN
aji-33	212	8	/	/	SYM
aji-33	212	9	mortality	mortality	NOUN
aji-33	212	10	in	in	ADP
aji-33	212	11	covid	covid	PROPN
aji-33	212	12	19	19	NUM
aji-33	212	13	patients	patient	NOUN
aji-33	212	14	.	.	PUNCT
aji-33	213	1	the	the	DET
aji-33	213	2	lab	lab	NOUN
aji-33	213	3	parameters	parameter	NOUN
aji-33	213	4	also	also	ADV
aji-33	213	5	vary	vary	VERB
aji-33	213	6	as	as	SCONJ
aji-33	213	7	the	the	DET
aji-33	213	8	disease	disease	NOUN
aji-33	213	9	progresses	progress	VERB
aji-33	213	10	.	.	PUNCT
aji-33	214	1	the	the	DET
aji-33	214	2	platelets	platelet	NOUN
aji-33	214	3	,	,	PUNCT
aji-33	214	4	the	the	DET
aji-33	214	5	neutrophils	neutrophil	NOUN
aji-33	214	6	and	and	CCONJ
aji-33	214	7	cd8+t	cd8+t	NOUN
aji-33	214	8	cells	cell	NOUN
aji-33	214	9	are	be	AUX
aji-33	214	10	found	find	VERB
aji-33	214	11	to	to	PART
aji-33	214	12	be	be	AUX
aji-33	214	13	normal	normal	ADJ
aji-33	214	14	in	in	ADP
aji-33	214	15	patients	patient	NOUN
aji-33	214	16	not	not	PART
aji-33	214	17	admitted	admit	VERB
aji-33	214	18	to	to	ADP
aji-33	214	19	icu	icu	PROPN
aji-33	214	20	,	,	PUNCT
aji-33	214	21	where	where	SCONJ
aji-33	214	22	as	as	ADP
aji-33	214	23	neutrophilia	neutrophilia	PROPN
aji-33	214	24	and	and	CCONJ
aji-33	214	25	low	low	ADJ
aji-33	214	26	platelets	platelet	NOUN
aji-33	214	27	and	and	CCONJ
aji-33	214	28	cd	cd	PROPN
aji-33	214	29	8	8	NUM
aji-33	214	30	+	+	NOUN
aji-33	214	31	t	t	NOUN
aji-33	214	32	cells	cell	NOUN
aji-33	214	33	counts	count	NOUN
aji-33	214	34	are	be	AUX
aji-33	214	35	seen	see	VERB
aji-33	214	36	in	in	ADP
aji-33	214	37	icu	icu	PROPN
aji-33	214	38	pts	pt	NOUN
aji-33	214	39	.	.	PUNCT
aji-33	215	1	the	the	DET
aji-33	215	2	icu	icu	PROPN
aji-33	215	3	patients	patient	NOUN
aji-33	215	4	have	have	AUX
aji-33	215	5	increased	increase	VERB
aji-33	215	6	risk	risk	NOUN
aji-33	215	7	of	of	ADP
aji-33	215	8	complications	complication	NOUN
aji-33	215	9	and	and	CCONJ
aji-33	215	10	mortality	mortality	NOUN
aji-33	215	11	.	.	PUNCT
aji-33	216	1	the	the	DET
aji-33	216	2	risk	risk	NOUN
aji-33	216	3	stratification	stratification	NOUN
aji-33	216	4	of	of	ADP
aji-33	216	5	covid	covid	PROPN
aji-33	216	6	19	19	NUM
aji-33	216	7	pneumonia	pneumonia	NOUN
aji-33	216	8	patients	patient	NOUN
aji-33	216	9	has	have	AUX
aji-33	216	10	been	be	AUX
aji-33	216	11	analyzed	analyze	VERB
aji-33	216	12	by	by	ADP
aji-33	216	13	janusz	janusz	PROPN
aji-33	216	14	jankowski	jankowski	PROPN
aji-33	216	15	t	t	PROPN
aji-33	216	16	al	al	PROPN
aji-33	216	17	.	.	PUNCT
aji-33	217	1	the	the	DET
aji-33	217	2	lab	lab	NOUN
aji-33	217	3	tests	test	NOUN
aji-33	217	4	found	find	VERB
aji-33	217	5	positive	positive	ADJ
aji-33	217	6	in	in	ADP
aji-33	217	7	covid	covid	PROPN
aji-33	217	8	19	19	NUM
aji-33	217	9	patients	patient	NOUN
aji-33	217	10	irrespective	irrespective	ADV
aji-33	217	11	of	of	ADP
aji-33	217	12	their	their	PRON
aji-33	217	13	stage	stage	NOUN
aji-33	217	14	of	of	ADP
aji-33	217	15	disease	disease	NOUN
aji-33	217	16	,	,	PUNCT
aji-33	217	17	and	and	CCONJ
aji-33	217	18	what	what	PRON
aji-33	217	19	they	they	PRON
aji-33	217	20	suggest	suggest	VERB
aji-33	217	21	are	be	AUX
aji-33	217	22	tabulated	tabulate	VERB
aji-33	217	23	and	and	CCONJ
aji-33	217	24	presented	present	VERB
aji-33	217	25	in	in	ADP
aji-33	217	26	appendix	appendix	NOUN
aji-33	217	27	3	3	NUM
aji-33	217	28	.	.	NOUN
aji-33	217	29	4	4	NUM
aji-33	217	30	.	.	X
aji-33	217	31	discussion	discussion	NOUN
aji-33	217	32	any	any	DET
aji-33	217	33	envisaged	envisage	VERB
aji-33	217	34	pathogenic	pathogenic	ADJ
aji-33	217	35	mechanism	mechanism	NOUN
aji-33	217	36	should	should	AUX
aji-33	217	37	explain	explain	VERB
aji-33	217	38	all	all	DET
aji-33	217	39	the	the	DET
aji-33	217	40	clues	clue	NOUN
aji-33	217	41	available	available	ADJ
aji-33	217	42	from	from	ADP
aji-33	217	43	the	the	DET
aji-33	217	44	clinicopathological	clinicopathological	ADJ
aji-33	217	45	data	datum	NOUN
aji-33	217	46	reviewed	review	VERB
aji-33	217	47	above	above	ADV
aji-33	217	48	.	.	PUNCT
aji-33	218	1	to	to	PART
aji-33	218	2	put	put	VERB
aji-33	218	3	it	it	PRON
aji-33	218	4	succinctly	succinctly	ADV
aji-33	218	5	,	,	PUNCT
aji-33	218	6	such	such	ADJ
aji-33	218	7	concept	concept	NOUN
aji-33	218	8	has	have	VERB
aji-33	218	9	a	a	DET
aji-33	218	10	clear	clear	ADJ
aji-33	218	11	beginning	beginning	NOUN
aji-33	218	12	(	(	PUNCT
aji-33	218	13	in	in	ADP
aji-33	218	14	the	the	DET
aji-33	218	15	form	form	NOUN
aji-33	218	16	of	of	ADP
aji-33	218	17	virus	virus	NOUN
aji-33	218	18	-	-	PUNCT
aji-33	218	19	host	host	NOUN
aji-33	218	20	interaction	interaction	NOUN
aji-33	218	21	)	)	PUNCT
aji-33	218	22	a	a	DET
aji-33	218	23	clear	clear	ADJ
aji-33	218	24	destination	destination	NOUN
aji-33	218	25	(	(	PUNCT
aji-33	218	26	the	the	DET
aji-33	218	27	pathology	pathology	NOUN
aji-33	218	28	elucidated	elucidate	VERB
aji-33	218	29	by	by	ADP
aji-33	218	30	autopsy	autopsy	ADJ
aji-33	218	31	findings	finding	NOUN
aji-33	218	32	)	)	PUNCT
aji-33	218	33	,	,	PUNCT
aji-33	218	34	a	a	DET
aji-33	218	35	clear	clear	ADJ
aji-33	218	36	source	source	NOUN
aji-33	218	37	(	(	PUNCT
aji-33	218	38	the	the	DET
aji-33	218	39	normal	normal	ADJ
aji-33	218	40	physiological	physiological	ADJ
aji-33	218	41	mechanisms	mechanism	NOUN
aji-33	218	42	)	)	PUNCT
aji-33	218	43	.	.	PUNCT
aji-33	219	1	what	what	PRON
aji-33	219	2	is	be	AUX
aji-33	219	3	to	to	PART
aji-33	219	4	be	be	AUX
aji-33	219	5	clinched	clinch	VERB
aji-33	219	6	is	be	AUX
aji-33	219	7	the	the	DET
aji-33	219	8	means	mean	NOUN
aji-33	219	9	by	by	ADP
aji-33	219	10	which	which	PRON
aji-33	219	11	the	the	DET
aji-33	219	12	normal	normal	ADJ
aji-33	219	13	physiology	physiology	NOUN
aji-33	219	14	is	be	AUX
aji-33	219	15	turned	turn	VERB
aji-33	219	16	into	into	ADP
aji-33	219	17	pathology	pathology	NOUN
aji-33	219	18	in	in	ADP
aji-33	219	19	the	the	DET
aji-33	219	20	context	context	NOUN
aji-33	219	21	of	of	ADP
aji-33	219	22	covid	covid	PROPN
aji-33	219	23	19	19	NUM
aji-33	219	24	.	.	PUNCT
aji-33	220	1	the	the	DET
aji-33	220	2	gaps	gap	NOUN
aji-33	220	3	in	in	ADP
aji-33	220	4	the	the	DET
aji-33	220	5	present	present	ADJ
aji-33	220	6	understanding	understanding	NOUN
aji-33	220	7	of	of	ADP
aji-33	220	8	the	the	DET
aji-33	220	9	issues	issue	NOUN
aji-33	220	10	involved	involve	VERB
aji-33	220	11	,	,	PUNCT
aji-33	220	12	leaves	leave	VERB
aji-33	220	13	no	no	DET
aji-33	220	14	alternative	alternative	NOUN
aji-33	220	15	than	than	ADP
aji-33	220	16	to	to	AUX
aji-33	220	17	‘	'	PUNCT
aji-33	220	18	hazard	hazard	VERB
aji-33	220	19	a	a	DET
aji-33	220	20	guess	guess	NOUN
aji-33	220	21	‘	'	PUNCT
aji-33	220	22	as	as	ADP
aji-33	220	23	to	to	ADP
aji-33	220	24	the	the	DET
aji-33	220	25	actual	actual	ADJ
aji-33	220	26	pathogenesis	pathogenesis	NOUN
aji-33	220	27	of	of	ADP
aji-33	220	28	the	the	DET
aji-33	220	29	disease	disease	NOUN
aji-33	220	30	.	.	PUNCT
aji-33	221	1	the	the	DET
aji-33	221	2	viral	viral	ADJ
aji-33	221	3	factors	factor	NOUN
aji-33	221	4	:	:	PUNCT
aji-33	221	5	the	the	DET
aji-33	221	6	genome	genome	NOUN
aji-33	221	7	of	of	ADP
aji-33	221	8	sars	sar	NOUN
aji-33	221	9	cov	cov	PROPN
aji-33	221	10	2	2	NUM
aji-33	221	11	encodes	encode	NOUN
aji-33	221	12	four	four	NUM
aji-33	221	13	main	main	ADJ
aji-33	221	14	structural	structural	ADJ
aji-33	221	15	proteins	protein	NOUN
aji-33	221	16	:	:	PUNCT
aji-33	221	17	spike	spike	X
aji-33	221	18	(	(	PUNCT
aji-33	221	19	s	s	NOUN
aji-33	221	20	)	)	PUNCT
aji-33	221	21	,	,	PUNCT
aji-33	221	22	(	(	PUNCT
aji-33	221	23	which	which	PRON
aji-33	221	24	has	have	VERB
aji-33	221	25	s1	s1	NOUN
aji-33	221	26	and	and	CCONJ
aji-33	221	27	s2	s2	VERB
aji-33	221	28	sub	sub	NOUN
aji-33	221	29	-	-	NOUN
aji-33	221	30	units	unit	NOUN
aji-33	221	31	)	)	PUNCT
aji-33	221	32	envelope	envelope	NOUN
aji-33	221	33	(	(	PUNCT
aji-33	221	34	e	e	NOUN
aji-33	221	35	)	)	PUNCT
aji-33	221	36	,	,	PUNCT
aji-33	221	37	nucleocapsid	nucleocapsid	NOUN
aji-33	221	38	(	(	PUNCT
aji-33	221	39	n	n	CCONJ
aji-33	221	40	)	)	PUNCT
aji-33	221	41	and	and	CCONJ
aji-33	221	42	membrane	membrane	NOUN
aji-33	221	43	(	(	PUNCT
aji-33	221	44	m	m	NOUN
aji-33	221	45	)	)	PUNCT
aji-33	221	46	proteins	protein	NOUN
aji-33	221	47	.it	.it	PUNCT
aji-33	221	48	is	be	AUX
aji-33	221	49	known	know	VERB
aji-33	221	50	that	that	SCONJ
aji-33	221	51	the	the	DET
aji-33	221	52	sars	sars	PROPN
aji-33	221	53	cov	cov	PROPN
aji-33	221	54	2	2	NUM
aji-33	221	55	attaches	attach	VERB
aji-33	221	56	through	through	ADP
aji-33	221	57	spike	spike	ADJ
aji-33	221	58	protein	protein	NOUN
aji-33	221	59	to	to	ADP
aji-33	221	60	the	the	DET
aji-33	221	61	cell	cell	NOUN
aji-33	221	62	surface	surface	NOUN
aji-33	221	63	negotiate	negotiate	VERB
aji-33	221	64	the	the	DET
aji-33	221	65	ace	ace	ADJ
aji-33	221	66	2	2	NUM
aji-33	221	67	receptor	receptor	NOUN
aji-33	221	68	of	of	ADP
aji-33	221	69	the	the	DET
aji-33	221	70	host	host	NOUN
aji-33	221	71	cell	cell	NOUN
aji-33	221	72	,	,	PUNCT
aji-33	221	73	to	to	PART
aji-33	221	74	gain	gain	VERB
aji-33	221	75	entry	entry	NOUN
aji-33	221	76	into	into	ADP
aji-33	221	77	the	the	DET
aji-33	221	78	body	body	NOUN
aji-33	221	79	.	.	PUNCT
aji-33	222	1	it	it	PRON
aji-33	222	2	is	be	AUX
aji-33	222	3	even	even	ADV
aji-33	222	4	suggested	suggest	VERB
aji-33	222	5	that	that	SCONJ
aji-33	222	6	by	by	ADP
aji-33	222	7	internalizing	internalize	VERB
aji-33	222	8	the	the	DET
aji-33	222	9	ace	ace	ADJ
aji-33	222	10	2	2	NUM
aji-33	222	11	receptor	receptor	NOUN
aji-33	222	12	down	down	ADV
aji-33	222	13	regulates	regulate	VERB
aji-33	222	14	its	its	PRON
aji-33	222	15	protective	protective	ADJ
aji-33	222	16	lung	lung	NOUN
aji-33	222	17	function	function	NOUN
aji-33	222	18	,	,	PUNCT
aji-33	222	19	prevailing	prevail	VERB
aji-33	222	20	under	under	ADP
aji-33	222	21	normal	normal	ADJ
aji-33	222	22	physiological	physiological	ADJ
aji-33	222	23	conditions	condition	NOUN
aji-33	222	24	the	the	DET
aji-33	222	25	difference	difference	NOUN
aji-33	222	26	in	in	ADP
aji-33	222	27	degree	degree	NOUN
aji-33	222	28	of	of	ADP
aji-33	222	29	severity	severity	NOUN
aji-33	222	30	and	and	CCONJ
aji-33	222	31	infectivity	infectivity	NOUN
aji-33	222	32	seen	see	VERB
aji-33	222	33	between	between	ADP
aji-33	222	34	the	the	DET
aji-33	222	35	different	different	ADJ
aji-33	222	36	countries	country	NOUN
aji-33	222	37	and	and	CCONJ
aji-33	222	38	within	within	ADP
aji-33	222	39	certain	certain	ADJ
aji-33	222	40	states	state	NOUN
aji-33	222	41	of	of	ADP
aji-33	222	42	a	a	DET
aji-33	222	43	country	country	NOUN
aji-33	222	44	,	,	PUNCT
aji-33	222	45	lead	lead	VERB
aji-33	222	46	to	to	ADP
aji-33	222	47	the	the	DET
aji-33	222	48	conclusion	conclusion	NOUN
aji-33	222	49	that	that	SCONJ
aji-33	222	50	there	there	PRON
aji-33	222	51	are	be	VERB
aji-33	222	52	different	different	ADJ
aji-33	222	53	strains	strain	NOUN
aji-33	222	54	of	of	ADP
aji-33	222	55	the	the	DET
aji-33	222	56	covid	covid	PROPN
aji-33	222	57	19	19	NUM
aji-33	222	58	virus	virus	NOUN
aji-33	222	59	and	and	CCONJ
aji-33	222	60	that	that	SCONJ
aji-33	222	61	the	the	DET
aji-33	222	62	virus	virus	NOUN
aji-33	222	63	suffered	suffer	VERB
aji-33	222	64	nearly	nearly	ADV
aji-33	222	65	200	200	NUM
aji-33	222	66	mutations	mutation	NOUN
aji-33	222	67	so	so	ADV
aji-33	222	68	far	far	ADV
aji-33	222	69	.	.	PUNCT
aji-33	223	1	the	the	DET
aji-33	223	2	worldwide	worldwide	ADJ
aji-33	223	3	distribution	distribution	NOUN
aji-33	223	4	belonged	belong	VERB
aji-33	223	5	to	to	PART
aji-33	223	6	strain	strain	VERB
aji-33	223	7	types	type	NOUN
aji-33	223	8	a2	a2	PROPN
aji-33	223	9	a	a	PRON
aji-33	223	10	,	,	PUNCT
aji-33	223	11	a3	a3	NOUN
aji-33	223	12	,	,	PUNCT
aji-33	223	13	b	b	PROPN
aji-33	223	14	and	and	CCONJ
aji-33	223	15	bb4	bb4	PROPN
aji-33	223	16	.	.	PUNCT
aji-33	224	1	the	the	DET
aji-33	224	2	ccmb	ccmb	NOUN
aji-33	224	3	(	(	PUNCT
aji-33	224	4	centre	centre	NOUN
aji-33	224	5	for	for	ADP
aji-33	224	6	cellular	cellular	ADJ
aji-33	224	7	and	and	CCONJ
aji-33	224	8	molecular	molecular	ADJ
aji-33	224	9	biology	biology	NOUN
aji-33	224	10	)	)	PUNCT
aji-33	224	11	,	,	PUNCT
aji-33	224	12	hyderabad	hyderabad	PROPN
aji-33	224	13	,	,	PUNCT
aji-33	224	14	india	india	PROPN
aji-33	224	15	,	,	PUNCT
aji-33	224	16	found	find	VERB
aji-33	224	17	that	that	SCONJ
aji-33	224	18	a	a	DET
aji-33	224	19	different	different	ADJ
aji-33	224	20	'	'	PUNCT
aji-33	224	21	cluster	cluster	NOUN
aji-33	224	22	of	of	ADP
aji-33	224	23	strains	strain	NOUN
aji-33	224	24	’	'	PUNCT
aji-33	224	25	,	,	PUNCT
aji-33	224	26	named	name	VERB
aji-33	224	27	as	as	ADP
aji-33	224	28	“	"	PUNCT
aji-33	224	29	clade	clade	NOUN
aji-33	224	30	a3i	a3i	NOUN
aji-33	224	31	"	"	PUNCT
aji-33	224	32	,	,	PUNCT
aji-33	224	33	responsible	responsible	ADJ
aji-33	224	34	for	for	ADP
aji-33	224	35	infection	infection	NOUN
aji-33	224	36	in	in	ADP
aji-33	224	37	different	different	ADJ
aji-33	224	38	states	state	NOUN
aji-33	224	39	in	in	ADP
aji-33	224	40	india	india	PROPN
aji-33	224	41	,	,	PUNCT
aji-33	224	42	some	some	PRON
aji-33	224	43	of	of	ADP
aji-33	224	44	which	which	PRON
aji-33	224	45	registered	register	VERB
aji-33	224	46	more	more	ADJ
aji-33	224	47	cases	case	NOUN
aji-33	224	48	/	/	SYM
aji-33	224	49	mortality	mortality	NOUN
aji-33	224	50	(	(	PUNCT
aji-33	224	51	maharashtra	maharashtra	PROPN
aji-33	224	52	,	,	PUNCT
aji-33	224	53	gujarat	gujarat	PROPN
aji-33	224	54	,	,	PUNCT
aji-33	224	55	tamil	tamil	PROPN
aji-33	224	56	nadu	nadu	NOUN
aji-33	224	57	and	and	CCONJ
aji-33	224	58	delhi	delhi	ADJ
aji-33	224	59	)	)	PUNCT
aji-33	224	60	than	than	ADP
aji-33	224	61	others	other	NOUN
aji-33	224	62	.	.	PUNCT
aji-33	225	1	(	(	PUNCT
aji-33	225	2	vide	vide	VERB
aji-33	225	3	the	the	DET
aji-33	225	4	pre	pre	ADJ
aji-33	225	5	-	-	ADJ
aji-33	225	6	publication	publication	ADJ
aji-33	225	7	press	press	NOUN
aji-33	225	8	note	note	NOUN
aji-33	225	9	released	release	VERB
aji-33	225	10	on	on	ADP
aji-33	225	11	3	3	NUM
aji-33	225	12	rd	rd	PROPN
aji-33	225	13	june	june	PROPN
aji-33	225	14	2020	2020	NUM
aji-33	225	15	)	)	PUNCT
aji-33	225	16	.	.	PUNCT
aji-33	226	1	the	the	DET
aji-33	226	2	host	host	NOUN
aji-33	226	3	factors	factor	NOUN
aji-33	226	4	:	:	PUNCT
aji-33	226	5	the	the	DET
aji-33	226	6	fight	fight	NOUN
aji-33	226	7	between	between	ADP
aji-33	226	8	the	the	DET
aji-33	226	9	virus	virus	NOUN
aji-33	226	10	and	and	CCONJ
aji-33	226	11	the	the	DET
aji-33	226	12	defence	defence	NOUN
aji-33	226	13	begins	begin	VERB
aji-33	226	14	with	with	ADP
aji-33	226	15	the	the	DET
aji-33	226	16	virus	virus	NOUN
aji-33	226	17	presenting	present	VERB
aji-33	226	18	prasad	prasad	PROPN
aji-33	226	19	;	;	PUNCT
aji-33	226	20	aji	aji	NOUN
aji-33	226	21	,	,	PUNCT
aji-33	226	22	3(1	3(1	NUM
aji-33	226	23	):	):	PUNCT
aji-33	226	24	233	233	NUM
aji-33	226	25	-	-	SYM
aji-33	226	26	252	252	NUM
aji-33	226	27	,	,	PUNCT
aji-33	226	28	2020	2020	NUM
aji-33	226	29	;	;	PUNCT
aji-33	226	30	article	article	NOUN
aji-33	226	31	no.aji.58422	no.aji.58422	NOUN
aji-33	226	32	237	237	NUM
aji-33	226	33	its	its	PRON
aji-33	226	34	conserved	conserved	ADJ
aji-33	226	35	molecular	molecular	ADJ
aji-33	226	36	signature	signature	NOUN
aji-33	226	37	expressed	express	VERB
aji-33	226	38	on	on	ADP
aji-33	226	39	its	its	PRON
aji-33	226	40	surface	surface	NOUN
aji-33	226	41	(	(	PUNCT
aji-33	226	42	pamps	pamp	NOUN
aji-33	226	43	)	)	PUNCT
aji-33	226	44	which	which	PRON
aji-33	226	45	the	the	DET
aji-33	226	46	defence	defence	NOUN
aji-33	226	47	cells	cell	NOUN
aji-33	226	48	recognize	recognize	VERB
aji-33	226	49	by	by	ADP
aji-33	226	50	special	special	ADJ
aji-33	226	51	receptors	receptor	NOUN
aji-33	226	52	located	locate	VERB
aji-33	226	53	on	on	ADP
aji-33	226	54	their	their	PRON
aji-33	226	55	surface	surface	NOUN
aji-33	226	56	(	(	PUNCT
aji-33	226	57	prrs	prrs	PROPN
aji-33	226	58	)	)	PUNCT
aji-33	226	59	pprs	pprs	ADJ
aji-33	226	60	and	and	CCONJ
aji-33	226	61	pamps	pamp	NOUN
aji-33	226	62	:	:	PUNCT
aji-33	226	63	pprs	pprs	ADJ
aji-33	226	64	(	(	PUNCT
aji-33	226	65	pattern	pattern	NOUN
aji-33	226	66	recognizing	recognize	VERB
aji-33	226	67	receptors	receptor	NOUN
aji-33	226	68	)	)	PUNCT
aji-33	226	69	are	be	AUX
aji-33	226	70	proteins	protein	NOUN
aji-33	226	71	which	which	PRON
aji-33	226	72	recognize	recognize	VERB
aji-33	226	73	pamps	pamp	NOUN
aji-33	226	74	(	(	PUNCT
aji-33	226	75	pattern	pattern	NOUN
aji-33	226	76	associated	associate	VERB
aji-33	226	77	molecular	molecular	ADJ
aji-33	226	78	patterns	pattern	NOUN
aji-33	226	79	)	)	PUNCT
aji-33	226	80	,	,	PUNCT
aji-33	226	81	a	a	DET
aji-33	226	82	conserved	conserve	VERB
aji-33	226	83	specific	specific	ADJ
aji-33	226	84	sequence	sequence	NOUN
aji-33	226	85	which	which	PRON
aji-33	226	86	the	the	DET
aji-33	226	87	pathogens	pathogen	NOUN
aji-33	226	88	display	display	VERB
aji-33	226	89	on	on	ADP
aji-33	226	90	their	their	PRON
aji-33	226	91	surface	surface	NOUN
aji-33	226	92	(	(	PUNCT
aji-33	226	93	epitopes	epitope	NOUN
aji-33	226	94	)	)	PUNCT
aji-33	226	95	for	for	ADP
aji-33	226	96	the	the	DET
aji-33	226	97	recognition	recognition	NOUN
aji-33	226	98	by	by	ADP
aji-33	226	99	the	the	DET
aji-33	226	100	prrs	prr	NOUN
aji-33	226	101	of	of	ADP
aji-33	226	102	the	the	DET
aji-33	226	103	effector	effector	NOUN
aji-33	226	104	immune	immune	ADJ
aji-33	226	105	cells	cell	NOUN
aji-33	226	106	the	the	DET
aji-33	226	107	details	detail	NOUN
aji-33	226	108	of	of	ADP
aji-33	226	109	the	the	DET
aji-33	226	110	pamps	pamp	NOUN
aji-33	226	111	and	and	CCONJ
aji-33	226	112	prrs	prr	NOUN
aji-33	226	113	in	in	ADP
aji-33	226	114	case	case	NOUN
aji-33	226	115	of	of	ADP
aji-33	226	116	covid	covid	PROPN
aji-33	226	117	19	19	NUM
aji-33	226	118	are	be	AUX
aji-33	226	119	still	still	ADV
aji-33	226	120	not	not	PART
aji-33	226	121	fully	fully	ADV
aji-33	226	122	elucidated	elucidated	ADJ
aji-33	226	123	.	.	PUNCT
aji-33	227	1	some	some	DET
aji-33	227	2	authors	author	NOUN
aji-33	227	3	dealing	deal	VERB
aji-33	227	4	with	with	ADP
aji-33	227	5	this	this	DET
aji-33	227	6	aspect	aspect	NOUN
aji-33	227	7	,	,	PUNCT
aji-33	227	8	quote	quote	INTJ
aji-33	227	9	the	the	DET
aji-33	227	10	information	information	NOUN
aji-33	227	11	available	available	ADJ
aji-33	227	12	on	on	ADP
aji-33	227	13	the	the	DET
aji-33	227	14	sars	sars	PROPN
aji-33	227	15	cov	cov	PROPN
aji-33	227	16	1	1	NUM
aji-33	227	17	,	,	PUNCT
aji-33	227	18	which	which	PRON
aji-33	227	19	holds	hold	VERB
aji-33	227	20	about	about	ADP
aji-33	227	21	79	79	NUM
aji-33	227	22	%	%	NOUN
aji-33	227	23	homology	homology	NOUN
aji-33	227	24	in	in	ADP
aji-33	227	25	antigenic	antigenic	ADJ
aji-33	227	26	structure	structure	NOUN
aji-33	227	27	with	with	ADP
aji-33	227	28	sars	sar	NOUN
aji-33	227	29	cov	cov	PROPN
aji-33	227	30	2	2	X
aji-33	227	31	.	.	PUNCT
aji-33	228	1	the	the	DET
aji-33	228	2	sofar	sofar	ADV
aji-33	228	3	known	know	VERB
aji-33	228	4	prrs	prr	NOUN
aji-33	228	5	and	and	CCONJ
aji-33	228	6	pamps	pamp	NOUN
aji-33	228	7	are	be	AUX
aji-33	228	8	listed	list	VERB
aji-33	228	9	in	in	ADP
aji-33	228	10	appendix	appendix	NOUN
aji-33	228	11	1	1	NUM
aji-33	228	12	,	,	PUNCT
aji-33	228	13	with	with	ADP
aji-33	228	14	the	the	DET
aji-33	228	15	assumption	assumption	NOUN
aji-33	228	16	that	that	SCONJ
aji-33	228	17	any	any	PRON
aji-33	228	18	of	of	ADP
aji-33	228	19	these	these	PRON
aji-33	228	20	might	might	AUX
aji-33	228	21	be	be	AUX
aji-33	228	22	found	find	VERB
aji-33	228	23	relevant	relevant	ADJ
aji-33	228	24	to	to	ADP
aji-33	228	25	the	the	DET
aji-33	228	26	context	context	NOUN
aji-33	228	27	of	of	ADP
aji-33	228	28	caved	caved	ADJ
aji-33	228	29	19	19	NUM
aji-33	228	30	,	,	PUNCT
aji-33	228	31	by	by	ADP
aji-33	228	32	future	future	ADJ
aji-33	228	33	research	research	NOUN
aji-33	228	34	.	.	PUNCT
aji-33	229	1	the	the	DET
aji-33	229	2	possible	possible	ADJ
aji-33	229	3	interactive	interactive	ADJ
aji-33	229	4	pathway	pathway	NOUN
aji-33	229	5	between	between	ADP
aji-33	229	6	the	the	DET
aji-33	229	7	pamps	pamp	NOUN
aji-33	229	8	and	and	CCONJ
aji-33	229	9	prrs	prr	NOUN
aji-33	229	10	is	be	AUX
aji-33	229	11	depicted	depict	VERB
aji-33	229	12	in	in	ADP
aji-33	229	13	appendix	appendix	NOUN
aji-33	229	14	2	2	NUM
aji-33	229	15	.	.	PUNCT
aji-33	230	1	the	the	DET
aji-33	230	2	recognized	recognize	VERB
aji-33	230	3	viral	viral	ADJ
aji-33	230	4	surface	surface	NOUN
aji-33	230	5	antigens	antigen	NOUN
aji-33	230	6	are	be	AUX
aji-33	230	7	presented	present	VERB
aji-33	230	8	by	by	ADP
aji-33	230	9	the	the	DET
aji-33	230	10	antigen	antigen	NOUN
aji-33	230	11	presenting	present	VERB
aji-33	230	12	cells	cell	NOUN
aji-33	230	13	(	(	PUNCT
aji-33	230	14	arc	arc	NOUN
aji-33	230	15	)	)	PUNCT
aji-33	230	16	of	of	ADP
aji-33	230	17	the	the	DET
aji-33	230	18	effect	effect	NOUN
aji-33	230	19	or	or	CCONJ
aji-33	230	20	immune	immune	ADJ
aji-33	230	21	cellular	cellular	ADJ
aji-33	230	22	elements	element	NOUN
aji-33	230	23	after	after	ADP
aji-33	230	24	being	be	AUX
aji-33	230	25	processed	process	VERB
aji-33	230	26	by	by	ADP
aji-33	230	27	mhc	mhc	PROPN
aji-33	230	28	class	class	NOUN
aji-33	230	29	2	2	NUM
aji-33	230	30	elements	element	NOUN
aji-33	230	31	.	.	PUNCT
aji-33	231	1	here	here	ADV
aji-33	231	2	also	also	ADV
aji-33	231	3	clarity	clarity	NOUN
aji-33	231	4	as	as	ADP
aji-33	231	5	to	to	ADP
aji-33	231	6	details	detail	NOUN
aji-33	231	7	are	be	AUX
aji-33	231	8	lacking	lack	VERB
aji-33	231	9	.	.	PUNCT
aji-33	232	1	this	this	PRON
aji-33	232	2	is	be	AUX
aji-33	232	3	followed	follow	VERB
aji-33	232	4	by	by	ADP
aji-33	232	5	the	the	DET
aji-33	232	6	humoral	humoral	ADJ
aji-33	232	7	or	or	CCONJ
aji-33	232	8	cellular	cellular	ADJ
aji-33	232	9	response	response	NOUN
aji-33	232	10	by	by	ADP
aji-33	232	11	both	both	CCONJ
aji-33	232	12	innate	innate	ADJ
aji-33	232	13	and	and	CCONJ
aji-33	232	14	adaptive	adaptive	ADJ
aji-33	232	15	immunity	immunity	NOUN
aji-33	232	16	systems	system	NOUN
aji-33	232	17	,	,	PUNCT
aji-33	232	18	the	the	DET
aji-33	232	19	sole	sole	ADJ
aji-33	232	20	purpose	purpose	NOUN
aji-33	232	21	being	be	AUX
aji-33	232	22	destruction	destruction	NOUN
aji-33	232	23	and	and	CCONJ
aji-33	232	24	elimination	elimination	NOUN
aji-33	232	25	of	of	ADP
aji-33	232	26	the	the	DET
aji-33	232	27	virus	virus	NOUN
aji-33	232	28	.	.	PUNCT
aji-33	233	1	here	here	ADV
aji-33	233	2	also	also	ADV
aji-33	233	3	gaps	gap	VERB
aji-33	233	4	in	in	ADP
aji-33	233	5	current	current	ADJ
aji-33	233	6	knowledge	knowledge	NOUN
aji-33	233	7	is	be	AUX
aji-33	233	8	considered	consider	VERB
aji-33	233	9	as	as	ADP
aji-33	233	10	hindrance	hindrance	NOUN
aji-33	233	11	to	to	ADP
aji-33	233	12	the	the	DET
aji-33	233	13	understanding	understanding	NOUN
aji-33	233	14	of	of	ADP
aji-33	233	15	actual	actual	ADJ
aji-33	233	16	happening	happen	VERB
aji-33	233	17	in	in	ADP
aji-33	233	18	the	the	DET
aji-33	233	19	context	context	NOUN
aji-33	233	20	of	of	ADP
aji-33	233	21	covid	covid	PROPN
aji-33	233	22	19	19	NUM
aji-33	233	23	pathogenicity	pathogenicity	NOUN
aji-33	233	24	.	.	PUNCT
aji-33	234	1	the	the	DET
aji-33	234	2	virus	virus	NOUN
aji-33	234	3	probably	probably	ADV
aji-33	234	4	and	and	CCONJ
aji-33	234	5	ingeniously	ingeniously	ADV
aji-33	234	6	turns	turn	VERB
aji-33	234	7	the	the	DET
aji-33	234	8	host	host	NOUN
aji-33	234	9	’s	’s	PART
aji-33	234	10	defense	defense	NOUN
aji-33	234	11	,	,	PUNCT
aji-33	234	12	against	against	ADP
aji-33	234	13	the	the	DET
aji-33	234	14	host	host	NOUN
aji-33	234	15	itself	itself	PRON
aji-33	234	16	by	by	ADP
aji-33	234	17	various	various	ADJ
aji-33	234	18	subversive	subversive	ADJ
aji-33	234	19	actions	action	NOUN
aji-33	234	20	,	,	PUNCT
aji-33	234	21	to	to	ADP
aji-33	234	22	far	far	ADV
aji-33	234	23	then	then	ADV
aji-33	234	24	their	their	PRON
aji-33	234	25	own	own	ADJ
aji-33	234	26	survival	survival	NOUN
aji-33	234	27	and	and	CCONJ
aji-33	234	28	multiplication	multiplication	NOUN
aji-33	234	29	,	,	PUNCT
aji-33	234	30	resulting	result	VERB
aji-33	234	31	in	in	ADP
aji-33	234	32	immune	immune	ADJ
aji-33	234	33	mediated	mediate	VERB
aji-33	234	34	injury	injury	NOUN
aji-33	234	35	to	to	ADP
aji-33	234	36	host	host	NOUN
aji-33	234	37	tissues	tissue	NOUN
aji-33	234	38	the	the	DET
aji-33	234	39	covid	covid	PROPN
aji-33	234	40	19	19	NUM
aji-33	234	41	lung	lung	NOUN
aji-33	234	42	pathology	pathology	NOUN
aji-33	234	43	should	should	AUX
aji-33	234	44	be	be	AUX
aji-33	234	45	considered	consider	VERB
aji-33	234	46	in	in	ADP
aji-33	234	47	these	these	DET
aji-33	234	48	lines	line	NOUN
aji-33	234	49	,	,	PUNCT
aji-33	234	50	as	as	ADP
aji-33	234	51	a	a	DET
aji-33	234	52	fallout	fallout	NOUN
aji-33	234	53	of	of	ADP
aji-33	234	54	the	the	DET
aji-33	234	55	aberrant	aberrant	ADJ
aji-33	234	56	immune	immune	ADJ
aji-33	234	57	response	response	NOUN
aji-33	234	58	.	.	PUNCT
aji-33	235	1	the	the	DET
aji-33	235	2	reported	report	VERB
aji-33	235	3	damage	damage	NOUN
aji-33	235	4	to	to	ADP
aji-33	235	5	the	the	DET
aji-33	235	6	lungs	lung	NOUN
aji-33	235	7	is	be	AUX
aji-33	235	8	belied	belie	VERB
aji-33	235	9	to	to	PART
aji-33	235	10	start	start	VERB
aji-33	235	11	within	within	ADP
aji-33	235	12	a	a	DET
aji-33	235	13	week	week	NOUN
aji-33	235	14	or	or	CCONJ
aji-33	235	15	so	so	ADV
aji-33	235	16	of	of	ADP
aji-33	235	17	the	the	DET
aji-33	235	18	patient	patient	NOUN
aji-33	235	19	becoming	become	VERB
aji-33	235	20	symptomatic	symptomatic	ADJ
aji-33	235	21	,	,	PUNCT
aji-33	235	22	the	the	DET
aji-33	235	23	role	role	NOUN
aji-33	235	24	played	play	VERB
aji-33	235	25	by	by	ADP
aji-33	235	26	the	the	DET
aji-33	235	27	innate	innate	ADJ
aji-33	235	28	immune	immune	ADJ
aji-33	235	29	mechanisms	mechanism	NOUN
aji-33	235	30	assume	assume	VERB
aji-33	235	31	importance	importance	NOUN
aji-33	235	32	,	,	PUNCT
aji-33	235	33	as	as	SCONJ
aji-33	235	34	they	they	PRON
aji-33	235	35	first	first	ADV
aji-33	235	36	encounter	encounter	VERB
aji-33	235	37	the	the	DET
aji-33	235	38	virus	virus	NOUN
aji-33	235	39	.	.	PUNCT
aji-33	236	1	it	it	PRON
aji-33	236	2	is	be	AUX
aji-33	236	3	only	only	ADV
aji-33	236	4	after	after	ADP
aji-33	236	5	a	a	DET
aji-33	236	6	week	week	NOUN
aji-33	236	7	or	or	CCONJ
aji-33	236	8	so	so	ADV
aji-33	236	9	,	,	PUNCT
aji-33	236	10	that	that	SCONJ
aji-33	236	11	the	the	DET
aji-33	236	12	adaptive	adaptive	ADJ
aji-33	236	13	immune	immune	ADJ
aji-33	236	14	mechanisms	mechanism	NOUN
aji-33	236	15	come	come	VERB
aji-33	236	16	to	to	ADP
aji-33	236	17	fore	fore	NOUN
aji-33	236	18	.	.	PUNCT
aji-33	237	1	so	so	ADV
aji-33	237	2	,	,	PUNCT
aji-33	237	3	in	in	ADP
aji-33	237	4	the	the	DET
aji-33	237	5	later	later	ADJ
aji-33	237	6	course	course	NOUN
aji-33	237	7	of	of	ADP
aji-33	237	8	the	the	DET
aji-33	237	9	disease	disease	NOUN
aji-33	237	10	,	,	PUNCT
aji-33	237	11	both	both	CCONJ
aji-33	237	12	the	the	DET
aji-33	237	13	immunity	immunity	NOUN
aji-33	237	14	mechanisms	mechanism	NOUN
aji-33	237	15	may	may	AUX
aji-33	237	16	supplement	supplement	VERB
aji-33	237	17	or	or	CCONJ
aji-33	237	18	compliment	compliment	VERB
aji-33	237	19	or	or	CCONJ
aji-33	237	20	act	act	VERB
aji-33	237	21	independently	independently	ADV
aji-33	237	22	to	to	PART
aji-33	237	23	sustain	sustain	VERB
aji-33	237	24	the	the	DET
aji-33	237	25	immunological	immunological	ADJ
aji-33	237	26	damage	damage	NOUN
aji-33	237	27	.	.	PUNCT
aji-33	238	1	the	the	DET
aji-33	238	2	humoral	humoral	ADJ
aji-33	238	3	and	and	CCONJ
aji-33	238	4	cellular	cellular	ADJ
aji-33	238	5	components	component	NOUN
aji-33	238	6	of	of	ADP
aji-33	238	7	both	both	DET
aji-33	238	8	system	system	NOUN
aji-33	238	9	play	play	VERB
aji-33	238	10	important	important	ADJ
aji-33	238	11	roles	role	NOUN
aji-33	238	12	but	but	CCONJ
aji-33	238	13	some	some	PRON
aji-33	238	14	play	play	VERB
aji-33	238	15	greater	great	ADJ
aji-33	238	16	role	role	NOUN
aji-33	238	17	than	than	ADP
aji-33	238	18	the	the	DET
aji-33	238	19	others	other	NOUN
aji-33	238	20	.	.	PUNCT
aji-33	239	1	so	so	ADV
aji-33	239	2	the	the	DET
aji-33	239	3	more	more	ADV
aji-33	239	4	important	important	ADJ
aji-33	239	5	elements	element	NOUN
aji-33	239	6	are	be	AUX
aji-33	239	7	discussed	discuss	VERB
aji-33	239	8	in	in	ADP
aji-33	239	9	detail	detail	NOUN
aji-33	239	10	while	while	SCONJ
aji-33	239	11	with	with	ADP
aji-33	239	12	due	due	ADJ
aji-33	239	13	consideration	consideration	NOUN
aji-33	239	14	to	to	ADP
aji-33	239	15	the	the	DET
aji-33	239	16	subsidiary	subsidiary	ADJ
aji-33	239	17	role	role	NOUN
aji-33	239	18	played	play	VERB
aji-33	239	19	by	by	ADP
aji-33	239	20	the	the	DET
aji-33	239	21	other	other	ADJ
aji-33	239	22	elements	element	NOUN
aji-33	239	23	,	,	PUNCT
aji-33	239	24	discussion	discussion	NOUN
aji-33	239	25	is	be	AUX
aji-33	239	26	limited	limit	VERB
aji-33	239	27	to	to	ADP
aji-33	239	28	a	a	DET
aji-33	239	29	brief	brief	ADJ
aji-33	239	30	consideration	consideration	NOUN
aji-33	239	31	about	about	ADP
aji-33	239	32	them	they	PRON
aji-33	239	33	.	.	PUNCT
aji-33	240	1	the	the	DET
aji-33	240	2	discussion	discussion	NOUN
aji-33	240	3	is	be	AUX
aji-33	240	4	in	in	ADP
aji-33	240	5	accordance	accordance	NOUN
aji-33	240	6	with	with	ADP
aji-33	240	7	the	the	DET
aji-33	240	8	importance	importance	NOUN
aji-33	240	9	of	of	ADP
aji-33	240	10	the	the	DET
aji-33	240	11	role	role	NOUN
aji-33	240	12	each	each	DET
aji-33	240	13	element	element	NOUN
aji-33	240	14	of	of	ADP
aji-33	240	15	both	both	DET
aji-33	240	16	the	the	DET
aji-33	240	17	systems	system	NOUN
aji-33	240	18	.	.	PUNCT
aji-33	241	1	the	the	DET
aji-33	241	2	discussion	discussion	NOUN
aji-33	241	3	is	be	AUX
aji-33	241	4	limited	limit	VERB
aji-33	241	5	only	only	ADV
aji-33	241	6	to	to	ADP
aji-33	241	7	the	the	DET
aji-33	241	8	destructive	destructive	ADJ
aji-33	241	9	immune	immune	ADJ
aji-33	241	10	mechanisms	mechanism	NOUN
aji-33	241	11	of	of	ADP
aji-33	241	12	both	both	CCONJ
aji-33	241	13	the	the	DET
aji-33	241	14	immunity	immunity	NOUN
aji-33	241	15	system	system	NOUN
aji-33	241	16	and	and	CCONJ
aji-33	241	17	nothing	nothing	PRON
aji-33	241	18	will	will	AUX
aji-33	241	19	be	be	AUX
aji-33	241	20	referred	refer	VERB
aji-33	241	21	to	to	ADP
aji-33	241	22	the	the	DET
aji-33	241	23	protective	protective	ADJ
aji-33	241	24	role	role	NOUN
aji-33	241	25	they	they	PRON
aji-33	241	26	play	play	VERB
aji-33	241	27	.	.	PUNCT
aji-33	242	1	4.1	4.1	NUM
aji-33	242	2	the	the	DET
aji-33	242	3	role	role	NOUN
aji-33	242	4	of	of	ADP
aji-33	242	5	innate	innate	ADJ
aji-33	242	6	immune	immune	ADJ
aji-33	242	7	system	system	NOUN
aji-33	242	8	4.1.1	4.1.1	NOUN
aji-33	242	9	role	role	NOUN
aji-33	242	10	of	of	ADP
aji-33	242	11	complement	complement	NOUN
aji-33	242	12	:	:	PUNCT
aji-33	242	13	the	the	DET
aji-33	242	14	alternative	alternative	ADJ
aji-33	242	15	pathway	pathway	NOUN
aji-33	242	16	:	:	PUNCT
aji-33	242	17	joshua	joshua	PROPN
aji-33	242	18	m.	m.	PROPN
aji-33	242	19	thurman	thurman	PROPN
aji-33	242	20	and	and	CCONJ
aji-33	242	21	v.	v.	PROPN
aji-33	242	22	michael	michael	PROPN
aji-33	242	23	holers	holers	PROPN
aji-33	242	24	,	,	PUNCT
aji-33	242	25	et	et	PROPN
aji-33	242	26	al	al	PROPN
aji-33	242	27	.	.	PUNCT
aji-33	243	1	[	[	X
aji-33	243	2	16	16	NUM
aji-33	243	3	]	]	PUNCT
aji-33	243	4	has	have	AUX
aji-33	243	5	reviewed	review	VERB
aji-33	243	6	this	this	DET
aji-33	243	7	matter	matter	NOUN
aji-33	243	8	:	:	PUNCT
aji-33	243	9	1	1	X
aji-33	243	10	.	.	PUNCT
aji-33	244	1	the	the	DET
aji-33	244	2	alternative	alternative	ADJ
aji-33	244	3	pathway	pathway	NOUN
aji-33	244	4	is	be	AUX
aji-33	244	5	capable	capable	ADJ
aji-33	244	6	of	of	ADP
aji-33	244	7	auto	auto	NOUN
aji-33	244	8	activation	activation	NOUN
aji-33	244	9	because	because	SCONJ
aji-33	244	10	of	of	ADP
aji-33	244	11	a	a	DET
aji-33	244	12	process	process	NOUN
aji-33	244	13	termed	term	VERB
aji-33	244	14	“	"	PUNCT
aji-33	244	15	tick	tick	VERB
aji-33	244	16	over	over	ADV
aji-33	244	17	”	"	PUNCT
aji-33	244	18	of	of	ADP
aji-33	244	19	c3	c3	PROPN
aji-33	244	20	[	[	X
aji-33	244	21	17	17	NUM
aji-33	244	22	]	]	PUNCT
aji-33	244	23	.	.	PUNCT
aji-33	245	1	2	2	X
aji-33	245	2	.	.	X
aji-33	245	3	tick	tick	NOUN
aji-33	245	4	over	over	ADP
aji-33	245	5	generates	generate	VERB
aji-33	245	6	a	a	DET
aji-33	245	7	conformationally	conformationally	ADV
aji-33	245	8	altered	alter	VERB
aji-33	245	9	c3	c3	PROPN
aji-33	245	10	,	,	PUNCT
aji-33	245	11	designated	designate	VERB
aji-33	245	12	c3(h2o	c3(h2o	NOUN
aji-33	245	13	)	)	PUNCT
aji-33	245	14	.	.	PUNCT
aji-33	246	1	3	3	X
aji-33	246	2	.	.	X
aji-33	246	3	this	this	PRON
aji-33	246	4	is	be	AUX
aji-33	246	5	capable	capable	ADJ
aji-33	246	6	of	of	ADP
aji-33	246	7	binding	bind	VERB
aji-33	246	8	,	,	PUNCT
aji-33	246	9	the	the	DET
aji-33	246	10	factor	factor	NOUN
aji-33	246	11	b	b	NOUN
aji-33	246	12	4	4	NUM
aji-33	246	13	.	.	PUNCT
aji-33	246	14	factor	factor	NOUN
aji-33	246	15	d	d	PROPN
aji-33	246	16	cleaves	cleave	VERB
aji-33	246	17	factor	factor	NOUN
aji-33	246	18	b	b	NOUN
aji-33	246	19	into	into	ADP
aji-33	246	20	ba	ba	PROPN
aji-33	246	21	and	and	CCONJ
aji-33	246	22	bb	bb	NOUN
aji-33	246	23	.	.	PROPN
aji-33	247	1	5	5	NUM
aji-33	247	2	.	.	X
aji-33	247	3	bb	bb	NOUN
aji-33	247	4	remains	remain	VERB
aji-33	247	5	bound	bind	VERB
aji-33	247	6	to	to	ADP
aji-33	247	7	c3(h2o	c3(h2o	NOUN
aji-33	247	8	)	)	PUNCT
aji-33	247	9	to	to	PART
aji-33	247	10	form	form	VERB
aji-33	247	11	c3(h2o)bb	c3(h2o)bb	NUM
aji-33	247	12	.	.	PUNCT
aji-33	248	1	(	(	PUNCT
aji-33	248	2	fluid	fluid	ADJ
aji-33	248	3	-	-	PUNCT
aji-33	248	4	phase	phase	NOUN
aji-33	248	5	c3	c3	NOUN
aji-33	248	6	-	-	PUNCT
aji-33	248	7	convertase	convertase	NOUN
aji-33	248	8	)	)	PUNCT
aji-33	248	9	.	.	PUNCT
aji-33	249	1	6	6	X
aji-33	249	2	.	.	X
aji-33	250	1	this	this	DET
aji-33	250	2	alternative	alternative	ADJ
aji-33	250	3	pathway	pathway	NOUN
aji-33	250	4	c3	c3	PROPN
aji-33	250	5	-	-	PUNCT
aji-33	250	6	convertase	convertase	NOUN
aji-33	250	7	,	,	PUNCT
aji-33	250	8	although	although	SCONJ
aji-33	250	9	only	only	ADV
aji-33	250	10	produced	produce	VERB
aji-33	250	11	in	in	ADP
aji-33	250	12	small	small	ADJ
aji-33	250	13	amounts	amount	NOUN
aji-33	250	14	,	,	PUNCT
aji-33	250	15	can	can	AUX
aji-33	250	16	cleave	cleave	VERB
aji-33	250	17	multiple	multiple	ADJ
aji-33	250	18	c3	c3	NOUN
aji-33	250	19	proteins	protein	NOUN
aji-33	250	20	into	into	ADP
aji-33	250	21	c3a	c3a	NOUN
aji-33	250	22	and	and	CCONJ
aji-33	250	23	c3b	c3b	NOUN
aji-33	250	24	.	.	PROPN
aji-33	251	1	7	7	NUM
aji-33	251	2	.	.	PUNCT
aji-33	251	3	the	the	DET
aji-33	251	4	complex	complex	NOUN
aji-33	251	5	is	be	AUX
aji-33	251	6	believed	believe	VERB
aji-33	251	7	to	to	PART
aji-33	251	8	be	be	AUX
aji-33	251	9	unstable	unstable	ADJ
aji-33	251	10	until	until	SCONJ
aji-33	251	11	it	it	PRON
aji-33	251	12	binds	bind	VERB
aji-33	251	13	properd	properd	NOUN
aji-33	251	14	in	in	ADP
aji-33	251	15	,	,	PUNCT
aji-33	251	16	a	a	DET
aji-33	251	17	serum	serum	NOUN
aji-33	251	18	protein	protein	NOUN
aji-33	251	19	.	.	PUNCT
aji-33	252	1	8	8	X
aji-33	252	2	.	.	PUNCT
aji-33	253	1	the	the	DET
aji-33	253	2	addition	addition	NOUN
aji-33	253	3	of	of	ADP
aji-33	253	4	properd	properd	NOUN
aji-33	253	5	in	in	ADP
aji-33	253	6	forms	form	NOUN
aji-33	253	7	the	the	DET
aji-33	253	8	complex	complex	ADJ
aji-33	253	9	c3bbbp	c3bbbp	NOUN
aji-33	253	10	,	,	PUNCT
aji-33	253	11	a	a	DET
aji-33	253	12	stable	stable	ADJ
aji-33	253	13	compound	compound	NOUN
aji-33	253	14	.	.	PUNCT
aji-33	254	1	9	9	X
aji-33	254	2	.	.	X
aji-33	254	3	this	this	PRON
aji-33	254	4	binds	bind	VERB
aji-33	254	5	an	an	DET
aji-33	254	6	additional	additional	ADJ
aji-33	254	7	c3b	c3b	NOUN
aji-33	254	8	to	to	PART
aji-33	254	9	form	form	VERB
aji-33	254	10	alternative	alternative	ADJ
aji-33	254	11	pathway	pathway	NOUN
aji-33	254	12	c5	c5	PROPN
aji-33	254	13	-	-	PUNCT
aji-33	254	14	convertase	convertase	NOUN
aji-33	254	15	.	.	PUNCT
aji-33	255	1	10	10	NUM
aji-33	255	2	.	.	PUNCT
aji-33	256	1	the	the	DET
aji-33	256	2	c5	c5	PROPN
aji-33	256	3	-	-	PUNCT
aji-33	256	4	convertase	convertase	NOUN
aji-33	256	5	of	of	ADP
aji-33	256	6	the	the	DET
aji-33	256	7	alternative	alternative	ADJ
aji-33	256	8	pathway	pathway	NOUN
aji-33	256	9	consists	consist	VERB
aji-33	256	10	of	of	ADP
aji-33	256	11	(	(	PUNCT
aji-33	256	12	c3b)2bbp	c3b)2bbp	INTJ
aji-33	256	13	(	(	PUNCT
aji-33	256	14	sometimes	sometimes	ADV
aji-33	256	15	referred	refer	VERB
aji-33	256	16	to	to	ADP
aji-33	256	17	as	as	ADP
aji-33	256	18	c3b2bb	c3b2bb	PROPN
aji-33	256	19	)	)	PUNCT
aji-33	256	20	.	.	PUNCT
aji-33	257	1	11	11	NUM
aji-33	257	2	.	.	PUNCT
aji-33	258	1	after	after	ADP
aji-33	258	2	this	this	DET
aji-33	258	3	step	step	NOUN
aji-33	258	4	,	,	PUNCT
aji-33	258	5	the	the	DET
aji-33	258	6	complement	complement	NOUN
aji-33	258	7	system	system	NOUN
aji-33	258	8	follows	follow	VERB
aji-33	258	9	the	the	DET
aji-33	258	10	same	same	ADJ
aji-33	258	11	path	path	NOUN
aji-33	258	12	regardless	regardless	ADV
aji-33	258	13	of	of	ADP
aji-33	258	14	the	the	DET
aji-33	258	15	means	mean	NOUN
aji-33	258	16	of	of	ADP
aji-33	258	17	activation	activation	NOUN
aji-33	258	18	(	(	PUNCT
aji-33	258	19	alternative	alternative	ADJ
aji-33	258	20	,	,	PUNCT
aji-33	258	21	classical	classical	ADJ
aji-33	258	22	,	,	PUNCT
aji-33	258	23	or	or	CCONJ
aji-33	258	24	lectin	lectin	NOUN
aji-33	258	25	)	)	PUNCT
aji-33	258	26	.	.	PUNCT
aji-33	259	1	12	12	NUM
aji-33	259	2	.	.	PUNCT
aji-33	260	1	c5	c5	PROPN
aji-33	260	2	-	-	PUNCT
aji-33	260	3	convertase	convertase	PROPN
aji-33	260	4	cleaves	cleave	VERB
aji-33	260	5	c5	c5	PROPN
aji-33	260	6	into	into	ADP
aji-33	260	7	c5a	c5a	PROPN
aji-33	260	8	and	and	CCONJ
aji-33	260	9	c5b	c5b	NOUN
aji-33	260	10	.	.	PROPN
aji-33	260	11	13	13	NUM
aji-33	260	12	.	.	PUNCT
aji-33	261	1	c5b	c5b	NOUN
aji-33	261	2	binds	bind	VERB
aji-33	261	3	sequentially	sequentially	ADV
aji-33	261	4	to	to	ADP
aji-33	261	5	c6	c6	PROPN
aji-33	261	6	,	,	PUNCT
aji-33	261	7	c7	c7	PROPN
aji-33	261	8	,	,	PUNCT
aji-33	261	9	c8	c8	PROPN
aji-33	261	10	and	and	CCONJ
aji-33	261	11	then	then	ADV
aji-33	261	12	to	to	ADP
aji-33	261	13	multiple	multiple	ADJ
aji-33	261	14	molecules	molecule	NOUN
aji-33	261	15	of	of	ADP
aji-33	261	16	c9	c9	NOUN
aji-33	261	17	to	to	PART
aji-33	261	18	form	form	VERB
aji-33	261	19	membrane	membrane	NOUN
aji-33	261	20	attack	attack	NOUN
aji-33	261	21	complex	complex	NOUN
aji-33	261	22	.	.	PUNCT
aji-33	262	1	(	(	PUNCT
aji-33	262	2	mac	mac	PROPN
aji-33	262	3	)	)	PUNCT
aji-33	262	4	.	.	PUNCT
aji-33	263	1	regulatory	regulatory	ADJ
aji-33	263	2	proteins	protein	NOUN
aji-33	263	3	that	that	PRON
aji-33	263	4	disrupt	disrupt	VERB
aji-33	263	5	the	the	DET
aji-33	263	6	complement	complement	NOUN
aji-33	263	7	activation	activation	NOUN
aji-33	263	8	process	process	NOUN
aji-33	263	9	:	:	PUNCT
aji-33	263	10	since	since	SCONJ
aji-33	263	11	c3b	c3b	NOUN
aji-33	263	12	is	be	AUX
aji-33	263	13	free	free	ADJ
aji-33	263	14	and	and	CCONJ
aji-33	263	15	abundant	abundant	ADJ
aji-33	263	16	in	in	ADP
aji-33	263	17	the	the	DET
aji-33	263	18	plasma	plasma	NOUN
aji-33	263	19	,	,	PUNCT
aji-33	263	20	it	it	PRON
aji-33	263	21	can	can	AUX
aji-33	263	22	bind	bind	VERB
aji-33	263	23	to	to	ADP
aji-33	263	24	either	either	CCONJ
aji-33	263	25	a	a	DET
aji-33	263	26	host	host	NOUN
aji-33	263	27	cell	cell	NOUN
aji-33	263	28	or	or	CCONJ
aji-33	263	29	a	a	DET
aji-33	263	30	pathogen	pathogen	NOUN
aji-33	263	31	surface	surface	NOUN
aji-33	263	32	antigen	antigen	ADV
aji-33	263	33	.	.	PUNCT
aji-33	264	1	thus	thus	ADV
aji-33	264	2	,	,	PUNCT
aji-33	264	3	the	the	DET
aji-33	264	4	complement	complement	NOUN
aji-33	264	5	activation	activation	NOUN
aji-33	264	6	can	can	AUX
aji-33	264	7	kill	kill	VERB
aji-33	264	8	a	a	DET
aji-33	264	9	virus	virus	NOUN
aji-33	264	10	infected	infect	VERB
aji-33	264	11	cell	cell	NOUN
aji-33	264	12	or	or	CCONJ
aji-33	264	13	even	even	ADV
aji-33	264	14	the	the	DET
aji-33	264	15	healthy	healthy	ADJ
aji-33	264	16	host	host	NOUN
aji-33	264	17	cells	cell	NOUN
aji-33	264	18	.	.	PUNCT
aji-33	265	1	to	to	PART
aji-33	265	2	prevent	prevent	VERB
aji-33	265	3	the	the	DET
aji-33	265	4	host	host	NOUN
aji-33	265	5	cell	cell	NOUN
aji-33	265	6	damage	damage	NOUN
aji-33	265	7	,	,	PUNCT
aji-33	265	8	there	there	PRON
aji-33	265	9	are	be	VERB
aji-33	265	10	several	several	ADJ
aji-33	265	11	inbuilt	inbuilt	ADJ
aji-33	265	12	inhibitory	inhibitory	ADJ
aji-33	265	13	mechanisms	mechanism	NOUN
aji-33	265	14	operating	operate	VERB
aji-33	265	15	under	under	ADP
aji-33	265	16	the	the	DET
aji-33	265	17	prasad	prasad	NOUN
aji-33	265	18	;	;	PUNCT
aji-33	265	19	aji	aji	NOUN
aji-33	265	20	,	,	PUNCT
aji-33	265	21	3(1	3(1	NUM
aji-33	265	22	):	):	PUNCT
aji-33	265	23	233	233	NUM
aji-33	265	24	-	-	SYM
aji-33	265	25	252	252	NUM
aji-33	265	26	,	,	PUNCT
aji-33	265	27	2020	2020	NUM
aji-33	265	28	;	;	PUNCT
aji-33	265	29	article	article	NOUN
aji-33	265	30	no.aji.58422	no.aji.58422	NOUN
aji-33	265	31	238	238	NUM
aji-33	265	32	physiological	physiological	ADJ
aji-33	265	33	conditions	condition	NOUN
aji-33	265	34	.	.	PUNCT
aji-33	266	1	conversely	conversely	ADV
aji-33	266	2	the	the	DET
aji-33	266	3	virus	virus	NOUN
aji-33	266	4	may	may	AUX
aji-33	266	5	subvert	subvert	VERB
aji-33	266	6	the	the	DET
aji-33	266	7	very	very	ADV
aji-33	266	8	same	same	ADJ
aji-33	266	9	mechanisms	mechanism	NOUN
aji-33	266	10	to	to	PART
aji-33	266	11	sustain	sustain	VERB
aji-33	266	12	its	its	PRON
aji-33	266	13	own	own	ADJ
aji-33	266	14	survival	survival	NOUN
aji-33	266	15	as	as	SCONJ
aji-33	266	16	seen	see	VERB
aji-33	266	17	in	in	ADP
aji-33	266	18	case	case	NOUN
aji-33	266	19	of	of	ADP
aji-33	266	20	some	some	DET
aji-33	266	21	the	the	DET
aji-33	266	22	virus	virus	NOUN
aji-33	266	23	(	(	PUNCT
aji-33	266	24	vide	vide	NOUN
aji-33	266	25	infra	infra	NOUN
aji-33	266	26	)	)	PUNCT
aji-33	266	27	.	.	PUNCT
aji-33	267	1	4.1.2	4.1.2	NUM
aji-33	267	2	physiological	physiological	ADJ
aji-33	267	3	inhibitors	inhibitor	NOUN
aji-33	267	4	of	of	ADP
aji-33	267	5	the	the	DET
aji-33	267	6	alternative	alternative	ADJ
aji-33	267	7	complement	complement	NOUN
aji-33	267	8	cascade	cascade	NOUN
aji-33	267	9	o	o	NOUN
aji-33	267	10	complement	complement	NOUN
aji-33	267	11	receptor	receptor	NOUN
aji-33	267	12	1	1	NUM
aji-33	267	13	(	(	PUNCT
aji-33	267	14	cr1	cr1	NOUN
aji-33	267	15	)	)	PUNCT
aji-33	267	16	or	or	CCONJ
aji-33	267	17	cd35	cd35	PROPN
aji-33	267	18	)	)	PUNCT
aji-33	267	19	and	and	CCONJ
aji-33	267	20	daf	daf	PROPN
aji-33	267	21	(	(	PUNCT
aji-33	267	22	decay	decay	VERB
aji-33	267	23	accelerating	accelerate	VERB
aji-33	267	24	factor	factor	NOUN
aji-33	267	25	also	also	ADV
aji-33	267	26	known	know	VERB
aji-33	267	27	as	as	ADP
aji-33	267	28	cd55	cd55	PROPN
aji-33	267	29	)	)	PUNCT
aji-33	267	30	completes	complete	VERB
aji-33	267	31	with	with	ADP
aji-33	267	32	factor	factor	NOUN
aji-33	267	33	b	b	NOUN
aji-33	267	34	in	in	ADP
aji-33	267	35	binding	bind	VERB
aji-33	267	36	with	with	ADP
aji-33	267	37	c3b	c3b	NOUN
aji-33	267	38	on	on	ADP
aji-33	267	39	the	the	DET
aji-33	267	40	cell	cell	NOUN
aji-33	267	41	surface	surface	NOUN
aji-33	267	42	and	and	CCONJ
aji-33	267	43	can	can	AUX
aji-33	267	44	even	even	ADV
aji-33	267	45	remove	remove	VERB
aji-33	267	46	bb	bb	NOUN
aji-33	267	47	from	from	ADP
aji-33	267	48	an	an	DET
aji-33	267	49	already	already	ADV
aji-33	267	50	formed	form	VERB
aji-33	267	51	c3bbb	c3bbb	ADJ
aji-33	267	52	complex	complex	NOUN
aji-33	267	53	.	.	PUNCT
aji-33	268	1	o	o	PROPN
aji-33	268	2	complement	complement	NOUN
aji-33	268	3	factor(cf	factor(cf	ADV
aji-33	268	4	)	)	PUNCT
aji-33	268	5	,	,	PUNCT
aji-33	268	6	a	a	DET
aji-33	268	7	plasma	plasma	NOUN
aji-33	268	8	protease	protease	NOUN
aji-33	268	9	,	,	PUNCT
aji-33	268	10	prevents	prevent	VERB
aji-33	268	11	the	the	DET
aji-33	268	12	formation	formation	NOUN
aji-33	268	13	of	of	ADP
aji-33	268	14	a	a	DET
aji-33	268	15	c3	c3	PROPN
aji-33	268	16	convertasewhich	convertasewhich	PROPN
aji-33	268	17	cleaves	cleave	VERB
aji-33	268	18	c3b	c3b	NOUN
aji-33	268	19	into	into	ADP
aji-33	268	20	its	its	PRON
aji-33	268	21	inactive	inactive	ADJ
aji-33	268	22	form	form	NOUN
aji-33	268	23	,	,	PUNCT
aji-33	268	24	ic3b	ic3b	PROPN
aji-33	268	25	.	.	PUNCT
aji-33	269	1	factor	factor	NOUN
aji-33	269	2	i	i	PRON
aji-33	269	3	requires	require	VERB
aji-33	269	4	a	a	DET
aji-33	269	5	c3bbinding	c3bbinde	VERB
aji-33	269	6	protein	protein	NOUN
aji-33	269	7	cofactor	cofactor	NOUN
aji-33	269	8	such	such	ADJ
aji-33	269	9	as	as	ADP
aji-33	269	10	complement	complement	NOUN
aji-33	269	11	factor	factor	NOUN
aji-33	269	12	h	h	NOUN
aji-33	269	13	,	,	PUNCT
aji-33	269	14	cr1	cr1	PROPN
aji-33	269	15	,	,	PUNCT
aji-33	269	16	or	or	CCONJ
aji-33	269	17	membrane	membrane	NOUN
aji-33	269	18	cofactor	cofactor	NOUN
aji-33	269	19	of	of	ADP
aji-33	269	20	proteolysis	proteolysis	NOUN
aji-33	269	21	(	(	PUNCT
aji-33	269	22	mcp	mcp	PROPN
aji-33	269	23	or	or	CCONJ
aji-33	269	24	cd46	cd46	PROPN
aji-33	269	25	)	)	PUNCT
aji-33	270	1	[	[	X
aji-33	270	2	18	18	NUM
aji-33	270	3	]	]	PUNCT
aji-33	270	4	.	.	PUNCT
aji-33	271	1	o	o	NOUN
aji-33	271	2	complement	complement	NOUN
aji-33	271	3	factor	factor	NOUN
aji-33	271	4	h	h	NOUN
aji-33	271	5	can	can	AUX
aji-33	271	6	inhibit	inhibit	VERB
aji-33	271	7	the	the	DET
aji-33	271	8	formation	formation	NOUN
aji-33	271	9	of	of	ADP
aji-33	271	10	the	the	DET
aji-33	271	11	c3	c3	PROPN
aji-33	271	12	convertase	convertase	NOUN
aji-33	271	13	by	by	ADP
aji-33	271	14	competing	compete	VERB
aji-33	271	15	with	with	ADP
aji-33	271	16	factor	factor	NOUN
aji-33	271	17	b	b	NOUN
aji-33	271	18	for	for	ADP
aji-33	271	19	binding	bind	VERB
aji-33	271	20	to	to	PART
aji-33	271	21	c3c3bl	c3c3bl	VERB
aji-33	272	1	[	[	X
aji-33	272	2	19	19	NUM
aji-33	272	3	]	]	PUNCT
aji-33	272	4	accelerate	accelerate	NOUN
aji-33	272	5	the	the	DET
aji-33	272	6	decay	decay	NOUN
aji-33	272	7	of	of	ADP
aji-33	272	8	the	the	DET
aji-33	272	9	c3	c3	PROPN
aji-33	272	10	convertase	convertase	NOUN
aji-33	272	11	.	.	PUNCT
aji-33	273	1	[	[	X
aji-33	273	2	20	20	NUM
aji-33	273	3	]	]	PUNCT
aji-33	273	4	and	and	CCONJ
aji-33	273	5	act	act	VERB
aji-33	273	6	as	as	ADP
aji-33	273	7	a	a	DET
aji-33	273	8	cofactor	cofactor	NOUN
aji-33	273	9	for	for	ADP
aji-33	273	10	factor	factor	NOUN
aji-33	273	11	i	i	PROPN
aji-33	273	12	-	-	PUNCT
aji-33	273	13	mediated	mediate	VERB
aji-33	273	14	cleavage	cleavage	NOUN
aji-33	273	15	of	of	ADP
aji-33	273	16	c3b	c3b	PROPN
aji-33	273	17	[	[	X
aji-33	273	18	21	21	NUM
aji-33	273	19	]	]	PUNCT
aji-33	273	20	.	.	PUNCT
aji-33	274	1	complement	complement	NOUN
aji-33	274	2	factor	factor	NOUN
aji-33	274	3	h	h	NOUN
aji-33	274	4	preferentially	preferentially	ADV
aji-33	274	5	binds	bind	VERB
aji-33	274	6	to	to	ADP
aji-33	274	7	vertebrate	vertebrate	ADJ
aji-33	274	8	cells	cell	NOUN
aji-33	274	9	(	(	PUNCT
aji-33	274	10	because	because	SCONJ
aji-33	274	11	of	of	ADP
aji-33	274	12	affinity	affinity	NOUN
aji-33	274	13	for	for	ADP
aji-33	274	14	sialic	sialic	ADJ
aji-33	274	15	acid	acid	NOUN
aji-33	274	16	residues	residue	NOUN
aji-33	274	17	)	)	PUNCT
aji-33	274	18	,	,	PUNCT
aji-33	274	19	allowing	allow	VERB
aji-33	274	20	preferential	preferential	ADJ
aji-33	274	21	protection	protection	NOUN
aji-33	274	22	of	of	ADP
aji-33	274	23	host	host	NOUN
aji-33	274	24	(	(	PUNCT
aji-33	274	25	as	as	SCONJ
aji-33	274	26	opposed	oppose	VERB
aji-33	274	27	to	to	ADP
aji-33	274	28	bacterial	bacterial	ADJ
aji-33	274	29	)	)	PUNCT
aji-33	274	30	cells	cell	NOUN
aji-33	274	31	from	from	ADP
aji-33	274	32	complement	complement	NOUN
aji-33	274	33	-	-	PUNCT
aji-33	274	34	mediated	mediate	VERB
aji-33	274	35	damage	damage	NOUN
aji-33	274	36	.	.	PUNCT
aji-33	275	1	o	o	X
aji-33	275	2	cfhr5	cfhr5	NOUN
aji-33	275	3	(	(	PUNCT
aji-33	275	4	complement	complement	NOUN
aji-33	275	5	factor	factor	NOUN
aji-33	275	6	h	h	NOUN
aji-33	275	7	-	-	PUNCT
aji-33	275	8	related	relate	VERB
aji-33	275	9	protein	protein	NOUN
aji-33	275	10	[	[	X
aji-33	275	11	22	22	NUM
aji-33	275	12	]	]	PUNCT
aji-33	275	13	.	.	PUNCT
aji-33	276	1	immune	immune	ADJ
aji-33	276	2	evasion	evasion	NOUN
aji-33	276	3	by	by	ADP
aji-33	276	4	the	the	DET
aji-33	276	5	virus	virus	NOUN
aji-33	276	6	:	:	PUNCT
aji-33	276	7	the	the	DET
aji-33	276	8	lipid	lipid	ADJ
aji-33	276	9	bi	bi	ADJ
aji-33	276	10	-	-	ADJ
aji-33	276	11	layer	layer	ADJ
aji-33	276	12	membrane	membrane	NOUN
aji-33	276	13	of	of	ADP
aji-33	276	14	covid	covid	PROPN
aji-33	276	15	19	19	NUM
aji-33	276	16	is	be	AUX
aji-33	276	17	cited	cite	VERB
aji-33	276	18	as	as	ADP
aji-33	276	19	the	the	DET
aji-33	276	20	cause	cause	NOUN
aji-33	276	21	of	of	ADP
aji-33	276	22	failure	failure	NOUN
aji-33	276	23	of	of	ADP
aji-33	276	24	host	host	NOUN
aji-33	276	25	’s	’s	PART
aji-33	276	26	immune	immune	ADJ
aji-33	276	27	system	system	NOUN
aji-33	276	28	.	.	PUNCT
aji-33	277	1	beyond	beyond	ADP
aji-33	277	2	this	this	PRON
aji-33	277	3	there	there	PRON
aji-33	277	4	is	be	VERB
aji-33	277	5	no	no	DET
aji-33	277	6	data	datum	NOUN
aji-33	277	7	as	as	ADP
aji-33	277	8	to	to	ADP
aji-33	277	9	how	how	SCONJ
aji-33	277	10	actually	actually	ADV
aji-33	277	11	sazrscov2	sazrscov2	NOUN
aji-33	277	12	evades	evade	VERB
aji-33	277	13	the	the	DET
aji-33	277	14	immune	immune	ADJ
aji-33	277	15	system	system	NOUN
aji-33	277	16	.	.	PUNCT
aji-33	278	1	other	other	ADJ
aji-33	278	2	others	other	NOUN
aji-33	278	3	have	have	AUX
aji-33	278	4	narrowed	narrow	VERB
aji-33	278	5	the	the	DET
aji-33	278	6	analogy	analogy	NOUN
aji-33	278	7	with	with	ADP
aji-33	278	8	sars	sars	PROPN
aji-33	278	9	cov	cov	PROPN
aji-33	278	10	1	1	NUM
aji-33	278	11	and	and	CCONJ
aji-33	278	12	mers	mers	PROPN
aji-33	278	13	cov	cov	PROPN
aji-33	278	14	.	.	PUNCT
aji-33	279	1	the	the	DET
aji-33	279	2	author	author	NOUN
aji-33	279	3	cites	cite	VERB
aji-33	279	4	few	few	ADJ
aji-33	279	5	examples	example	NOUN
aji-33	279	6	of	of	ADP
aji-33	279	7	other	other	ADJ
aji-33	279	8	virus	virus	NOUN
aji-33	279	9	whose	whose	DET
aji-33	279	10	immune	immune	ADJ
aji-33	279	11	evading	evading	NOUN
aji-33	279	12	mechanism	mechanism	NOUN
aji-33	279	13	was	be	AUX
aji-33	279	14	studied	study	VERB
aji-33	279	15	and	and	CCONJ
aji-33	279	16	reported	report	VERB
aji-33	279	17	.	.	PUNCT
aji-33	280	1	the	the	DET
aji-33	280	2	future	future	ADJ
aji-33	280	3	research	research	NOUN
aji-33	280	4	is	be	AUX
aji-33	280	5	expected	expect	VERB
aji-33	280	6	to	to	PART
aji-33	280	7	throw	throw	VERB
aji-33	280	8	more	more	ADJ
aji-33	280	9	light	light	NOUN
aji-33	280	10	on	on	ADP
aji-33	280	11	this	this	DET
aji-33	280	12	aspect	aspect	NOUN
aji-33	280	13	.	.	PUNCT
aji-33	281	1	4.1.3	4.1.3	NUM
aji-33	281	2	illustrations	illustration	NOUN
aji-33	281	3	of	of	ADP
aji-33	281	4	how	how	SCONJ
aji-33	281	5	some	some	DET
aji-33	281	6	virus	virus	NOUN
aji-33	281	7	subvert	subvert	VERB
aji-33	281	8	the	the	DET
aji-33	281	9	defence	defence	NOUN
aji-33	281	10	against	against	ADP
aji-33	281	11	self	self	NOUN
aji-33	281	12	cell	cell	NOUN
aji-33	281	13	destruction	destruction	NOUN
aji-33	281	14	1	1	NUM
aji-33	281	15	.	.	PUNCT
aji-33	281	16	synthesis	synthesis	NOUN
aji-33	281	17	of	of	ADP
aji-33	281	18	new	new	ADJ
aji-33	281	19	regulatory	regulatory	ADJ
aji-33	281	20	proteins	protein	NOUN
aji-33	281	21	illustration	illustration	NOUN
aji-33	281	22	:	:	PUNCT
aji-33	281	23	west	west	PROPN
aji-33	281	24	nile	nile	PROPN
aji-33	281	25	virus	virus	PROPN
aji-33	281	26	synthesizes	synthesize	VERB
aji-33	281	27	two	two	NUM
aji-33	281	28	isoforms	isoform	NOUN
aji-33	281	29	of	of	ADP
aji-33	281	30	ns1	ns1	NOUN
aji-33	281	31	protein	protein	NOUN
aji-33	281	32	to	to	PART
aji-33	281	33	regulate	regulate	VERB
aji-33	281	34	c3	c3	PROPN
aji-33	281	35	.	.	PUNCT
aji-33	282	1	soluble	soluble	ADJ
aji-33	282	2	ns1	ns1	PROPN
aji-33	282	3	increases	increase	NOUN
aji-33	282	4	factor	factor	NOUN
aji-33	282	5	i	i	NOUN
aji-33	282	6	-	-	PUNCT
aji-33	282	7	mediated	mediate	VERB
aji-33	282	8	cleavage	cleavage	NOUN
aji-33	282	9	of	of	ADP
aji-33	282	10	c3b	c3b	NOUN
aji-33	282	11	to	to	ADP
aji-33	282	12	ic3b	ic3b	PROPN
aji-33	282	13	while	while	SCONJ
aji-33	282	14	the	the	DET
aji-33	282	15	cell	cell	NOUN
aji-33	282	16	surface	surface	NOUN
aji-33	282	17	-	-	PUNCT
aji-33	282	18	bound	bind	VERB
aji-33	282	19	ns1	ns1	NOUN
aji-33	282	20	decreases	decrease	VERB
aji-33	282	21	deposition	deposition	NOUN
aji-33	282	22	of	of	ADP
aji-33	282	23	c3b	c3b	PROPN
aji-33	282	24	and	and	CCONJ
aji-33	282	25	mac	mac	PROPN
aji-33	283	1	[	[	X
aji-33	283	2	23	23	NUM
aji-33	283	3	]	]	PUNCT
aji-33	283	4	.	.	PUNCT
aji-33	284	1	2	2	X
aji-33	284	2	.	.	X
aji-33	284	3	incorporation	incorporation	NOUN
aji-33	284	4	of	of	ADP
aji-33	284	5	the	the	DET
aji-33	284	6	host	host	NOUN
aji-33	284	7	complement	complement	VERB
aji-33	284	8	regulatory	regulatory	ADJ
aji-33	284	9	proteins	protein	NOUN
aji-33	284	10	to	to	ADP
aji-33	284	11	virions	virion	NOUN
aji-33	284	12	:	:	PUNCT
aji-33	284	13	to	to	PART
aji-33	284	14	evade	evade	VERB
aji-33	284	15	complement	complement	NOUN
aji-33	284	16	-	-	PUNCT
aji-33	284	17	mediated	mediate	VERB
aji-33	284	18	destruction	destruction	NOUN
aji-33	284	19	,	,	PUNCT
aji-33	284	20	human	human	ADJ
aji-33	284	21	immunodeficiency	immunodeficiency	NOUN
aji-33	284	22	virus-1	virus-1	NOUN
aji-33	284	23	(	(	PUNCT
aji-33	284	24	hiv-1	hiv-1	NUM
aji-33	284	25	)	)	PUNCT
aji-33	284	26	,	,	PUNCT
aji-33	284	27	human	human	PROPN
aji-33	284	28	t	t	PROPN
aji-33	284	29	-	-	PUNCT
aji-33	284	30	lymphotropic	lymphotropic	NOUN
aji-33	284	31	virus-1	virus-1	PROPN
aji-33	284	32	(	(	PUNCT
aji-33	284	33	htlv-1	htlv-1	NUM
aji-33	284	34	)	)	PUNCT
aji-33	284	35	and	and	CCONJ
aji-33	284	36	human	human	ADJ
aji-33	284	37	cytomegalovirus	cytomegalovirus	NOUN
aji-33	284	38	(	(	PUNCT
aji-33	284	39	hcmv	hcmv	NOUN
aji-33	284	40	)	)	PUNCT
aji-33	284	41	incorporate	incorporate	VERB
aji-33	284	42	the	the	DET
aji-33	284	43	complement	complement	NOUN
aji-33	284	44	controlled	control	VERB
aji-33	284	45	proteins	protein	NOUN
aji-33	284	46	cd55	cd55	PROPN
aji-33	284	47	and	and	CCONJ
aji-33	284	48	cd59	cd59	PROPN
aji-33	284	49	into	into	ADP
aji-33	284	50	their	their	PRON
aji-33	284	51	virions	virion	NOUN
aji-33	284	52	to	to	PART
aji-33	284	53	circumvent	circumvent	VERB
aji-33	284	54	the	the	DET
aji-33	284	55	complement	complement	NOUN
aji-33	284	56	response	response	NOUN
aji-33	284	57	[	[	X
aji-33	284	58	24,25	24,25	NUM
aji-33	284	59	]	]	PUNCT
aji-33	284	60	.	.	PUNCT
aji-33	285	1	3	3	X
aji-33	285	2	.	.	X
aji-33	285	3	prevention	prevention	NOUN
aji-33	285	4	of	of	ADP
aji-33	285	5	the	the	DET
aji-33	285	6	cell	cell	NOUN
aji-33	285	7	lysis	lysis	NOUN
aji-33	285	8	by	by	ADP
aji-33	285	9	inhibiting	inhibit	VERB
aji-33	285	10	the	the	DET
aji-33	285	11	remainder	remainder	NOUN
aji-33	285	12	of	of	ADP
aji-33	285	13	the	the	DET
aji-33	285	14	complement	complement	NOUN
aji-33	285	15	cascade	cascade	NOUN
aji-33	285	16	illustration	illustration	NOUN
aji-33	285	17	:	:	PUNCT
aji-33	285	18	hiv	hiv	PROPN
aji-33	285	19	enters	enter	VERB
aji-33	285	20	human	human	PROPN
aji-33	285	21	cd4	cd4	PROPN
aji-33	285	22	+	+	PROPN
aji-33	285	23	t	t	NOUN
aji-33	285	24	cells	cell	NOUN
aji-33	285	25	through	through	ADP
aji-33	285	26	complement	complement	NOUN
aji-33	285	27	receptors	receptor	NOUN
aji-33	285	28	.	.	PUNCT
aji-33	286	1	hiv	hiv	PROPN
aji-33	286	2	gp41	gp41	PROPN
aji-33	286	3	and	and	CCONJ
aji-33	286	4	gp120	gp120	PROPN
aji-33	286	5	proteins	protein	NOUN
aji-33	286	6	activate	activate	VERB
aji-33	286	7	complement	complement	NOUN
aji-33	286	8	through	through	ADP
aji-33	286	9	the	the	DET
aji-33	286	10	classical	classical	ADJ
aji-33	286	11	and	and	CCONJ
aji-33	286	12	lectin	lectin	NOUN
aji-33	286	13	pathways	pathway	NOUN
aji-33	286	14	,	,	PUNCT
aji-33	286	15	respectively	respectively	ADV
aji-33	286	16	.	.	PUNCT
aji-33	287	1	at	at	ADP
aji-33	287	2	the	the	DET
aji-33	287	3	same	same	ADJ
aji-33	287	4	time	time	NOUN
aji-33	287	5	,	,	PUNCT
aji-33	287	6	the	the	DET
aji-33	287	7	above	above	ADJ
aji-33	287	8	two	two	NUM
aji-33	287	9	proteins	protein	NOUN
aji-33	287	10	inhibit	inhibit	NOUN
aji-33	287	11	mac	mac	NOUN
aji-33	287	12	formation	formation	NOUN
aji-33	287	13	by	by	ADP
aji-33	287	14	recruiting	recruiting	NOUN
aji-33	287	15	factor	factor	NOUN
aji-33	287	16	h	h	NOUN
aji-33	287	17	and	and	CCONJ
aji-33	287	18	cd59	cd59	PROPN
aji-33	287	19	to	to	ADP
aji-33	287	20	the	the	DET
aji-33	287	21	surface	surface	NOUN
aji-33	287	22	of	of	ADP
aji-33	287	23	the	the	DET
aji-33	287	24	virally	virally	ADV
aji-33	287	25	-	-	PUNCT
aji-33	287	26	infected	infect	VERB
aji-33	287	27	host	host	NOUN
aji-33	287	28	cell	cell	NOUN
aji-33	287	29	to	to	PART
aji-33	287	30	abolish	abolish	VERB
aji-33	287	31	complement	complement	NOUN
aji-33	287	32	-	-	PUNCT
aji-33	287	33	mediated	mediate	VERB
aji-33	287	34	lysis	lysis	NOUN
aji-33	288	1	[	[	X
aji-33	288	2	26	26	NUM
aji-33	288	3	]	]	PUNCT
aji-33	288	4	.	.	PUNCT
aji-33	289	1	4	4	X
aji-33	289	2	.	.	X
aji-33	289	3	modulate	modulate	VERB
aji-33	289	4	cytokine	cytokine	ADJ
aji-33	289	5	expression	expression	NOUN
aji-33	289	6	to	to	PART
aji-33	289	7	induce	induce	VERB
aji-33	289	8	a	a	DET
aji-33	289	9	pro	pro	ADJ
aji-33	289	10	-	-	ADJ
aji-33	289	11	coagulant	coagulant	ADJ
aji-33	289	12	state	state	NOUN
aji-33	289	13	illustration	illustration	NOUN
aji-33	289	14	:	:	PUNCT
aji-33	289	15	mediated	mediate	VERB
aji-33	289	16	by	by	ADP
aji-33	289	17	il-1(interleukin	il-1(interleukin	NOUN
aji-33	289	18	)	)	PUNCT
aji-33	289	19	,	,	PUNCT
aji-33	289	20	tnfα,(tumour	tnfα,(tumour	ADJ
aji-33	289	21	necrosis	necrosis	NOUN
aji-33	289	22	factor	factor	NOUN
aji-33	289	23	)	)	PUNCT
aji-33	289	24	and	and	CCONJ
aji-33	289	25	il-6	il-6	NUM
aji-33	289	26	,	,	PUNCT
aji-33	289	27	marburg	marburg	PROPN
aji-33	289	28	virus	virus	PROPN
aji-33	289	29	,	,	PUNCT
aji-33	289	30	ebola	ebola	PROPN
aji-33	289	31	virus	virus	NOUN
aji-33	289	32	and	and	CCONJ
aji-33	289	33	hanta	hanta	NOUN
aji-33	289	34	virus	virus	NOUN
aji-33	289	35	induce	induce	VERB
aji-33	289	36	tissue	tissue	NOUN
aji-33	289	37	factor	factor	NOUN
aji-33	289	38	expression	expression	NOUN
aji-33	289	39	on	on	ADP
aji-33	289	40	the	the	DET
aji-33	289	41	endothelial	endothelial	ADJ
aji-33	289	42	surface	surface	NOUN
aji-33	290	1	[	[	X
aji-33	290	2	27,28	27,28	X
aji-33	290	3	]	]	X
aji-33	290	4	.	.	PUNCT
aji-33	291	1	5	5	X
aji-33	291	2	.	.	X
aji-33	291	3	use	use	VERB
aji-33	291	4	coagulation	coagulation	NOUN
aji-33	291	5	factors	factor	NOUN
aji-33	291	6	to	to	PART
aji-33	291	7	enhance	enhance	VERB
aji-33	291	8	viral	viral	ADJ
aji-33	291	9	binding	bind	VERB
aji-33	291	10	and	and	CCONJ
aji-33	291	11	replication	replication	NOUN
aji-33	291	12	illustration	illustration	NOUN
aji-33	291	13	:	:	PUNCT
aji-33	291	14	human	human	ADJ
aji-33	291	15	species	specie	NOUN
aji-33	291	16	a	a	DET
aji-33	291	17	adenovirus-18	adenovirus-18	PROPN
aji-33	291	18	(	(	PUNCT
aji-33	291	19	hadv-18	hadv-18	PROPN
aji-33	291	20	)	)	PUNCT
aji-33	291	21	and	and	CCONJ
aji-33	291	22	31(hadv-31	31(hadv-31	NUM
aji-33	291	23	)	)	PUNCT
aji-33	291	24	.	.	PUNCT
aji-33	292	1	it	it	PRON
aji-33	292	2	is	be	AUX
aji-33	292	3	known	know	VERB
aji-33	292	4	that	that	SCONJ
aji-33	292	5	the	the	DET
aji-33	292	6	innate	innate	ADJ
aji-33	292	7	immune	immune	ADJ
aji-33	292	8	reaction	reaction	NOUN
aji-33	292	9	recruits	recruit	VERB
aji-33	292	10	the	the	DET
aji-33	292	11	alternate	alternate	ADJ
aji-33	292	12	complement	complement	NOUN
aji-33	292	13	activation	activation	NOUN
aji-33	292	14	pathway	pathway	NOUN
aji-33	292	15	and	and	CCONJ
aji-33	292	16	the	the	DET
aji-33	292	17	adaptive	adaptive	ADJ
aji-33	292	18	immune	immune	ADJ
aji-33	292	19	response	response	NOUN
aji-33	292	20	involves	involve	VERB
aji-33	292	21	the	the	DET
aji-33	292	22	classical	classical	ADJ
aji-33	292	23	complement	complement	NOUN
aji-33	292	24	activation	activation	NOUN
aji-33	292	25	pathway	pathway	NOUN
aji-33	292	26	.	.	PUNCT
aji-33	293	1	there	there	PRON
aji-33	293	2	is	be	VERB
aji-33	293	3	a	a	DET
aji-33	293	4	third	third	ADJ
aji-33	293	5	,	,	PUNCT
aji-33	293	6	the	the	DET
aji-33	293	7	lectin	lectin	ADJ
aji-33	293	8	pathway	pathway	NOUN
aji-33	293	9	.	.	PUNCT
aji-33	294	1	the	the	DET
aji-33	294	2	alternate	alternate	ADJ
aji-33	294	3	complementary	complementary	ADJ
aji-33	294	4	pathway	pathway	NOUN
aji-33	294	5	starts	start	VERB
aji-33	294	6	with	with	ADP
aji-33	294	7	cleaving	cleaving	NOUN
aji-33	294	8	of	of	ADP
aji-33	294	9	c3	c3	PROPN
aji-33	294	10	.	.	PUNCT
aji-33	295	1	the	the	DET
aji-33	295	2	classical	classical	ADJ
aji-33	295	3	pathway	pathway	NOUN
aji-33	295	4	and	and	CCONJ
aji-33	295	5	the	the	DET
aji-33	295	6	lectin	lectin	ADJ
aji-33	295	7	pathway	pathway	NOUN
aji-33	295	8	both	both	CCONJ
aji-33	295	9	converge	converge	VERB
aji-33	295	10	on	on	ADP
aji-33	295	11	production	production	NOUN
aji-33	295	12	of	of	ADP
aji-33	295	13	c3	c3	PROPN
aji-33	295	14	by	by	ADP
aji-33	295	15	a	a	DET
aji-33	295	16	loop	loop	NOUN
aji-33	295	17	.	.	PUNCT
aji-33	296	1	4.1.4	4.1.4	DET
aji-33	296	2	complement	complement	NOUN
aji-33	296	3	mediated	mediate	VERB
aji-33	296	4	immune	immune	ADJ
aji-33	296	5	damage	damage	NOUN
aji-33	296	6	4.1.4.1	4.1.4.1	NUM
aji-33	296	7	explanation	explanation	NOUN
aji-33	296	8	for	for	ADP
aji-33	296	9	interstitial	interstitial	ADJ
aji-33	296	10	pneumonia	pneumonia	NOUN
aji-33	296	11	in	in	ADP
aji-33	296	12	lung	lung	NOUN
aji-33	296	13	pathology	pathology	NOUN
aji-33	296	14	1	1	NUM
aji-33	296	15	.	.	PUNCT
aji-33	297	1	c3	c3	PROPN
aji-33	297	2	is	be	AUX
aji-33	297	3	cleaved	cleave	VERB
aji-33	297	4	into	into	ADP
aji-33	297	5	c3b(catalytic	c3b(catalytic	ADJ
aji-33	297	6	fragment	fragment	NOUN
aji-33	297	7	)	)	PUNCT
aji-33	297	8	and	and	CCONJ
aji-33	297	9	c3bi	c3bi	NUM
aji-33	297	10	(	(	PUNCT
aji-33	297	11	non	non	X
aji-33	297	12	catalytic	catalytic	ADJ
aji-33	297	13	fragment	fragment	NOUN
aji-33	297	14	)	)	PUNCT
aji-33	297	15	.	.	PUNCT
aji-33	298	1	further	further	ADJ
aji-33	298	2	events	event	NOUN
aji-33	298	3	may	may	AUX
aji-33	298	4	follow	follow	VERB
aji-33	298	5	either	either	PRON
aji-33	298	6	of	of	ADP
aji-33	298	7	the	the	DET
aji-33	298	8	following	follow	VERB
aji-33	298	9	pathways	pathway	NOUN
aji-33	298	10	.	.	PUNCT
aji-33	299	1	2	2	X
aji-33	299	2	.	.	X
aji-33	299	3	the	the	DET
aji-33	299	4	c3i	c3i	NOUN
aji-33	299	5	pathway	pathway	NOUN
aji-33	299	6	:	:	PUNCT
aji-33	299	7	c3bi	c3bi	PUNCT
aji-33	299	8	is	be	AUX
aji-33	299	9	bound	bind	VERB
aji-33	299	10	to	to	ADP
aji-33	299	11	cr	cr	PROPN
aji-33	299	12	3	3	NUM
aji-33	299	13	(	(	PUNCT
aji-33	299	14	cd11b	cd11b	X
aji-33	299	15	/	/	SYM
aji-33	299	16	cd18	cd18	PROPN
aji-33	299	17	)	)	PUNCT
aji-33	299	18	,	,	PUNCT
aji-33	299	19	integrin	integrin	PROPN
aji-33	299	20	αmβ2	αmβ2	PROPN
aji-33	299	21	)	)	PUNCT
aji-33	299	22	receptor	receptor	NOUN
aji-33	299	23	of	of	ADP
aji-33	299	24	the	the	DET
aji-33	299	25	macrophage	macrophage	NOUN
aji-33	299	26	.	.	PUNCT
aji-33	300	1	3	3	X
aji-33	300	2	.	.	X
aji-33	300	3	affinity	affinity	NOUN
aji-33	300	4	modulation	modulation	NOUN
aji-33	300	5	of	of	ADP
aji-33	300	6	macrophage	macrophage	ADJ
aji-33	300	7	integrins	integrin	NOUN
aji-33	300	8	is	be	AUX
aji-33	300	9	sufficient	sufficient	ADJ
aji-33	300	10	to	to	PART
aji-33	300	11	allow	allow	VERB
aji-33	300	12	binding	bind	VERB
aji-33	300	13	of	of	ADP
aji-33	300	14	prasad	prasad	NOUN
aji-33	300	15	;	;	PUNCT
aji-33	300	16	aji	aji	NOUN
aji-33	300	17	,	,	PUNCT
aji-33	300	18	3(1	3(1	NUM
aji-33	300	19	):	):	PUNCT
aji-33	300	20	233	233	NUM
aji-33	300	21	-	-	SYM
aji-33	300	22	252	252	NUM
aji-33	300	23	,	,	PUNCT
aji-33	300	24	2020	2020	NUM
aji-33	300	25	;	;	PUNCT
aji-33	300	26	article	article	NOUN
aji-33	300	27	no.aji.58422	no.aji.58422	NOUN
aji-33	300	28	239	239	NUM
aji-33	300	29	opsonized	opsonize	VERB
aji-33	300	30	particles	particle	NOUN
aji-33	300	31	,	,	PUNCT
aji-33	300	32	but	but	CCONJ
aji-33	300	33	increased	increase	VERB
aji-33	300	34	diffusion	diffusion	NOUN
aji-33	300	35	to	to	PART
aji-33	300	36	allow	allow	VERB
aji-33	300	37	clustering	clustering	NOUN
aji-33	300	38	is	be	AUX
aji-33	300	39	required	require	VERB
aji-33	300	40	in	in	ADP
aji-33	300	41	order	order	NOUN
aji-33	300	42	to	to	PART
aji-33	300	43	activate	activate	VERB
aji-33	300	44	phagocytosis	phagocytosis	NOUN
aji-33	300	45	,	,	PUNCT
aji-33	300	46	which	which	PRON
aji-33	300	47	is	be	AUX
aji-33	300	48	facilitated	facilitate	VERB
aji-33	300	49	by	by	ADP
aji-33	300	50	cytokines	cytokine	NOUN
aji-33	300	51	il-4	il-4	X
aji-33	300	52	,	,	PUNCT
aji-33	300	53	m	m	PROPN
aji-33	300	54	-	-	PUNCT
aji-33	300	55	csf	csf	PROPN
aji-33	300	56	,	,	PUNCT
aji-33	300	57	tnf	tnf	PROPN
aji-33	300	58	-	-	PUNCT
aji-33	300	59	α	α	PROPN
aji-33	300	60	and	and	CCONJ
aji-33	300	61	gmcsf	gmcsf	ADJ
aji-33	300	62	.	.	PUNCT
aji-33	301	1	c3b	c3b	NOUN
aji-33	301	2	pathway	pathway	NOUN
aji-33	301	3	:	:	PUNCT
aji-33	301	4	this	this	DET
aji-33	301	5	catalytic	catalytic	ADJ
aji-33	301	6	fragments	fragment	NOUN
aji-33	301	7	continues	continue	VERB
aji-33	301	8	the	the	DET
aji-33	301	9	cascade	cascade	NOUN
aji-33	301	10	of	of	ADP
aji-33	301	11	alternate	alternate	ADJ
aji-33	301	12	complement	complement	NOUN
aji-33	301	13	activation	activation	NOUN
aji-33	301	14	pathway	pathway	NOUN
aji-33	301	15	with	with	ADP
aji-33	301	16	ultimate	ultimate	ADJ
aji-33	301	17	production	production	NOUN
aji-33	301	18	of	of	ADP
aji-33	301	19	mac	mac	PROPN
aji-33	301	20	complex	complex	NOUN
aji-33	301	21	which	which	PRON
aji-33	301	22	cause	cause	VERB
aji-33	301	23	the	the	DET
aji-33	301	24	lysis	lysis	NOUN
aji-33	301	25	and	and	CCONJ
aji-33	301	26	death	death	NOUN
aji-33	301	27	of	of	ADP
aji-33	301	28	the	the	DET
aji-33	301	29	infected	infected	ADJ
aji-33	301	30	cell	cell	NOUN
aji-33	301	31	including	include	VERB
aji-33	301	32	the	the	DET
aji-33	301	33	virus	virus	NOUN
aji-33	301	34	.	.	PUNCT
aji-33	302	1	the	the	DET
aji-33	302	2	complement	complement	NOUN
aji-33	302	3	receptor	receptor	NOUN
aji-33	302	4	activated	activate	VERB
aji-33	302	5	stimulation	stimulation	NOUN
aji-33	302	6	will	will	AUX
aji-33	302	7	not	not	PART
aji-33	302	8	elicited	elicited	VERB
aji-33	302	9	inflammatory	inflammatory	ADJ
aji-33	302	10	reaction	reaction	NOUN
aji-33	302	11	as	as	SCONJ
aji-33	302	12	it	it	PRON
aji-33	302	13	can	can	AUX
aji-33	302	14	not	not	PART
aji-33	302	15	recruit	recruit	VERB
aji-33	302	16	the	the	DET
aji-33	302	17	pro	pro	ADJ
aji-33	302	18	-	-	ADJ
aji-33	302	19	inflammatory	inflammatory	ADJ
aji-33	302	20	cytokines	cytokine	NOUN
aji-33	302	21	and	and	CCONJ
aji-33	302	22	chemokines	chemokine	NOUN
aji-33	302	23	.	.	PUNCT
aji-33	303	1	it	it	PRON
aji-33	303	2	could	could	AUX
aji-33	303	3	be	be	AUX
aji-33	303	4	inferred	infer	VERB
aji-33	303	5	from	from	ADP
aji-33	303	6	the	the	DET
aji-33	303	7	polymorphism	polymorphism	NOUN
aji-33	303	8	(	(	PUNCT
aji-33	303	9	see	see	VERB
aji-33	303	10	below	below	ADV
aji-33	303	11	)	)	PUNCT
aji-33	303	12	exhibited	exhibit	VERB
aji-33	303	13	by	by	ADP
aji-33	303	14	the	the	DET
aji-33	303	15	alveolar	alveolar	ADJ
aji-33	303	16	macrophages	macrophage	NOUN
aji-33	303	17	that	that	SCONJ
aji-33	303	18	the	the	DET
aji-33	303	19	complement	complement	NOUN
aji-33	303	20	mediated	mediate	VERB
aji-33	303	21	perhaps	perhaps	ADV
aji-33	303	22	stimulates	stimulate	VERB
aji-33	303	23	the	the	DET
aji-33	303	24	alternatively	alternatively	ADV
aji-33	303	25	activated	activate	VERB
aji-33	303	26	m2	m2	PROPN
aji-33	303	27	type	type	NOUN
aji-33	303	28	macrophages	macrophage	NOUN
aji-33	303	29	which	which	PRON
aji-33	303	30	are	be	AUX
aji-33	303	31	known	know	VERB
aji-33	303	32	to	to	PART
aji-33	303	33	be	be	AUX
aji-33	303	34	anti	anti	ADJ
aji-33	303	35	inflammatory	inflammatory	ADJ
aji-33	303	36	in	in	ADP
aji-33	303	37	response	response	NOUN
aji-33	303	38	.	.	PUNCT
aji-33	304	1	this	this	PRON
aji-33	304	2	could	could	AUX
aji-33	304	3	come	come	VERB
aji-33	304	4	as	as	ADV
aji-33	304	5	handicap	handicap	NOUN
aji-33	304	6	to	to	ADP
aji-33	304	7	the	the	DET
aji-33	304	8	host	host	NOUN
aji-33	304	9	because	because	SCONJ
aji-33	304	10	,	,	PUNCT
aji-33	304	11	m2	m2	PROPN
aji-33	304	12	type	type	NOUN
aji-33	304	13	stimulation	stimulation	NOUN
aji-33	304	14	also	also	ADV
aji-33	304	15	stimulates	stimulate	VERB
aji-33	304	16	the	the	DET
aji-33	304	17	extracellular	extracellular	ADJ
aji-33	304	18	matrix	matrix	NOUN
aji-33	304	19	protein	protein	NOUN
aji-33	304	20	,	,	PUNCT
aji-33	304	21	collagen	collagen	NOUN
aji-33	304	22	,	,	PUNCT
aji-33	304	23	which	which	PRON
aji-33	304	24	produces	produce	VERB
aji-33	304	25	interstitial	interstitial	ADJ
aji-33	304	26	fibrosis	fibrosis	NOUN
aji-33	304	27	as	as	SCONJ
aji-33	304	28	seen	see	VERB
aji-33	304	29	in	in	ADP
aji-33	304	30	the	the	DET
aji-33	304	31	covid	covid	PROPN
aji-33	304	32	19	19	NUM
aji-33	304	33	lung	lung	NOUN
aji-33	304	34	.	.	PUNCT
aji-33	305	1	thus	thus	ADV
aji-33	305	2	one	one	NUM
aji-33	305	3	of	of	ADP
aji-33	305	4	the	the	DET
aji-33	305	5	pathological	pathological	ADJ
aji-33	305	6	/	/	SYM
aji-33	305	7	radiological	radiological	ADJ
aji-33	305	8	feature	feature	NOUN
aji-33	305	9	of	of	ADP
aji-33	305	10	interstitial	interstitial	ADJ
aji-33	305	11	pneumonia/	pneumonia/	NUM
aji-33	305	12	fibrosis	fibrosis	NOUN
aji-33	305	13	is	be	AUX
aji-33	305	14	explained	explain	VERB
aji-33	305	15	.	.	PUNCT
aji-33	306	1	secondly	secondly	ADV
aji-33	306	2	since	since	SCONJ
aji-33	306	3	this	this	PRON
aji-33	306	4	inhibits	inhibit	VERB
aji-33	306	5	the	the	DET
aji-33	306	6	expression	expression	NOUN
aji-33	306	7	of	of	ADP
aji-33	306	8	the	the	DET
aji-33	306	9	inflammatory	inflammatory	ADJ
aji-33	306	10	mediated	mediate	VERB
aji-33	306	11	m1	m1	NOUN
aji-33	306	12	type	type	NOUN
aji-33	306	13	macrophages	macrophage	NOUN
aji-33	306	14	.	.	PUNCT
aji-33	307	1	absence	absence	NOUN
aji-33	307	2	of	of	ADP
aji-33	307	3	inflammatory	inflammatory	ADJ
aji-33	307	4	stimulus	stimulus	NOUN
aji-33	307	5	may	may	AUX
aji-33	307	6	make	make	VERB
aji-33	307	7	the	the	DET
aji-33	307	8	pt	pt	NOUN
aji-33	307	9	in	in	ADP
aji-33	307	10	whom	whom	PRON
aji-33	307	11	this	this	DET
aji-33	307	12	pathway	pathway	NOUN
aji-33	307	13	acts	act	VERB
aji-33	307	14	asymptomatic	asymptomatic	ADJ
aji-33	307	15	but	but	CCONJ
aji-33	307	16	yet	yet	ADV
aji-33	307	17	the	the	DET
aji-33	307	18	lung	lung	NOUN
aji-33	307	19	damage	damage	NOUN
aji-33	307	20	in	in	ADP
aji-33	307	21	the	the	DET
aji-33	307	22	form	form	NOUN
aji-33	307	23	of	of	ADP
aji-33	307	24	interstitial	interstitial	ADJ
aji-33	307	25	fibrosis	fibrosis	NOUN
aji-33	307	26	progresses	progress	VERB
aji-33	307	27	.	.	PUNCT
aji-33	308	1	it	it	PRON
aji-33	308	2	is	be	AUX
aji-33	308	3	known	know	VERB
aji-33	308	4	that	that	SCONJ
aji-33	308	5	the	the	DET
aji-33	308	6	symptoms	symptom	NOUN
aji-33	308	7	of	of	ADP
aji-33	308	8	covid	covid	PROPN
aji-33	308	9	19	19	NUM
aji-33	308	10	are	be	AUX
aji-33	308	11	due	due	ADJ
aji-33	308	12	to	to	ADP
aji-33	308	13	inflammatory	inflammatory	ADJ
aji-33	308	14	response	response	NOUN
aji-33	308	15	mounted	mount	VERB
aji-33	308	16	by	by	ADP
aji-33	308	17	the	the	DET
aji-33	308	18	body	body	NOUN
aji-33	308	19	of	of	ADP
aji-33	308	20	the	the	DET
aji-33	308	21	hostpatient	hostpatient	NOUN
aji-33	308	22	.	.	PUNCT
aji-33	309	1	role	role	NOUN
aji-33	309	2	of	of	ADP
aji-33	309	3	tissue	tissue	NOUN
aji-33	309	4	factor(tf)/(extrinsic	factor(tf)/(extrinsic	ADJ
aji-33	309	5	)	)	PUNCT
aji-33	309	6	pathway	pathway	NOUN
aji-33	309	7	in	in	ADP
aji-33	309	8	the	the	DET
aji-33	309	9	pathogenesis	pathogenesis	NOUN
aji-33	309	10	of	of	ADP
aji-33	309	11	covid	covid	PROPN
aji-33	309	12	19	19	NUM
aji-33	309	13	:	:	PUNCT
aji-33	309	14			NOUN
aji-33	309	15	the	the	DET
aji-33	309	16	increase	increase	NOUN
aji-33	309	17	pt	pt	X
aji-33	309	18	(	(	PUNCT
aji-33	309	19	prothrombin	prothrombin	NOUN
aji-33	309	20	time	time	NOUN
aji-33	309	21	)	)	PUNCT
aji-33	309	22	and	and	CCONJ
aji-33	309	23	injury	injury	NOUN
aji-33	309	24	to	to	ADP
aji-33	309	25	subendothelial	subendothelial	ADJ
aji-33	309	26	tissues	tissue	NOUN
aji-33	309	27	by	by	ADP
aji-33	309	28	cytokine	cytokine	NOUN
aji-33	309	29	induced	induce	VERB
aji-33	309	30	vascular	vascular	ADJ
aji-33	309	31	damage	damage	NOUN
aji-33	309	32	implicate	implicate	VERB
aji-33	309	33	a	a	DET
aji-33	309	34	role	role	NOUN
aji-33	309	35	of	of	ADP
aji-33	309	36	this	this	DET
aji-33	309	37	pathway	pathway	NOUN
aji-33	309	38	in	in	ADP
aji-33	309	39	the	the	DET
aji-33	309	40	coagulopathy	coagulopathy	ADJ
aji-33	309	41	seen	see	VERB
aji-33	309	42	in	in	ADP
aji-33	309	43	covid	covid	PROPN
aji-33	309	44	19	19	NUM
aji-33	309	45	.	.	PUNCT
aji-33	309	46	tissue	tissue	NOUN
aji-33	309	47	factor(extrinsic	factor(extrinsic	NOUN
aji-33	309	48	)	)	PUNCT
aji-33	309	49	path	path	NOUN
aji-33	309	50	way	way	NOUN
aji-33	309	51	:	:	PUNCT
aji-33	309	52			NOUN
aji-33	309	53	tissue	tissue	NOUN
aji-33	309	54	factor	factor	NOUN
aji-33	309	55	/	/	SYM
aji-33	309	56	plateletthromboplastin/	plateletthromboplastin/	NOUN
aji-33	309	57	factor3/	factor3/	NOUN
aji-33	309	58	cd	cd	NOUN
aji-33	309	59	135	135	NUM
aji-33	309	60	.	.	PUNCT
aji-33	310	1	it	it	PRON
aji-33	310	2	is	be	AUX
aji-33	310	3	produced	produce	VERB
aji-33	310	4	by	by	ADP
aji-33	310	5	sub	sub	NOUN
aji-33	310	6	endothelial	endothelial	ADJ
aji-33	310	7	cells	cell	NOUN
aji-33	310	8	and	and	CCONJ
aji-33	310	9	leukocytes	leukocyte	NOUN
aji-33	310	10	.	.	PUNCT
aji-33	311	1	injury	injury	NOUN
aji-33	311	2	to	to	PART
aji-33	311	3	sub	sub	VERB
aji-33	311	4	endothelial	endothelial	ADJ
aji-33	311	5	cells/	cells/	NUM
aji-33	311	6	platelets	platelet	NOUN
aji-33	311	7	releases	release	NOUN
aji-33	311	8	this	this	DET
aji-33	311	9	factor	factor	NOUN
aji-33	311	10	which	which	PRON
aji-33	311	11	initiates	initiate	VERB
aji-33	311	12	the	the	DET
aji-33	311	13	coagulation	coagulation	NOUN
aji-33	311	14	process	process	NOUN
aji-33	311	15	.	.	PUNCT
aji-33	312	1	in	in	ADP
aji-33	312	2	combination	combination	NOUN
aji-33	312	3	with	with	ADP
aji-33	312	4	factor	factor	NOUN
aji-33	312	5	v11	v11	NOUN
aji-33	312	6	,	,	PUNCT
aji-33	312	7	it	it	PRON
aji-33	312	8	activates	activate	VERB
aji-33	312	9	factor	factor	NOUN
aji-33	312	10	x	x	VERB
aji-33	312	11	to	to	PART
aji-33	312	12	factor	factor	VERB
aji-33	312	13	xa	xa	PROPN
aji-33	312	14	.	.	PUNCT
aji-33	313	1	the	the	DET
aji-33	313	2	(	(	PUNCT
aji-33	313	3	tissue	tissue	NOUN
aji-33	313	4	factor	factor	NOUN
aji-33	313	5	pathway	pathway	NOUN
aji-33	313	6	inhibitor	inhibitor	NOUN
aji-33	313	7	(	(	PUNCT
aji-33	313	8	tfpi	tfpi	ADJ
aji-33	313	9	)	)	PUNCT
aji-33	313	10	is	be	AUX
aji-33	313	11	a	a	DET
aji-33	313	12	protease	protease	NOUN
aji-33	313	13	present	present	NOUN
aji-33	313	14	in	in	ADP
aji-33	313	15	the	the	DET
aji-33	313	16	ecs	ecs	PROPN
aji-33	313	17	inhibits	inhibit	VERB
aji-33	313	18	the	the	DET
aji-33	313	19	tf	tf	NOUN
aji-33	313	20	and	and	CCONJ
aji-33	313	21	is	be	AUX
aji-33	313	22	a	a	DET
aji-33	313	23	natural	natural	ADJ
aji-33	313	24	anticoagulant	anticoagulant	NOUN
aji-33	313	25	.	.	PUNCT
aji-33	314	1	tf	tf	X
aji-33	314	2	,	,	PUNCT
aji-33	314	3	produced	produce	VERB
aji-33	314	4	by	by	ADP
aji-33	314	5	sub	sub	ADJ
aji-33	314	6	-	-	ADJ
aji-33	314	7	endothelial	endothelial	ADJ
aji-33	314	8	cells	cell	NOUN
aji-33	314	9	and	and	CCONJ
aji-33	314	10	leukocytesinjury	leukocytesinjury	PROPN
aji-33	314	11	to	to	AUX
aji-33	314	12	sub	sub	VERB
aji-33	314	13	-	-	ADJ
aji-33	314	14	endothelial	endothelial	ADJ
aji-33	314	15	cells/	cells/	NUM
aji-33	314	16	platelets	platelet	NOUN
aji-33	314	17	initiates	initiate	VERB
aji-33	314	18	the	the	DET
aji-33	314	19	coagulation	coagulation	NOUN
aji-33	314	20	process	process	NOUN
aji-33	314	21	.	.	PUNCT
aji-33	315	1	in	in	ADP
aji-33	315	2	combination	combination	NOUN
aji-33	315	3	with	with	ADP
aji-33	315	4	factor	factor	NOUN
aji-33	315	5	v11	v11	NOUN
aji-33	315	6	,	,	PUNCT
aji-33	315	7	it	it	PRON
aji-33	315	8	activates	activate	VERB
aji-33	315	9	factor	factor	NOUN
aji-33	315	10	x	x	VERB
aji-33	315	11	to	to	PART
aji-33	315	12	factor	factor	VERB
aji-33	315	13	xa	xa	PROPN
aji-33	315	14	.	.	PUNCT
aji-33	316	1	the	the	DET
aji-33	316	2	(	(	PUNCT
aji-33	316	3	tissue	tissue	NOUN
aji-33	316	4	factor	factor	NOUN
aji-33	316	5	pathway	pathway	NOUN
aji-33	316	6	inhibitor	inhibitor	NOUN
aji-33	316	7	(	(	PUNCT
aji-33	316	8	tfpi	tfpi	ADJ
aji-33	316	9	)	)	PUNCT
aji-33	316	10	is	be	AUX
aji-33	316	11	a	a	DET
aji-33	316	12	protease	protease	NOUN
aji-33	316	13	present	present	NOUN
aji-33	316	14	in	in	ADP
aji-33	316	15	the	the	DET
aji-33	316	16	ecs	ecs	PROPN
aji-33	316	17	inhibits	inhibit	VERB
aji-33	316	18	the	the	DET
aji-33	316	19	tf	tf	NOUN
aji-33	316	20	and	and	CCONJ
aji-33	316	21	is	be	AUX
aji-33	316	22	a	a	DET
aji-33	316	23	natural	natural	ADJ
aji-33	316	24	anticoagulant	anticoagulant	NOUN
aji-33	316	25	.	.	PUNCT
aji-33	317	1	the	the	DET
aji-33	317	2	tf	tf	PROPN
aji-33	317	3	pathway	pathway	NOUN
aji-33	317	4	may	may	AUX
aji-33	317	5	be	be	AUX
aji-33	317	6	recruited	recruit	VERB
aji-33	317	7	by	by	ADP
aji-33	317	8	the	the	DET
aji-33	317	9	cytokine	cytokine	NOUN
aji-33	317	10	induced	induce	VERB
aji-33	317	11	damage	damage	NOUN
aji-33	317	12	of	of	ADP
aji-33	317	13	the	the	DET
aji-33	317	14	vasculature	vasculature	NOUN
aji-33	317	15	orinjury	orinjury	NOUN
aji-33	317	16	to	to	ADP
aji-33	317	17	the	the	DET
aji-33	317	18	platelets	platelet	NOUN
aji-33	317	19	which	which	PRON
aji-33	317	20	consequently	consequently	ADV
aji-33	317	21	release	release	VERB
aji-33	317	22	the	the	DET
aji-33	317	23	tf	tf	X
aji-33	317	24	.	.	PUNCT
aji-33	318	1	this	this	PRON
aji-33	318	2	is	be	AUX
aji-33	318	3	supported	support	VERB
aji-33	318	4	by	by	ADP
aji-33	318	5	the	the	DET
aji-33	318	6	immature	immature	ADJ
aji-33	318	7	megakaryocytes(indicating	megakaryocytes(indicating	NOUN
aji-33	318	8	rapid	rapid	ADJ
aji-33	318	9	turnover	turnover	NOUN
aji-33	318	10	/	/	SYM
aji-33	318	11	distruction	distruction	NOUN
aji-33	318	12	of	of	ADP
aji-33	318	13	the	the	DET
aji-33	318	14	platlets	platlet	NOUN
aji-33	318	15	)	)	PUNCT
aji-33	318	16	found	find	VERB
aji-33	318	17	in	in	ADP
aji-33	318	18	the	the	DET
aji-33	318	19	microscopic	microscopic	ADJ
aji-33	318	20	findings	finding	NOUN
aji-33	318	21	of	of	ADP
aji-33	318	22	autopsy	autopsy	ADJ
aji-33	318	23	.	.	PUNCT
aji-33	319	1	the	the	DET
aji-33	319	2	role	role	NOUN
aji-33	319	3	of	of	ADP
aji-33	319	4	mbl	mbl	PROPN
aji-33	319	5	(	(	PUNCT
aji-33	319	6	mannose	mannose	NOUN
aji-33	319	7	binding	bind	VERB
aji-33	319	8	leptin	leptin	NOUN
aji-33	319	9	)	)	PUNCT
aji-33	319	10	/	/	SYM
aji-33	319	11	lectin	lectin	NOUN
aji-33	319	12	pathway	pathway	NOUN
aji-33	319	13	:	:	PUNCT
aji-33	319	14	the	the	DET
aji-33	319	15	activation	activation	NOUN
aji-33	319	16	of	of	ADP
aji-33	319	17	complement	complement	NOUN
aji-33	319	18	via	via	ADP
aji-33	319	19	the	the	DET
aji-33	319	20	mannan	mannan	NOUN
aji-33	319	21	-	-	PUNCT
aji-33	319	22	binding	bind	VERB
aji-33	319	23	lectin	lectin	NOUN
aji-33	319	24	(	(	PUNCT
aji-33	319	25	mbl	mbl	NOUN
aji-33	319	26	)	)	PUNCT
aji-33	319	27	pathway	pathway	NOUN
aji-33	319	28	is	be	AUX
aji-33	319	29	initiated	initiate	VERB
aji-33	319	30	by	by	ADP
aji-33	319	31	the	the	DET
aji-33	319	32	mbl	mbl	NOUN
aji-33	319	33	complex	complex	NOUN
aji-33	319	34	consisting	consist	VERB
aji-33	319	35	of	of	ADP
aji-33	319	36	the	the	DET
aji-33	319	37	carbohydrate	carbohydrate	NOUN
aji-33	319	38	binding	bind	VERB
aji-33	319	39	molecule	molecule	NOUN
aji-33	319	40	,	,	PUNCT
aji-33	319	41	mbl	mbl	NOUN
aji-33	319	42	,	,	PUNCT
aji-33	319	43	two	two	NUM
aji-33	319	44	associated	associated	ADJ
aji-33	319	45	serine	serine	NOUN
aji-33	319	46	proteases	protease	NOUN
aji-33	319	47	,	,	PUNCT
aji-33	319	48	masp-1(mannoseassociated	masp-1(mannoseassociate	VERB
aji-33	319	49	serine	serine	NOUN
aji-33	319	50	protease	protease	NOUN
aji-33	319	51	)	)	PUNCT
aji-33	319	52	and	and	CCONJ
aji-33	319	53	masp-2	masp-2	PROPN
aji-33	319	54	,	,	PUNCT
aji-33	319	55	and	and	CCONJ
aji-33	319	56	a	a	DET
aji-33	319	57	third	third	ADJ
aji-33	319	58	protein	protein	NOUN
aji-33	319	59	,	,	PUNCT
aji-33	319	60	masp-19	masp-19	PROPN
aji-33	319	61	.	.	PUNCT
aji-33	320	1	when	when	SCONJ
aji-33	320	2	the	the	DET
aji-33	320	3	carbohydraterecognising	carbohydraterecognising	NOUN
aji-33	320	4	heads	head	NOUN
aji-33	320	5	of	of	ADP
aji-33	320	6	mbl	mbl	NOUN
aji-33	320	7	bind	bind	VERB
aji-33	320	8	to	to	ADP
aji-33	320	9	specifically	specifically	ADV
aji-33	320	10	arranged	arrange	VERB
aji-33	320	11	mannose	mannose	NOUN
aji-33	320	12	residues	residue	NOUN
aji-33	320	13	on	on	ADP
aji-33	320	14	the	the	DET
aji-33	320	15	surface	surface	NOUN
aji-33	320	16	of	of	ADP
aji-33	320	17	a	a	DET
aji-33	320	18	pathogen	pathogen	NOUN
aji-33	320	19	,	,	PUNCT
aji-33	320	20	masp-1	masp-1	PROPN
aji-33	320	21	and	and	CCONJ
aji-33	320	22	masp-2	masp-2	PROPN
aji-33	320	23	are	be	AUX
aji-33	320	24	activated	activate	VERB
aji-33	320	25	to	to	PART
aji-33	320	26	cleave	cleave	VERB
aji-33	320	27	complement	complement	NOUN
aji-33	320	28	components	component	NOUN
aji-33	320	29	c4	c4	NOUN
aji-33	320	30	and	and	CCONJ
aji-33	320	31	c2	c2	PROPN
aji-33	320	32	into	into	ADP
aji-33	320	33	c4a	c4a	ADJ
aji-33	320	34	,	,	PUNCT
aji-33	320	35	c4b	c4b	NOUN
aji-33	320	36	,	,	PUNCT
aji-33	320	37	c2a	c2a	PROPN
aji-33	320	38	,	,	PUNCT
aji-33	320	39	and	and	CCONJ
aji-33	320	40	c2b	c2b	PROPN
aji-33	320	41	.	.	PROPN
aji-33	321	1	in	in	ADP
aji-33	321	2	f	f	PROPN
aji-33	321	3	,	,	PUNCT
aji-33	321	4	two	two	NUM
aji-33	321	5	smaller	small	ADJ
aji-33	321	6	mblassociated	mblassociate	VERB
aji-33	321	7	proteins	protein	NOUN
aji-33	321	8	(	(	PUNCT
aji-33	321	9	maps	map	NOUN
aji-33	321	10	)	)	PUNCT
aji-33	321	11	are	be	AUX
aji-33	321	12	found	find	VERB
aji-33	321	13	in	in	ADP
aji-33	321	14	complex	complex	NOUN
aji-33	321	15	with	with	ADP
aji-33	321	16	mblc4b2a3b	mblc4b2a3b	NUM
aji-33	321	17	,	,	PUNCT
aji-33	321	18	the	the	DET
aji-33	321	19	c3	c3	PROPN
aji-33	321	20	esterase	esterase	NOUN
aji-33	321	21	so	so	ADV
aji-33	321	22	formed	form	VERB
aji-33	321	23	carries	carry	VERB
aji-33	321	24	onwards	onwards	ADP
aji-33	321	25	the	the	DET
aji-33	321	26	complement	complement	NOUN
aji-33	321	27	cascade	cascade	NOUN
aji-33	321	28	in	in	ADP
aji-33	321	29	the	the	DET
aji-33	321	30	same	same	ADJ
aji-33	321	31	way	way	NOUN
aji-33	321	32	as	as	SCONJ
aji-33	321	33	the	the	DET
aji-33	321	34	alternative	alternative	ADJ
aji-33	321	35	pathway	pathway	NOUN
aji-33	321	36	described	describe	VERB
aji-33	321	37	in	in	ADP
aji-33	321	38	detail	detail	NOUN
aji-33	321	39	above	above	ADV
aji-33	321	40	.	.	PUNCT
aji-33	322	1	the	the	DET
aji-33	322	2	involvement	involvement	NOUN
aji-33	322	3	of	of	ADP
aji-33	322	4	the	the	DET
aji-33	322	5	lectin	lectin	ADJ
aji-33	322	6	pathology	pathology	NOUN
aji-33	322	7	is	be	AUX
aji-33	322	8	supported	support	VERB
aji-33	322	9	by	by	ADP
aji-33	322	10	the	the	DET
aji-33	322	11	finding	finding	NOUN
aji-33	322	12	reported	report	VERB
aji-33	322	13	by	by	ADP
aji-33	322	14	cynthia	cynthia	PROPN
aji-33	322	15	magro	magro	PROPN
aji-33	322	16	(	(	PUNCT
aji-33	322	17	2020)of	2020)of	NUM
aji-33	322	18	deposits	deposit	NOUN
aji-33	322	19	of	of	ADP
aji-33	322	20	terminal	terminal	ADJ
aji-33	322	21	complement	complement	NOUN
aji-33	322	22	components	component	NOUN
aji-33	322	23	c5b-9	c5b-9	PROPN
aji-33	322	24	(	(	PUNCT
aji-33	322	25	membrane	membrane	NOUN
aji-33	322	26	attack	attack	NOUN
aji-33	322	27	complex	complex	NOUN
aji-33	322	28	)	)	PUNCT
aji-33	322	29	,	,	PUNCT
aji-33	322	30	c4d	c4d	PROPN
aji-33	322	31	,	,	PUNCT
aji-33	322	32	and	and	CCONJ
aji-33	322	33	mannose	mannose	NOUN
aji-33	322	34	binding	bind	VERB
aji-33	322	35	lectin	lectin	NOUN
aji-33	322	36	(	(	PUNCT
aji-33	322	37	mbl)-associated	mbl)-associate	VERB
aji-33	322	38	serine	serine	NOUN
aji-33	322	39	protease	protease	NOUN
aji-33	322	40	(	(	PUNCT
aji-33	322	41	masp)2	masp)2	NOUN
aji-33	322	42	,	,	PUNCT
aji-33	322	43	in	in	ADP
aji-33	322	44	the	the	DET
aji-33	322	45	microvasculature	microvasculature	NOUN
aji-33	322	46	,	,	PUNCT
aji-33	322	47	leptin	leptin	NOUN
aji-33	322	48	is	be	AUX
aji-33	322	49	a	a	DET
aji-33	322	50	glycoprotein	glycoprotein	NOUN
aji-33	322	51	and	and	CCONJ
aji-33	322	52	the	the	DET
aji-33	322	53	sars	sars	PROPN
aji-33	322	54	cov	cov	PROPN
aji-33	322	55	has	have	AUX
aji-33	322	56	glycoprotein	glycoprotein	NOUN
aji-33	322	57	antigens	antigen	NOUN
aji-33	322	58	which	which	PRON
aji-33	322	59	may	may	AUX
aji-33	322	60	be	be	AUX
aji-33	322	61	recognized	recognize	VERB
aji-33	322	62	by	by	ADP
aji-33	322	63	the	the	DET
aji-33	322	64	c	c	PROPN
aji-33	322	65	lectin	lectin	NOUN
aji-33	322	66	receptors	receptor	NOUN
aji-33	322	67	(	(	PUNCT
aji-33	322	68	pprs	pprs	ADJ
aji-33	322	69	)	)	PUNCT
aji-33	322	70	present	present	NOUN
aji-33	322	71	on	on	ADP
aji-33	322	72	the	the	DET
aji-33	322	73	surface	surface	NOUN
aji-33	322	74	of	of	ADP
aji-33	322	75	the	the	DET
aji-33	322	76	macrophages	macrophage	NOUN
aji-33	322	77	and	and	CCONJ
aji-33	322	78	other	other	ADJ
aji-33	322	79	effector	effector	NOUN
aji-33	322	80	cells	cell	NOUN
aji-33	322	81	,	,	PUNCT
aji-33	322	82	leading	lead	VERB
aji-33	322	83	to	to	ADP
aji-33	322	84	their	their	PRON
aji-33	322	85	activation	activation	NOUN
aji-33	322	86	leptin	leptin	NOUN
aji-33	322	87	can	can	AUX
aji-33	322	88	modulate	modulate	VERB
aji-33	322	89	the	the	DET
aji-33	322	90	response	response	NOUN
aji-33	322	91	to	to	ADP
aji-33	322	92	an	an	DET
aji-33	322	93	inflammatory	inflammatory	ADJ
aji-33	322	94	challenge	challenge	NOUN
aji-33	322	95	by	by	ADP
aji-33	322	96	altering	alter	VERB
aji-33	322	97	production	production	NOUN
aji-33	322	98	of	of	ADP
aji-33	322	99	proinflammatory	proinflammatory	ADJ
aji-33	322	100	and	and	CCONJ
aji-33	322	101	antiinflammatory	antiinflammatory	NOUN
aji-33	322	102	cytokines	cytokine	NOUN
aji-33	322	103	and	and	CCONJ
aji-33	322	104	may	may	AUX
aji-33	322	105	also	also	ADV
aji-33	322	106	affect	affect	VERB
aji-33	322	107	cytokine	cytokine	NOUN
aji-33	322	108	signalling	signal	VERB
aji-33	322	109	by	by	ADP
aji-33	322	110	a	a	DET
aji-33	322	111	variety	variety	NOUN
aji-33	322	112	of	of	ADP
aji-33	322	113	mechanisms	mechanism	NOUN
aji-33	322	114	,	,	PUNCT
aji-33	322	115	including	include	VERB
aji-33	322	116	induction	induction	NOUN
aji-33	322	117	of	of	ADP
aji-33	322	118	socs-3.(suppressor	socs-3.(suppressor	NOUN
aji-33	322	119	of	of	ADP
aji-33	322	120	cytokine	cytokine	NOUN
aji-33	322	121	signalling	signal	VERB
aji-33	322	122	)	)	PUNCT
aji-33	322	123	.	.	PUNCT
aji-33	323	1	4.1.5	4.1.5	NUM
aji-33	323	2	explanation	explanation	NOUN
aji-33	323	3	for	for	ADP
aji-33	323	4	vascular	vascular	ADJ
aji-33	323	5	changes	change	NOUN
aji-33	323	6	in	in	ADP
aji-33	323	7	lung	lung	NOUN
aji-33	323	8	pathology	pathology	NOUN
aji-33	323	9	:	:	PUNCT
aji-33	323	10	these	these	PRON
aji-33	323	11	can	can	AUX
aji-33	323	12	be	be	AUX
aji-33	323	13	explained	explain	VERB
aji-33	323	14	by	by	ADP
aji-33	323	15	activation	activation	NOUN
aji-33	323	16	of	of	ADP
aji-33	323	17	the	the	DET
aji-33	323	18	contact	contact	NOUN
aji-33	323	19	cascade	cascade	NOUN
aji-33	323	20	or	or	CCONJ
aji-33	323	21	by	by	ADP
aji-33	323	22	cytokine	cytokine	ADJ
aji-33	323	23	induced	induce	VERB
aji-33	323	24	damage	damage	NOUN
aji-33	323	25	.	.	PUNCT
aji-33	324	1	https://en.m.wikipedia.org/wiki/complement_component_4	https://en.m.wikipedia.org/wiki/complement_component_4	NOUN
aji-33	324	2	https://en.m.wikipedia.org/wiki/complement_component_2	https://en.m.wikipedia.org/wiki/complement_component_2	PROPN
aji-33	324	3	prasad	prasad	PROPN
aji-33	324	4	;	;	PUNCT
aji-33	324	5	aji	aji	NOUN
aji-33	324	6	,	,	PUNCT
aji-33	324	7	3(1	3(1	NUM
aji-33	324	8	):	):	PUNCT
aji-33	324	9	233	233	NUM
aji-33	324	10	-	-	SYM
aji-33	324	11	252	252	NUM
aji-33	324	12	,	,	PUNCT
aji-33	324	13	2020	2020	NUM
aji-33	324	14	;	;	PUNCT
aji-33	324	15	article	article	NOUN
aji-33	324	16	no.aji.58422	no.aji.58422	NOUN
aji-33	324	17	240	240	NUM
aji-33	324	18			NOUN
aji-33	324	19	contact	contact	NOUN
aji-33	324	20	cascade	cascade	NOUN
aji-33	324	21	1	1	NUM
aji-33	324	22	)	)	PUNCT
aji-33	324	23	factor	factor	NOUN
aji-33	324	24	xii	xii	NOUN
aji-33	324	25	(	(	PUNCT
aji-33	324	26	fxii	fxii	NOUN
aji-33	324	27	;	;	PUNCT
aji-33	324	28	hageman	hageman	NOUN
aji-33	324	29	factor	factor	NOUN
aji-33	324	30	)	)	PUNCT
aji-33	324	31	of	of	ADP
aji-33	324	32	the	the	DET
aji-33	324	33	contact	contact	NOUN
aji-33	324	34	system	system	NOUN
aji-33	324	35	is	be	AUX
aji-33	324	36	proteolyticallycleaved	proteolyticallycleave	VERB
aji-33	324	37	to	to	PART
aji-33	324	38	fxiia	fxiia	VERB
aji-33	324	39	by	by	ADP
aji-33	324	40	negatively	negatively	ADV
aji-33	324	41	charged	charge	VERB
aji-33	324	42	surfaces	surface	NOUN
aji-33	324	43	of	of	ADP
aji-33	324	44	damaged	damaged	ADJ
aji-33	324	45	cells	cell	NOUN
aji-33	324	46	,	,	PUNCT
aji-33	324	47	and	and	CCONJ
aji-33	324	48	also	also	ADV
aji-33	324	49	activated	activate	VERB
aji-33	324	50	platelet	platelet	NOUN
aji-33	324	51	plasma	plasma	NOUN
aji-33	324	52	membrane	membrane	NOUN
aji-33	324	53	.	.	PUNCT
aji-33	325	1	2	2	NUM
aji-33	325	2	)	)	PUNCT
aji-33	325	3	fxiiainitiates	fxiiainitiate	VERB
aji-33	325	4	the	the	DET
aji-33	325	5	coagulation	coagulation	NOUN
aji-33	325	6	cascade	cascade	NOUN
aji-33	325	7	leading	lead	VERB
aji-33	325	8	to	to	ADP
aji-33	325	9	clot	clot	NOUN
aji-33	325	10	formation	formation	NOUN
aji-33	325	11	.	.	PUNCT
aji-33	326	1	3	3	X
aji-33	326	2	)	)	PUNCT
aji-33	326	3	cleaves	cleave	VERB
aji-33	326	4	prekallikrein	prekallikrein	ADV
aji-33	326	5	to	to	PART
aji-33	326	6	kallikreinfor	kallikreinfor	VERB
aji-33	326	7	subsequent	subsequent	ADJ
aji-33	326	8	release	release	NOUN
aji-33	326	9	of	of	ADP
aji-33	326	10	bradykinin	bradykinin	PROPN
aji-33	326	11	.	.	PUNCT
aji-33	327	1	4	4	NUM
aji-33	327	2	)	)	PUNCT
aji-33	327	3	through	through	ADP
aji-33	327	4	an	an	DET
aji-33	327	5	endothelial	endothelial	NOUN
aji-33	327	6	g	g	NOUN
aji-33	327	7	-	-	PUNCT
aji-33	327	8	coupled	couple	VERB
aji-33	327	9	receptor	receptor	NOUN
aji-33	327	10	(	(	PUNCT
aji-33	327	11	bradykinin	bradykinin	NOUN
aji-33	327	12	receptor	receptor	NOUN
aji-33	327	13	1	1	NUM
aji-33	327	14	;	;	PUNCT
aji-33	327	15	bkr1	bkr1	PROPN
aji-33	327	16	)	)	PUNCT
aji-33	327	17	,	,	PUNCT
aji-33	327	18	bradykinin	bradykinin	PROPN
aji-33	327	19	induces	induce	VERB
aji-33	327	20	vasodilation	vasodilation	NOUN
aji-33	327	21	,	,	PUNCT
aji-33	327	22	neutrophil	neutrophil	ADJ
aji-33	327	23	chemotaxis	chemotaxis	ADJ
aji-33	327	24	and	and	CCONJ
aji-33	327	25	vascular	vascular	ADJ
aji-33	327	26	permeability	permeability	NOUN
aji-33	327	27	[	[	X
aji-33	327	28	29	29	NUM
aji-33	327	29	]	]	PUNCT
aji-33	327	30	.	.	PUNCT
aji-33	328	1			PUNCT
aji-33	329	1	the	the	DET
aji-33	329	2	cytokine	cytokine	NOUN
aji-33	329	3	induced	induce	VERB
aji-33	329	4	vascular	vascular	ADJ
aji-33	329	5	changes	change	NOUN
aji-33	329	6	in	in	ADP
aji-33	329	7	the	the	DET
aji-33	329	8	lungs	lung	NOUN
aji-33	329	9	:	:	PUNCT
aji-33	329	10	alexander	alexander	PROPN
aji-33	329	11	h.	h.	PROPN
aji-33	329	12	sprague	sprague	PROPN
aji-33	329	13	and	and	CCONJ
aji-33	329	14	raouf	raouf	PROPN
aji-33	329	15	a.	a.	PROPN
aji-33	329	16	khalil	khalil	PROPN
aji-33	329	17	et	et	PROPN
aji-33	329	18	al	al	PROPN
aji-33	329	19	.	.	PUNCT
aji-33	330	1	[	[	X
aji-33	330	2	30	30	NUM
aji-33	330	3	]	]	PUNCT
aji-33	330	4	and	and	CCONJ
aji-33	330	5	.	.	PUNCT
aji-33	331	1	marlies	marlies	PROPN
aji-33	331	2	van	van	PROPN
aji-33	331	3	de	de	PROPN
aji-33	331	4	,	,	PUNCT
aji-33	331	5	wouwer	wouwer	NOUN
aji-33	331	6	désiré	désiré	PROPN
aji-33	331	7	colle	colle	PROPN
aji-33	331	8	,	,	PUNCT
aji-33	331	9	edward	edward	PROPN
aji-33	331	10	m.	m.	PROPN
aji-33	331	11	conway	conway	PROPN
aji-33	331	12	metal	metal	PROPN
aji-33	332	1	[	[	X
aji-33	332	2	31	31	NUM
aji-33	332	3	]	]	PUNCT
aji-33	332	4	have	have	AUX
aji-33	332	5	extensively	extensively	ADV
aji-33	332	6	reviewed	review	VERB
aji-33	332	7	this	this	DET
aji-33	332	8	subject	subject	NOUN
aji-33	332	9	matter	matter	NOUN
aji-33	332	10	.	.	PUNCT
aji-33	333	1	interested	interested	ADJ
aji-33	333	2	readers	reader	NOUN
aji-33	333	3	may	may	AUX
aji-33	333	4	refer	refer	VERB
aji-33	333	5	these	these	DET
aji-33	333	6	articles	article	NOUN
aji-33	333	7	for	for	ADP
aji-33	333	8	full	full	ADJ
aji-33	333	9	details	detail	NOUN
aji-33	333	10	.	.	PUNCT
aji-33	334	1	cytokines	cytokine	NOUN
aji-33	334	2	are	be	AUX
aji-33	334	3	a	a	DET
aji-33	334	4	diverse	diverse	ADJ
aji-33	334	5	group	group	NOUN
aji-33	334	6	of	of	ADP
aji-33	334	7	soluble	soluble	ADJ
aji-33	334	8	short	short	ADJ
aji-33	334	9	acting	act	VERB
aji-33	334	10	proteins	protein	NOUN
aji-33	334	11	,	,	PUNCT
aji-33	334	12	glycoproteins	glycoprotein	NOUN
aji-33	334	13	and	and	CCONJ
aji-33	334	14	peptides	peptide	NOUN
aji-33	334	15	produced	produce	VERB
aji-33	334	16	by	by	ADP
aji-33	334	17	various	various	ADJ
aji-33	334	18	immune	immune	ADJ
aji-33	334	19	cells	cell	NOUN
aji-33	334	20	and	and	CCONJ
aji-33	334	21	vascular	vascular	ADJ
aji-33	334	22	cells	cell	NOUN
aji-33	334	23	,	,	PUNCT
aji-33	334	24	activate	activate	VERB
aji-33	334	25	specific	specific	ADJ
aji-33	334	26	receptors	receptor	NOUN
aji-33	334	27	and	and	CCONJ
aji-33	334	28	modulate	modulate	VERB
aji-33	334	29	the	the	DET
aji-33	334	30	functions	function	NOUN
aji-33	334	31	of	of	ADP
aji-33	334	32	many	many	ADJ
aji-33	334	33	cells	cell	NOUN
aji-33	334	34	and	and	CCONJ
aji-33	334	35	tissues	tissue	NOUN
aji-33	334	36	.	.	PUNCT
aji-33	335	1			X
aji-33	335	2	cytokines	cytokine	NOUN
aji-33	335	3	include	include	VERB
aji-33	335	4	tumour	tumour	ADJ
aji-33	335	5	necrosis	necrosis	NOUN
aji-33	335	6	factors	factor	NOUN
aji-33	335	7	,	,	PUNCT
aji-33	335	8	interleukins	interleukin	NOUN
aji-33	335	9	,	,	PUNCT
aji-33	335	10	lymphokines	lymphokine	NOUN
aji-33	335	11	,	,	PUNCT
aji-33	335	12	monokines	monokine	NOUN
aji-33	335	13	,	,	PUNCT
aji-33	335	14	chemokines	chemokine	NOUN
aji-33	335	15	,	,	PUNCT
aji-33	335	16	interferons	interferon	NOUN
aji-33	335	17	,	,	PUNCT
aji-33	335	18	colony	colony	NOUN
aji-33	335	19	stimulating	stimulating	ADJ
aji-33	335	20	factors	factor	NOUN
aji-33	335	21	,	,	PUNCT
aji-33	335	22	and	and	CCONJ
aji-33	335	23	transforming	transform	VERB
aji-33	335	24	growth	growth	NOUN
aji-33	335	25	factors	factor	NOUN
aji-33	335	26	.	.	PUNCT
aji-33	336	1			X
aji-33	336	2	cytokines	cytokine	NOUN
aji-33	336	3	are	be	AUX
aji-33	336	4	produced	produce	VERB
aji-33	336	5	by	by	ADP
aji-33	336	6	macrophages	macrophage	NOUN
aji-33	336	7	,	,	PUNCT
aji-33	336	8	t	t	NOUN
aji-33	336	9	cells	cell	NOUN
aji-33	336	10	and	and	CCONJ
aji-33	336	11	monocytes	monocyte	NOUN
aji-33	336	12	,	,	PUNCT
aji-33	336	13	platelets	platelet	NOUN
aji-33	336	14	,	,	PUNCT
aji-33	336	15	endothelial	endothelial	ADJ
aji-33	336	16	cells	cell	NOUN
aji-33	336	17	(	(	PUNCT
aji-33	336	18	ecs	ec	NOUN
aji-33	336	19	)	)	PUNCT
aji-33	336	20	and	and	CCONJ
aji-33	336	21	vascular	vascular	ADJ
aji-33	336	22	smooth	smooth	ADJ
aji-33	336	23	muscle	muscle	NOUN
aji-33	336	24	cells	cell	NOUN
aji-33	336	25	(	(	PUNCT
aji-33	336	26	vsmcs	vsmcs	ADJ
aji-33	336	27	)	)	PUNCT
aji-33	336	28	.	.	PUNCT
aji-33	337	1			X
aji-33	337	2	cytokines	cytokine	NOUN
aji-33	337	3	elicit	elicit	VERB
aji-33	337	4	inflammatory	inflammatory	ADJ
aji-33	337	5	response	response	NOUN
aji-33	337	6	by	by	ADP
aji-33	337	7	interacting	interact	VERB
aji-33	337	8	with	with	ADP
aji-33	337	9	specific	specific	ADJ
aji-33	337	10	receptors	receptor	NOUN
aji-33	337	11	on	on	ADP
aji-33	337	12	various	various	ADJ
aji-33	337	13	cell	cell	NOUN
aji-33	337	14	types	type	NOUN
aji-33	337	15	and	and	CCONJ
aji-33	337	16	activate	activate	VERB
aji-33	337	17	jak	jak	NOUN
aji-33	337	18	-	-	PUNCT
aji-33	337	19	stat	stat	PROPN
aji-33	337	20	,	,	PUNCT
aji-33	337	21	(	(	PUNCT
aji-33	337	22	janus	janus	PROPN
aji-33	337	23	kinase	kinase	PROPN
aji-33	337	24	/	/	SYM
aji-33	337	25	signal	signal	NOUN
aji-33	337	26	transducers	transducer	NOUN
aji-33	337	27	and	and	CCONJ
aji-33	337	28	activators	activator	NOUN
aji-33	337	29	of	of	ADP
aji-33	337	30	transcription	transcription	NOUN
aji-33	337	31	nf	nf	NOUN
aji-33	337	32	-	-	PUNCT
aji-33	337	33	κb	κb	NOUN
aji-33	337	34	,	,	PUNCT
aji-33	337	35	and	and	CCONJ
aji-33	337	36	smad	smad	PROPN
aji-33	337	37	(	(	PUNCT
aji-33	337	38	suppressor	suppressor	NOUN
aji-33	337	39	of	of	ADP
aji-33	337	40	mothers	mother	NOUN
aji-33	337	41	against	against	ADP
aji-33	337	42	decapentaplegic	decapentaplegic	NOUN
aji-33	337	43	.	.	PUNCT
aji-33	338	1	miscellaneous)signalling	miscellaneous)signalling	NOUN
aji-33	338	2	pathways	pathway	NOUN
aji-33	338	3	leading	lead	VERB
aji-33	338	4	to	to	ADP
aji-33	338	5	cell	cell	NOUN
aji-33	338	6	adhesion	adhesion	NOUN
aji-33	338	7	,	,	PUNCT
aji-33	338	8	permeability	permeability	NOUN
aji-33	338	9	and	and	CCONJ
aji-33	338	10	apoptosis	apoptosis	NOUN
aji-33	338	11			NOUN
aji-33	338	12	cytokines	cytokine	NOUN
aji-33	338	13	also	also	ADV
aji-33	338	14	interact	interact	VERB
aji-33	338	15	with	with	ADP
aji-33	338	16	mitochondria	mitochondria	NOUN
aji-33	338	17	to	to	PART
aji-33	338	18	increase	increase	VERB
aji-33	338	19	the	the	DET
aji-33	338	20	production	production	NOUN
aji-33	338	21	of	of	ADP
aji-33	338	22	reactive	reactive	ADJ
aji-33	338	23	oxygen	oxygen	NOUN
aji-33	338	24	species	specie	NOUN
aji-33	338	25	.	.	PUNCT
aji-33	339	1			X
aji-33	339	2	cytokine	cytokine	NOUN
aji-33	339	3	-	-	PUNCT
aji-33	339	4	induced	induce	VERB
aji-33	339	5	activation	activation	NOUN
aji-33	339	6	of	of	ADP
aji-33	339	7	these	these	DET
aji-33	339	8	pathways	pathway	NOUN
aji-33	339	9	in	in	ADP
aji-33	339	10	ecs	ecs	PROPN
aji-33	339	11	modifies	modify	VERB
aji-33	339	12	the	the	DET
aji-33	339	13	production/	production/	NUM
aji-33	339	14	activity	activity	NOUN
aji-33	339	15	of	of	ADP
aji-33	339	16	vasodilator	vasodilator	NOUN
aji-33	339	17	mediators	mediator	NOUN
aji-33	339	18	such	such	ADJ
aji-33	339	19	nitric	nitric	ADJ
aji-33	339	20	oxide	oxide	NOUN
aji-33	339	21	,	,	PUNCT
aji-33	339	22	prostacyclin	prostacyclin	PROPN
aji-33	339	23	,	,	PUNCT
aji-33	339	24	endotheliumderived	endotheliumderive	VERB
aji-33	339	25	hyperpolarizing	hyperpolarizing	NOUN
aji-33	339	26	factor	factor	NOUN
aji-33	339	27	,	,	PUNCT
aji-33	339	28	bradykinin	bradykinin	PROPN
aji-33	339	29	,	,	PUNCT
aji-33	339	30	vasocontractile	vasocontractile	ADJ
aji-33	339	31	mediators	mediator	NOUN
aji-33	339	32	:	:	PUNCT
aji-33	339	33	endothelin	endothelin	PROPN
aji-33	339	34	,	,	PUNCT
aji-33	339	35	angiotensin	angiotensin	PROPN
aji-33	339	36	ii	ii	PROPN
aji-33	339	37	.	.	PUNCT
aji-33	340	1			PROPN
aji-33	340	2	cytokines	cytokine	NOUN
aji-33	340	3	interact	interact	VERB
aji-33	340	4	with	with	ADP
aji-33	340	5	vsmcs(vascular	vsmcs(vascular	ADJ
aji-33	340	6	smooth	smooth	ADJ
aji-33	340	7	muscle	muscle	NOUN
aji-33	340	8	cells	cell	NOUN
aji-33	340	9	)	)	PUNCT
aji-33	340	10	to	to	PART
aji-33	340	11	activate	activate	VERB
aji-33	340	12	ca2	ca2	PROPN
aji-33	340	13	+	+	PROPN
aji-33	340	14	,	,	PUNCT
aji-33	340	15	protein	protein	NOUN
aji-33	340	16	kinase	kinase	NOUN
aji-33	340	17	c	c	X
aji-33	340	18	,	,	PUNCT
aji-33	340	19	rho	rho	ADJ
aji-33	340	20	-	-	NOUN
aji-33	340	21	kinase	kinase	NOUN
aji-33	340	22	,	,	PUNCT
aji-33	340	23	and	and	CCONJ
aji-33	340	24	mapk	mapk	NOUN
aji-33	340	25	pathways	pathway	NOUN
aji-33	340	26	,	,	PUNCT
aji-33	340	27	which	which	PRON
aji-33	340	28	promote	promote	VERB
aji-33	340	29	cell	cell	NOUN
aji-33	340	30	growth	growth	NOUN
aji-33	340	31	and	and	CCONJ
aji-33	340	32	migration	migration	NOUN
aji-33	340	33	,	,	PUNCT
aji-33	340	34	and	and	CCONJ
aji-33	340	35	vsm	vsm	PROPN
aji-33	340	36	reactivity	reactivity	NOUN
aji-33	340	37	.	.	PUNCT
aji-33	341	1	cytokines	cytokine	NOUN
aji-33	341	2	are	be	AUX
aji-33	341	3	either	either	CCONJ
aji-33	341	4	proinflammatory	proinflammatory	ADJ
aji-33	341	5	or	or	CCONJ
aji-33	341	6	inflammatory	inflammatory	ADJ
aji-33	341	7	.	.	PUNCT
aji-33	342	1			X
aji-33	342	2	proinflammatory	proinflammatory	ADJ
aji-33	342	3	cytokines	cytokine	NOUN
aji-33	342	4	:	:	PUNCT
aji-33	342	5	produced	produce	VERB
aji-33	342	6	by	by	ADP
aji-33	342	7	activated	activate	VERB
aji-33	342	8	macrophages	macrophage	NOUN
aji-33	342	9	,	,	PUNCT
aji-33	342	10	mediate	mediate	VERB
aji-33	342	11	the	the	DET
aji-33	342	12	following	follow	VERB
aji-33	342	13	effectsup	effectsup	ADJ
aji-33	342	14	regulation	regulation	NOUN
aji-33	342	15	of	of	ADP
aji-33	342	16	inflammatory	inflammatory	ADJ
aji-33	342	17	reaction	reaction	NOUN
aji-33	342	18	by	by	ADP
aji-33	342	19	tnf	tnf	PROPN
aji-33	342	20	-	-	PUNCT
aji-33	342	21	α	α	PROPN
aji-33	342	22	,	,	PUNCT
aji-33	342	23	il-1	il-1	NUM
aji-33	342	24	,	,	PUNCT
aji-33	342	25	il6	il6	NOUN
aji-33	342	26	,	,	PUNCT
aji-33	342	27	il-12	il-12	NOUN
aji-33	342	28	,	,	PUNCT
aji-33	342	29	il-19	il-19	PRON
aji-33	342	30	,	,	PUNCT
aji-33	342	31	and	and	CCONJ
aji-33	342	32	ifn-β.stimulation	ifn-β.stimulation	NOUN
aji-33	342	33	of	of	ADP
aji-33	342	34	acute	acute	ADJ
aji-33	342	35	phase	phase	NOUN
aji-33	342	36	reactants	reactant	VERB
aji-33	342	37	tnf	tnf	PROPN
aji-33	342	38	-	-	PUNCT
aji-33	342	39	α	α	PROPN
aji-33	342	40	,	,	PUNCT
aji-33	342	41	il-1	il-1	ADP
aji-33	342	42	,	,	PUNCT
aji-33	342	43	il-6	il-6	NUM
aji-33	342	44	,	,	PUNCT
aji-33	342	45	il-11	il-11	ADV
aji-33	342	46	,	,	PUNCT
aji-33	342	47	ifn	ifn	PROPN
aji-33	342	48	-	-	PUNCT
aji-33	342	49	γ	γ	NOUN
aji-33	342	50	,	,	PUNCT
aji-33	342	51	tgf-β.chemoattractant	tgf-β.chemoattractant	NOUN
aji-33	342	52	such	such	ADJ
aji-33	342	53	as	as	ADP
aji-33	342	54	il-8	il-8	NOUN
aji-33	342	55	,	,	PUNCT
aji-33	342	56	mip-1α	mip-1α	NOUN
aji-33	342	57	(	(	PUNCT
aji-33	342	58	macrophage	macrophage	ADJ
aji-33	342	59	inflammatory	inflammatory	ADJ
aji-33	342	60	proteins	protein	NOUN
aji-33	342	61	)	)	PUNCT
aji-33	342	62	,	,	PUNCT
aji-33	342	63	mip-1β	mip-1β	PROPN
aji-33	342	64	,	,	PUNCT
aji-33	342	65	rantes(regulated	rantes(regulate	VERB
aji-33	342	66	on	on	ADP
aji-33	342	67	activation	activation	NOUN
aji-33	342	68	,	,	PUNCT
aji-33	342	69	normal	normal	ADJ
aji-33	342	70	t	t	NOUN
aji-33	342	71	cell	cell	NOUN
aji-33	342	72	expressed	express	VERB
aji-33	342	73	and	and	CCONJ
aji-33	342	74	secreted	secrete	VERB
aji-33	342	75	)	)	PUNCT
aji-33	342	76	pf-4	pf-4	PROPN
aji-33	342	77	,	,	PUNCT
aji-33	342	78	mcp-1	mcp-1	NOUN
aji-33	342	79	,	,	PUNCT
aji-33	342	80	-2	-2	INTJ
aji-33	342	81	,	,	PUNCT
aji-33	342	82	-3(monocyte	-3(monocyte	PROPN
aji-33	342	83	chemoattractant	chemoattractant	NOUN
aji-33	342	84	protein	protein	NOUN
aji-33	342	85	)	)	PUNCT
aji-33	342	86			PRON
aji-33	342	87	anti	anti	ADJ
aji-33	342	88	-	-	ADJ
aji-33	342	89	inflammatory	inflammatory	ADJ
aji-33	342	90	cytokines	cytokine	NOUN
aji-33	342	91	are	be	AUX
aji-33	342	92	involved	involve	VERB
aji-33	342	93	in	in	ADP
aji-33	342	94	the	the	DET
aji-33	342	95	down	down	NOUN
aji-33	342	96	-	-	PUNCT
aji-33	342	97	regulation	regulation	NOUN
aji-33	342	98	of	of	ADP
aji-33	342	99	inflammatory	inflammatory	ADJ
aji-33	342	100	reactions	reaction	NOUN
aji-33	342	101	.	.	PUNCT
aji-33	343	1	they	they	PRON
aji-33	343	2	include	include	VERB
aji-33	343	3	il-4	il-4	NOUN
aji-33	343	4	,	,	PUNCT
aji-33	343	5	il-10	il-10	PRON
aji-33	343	6	,	,	PUNCT
aji-33	343	7	il-13	il-13	NUM
aji-33	343	8	,	,	PUNCT
aji-33	343	9	ifn	ifn	PROPN
aji-33	343	10	-	-	PUNCT
aji-33	343	11	α	α	NOUN
aji-33	343	12	,	,	PUNCT
aji-33	343	13	and	and	CCONJ
aji-33	343	14	tgfβ	tgfβ	ADJ
aji-33	343	15	.	.	PUNCT
aji-33	344	1	(	(	PUNCT
aji-33	344	2	transforming	transform	VERB
aji-33	344	3	growth	growth	NOUN
aji-33	344	4	factor	factor	NOUN
aji-33	344	5	)	)	PUNCT
aji-33	344	6	the	the	DET
aji-33	344	7	antiinflammation	antiinflammation	NOUN
aji-33	344	8	induced	induce	VERB
aji-33	344	9	vascular	vascular	ADJ
aji-33	344	10	injury	injury	NOUN
aji-33	344	11	results	result	NOUN
aji-33	344	12	from	from	ADP
aji-33	344	13	interaction	interaction	NOUN
aji-33	344	14	of	of	ADP
aji-33	344	15	the	the	DET
aji-33	344	16	inflammatory	inflammatory	ADJ
aji-33	344	17	cells	cell	NOUN
aji-33	344	18	,	,	PUNCT
aji-33	344	19	the	the	DET
aji-33	344	20	endothelial	endothelial	ADJ
aji-33	344	21	cells(ec	cells(ec	NOUN
aji-33	344	22	)	)	PUNCT
aji-33	344	23	,	,	PUNCT
aji-33	344	24	vascular	vascular	ADJ
aji-33	344	25	smooth	smooth	ADJ
aji-33	344	26	muscle	muscle	NOUN
aji-33	344	27	cells(vsmc	cells(vsmc	NOUN
aji-33	344	28	)	)	PUNCT
aji-33	344	29	and	and	CCONJ
aji-33	344	30	extra	extra	ADJ
aji-33	344	31	-	-	ADJ
aji-33	344	32	cellular	cellular	ADJ
aji-33	344	33	matrix	matrix	NOUN
aji-33	344	34	(	(	PUNCT
aji-33	344	35	ecm	ecm	PROPN
aji-33	344	36	)	)	PUNCT
aji-33	344	37	.	.	PUNCT
aji-33	345	1			PROPN
aji-33	345	2	ecs	ecs	PROPN
aji-33	345	3	are	be	AUX
aji-33	345	4	major	major	ADJ
aji-33	345	5	determinant	determinant	ADJ
aji-33	345	6	of	of	ADP
aji-33	345	7	vascular	vascular	ADJ
aji-33	345	8	tone	tone	NOUN
aji-33	345	9	,	,	PUNCT
aji-33	345	10	leukocyte	leukocyte	NOUN
aji-33	345	11	adhesion	adhesion	NOUN
aji-33	345	12	,	,	PUNCT
aji-33	345	13	and	and	CCONJ
aji-33	345	14	smc	smc	PROPN
aji-33	345	15	proliferation	proliferation	NOUN
aji-33	345	16	.	.	PUNCT
aji-33	345	17	il1activates	il1activates	PROPN
aji-33	346	1	t	t	PROPN
aji-33	346	2	cells;il-2	cells;il-2	PROPN
aji-33	346	3	,	,	PUNCT
aji-33	346	4	which	which	PRON
aji-33	346	5	stimulates	stimulate	VERB
aji-33	346	6	proliferation	proliferation	NOUN
aji-33	346	7	of	of	ADP
aji-33	346	8	antigenactivated	antigenactivate	VERB
aji-33	346	9	t	t	PROPN
aji-33	346	10	and	and	CCONJ
aji-33	346	11	b	b	NOUN
aji-33	346	12	cells	cell	NOUN
aji-33	346	13	;	;	PUNCT
aji-33	346	14	il-4	il-4	NOUN
aji-33	346	15	,	,	PUNCT
aji-33	346	16	il-5	il-5	NOUN
aji-33	346	17	,	,	PUNCT
aji-33	346	18	and	and	CCONJ
aji-33	346	19	il-6	il-6	NOUN
aji-33	346	20	,	,	PUNCT
aji-33	346	21	which	which	PRON
aji-33	346	22	stimulate	stimulate	VERB
aji-33	346	23	proliferation	proliferation	NOUN
aji-33	346	24	and	and	CCONJ
aji-33	346	25	differentiation	differentiation	NOUN
aji-33	346	26	of	of	ADP
aji-33	346	27	b	b	NOUN
aji-33	346	28	cells	cell	NOUN
aji-33	346	29	;	;	PUNCT
aji-33	346	30			PRON
aji-33	346	31	ifnγ	ifnγ	NOUN
aji-33	346	32	,	,	PUNCT
aji-33	346	33	which	which	PRON
aji-33	346	34	activates	activate	VERB
aji-33	346	35	macrophages	macrophage	NOUN
aji-33	346	36	;	;	PUNCT
aji-33	346	37	and	and	CCONJ
aji-33	346	38	il-3	il-3	NUM
aji-33	346	39	,	,	PUNCT
aji-33	346	40	il-7	il-7	VERB
aji-33	346	41	tnfα	tnfα	NOUN
aji-33	346	42	,	,	PUNCT
aji-33	346	43	ifn	ifn	PROPN
aji-33	346	44	-	-	PUNCT
aji-33	346	45	γ	γ	NOUN
aji-33	346	46	,	,	PUNCT
aji-33	346	47	il-8	il-8	NOUN
aji-33	346	48	,	,	PUNCT
aji-33	346	49	and	and	CCONJ
aji-33	346	50	mcp-1	mcp-1	ADP
aji-33	346	51	influenced	influence	VERB
aji-33	346	52	tissue	tissue	NOUN
aji-33	346	53	factors	factor	NOUN
aji-33	346	54	which	which	PRON
aji-33	346	55	initiated	initiate	VERB
aji-33	346	56	coagulation	coagulation	NOUN
aji-33	346	57	cascade	cascade	NOUN
aji-33	346	58	and	and	CCONJ
aji-33	346	59	down	down	ADV
aji-33	346	60	-	-	PUNCT
aji-33	346	61	regulated	regulate	VERB
aji-33	346	62	anticoagulant	anticoagulant	ADJ
aji-33	346	63	thrombomodulin	thrombomodulin	PROPN
aji-33	346	64	.	.	PUNCT
aji-33	346	65			X
aji-33	347	1	tnf	tnf	PROPN
aji-33	347	2	-	-	PUNCT
aji-33	347	3	α	α	PROPN
aji-33	347	4	enhanced	enhance	VERB
aji-33	347	5	the	the	DET
aji-33	347	6	endothelial	endothelial	ADJ
aji-33	347	7	cells	cell	NOUN
aji-33	347	8	to	to	PART
aji-33	347	9	produce	produce	VERB
aji-33	347	10	anti	anti	ADJ
aji-33	347	11	-	-	ADJ
aji-33	347	12	fibrinolysis	fibrinolysis	ADJ
aji-33	347	13	pai-1	pai-1	PRON
aji-33	347	14	[	[	X
aji-33	347	15	32	32	NUM
aji-33	347	16	]	]	PUNCT
aji-33	347	17	.	.	PUNCT
aji-33	348	1	gmcsf	gmcsf	PROPN
aji-33	348	2	,	,	PUNCT
aji-33	348	3	which	which	PRON
aji-33	348	4	stimulate	stimulate	VERB
aji-33	348	5	haematopoiesis	haematopoiesis	NOUN
aji-33	348	6	.	.	PUNCT
aji-33	349	1	platelet	platelet	NOUN
aji-33	349	2	derived	derive	VERB
aji-33	349	3	growth	growth	NOUN
aji-33	349	4	factors	factor	NOUN
aji-33	349	5	were	be	AUX
aji-33	349	6	the	the	DET
aji-33	349	7	main	main	ADJ
aji-33	349	8	inducers	inducer	NOUN
aji-33	349	9	of	of	ADP
aji-33	349	10	mcp-1	mcp-1	NOUN
aji-33	349	11	gene	gene	NOUN
aji-33	349	12	[	[	X
aji-33	349	13	33	33	NUM
aji-33	349	14	]	]	PUNCT
aji-33	349	15	.	.	PUNCT
aji-33	350	1			PUNCT
aji-33	351	1	the	the	DET
aji-33	351	2	activated	activate	VERB
aji-33	351	3	platelets	platelet	NOUN
aji-33	351	4	stimulated	stimulate	VERB
aji-33	351	5	nf	nf	NOUN
aji-33	351	6	-	-	PUNCT
aji-33	351	7	κb	κb	NOUN
aji-33	351	8	in	in	ADP
aji-33	351	9	endothelial	endothelial	ADJ
aji-33	351	10	cells	cell	NOUN
aji-33	351	11	and	and	CCONJ
aji-33	351	12	enhanced	enhance	VERB
aji-33	351	13	the	the	DET
aji-33	351	14	expression	expression	NOUN
aji-33	351	15	of	of	ADP
aji-33	351	16	leukocyte	leukocyte	NOUN
aji-33	351	17	receptors	receptor	NOUN
aji-33	351	18	which	which	PRON
aji-33	351	19	induced	induce	VERB
aji-33	351	20	the	the	DET
aji-33	351	21	secretion	secretion	NOUN
aji-33	351	22	of	of	ADP
aji-33	351	23	mcp-1	mcp-1	NOUN
aji-33	351	24	and	and	CCONJ
aji-33	351	25	il-8	il-8	NOUN
aji-33	351	26	.	.	PUNCT
aji-33	352	1	besides	besides	SCONJ
aji-33	352	2	,	,	PUNCT
aji-33	352	3	the	the	DET
aji-33	352	4	significant	significant	ADJ
aji-33	352	5	increased	increase	VERB
aji-33	352	6	expression	expression	NOUN
aji-33	352	7	of	of	ADP
aji-33	352	8	lung	lung	NOUN
aji-33	352	9	par-1	par-1	VERB
aji-33	352	10	on	on	ADP
aji-33	352	11	pulmonary	pulmonary	ADJ
aji-33	352	12	cells	cell	NOUN
aji-33	352	13	,	,	PUNCT
aji-33	352	14	as	as	SCONJ
aji-33	352	15	fibroblasts	fibroblast	NOUN
aji-33	352	16	,	,	PUNCT
aji-33	352	17	macrophages	macrophage	NOUN
aji-33	352	18	,	,	PUNCT
aji-33	352	19	epithelial	epithelial	ADJ
aji-33	352	20	and	and	CCONJ
aji-33	352	21	endothelial	endothelial	NOUN
aji-33	352	22	cells	cell	NOUN
aji-33	352	23	might	might	AUX
aji-33	352	24	prasad	prasad	NOUN
aji-33	352	25	;	;	PUNCT
aji-33	352	26	aji	aji	NOUN
aji-33	352	27	,	,	PUNCT
aji-33	352	28	3(1	3(1	NUM
aji-33	352	29	):	):	PUNCT
aji-33	352	30	233	233	NUM
aji-33	352	31	-	-	SYM
aji-33	352	32	252	252	NUM
aji-33	352	33	,	,	PUNCT
aji-33	352	34	2020	2020	NUM
aji-33	352	35	;	;	PUNCT
aji-33	352	36	article	article	NOUN
aji-33	352	37	no.aji.58422	no.aji.58422	NOUN
aji-33	352	38	241	241	PRON
aji-33	352	39	represent	represent	VERB
aji-33	352	40	another	another	DET
aji-33	352	41	cause	cause	NOUN
aji-33	352	42	for	for	ADP
aji-33	352	43	elevated	elevated	ADJ
aji-33	352	44	mcp-1	mcp-1	X
aji-33	352	45	(	(	PUNCT
aji-33	352	46	monocyte	monocyte	NOUN
aji-33	352	47	chemoattractant	chemoattractant	NOUN
aji-33	352	48	protein	protein	NOUN
aji-33	352	49	and	and	CCONJ
aji-33	352	50	il-8	il-8	VERB
aji-33	352	51	chemotaxis	chemotaxis	ADJ
aji-33	352	52	molecules	molecule	NOUN
aji-33	352	53	[	[	X
aji-33	352	54	34	34	NUM
aji-33	352	55	]	]	PUNCT
aji-33	352	56	.	.	PUNCT
aji-33	353	1	role	role	NOUN
aji-33	353	2	of	of	ADP
aji-33	353	3	endothelial	endothelial	ADJ
aji-33	353	4	cells	cell	NOUN
aji-33	353	5	:	:	PUNCT
aji-33	353	6	under	under	ADP
aji-33	353	7	normal	normal	ADJ
aji-33	353	8	conditions	condition	NOUN
aji-33	353	9	,	,	PUNCT
aji-33	353	10	the	the	DET
aji-33	353	11	endothelium	endothelium	NOUN
aji-33	353	12	maintains	maintain	VERB
aji-33	353	13	a	a	DET
aji-33	353	14	vasodilator	vasodilator	NOUN
aji-33	353	15	,	,	PUNCT
aji-33	353	16	antithrombotic	antithrombotic	ADJ
aji-33	353	17	and	and	CCONJ
aji-33	353	18	anti	anti	ADJ
aji-33	353	19	-	-	ADJ
aji-33	353	20	inflammatory	inflammatory	ADJ
aji-33	353	21	state	state	NOUN
aji-33	353	22	.	.	PUNCT
aji-33	354	1	for	for	ADP
aji-33	354	2	vascular	vascular	ADJ
aji-33	354	3	homeostasis	homeostasis	NOUN
aji-33	354	4	,	,	PUNCT
aji-33	354	5	endothelial	endothelial	ADJ
aji-33	354	6	cells	cell	NOUN
aji-33	354	7	are	be	AUX
aji-33	354	8	of	of	ADP
aji-33	354	9	utmost	utmost	ADJ
aji-33	354	10	importance	importance	NOUN
aji-33	354	11	and	and	CCONJ
aji-33	354	12	they	they	PRON
aji-33	354	13	produce	produce	VERB
aji-33	354	14	a	a	DET
aji-33	354	15	variety	variety	NOUN
aji-33	354	16	of	of	ADP
aji-33	354	17	mediators	mediator	NOUN
aji-33	354	18	,	,	PUNCT
aji-33	354	19	surface	surface	NOUN
aji-33	354	20	proteins	protein	NOUN
aji-33	354	21	,	,	PUNCT
aji-33	354	22	and	and	CCONJ
aji-33	354	23	autocoids	autocoid	NOUN
aji-33	354	24	involved	involve	VERB
aji-33	354	25	in	in	ADP
aji-33	354	26	vasomotion	vasomotion	NOUN
aji-33	354	27	,	,	PUNCT
aji-33	354	28	coagulation	coagulation	NOUN
aji-33	354	29	,	,	PUNCT
aji-33	354	30	and	and	CCONJ
aji-33	354	31	inflammation	inflammation	NOUN
aji-33	354	32	[	[	X
aji-33	354	33	35	35	NUM
aji-33	354	34	]	]	PUNCT
aji-33	354	35	.	.	PUNCT
aji-33	355	1	endothelium	endothelium	NOUN
aji-33	355	2	separates	separate	VERB
aji-33	355	3	blood	blood	NOUN
aji-33	355	4	clotting	clot	VERB
aji-33	355	5	factors	factor	NOUN
aji-33	355	6	from	from	ADP
aji-33	355	7	exposure	exposure	NOUN
aji-33	355	8	to	to	ADP
aji-33	355	9	subendothelial	subendothelial	ADJ
aji-33	355	10	prothrombotic	prothrombotic	ADJ
aji-33	355	11	extracellular	extracellular	ADJ
aji-33	355	12	matrix	matrix	NOUN
aji-33	355	13	components	component	NOUN
aji-33	355	14	.	.	PUNCT
aji-33	356	1	endothelium	endothelium	NOUN
aji-33	356	2	also	also	ADV
aji-33	356	3	expresses	express	VERB
aji-33	356	4	vasoactive	vasoactive	ADJ
aji-33	356	5	factors	factor	NOUN
aji-33	356	6	that	that	PRON
aji-33	356	7	modulate	modulate	VERB
aji-33	356	8	platelet	platelet	NOUN
aji-33	356	9	reactivity	reactivity	NOUN
aji-33	356	10	,	,	PUNCT
aji-33	356	11	coagulation	coagulation	NOUN
aji-33	356	12	,	,	PUNCT
aji-33	356	13	fibrinolysis	fibrinolysis	NOUN
aji-33	356	14	and	and	CCONJ
aji-33	356	15	vascular	vascular	ADJ
aji-33	356	16	contractility	contractility	NOUN
aji-33	356	17	,	,	PUNCT
aji-33	356	18	all	all	PRON
aji-33	356	19	of	of	ADP
aji-33	356	20	which	which	PRON
aji-33	356	21	contribute	contribute	VERB
aji-33	356	22	to	to	ADP
aji-33	356	23	thrombotic	thrombotic	ADJ
aji-33	356	24	formation	formation	NOUN
aji-33	356	25	.	.	PUNCT
aji-33	357	1	such	such	ADJ
aji-33	357	2	factors	factor	NOUN
aji-33	357	3	include	include	VERB
aji-33	357	4	nitric	nitric	ADJ
aji-33	357	5	oxide	oxide	NOUN
aji-33	357	6	,	,	PUNCT
aji-33	357	7	prostacyclin	prostacyclin	PROPN
aji-33	357	8	,	,	PUNCT
aji-33	357	9	von	von	PROPN
aji-33	357	10	willebrand	willebrand	NOUN
aji-33	357	11	factor	factor	NOUN
aji-33	357	12	(	(	PUNCT
aji-33	357	13	vwf	vwf	NOUN
aji-33	357	14	)	)	PUNCT
aji-33	357	15	,	,	PUNCT
aji-33	357	16	thrombomodulin	thrombomodulin	PROPN
aji-33	357	17	,	,	PUNCT
aji-33	357	18	endothelin	endothelin	PROPN
aji-33	357	19	,	,	PUNCT
aji-33	357	20	etc	etc	X
aji-33	357	21	.	.	X
aji-33	357	22	endothelial	endothelial	ADJ
aji-33	357	23	cells	cell	NOUN
aji-33	357	24	counteract	counteract	VERB
aji-33	357	25	coagulation	coagulation	NOUN
aji-33	357	26	by	by	ADP
aji-33	357	27	providing	provide	VERB
aji-33	357	28	tissue	tissue	NOUN
aji-33	357	29	factor	factor	NOUN
aji-33	357	30	and	and	CCONJ
aji-33	357	31	thrombin	thrombin	NOUN
aji-33	357	32	inhibitors	inhibitor	NOUN
aji-33	357	33	and	and	CCONJ
aji-33	357	34	receptors	receptor	NOUN
aji-33	357	35	for	for	ADP
aji-33	357	36	protein	protein	NOUN
aji-33	357	37	c	c	NOUN
aji-33	357	38	activation	activation	NOUN
aji-33	357	39	.	.	PUNCT
aji-33	358	1	role	role	NOUN
aji-33	358	2	of	of	ADP
aji-33	358	3	tnf	tnf	PROPN
aji-33	358	4	alfa	alfa	PROPN
aji-33	358	5	and	and	CCONJ
aji-33	358	6	c3	c3	PROPN
aji-33	358	7	:	:	PUNCT
aji-33	358	8	when	when	SCONJ
aji-33	358	9	tnf	tnf	PROPN
aji-33	358	10	-	-	PUNCT
aji-33	358	11	α	α	PROPN
aji-33	358	12	is	be	AUX
aji-33	358	13	upregulated	upregulate	VERB
aji-33	358	14	,	,	PUNCT
aji-33	358	15	it	it	PRON
aji-33	358	16	contributes	contribute	VERB
aji-33	358	17	to	to	ADP
aji-33	358	18	changes	change	NOUN
aji-33	358	19	in	in	ADP
aji-33	358	20	coagulation	coagulation	NOUN
aji-33	358	21	and	and	CCONJ
aji-33	358	22	c3	c3	NOUN
aji-33	358	23	induction	induction	NOUN
aji-33	358	24	[	[	X
aji-33	358	25	36	36	NUM
aji-33	358	26	]	]	PUNCT
aji-33	358	27	.	.	PUNCT
aji-33	359	1	tnf	tnf	PROPN
aji-33	359	2	-	-	PUNCT
aji-33	359	3	α	α	PROPN
aji-33	359	4	plays	play	VERB
aji-33	359	5	a	a	DET
aji-33	359	6	pivotal	pivotal	ADJ
aji-33	359	7	role	role	NOUN
aji-33	359	8	in	in	ADP
aji-33	359	9	the	the	DET
aji-33	359	10	disruption	disruption	NOUN
aji-33	359	11	of	of	ADP
aji-33	359	12	macrovascular	macrovascular	ADJ
aji-33	359	13	and	and	CCONJ
aji-33	359	14	microvascular	microvascular	ADJ
aji-33	359	15	circulation	circulation	NOUN
aji-33	359	16	both	both	PRON
aji-33	359	17	in	in	ADP
aji-33	359	18	vivo	vivo	NOUN
aji-33	359	19	and	and	CCONJ
aji-33	359	20	in	in	ADP
aji-33	359	21	vitro	vitro	X
aji-33	359	22	[	[	X
aji-33	359	23	37	37	NUM
aji-33	359	24	]	]	PUNCT
aji-33	359	25	and	and	CCONJ
aji-33	359	26	is	be	AUX
aji-33	359	27	an	an	DET
aji-33	359	28	important	important	ADJ
aji-33	359	29	cytokine	cytokine	NOUN
aji-33	359	30	that	that	PRON
aji-33	359	31	can	can	AUX
aji-33	359	32	induce	induce	VERB
aji-33	359	33	both	both	CCONJ
aji-33	359	34	apoptosis	apoptosis	NOUN
aji-33	359	35	and	and	CCONJ
aji-33	359	36	inflammation	inflammation	NOUN
aji-33	359	37	[	[	X
aji-33	359	38	38	38	NUM
aji-33	359	39	]	]	PUNCT
aji-33	359	40	.	.	PUNCT
aji-33	360	1	in	in	ADP
aji-33	360	2	the	the	DET
aji-33	360	3	presence	presence	NOUN
aji-33	360	4	of	of	ADP
aji-33	360	5	ros	ros	PROPN
aji-33	360	6	,	,	PUNCT
aji-33	360	7	there	there	PRON
aji-33	360	8	is	be	VERB
aji-33	360	9	an	an	DET
aji-33	360	10	increased	increase	VERB
aji-33	360	11	production	production	NOUN
aji-33	360	12	of	of	ADP
aji-33	360	13	tnf	tnf	PROPN
aji-33	360	14	-	-	PUNCT
aji-33	360	15	α	α	PROPN
aji-33	360	16	and	and	CCONJ
aji-33	360	17	,	,	PUNCT
aji-33	360	18	in	in	ADP
aji-33	360	19	turn	turn	NOUN
aji-33	360	20	,	,	PUNCT
aji-33	360	21	tnf	tnf	PROPN
aji-33	360	22	-	-	PUNCT
aji-33	360	23	α	α	PROPN
aji-33	360	24	signalling	signal	VERB
aji-33	360	25	accentuates	accentuate	NOUN
aji-33	360	26	oxidative	oxidative	ADJ
aji-33	360	27	stress	stress	NOUN
aji-33	360	28	[	[	X
aji-33	360	29	39	39	NUM
aji-33	360	30	]	]	PUNCT
aji-33	360	31	.	.	PUNCT
aji-33	361	1	tnfα	tnfα	NOUN
aji-33	361	2	up	up	ADP
aji-33	361	3	regulation	regulation	NOUN
aji-33	361	4	is	be	AUX
aji-33	361	5	also	also	ADV
aji-33	361	6	associated	associate	VERB
aji-33	361	7	with	with	ADP
aji-33	361	8	a	a	DET
aji-33	361	9	changed	change	VERB
aji-33	361	10	coagulation	coagulation	NOUN
aji-33	361	11	propensity	propensity	NOUN
aji-33	361	12	[	[	X
aji-33	361	13	40	40	NUM
aji-33	361	14	]	]	PUNCT
aji-33	361	15	.	.	PUNCT
aji-33	362	1	in	in	ADP
aji-33	362	2	short	short	ADJ
aji-33	362	3	,	,	PUNCT
aji-33	362	4	tnf	tnf	PROPN
aji-33	362	5	-	-	PUNCT
aji-33	362	6	α	α	PROPN
aji-33	362	7	participates	participate	VERB
aji-33	362	8	in	in	ADP
aji-33	362	9	vasodilatation	vasodilatation	NOUN
aji-33	362	10	and	and	CCONJ
aji-33	362	11	oedema	oedema	ADJ
aji-33	362	12	formation	formation	NOUN
aji-33	362	13	,	,	PUNCT
aji-33	362	14	as	as	ADV
aji-33	362	15	well	well	ADV
aji-33	362	16	as	as	ADP
aji-33	362	17	leukocyte	leukocyte	ADJ
aji-33	362	18	adhesion	adhesion	NOUN
aji-33	362	19	to	to	ADP
aji-33	362	20	the	the	DET
aji-33	362	21	epithelium	epithelium	NOUN
aji-33	362	22	through	through	ADP
aji-33	362	23	expression	expression	NOUN
aji-33	362	24	of	of	ADP
aji-33	362	25	adhesion	adhesion	NOUN
aji-33	362	26	molecules	molecule	NOUN
aji-33	362	27	.	.	PUNCT
aji-33	363	1	furthermore	furthermore	ADV
aji-33	363	2	,	,	PUNCT
aji-33	363	3	it	it	PRON
aji-33	363	4	regulates	regulate	VERB
aji-33	363	5	blood	blood	NOUN
aji-33	363	6	coagulation	coagulation	NOUN
aji-33	363	7	,	,	PUNCT
aji-33	363	8	contributes	contribute	VERB
aji-33	363	9	to	to	PART
aji-33	363	10	oxidative	oxidative	ADJ
aji-33	363	11	stress	stress	NOUN
aji-33	363	12	at	at	ADP
aji-33	363	13	sites	site	NOUN
aji-33	363	14	of	of	ADP
aji-33	363	15	inflammation	inflammation	NOUN
aji-33	363	16	,	,	PUNCT
aji-33	363	17	and	and	CCONJ
aji-33	363	18	indirectly	indirectly	ADV
aji-33	363	19	induces	induce	VERB
aji-33	363	20	fever	fever	NOUN
aji-33	363	21	[	[	X
aji-33	363	22	41	41	NUM
aji-33	363	23	]	]	PUNCT
aji-33	363	24	.	.	PUNCT
aji-33	364	1	tnf	tnf	PROPN
aji-33	364	2	-	-	PUNCT
aji-33	364	3	α	α	PROPN
aji-33	364	4	also	also	ADV
aji-33	364	5	plays	play	VERB
aji-33	364	6	a	a	DET
aji-33	364	7	central	central	ADJ
aji-33	364	8	role	role	NOUN
aji-33	364	9	in	in	ADP
aji-33	364	10	the	the	DET
aji-33	364	11	pathogenesis	pathogenesis	NOUN
aji-33	364	12	of	of	ADP
aji-33	364	13	insulin	insulin	NOUN
aji-33	364	14	-	-	PUNCT
aji-33	364	15	resistant	resistant	ADJ
aji-33	364	16	metabolic	metabolic	NOUN
aji-33	364	17	derangements	derangement	NOUN
aji-33	364	18	.	.	PUNCT
aji-33	365	1	when	when	SCONJ
aji-33	365	2	tnf	tnf	PROPN
aji-33	365	3	-	-	PUNCT
aji-33	365	4	α	α	PROPN
aji-33	365	5	is	be	AUX
aji-33	365	6	upregulated	upregulate	VERB
aji-33	365	7	,	,	PUNCT
aji-33	365	8	it	it	PRON
aji-33	365	9	contributes	contribute	VERB
aji-33	365	10	to	to	ADP
aji-33	365	11	changes	change	NOUN
aji-33	365	12	in	in	ADP
aji-33	365	13	coagulation	coagulation	NOUN
aji-33	365	14	and	and	CCONJ
aji-33	365	15	c3	c3	NOUN
aji-33	365	16	induction	induction	NOUN
aji-33	365	17	.	.	PUNCT
aji-33	366	1	tnf	tnf	PROPN
aji-33	366	2	-	-	PUNCT
aji-33	366	3	α	α	PROPN
aji-33	366	4	plays	play	VERB
aji-33	366	5	a	a	DET
aji-33	366	6	pivotal	pivotal	ADJ
aji-33	366	7	role	role	NOUN
aji-33	366	8	in	in	ADP
aji-33	366	9	the	the	DET
aji-33	366	10	disruption	disruption	NOUN
aji-33	366	11	of	of	ADP
aji-33	366	12	macro	macro	ADJ
aji-33	366	13	vascular	vascular	NOUN
aji-33	366	14	and	and	CCONJ
aji-33	366	15	microvascular	microvascular	ADJ
aji-33	366	16	circulation	circulation	NOUN
aji-33	366	17	both	both	PRON
aji-33	366	18	in	in	ADP
aji-33	366	19	vivo	vivo	NOUN
aji-33	366	20	and	and	CCONJ
aji-33	366	21	in	in	ADP
aji-33	366	22	vitro	vitro	X
aji-33	366	23	and	and	CCONJ
aji-33	366	24	is	be	AUX
aji-33	366	25	an	an	DET
aji-33	366	26	important	important	ADJ
aji-33	366	27	cytokine	cytokine	NOUN
aji-33	366	28	that	that	PRON
aji-33	366	29	can	can	AUX
aji-33	366	30	induce	induce	VERB
aji-33	366	31	both	both	CCONJ
aji-33	366	32	apoptosis	apoptosis	NOUN
aji-33	366	33	and	and	CCONJ
aji-33	366	34	inflammation	inflammation	NOUN
aji-33	366	35	.	.	PUNCT
aji-33	367	1	in	in	ADP
aji-33	367	2	the	the	DET
aji-33	367	3	presence	presence	NOUN
aji-33	367	4	of	of	ADP
aji-33	367	5	ros	ros	PROPN
aji-33	367	6	,	,	PUNCT
aji-33	367	7	there	there	PRON
aji-33	367	8	is	be	VERB
aji-33	367	9	an	an	DET
aji-33	367	10	increased	increase	VERB
aji-33	367	11	production	production	NOUN
aji-33	367	12	of	of	ADP
aji-33	367	13	tnf	tnf	PROPN
aji-33	367	14	-	-	PUNCT
aji-33	367	15	α	α	PROPN
aji-33	367	16	and	and	CCONJ
aji-33	367	17	,	,	PUNCT
aji-33	367	18	in	in	ADP
aji-33	367	19	turn	turn	NOUN
aji-33	367	20	,	,	PUNCT
aji-33	367	21	tnf	tnf	PROPN
aji-33	367	22	-	-	PUNCT
aji-33	367	23	α	α	PROPN
aji-33	367	24	signalling	signal	VERB
aji-33	367	25	accentuates	accentuate	NOUN
aji-33	367	26	oxidative	oxidative	ADJ
aji-33	367	27	stress	stress	NOUN
aji-33	367	28	.	.	PUNCT
aji-33	368	1	tnf	tnf	PROPN
aji-33	368	2	-	-	PUNCT
aji-33	368	3	α	α	PROPN
aji-33	368	4	upregulation	upregulation	NOUN
aji-33	368	5	is	be	AUX
aji-33	368	6	also	also	ADV
aji-33	368	7	associated	associate	VERB
aji-33	368	8	with	with	ADP
aji-33	368	9	a	a	DET
aji-33	368	10	changed	change	VERB
aji-33	368	11	coagulation	coagulation	NOUN
aji-33	368	12	propensity	propensity	NOUN
aji-33	368	13	.	.	PUNCT
aji-33	369	1	in	in	ADP
aji-33	369	2	short	short	ADJ
aji-33	369	3	,	,	PUNCT
aji-33	369	4	tnf	tnf	PROPN
aji-33	369	5	-	-	PUNCT
aji-33	369	6	α	α	PROPN
aji-33	369	7	participates	participate	VERB
aji-33	369	8	in	in	ADP
aji-33	369	9	vasodilatation	vasodilatation	NOUN
aji-33	369	10	and	and	CCONJ
aji-33	369	11	oedema	oedema	ADJ
aji-33	369	12	formation	formation	NOUN
aji-33	369	13	,	,	PUNCT
aji-33	369	14	as	as	ADV
aji-33	369	15	well	well	ADV
aji-33	369	16	as	as	ADP
aji-33	369	17	leukocyte	leukocyte	ADJ
aji-33	369	18	adhesion	adhesion	NOUN
aji-33	369	19	to	to	ADP
aji-33	369	20	the	the	DET
aji-33	369	21	epithelium	epithelium	NOUN
aji-33	369	22	through	through	ADP
aji-33	369	23	expression	expression	NOUN
aji-33	369	24	of	of	ADP
aji-33	369	25	adhesion	adhesion	NOUN
aji-33	369	26	molecules	molecule	NOUN
aji-33	369	27	.	.	PUNCT
aji-33	370	1	furthermore	furthermore	ADV
aji-33	370	2	,	,	PUNCT
aji-33	370	3	it	it	PRON
aji-33	370	4	regulates	regulate	VERB
aji-33	370	5	blood	blood	NOUN
aji-33	370	6	coagulation	coagulation	NOUN
aji-33	370	7	,	,	PUNCT
aji-33	370	8	contributes	contribute	VERB
aji-33	370	9	to	to	PART
aji-33	370	10	oxidative	oxidative	ADJ
aji-33	370	11	stress	stress	NOUN
aji-33	370	12	at	at	ADP
aji-33	370	13	sites	site	NOUN
aji-33	370	14	of	of	ADP
aji-33	370	15	inflammation	inflammation	NOUN
aji-33	370	16	,	,	PUNCT
aji-33	370	17	and	and	CCONJ
aji-33	370	18	indirectly	indirectly	ADV
aji-33	370	19	induces	induce	VERB
aji-33	370	20	fever	fever	NOUN
aji-33	370	21	.	.	PUNCT
aji-33	371	1	tnf	tnf	PROPN
aji-33	371	2	-	-	PUNCT
aji-33	371	3	α	α	PROPN
aji-33	371	4	also	also	ADV
aji-33	371	5	plays	play	VERB
aji-33	371	6	a	a	DET
aji-33	371	7	central	central	ADJ
aji-33	371	8	role	role	NOUN
aji-33	371	9	in	in	ADP
aji-33	371	10	the	the	DET
aji-33	371	11	pathogenesis	pathogenesis	NOUN
aji-33	371	12	of	of	ADP
aji-33	371	13	insulin	insulin	NOUN
aji-33	371	14	-	-	PUNCT
aji-33	371	15	resistant	resistant	ADJ
aji-33	371	16	metabolic	metabolic	NOUN
aji-33	371	17	derangements	derangement	NOUN
aji-33	371	18	.	.	PUNCT
aji-33	372	1	tnf	tnf	PROPN
aji-33	372	2	can	can	AUX
aji-33	372	3	induce	induce	VERB
aji-33	372	4	platelet	platelet	NOUN
aji-33	372	5	consumption	consumption	NOUN
aji-33	372	6	,	,	PUNCT
aji-33	372	7	and	and	CCONJ
aji-33	372	8	platelets	platelet	NOUN
aji-33	372	9	do	do	AUX
aji-33	372	10	express	express	VERB
aji-33	372	11	tnfr1	tnfr1	NOUN
aji-33	372	12	and	and	CCONJ
aji-33	372	13	tnfr2	tnfr2	NOUN
aji-33	373	1	[	[	X
aji-33	373	2	42,43	42,43	X
aji-33	373	3	]	]	PUNCT
aji-33	373	4	.	.	PUNCT
aji-33	374	1	tnfr1	tnfr1	PROPN
aji-33	374	2	expressed	express	VERB
aji-33	374	3	on	on	ADP
aji-33	374	4	other	other	ADJ
aji-33	374	5	cells	cell	NOUN
aji-33	374	6	also	also	ADV
aji-33	374	7	causes	cause	VERB
aji-33	374	8	the	the	DET
aji-33	374	9	release	release	NOUN
aji-33	374	10	of	of	ADP
aji-33	374	11	factors	factor	NOUN
aji-33	374	12	with	with	ADP
aji-33	374	13	agonist	agonist	NOUN
aji-33	374	14	activity	activity	NOUN
aji-33	374	15	for	for	ADP
aji-33	374	16	platelets	platelet	NOUN
aji-33	374	17	and	and	CCONJ
aji-33	374	18	tnf	tnf	PROPN
aji-33	374	19	-	-	PUNCT
aji-33	374	20	α	α	PROPN
aji-33	374	21	is	be	AUX
aji-33	374	22	able	able	ADJ
aji-33	374	23	to	to	PART
aji-33	374	24	activate	activate	VERB
aji-33	374	25	platelets	platelet	NOUN
aji-33	374	26	through	through	ADP
aji-33	374	27	stimulation	stimulation	NOUN
aji-33	374	28	of	of	ADP
aji-33	374	29	the	the	DET
aji-33	374	30	arachidonic	arachidonic	ADJ
aji-33	374	31	acid	acid	NOUN
aji-33	374	32	pathway	pathway	NOUN
aji-33	374	33	.	.	PUNCT
aji-33	375	1	complement	complement	PROPN
aji-33	375	2	c3	c3	PROPN
aji-33	375	3	:	:	PUNCT
aji-33	375	4	rbcs	rbc	NOUN
aji-33	375	5	carry	carry	VERB
aji-33	375	6	the	the	DET
aji-33	375	7	complement	complement	NOUN
aji-33	375	8	receptor	receptor	NOUN
aji-33	375	9	1	1	NUM
aji-33	375	10	(	(	PUNCT
aji-33	375	11	cr1	cr1	PROPN
aji-33	375	12	)	)	PUNCT
aji-33	375	13	,	,	PUNCT
aji-33	375	14	also	also	ADV
aji-33	375	15	known	know	VERB
aji-33	375	16	as	as	ADP
aji-33	375	17	c3b	c3b	NOUN
aji-33	375	18	/	/	SYM
aji-33	375	19	c4b	c4b	ADJ
aji-33	375	20	receptor	receptor	NOUN
aji-33	375	21	or	or	CCONJ
aji-33	375	22	cd35	cd35	PROPN
aji-33	375	23	,	,	PUNCT
aji-33	375	24	on	on	ADP
aji-33	375	25	its	its	PRON
aji-33	375	26	membrane	membrane	NOUN
aji-33	375	27	[	[	X
aji-33	375	28	44	44	NUM
aji-33	375	29	]	]	PUNCT
aji-33	375	30	.	.	PUNCT
aji-33	376	1	immune	immune	ADJ
aji-33	376	2	complexes	complex	NOUN
aji-33	376	3	,	,	PUNCT
aji-33	376	4	which	which	PRON
aji-33	376	5	have	have	AUX
aji-33	376	6	reacted	react	VERB
aji-33	376	7	with	with	ADP
aji-33	376	8	complement	complement	NOUN
aji-33	376	9	and	and	CCONJ
aji-33	376	10	bear	bear	VERB
aji-33	376	11	c3b	c3b	NOUN
aji-33	376	12	fragments	fragment	NOUN
aji-33	376	13	also	also	ADV
aji-33	376	14	bind	bind	VERB
aji-33	376	15	to	to	ADP
aji-33	376	16	the	the	DET
aji-33	376	17	cr1	cr1	NOUN
aji-33	376	18	on	on	ADP
aji-33	376	19	human	human	ADJ
aji-33	376	20	rbcs	rbc	NOUN
aji-33	376	21	,	,	PUNCT
aji-33	376	22	and	and	CCONJ
aji-33	376	23	cr1	cr1	NOUN
aji-33	376	24	on	on	ADP
aji-33	376	25	rbcs	rbc	NOUN
aji-33	376	26	serves	serve	VERB
aji-33	376	27	as	as	ADP
aji-33	376	28	a	a	DET
aji-33	376	29	transport	transport	NOUN
aji-33	376	30	system	system	NOUN
aji-33	376	31	for	for	ADP
aji-33	376	32	immune	immune	ADJ
aji-33	376	33	complexes	complex	NOUN
aji-33	376	34	in	in	ADP
aji-33	376	35	the	the	DET
aji-33	376	36	circulation	circulation	NOUN
aji-33	376	37	to	to	PART
aji-33	376	38	prevent	prevent	VERB
aji-33	376	39	immune	immune	ADJ
aji-33	376	40	complex	complex	ADJ
aji-33	376	41	deposition	deposition	NOUN
aji-33	376	42	outside	outside	ADP
aji-33	376	43	the	the	DET
aji-33	376	44	fixed	fix	VERB
aji-33	376	45	macrophage	macrophage	ADJ
aji-33	376	46	system	system	NOUN
aji-33	376	47	[	[	X
aji-33	376	48	45,46	45,46	NOUN
aji-33	376	49	]	]	PUNCT
aji-33	376	50	.	.	PUNCT
aji-33	377	1	complement	complement	NOUN
aji-33	377	2	also	also	ADV
aji-33	377	3	interacts	interact	VERB
aji-33	377	4	with	with	ADP
aji-33	377	5	the	the	DET
aji-33	377	6	surface	surface	NOUN
aji-33	377	7	of	of	ADP
aji-33	377	8	activated	activate	VERB
aji-33	377	9	platelets	platelet	NOUN
aji-33	377	10	as	as	ADV
aji-33	377	11	well	well	ADV
aji-33	377	12	as	as	ADP
aji-33	377	13	with	with	ADP
aji-33	377	14	other	other	ADJ
aji-33	377	15	components	component	NOUN
aji-33	377	16	of	of	ADP
aji-33	377	17	the	the	DET
aji-33	377	18	complement	complement	NOUN
aji-33	377	19	system	system	NOUN
aji-33	377	20	including	include	VERB
aji-33	377	21	,	,	PUNCT
aji-33	377	22	c1q	c1q	NOUN
aji-33	377	23	,	,	PUNCT
aji-33	377	24	c4	c4	NOUN
aji-33	377	25	,	,	PUNCT
aji-33	377	26	c3	c3	NOUN
aji-33	377	27	and	and	CCONJ
aji-33	377	28	c9	c9	PROPN
aji-33	377	29	,	,	PUNCT
aji-33	377	30	which	which	PRON
aji-33	377	31	bind	bind	VERB
aji-33	377	32	to	to	ADP
aji-33	377	33	activated	activate	VERB
aji-33	377	34	platelets	platelet	NOUN
aji-33	377	35	,	,	PUNCT
aji-33	377	36	[	[	X
aji-33	377	37	47	47	NUM
aji-33	377	38	]	]	PUNCT
aji-33	377	39	.	.	PUNCT
aji-33	378	1	furthermore	furthermore	ADV
aji-33	378	2	,	,	PUNCT
aji-33	378	3	thrombinactivated	thrombinactivate	VERB
aji-33	378	4	platelets	platelet	NOUN
aji-33	378	5	can	can	AUX
aji-33	378	6	actually	actually	ADV
aji-33	378	7	initiate	initiate	VERB
aji-33	378	8	the	the	DET
aji-33	378	9	complement	complement	NOUN
aji-33	378	10	cascade	cascade	NOUN
aji-33	378	11	,	,	PUNCT
aji-33	378	12	[	[	X
aji-33	378	13	48	48	NUM
aji-33	378	14	]	]	PUNCT
aji-33	378	15	and	and	CCONJ
aji-33	378	16	c3a	c3a	PROPN
aji-33	378	17	and	and	CCONJ
aji-33	378	18	its	its	PRON
aji-33	378	19	derivative	derivative	ADJ
aji-33	378	20	c3a	c3a	PROPN
aji-33	378	21	-	-	PUNCT
aji-33	378	22	des	des	ADJ
aji-33	378	23	-	-	NOUN
aji-33	378	24	arg	arg	NOUN
aji-33	378	25	,	,	PUNCT
aji-33	378	26	induce	induce	VERB
aji-33	378	27	platelet	platelet	NOUN
aji-33	378	28	activation	activation	NOUN
aji-33	378	29	and	and	CCONJ
aji-33	378	30	aggregation	aggregation	NOUN
aji-33	378	31	in	in	ADP
aji-33	378	32	vitro	vitro	X
aji-33	378	33	[	[	X
aji-33	378	34	49	49	NUM
aji-33	378	35	]	]	PUNCT
aji-33	378	36	.	.	PUNCT
aji-33	379	1	platelets	platelet	NOUN
aji-33	379	2	express	express	VERB
aji-33	379	3	complement	complement	NOUN
aji-33	379	4	receptors	receptor	NOUN
aji-33	379	5	c3ar	c3ar	NOUN
aji-33	379	6	,	,	PUNCT
aji-33	379	7	cr4	cr4	NOUN
aji-33	379	8	,	,	PUNCT
aji-33	379	9	as	as	ADV
aji-33	379	10	well	well	ADV
aji-33	379	11	as	as	ADP
aji-33	379	12	a	a	DET
aji-33	379	13	receptor	receptor	NOUN
aji-33	379	14	for	for	ADP
aji-33	379	15	ic3b	ic3b	PROPN
aji-33	379	16	and	and	CCONJ
aji-33	379	17	c5a	c5a	NOUN
aji-33	379	18	,	,	PUNCT
aji-33	379	19	and	and	CCONJ
aji-33	379	20	the	the	DET
aji-33	379	21	c1q	c1q	PROPN
aji-33	379	22	receptors	receptor	NOUN
aji-33	379	23	gc1qr	gc1qr	PROPN
aji-33	379	24	and	and	CCONJ
aji-33	379	25	cc1qr	cc1qr	VERB
aji-33	379	26	on	on	ADP
aji-33	379	27	their	their	PRON
aji-33	379	28	membranes	membrane	NOUN
aji-33	379	29	.	.	PUNCT
aji-33	380	1	cc1qr	cc1qr	VERB
aji-33	380	2	,	,	PUNCT
aji-33	380	3	in	in	ADP
aji-33	380	4	particular	particular	ADJ
aji-33	380	5	,	,	PUNCT
aji-33	380	6	was	be	AUX
aji-33	380	7	shown	show	VERB
aji-33	380	8	to	to	PART
aji-33	380	9	mediate	mediate	VERB
aji-33	380	10	platelet	platelet	NOUN
aji-33	380	11	aggregating	aggregating	NOUN
aji-33	380	12	and	and	CCONJ
aji-33	380	13	activating	activate	VERB
aji-33	380	14	effects	effect	NOUN
aji-33	380	15	.	.	PUNCT
aji-33	381	1	of	of	ADP
aji-33	381	2	importance	importance	NOUN
aji-33	381	3	is	be	AUX
aji-33	381	4	that	that	SCONJ
aji-33	381	5	platelets	platelet	NOUN
aji-33	381	6	may	may	AUX
aji-33	381	7	also	also	ADV
aji-33	381	8	interact	interact	VERB
aji-33	381	9	with	with	ADP
aji-33	381	10	the	the	DET
aji-33	381	11	complement	complement	NOUN
aji-33	381	12	system	system	NOUN
aji-33	381	13	via	via	ADP
aji-33	381	14	proteins	protein	NOUN
aji-33	381	15	that	that	PRON
aji-33	381	16	are	be	AUX
aji-33	381	17	not	not	PART
aji-33	381	18	considered	consider	VERB
aji-33	381	19	classical	classical	ADJ
aji-33	381	20	complement	complement	NOUN
aji-33	381	21	receptors	receptor	NOUN
aji-33	381	22	,	,	PUNCT
aji-33	381	23	such	such	ADJ
aji-33	381	24	as	as	ADP
aji-33	381	25	p	p	NOUN
aji-33	381	26	-	-	PUNCT
aji-33	381	27	selectin	selectin	NOUN
aji-33	381	28	[	[	X
aji-33	381	29	50	50	NUM
aji-33	381	30	]	]	PUNCT
aji-33	381	31	or	or	CCONJ
aji-33	381	32	gp1bα	gp1bα	VERB
aji-33	382	1	[	[	X
aji-33	382	2	51	51	NUM
aji-33	382	3	]	]	PUNCT
aji-33	382	4	.	.	PUNCT
aji-33	383	1	tm	tm	PROPN
aji-33	383	2	-	-	PUNCT
aji-33	383	3	ps	ps	ADJ
aji-33	383	4	-	-	PUNCT
aji-33	383	5	epcr	epcr	ADJ
aji-33	383	6	system	system	NOUN
aji-33	383	7	:	:	PUNCT
aji-33	383	8	marlies	marlies	PROPN
aji-33	383	9	van	van	PROPN
aji-33	383	10	de	de	PROPN
aji-33	383	11	wouwdésiré	wouwdésiré	PROPN
aji-33	383	12	collen	collen	PROPN
aji-33	383	13	and	and	CCONJ
aji-33	383	14	edward	edward	PROPN
aji-33	383	15	m.	m.	PROPN
aji-33	383	16	conway	conway	PROPN
aji-33	383	17	et	et	PROPN
aji-33	383	18	al	al	PROPN
aji-33	383	19	extensively	extensively	ADV
aji-33	383	20	reviewed	review	VERB
aji-33	383	21	this	this	DET
aji-33	383	22	aspect	aspect	NOUN
aji-33	383	23	[	[	X
aji-33	383	24	52	52	NUM
aji-33	383	25	]	]	PUNCT
aji-33	383	26	to	to	PART
aji-33	383	27	which	which	PRON
aji-33	383	28	interested	interested	ADJ
aji-33	383	29	readers	reader	NOUN
aji-33	383	30	may	may	AUX
aji-33	383	31	refer	refer	VERB
aji-33	383	32	for	for	ADP
aji-33	383	33	more	more	ADJ
aji-33	383	34	details	detail	NOUN
aji-33	383	35	.	.	PUNCT
aji-33	384	1	thrombin	thrombin	NOUN
aji-33	384	2	-	-	PUNCT
aji-33	384	3	mediates	mediate	NOUN
aji-33	384	4	activation	activation	NOUN
aji-33	384	5	of	of	ADP
aji-33	384	6	protein	protein	NOUN
aji-33	384	7	c	c	NOUN
aji-33	384	8	(	(	PUNCT
aji-33	384	9	pc	pc	NOUN
aji-33	384	10	)	)	PUNCT
aji-33	384	11	,	,	PUNCT
aji-33	384	12	with	with	ADP
aji-33	384	13	thrombomodulin	thrombomodulin	PROPN
aji-33	384	14	(	(	PUNCT
aji-33	384	15	tm	tm	PROPN
aji-33	384	16	)	)	PUNCT
aji-33	384	17	,	,	PUNCT
aji-33	384	18	acting	act	VERB
aji-33	384	19	as	as	ADP
aji-33	384	20	a	a	DET
aji-33	384	21	cofaactor	cofaactor	NOUN
aji-33	384	22	.	.	PUNCT
aji-33	385	1	thrombomodulin	thrombomodulin	PROPN
aji-33	385	2	,	,	PUNCT
aji-33	385	3	a	a	DET
aji-33	385	4	cell	cell	NOUN
aji-33	385	5	surfaceexpressed	surfaceexpresse	VERB
aji-33	385	6	glycoprotein	glycoprotein	NOUN
aji-33	385	7	,	,	PUNCT
aji-33	385	8	synthesized	synthesize	VERB
aji-33	385	9	by	by	ADP
aji-33	385	10	vascular	vascular	ADJ
aji-33	385	11	endothelial	endothelial	ADJ
aji-33	385	12	cells	cell	NOUN
aji-33	385	13	,	,	PUNCT
aji-33	385	14	is	be	AUX
aji-33	385	15	critical	critical	ADJ
aji-33	385	16	for	for	ADP
aji-33	385	17	pc	pc	NOUN
aji-33	385	18	activation	activation	NOUN
aji-33	385	19	y	y	PROPN
aji-33	385	20	the	the	DET
aji-33	385	21	thrombin	thrombin	NOUN
aji-33	385	22	–	–	PUNCT
aji-33	385	23	tm	tm	DET
aji-33	385	24	complex	complex	NOUN
aji-33	385	25	is	be	AUX
aji-33	385	26	further	far	ADV
aji-33	385	27	enhanced	enhance	VERB
aji-33	385	28	≈20	≈20	PROPN
aji-33	385	29	prasad	prasad	PROPN
aji-33	385	30	;	;	PUNCT
aji-33	385	31	aji	aji	NOUN
aji-33	385	32	,	,	PUNCT
aji-33	385	33	3(1	3(1	NUM
aji-33	385	34	):	):	PUNCT
aji-33	385	35	233	233	NUM
aji-33	385	36	-	-	SYM
aji-33	385	37	252	252	NUM
aji-33	385	38	,	,	PUNCT
aji-33	385	39	2020	2020	NUM
aji-33	385	40	;	;	PUNCT
aji-33	385	41	article	article	NOUN
aji-33	385	42	no.aji.58422	no.aji.58422	NOUN
aji-33	385	43	242	242	NUM
aji-33	385	44	fold	fold	VERB
aji-33	385	45	in	in	ADV
aji-33	385	46	vivo	vivo	NOUN
aji-33	385	47	when	when	SCONJ
aji-33	385	48	pc	pc	NOUN
aji-33	385	49	is	be	AUX
aji-33	385	50	bound	bind	VERB
aji-33	385	51	to	to	ADP
aji-33	385	52	the	the	DET
aji-33	385	53	endothelial	endothelial	ADJ
aji-33	385	54	cell	cell	NOUN
aji-33	385	55	protein	protein	NOUN
aji-33	385	56	c	c	NOUN
aji-33	385	57	receptor	receptor	NOUN
aji-33	385	58	(	(	PUNCT
aji-33	385	59	epcr	epcr	ADJ
aji-33	385	60	)	)	PUNCT
aji-33	385	61	.	.	PUNCT
aji-33	386	1	platelet	platelet	NOUN
aji-33	386	2	factor	factor	NOUN
aji-33	386	3	4	4	NUM
aji-33	386	4	(	(	PUNCT
aji-33	386	5	pf4	pf4	NOUN
aji-33	386	6	)	)	PUNCT
aji-33	386	7	accelerates	accelerate	VERB
aji-33	386	8	pc	pc	NOUN
aji-33	386	9	activation	activation	NOUN
aji-33	386	10	by	by	ADP
aji-33	386	11	inducing	induce	VERB
aji-33	386	12	a	a	DET
aji-33	386	13	conformational	conformational	ADJ
aji-33	386	14	change	change	NOUN
aji-33	386	15	that	that	PRON
aji-33	386	16	increases	increase	VERB
aji-33	386	17	its	its	PRON
aji-33	386	18	affinity	affinity	NOUN
aji-33	386	19	for	for	ADP
aji-33	386	20	thrombin	thrombin	NOUN
aji-33	386	21	–	–	PUNCT
aji-33	386	22	tm	tm	PRON
aji-33	386	23	complex	complex	ADJ
aji-33	386	24	.activated	.activated	ADJ
aji-33	386	25	pc	pc	NOUN
aji-33	386	26	(	(	PUNCT
aji-33	386	27	apc	apc	PROPN
aji-33	386	28	)	)	PUNCT
aji-33	386	29	is	be	AUX
aji-33	386	30	a	a	DET
aji-33	386	31	known	know	VERB
aji-33	386	32	natural	natural	ADJ
aji-33	386	33	anticoagulant	anticoagulant	NOUN
aji-33	386	34	.	.	PUNCT
aji-33	387	1	apc	apc	PROPN
aji-33	387	2	and	and	CCONJ
aji-33	387	3	epcr	epcr	ADV
aji-33	387	4	have	have	VERB
aji-33	387	5	a	a	DET
aji-33	387	6	role	role	NOUN
aji-33	387	7	not	not	PART
aji-33	387	8	only	only	ADV
aji-33	387	9	in	in	ADP
aji-33	387	10	coagulation	coagulation	NOUN
aji-33	387	11	but	but	CCONJ
aji-33	387	12	also	also	ADV
aji-33	387	13	in	in	ADP
aji-33	387	14	inflammation	inflammation	NOUN
aji-33	387	15	also	also	ADV
aji-33	387	16	apc	apc	PROPN
aji-33	387	17	suppress	suppress	VERB
aji-33	387	18	further	further	ADJ
aji-33	387	19	thrombin	thrombin	NOUN
aji-33	387	20	formation	formation	NOUN
aji-33	387	21	by	by	ADP
aji-33	387	22	proteolytic	proteolytic	ADJ
aji-33	387	23	inactivation	inactivation	NOUN
aji-33	387	24	of	of	ADP
aji-33	387	25	the	the	DET
aji-33	387	26	coagulation	coagulation	NOUN
aji-33	387	27	factorsva	factorsva	ADJ
aji-33	387	28	and	and	CCONJ
aji-33	387	29	viiia	viiia	NOUN
aji-33	387	30	.	.	PUNCT
aji-33	388	1	along	along	ADP
aji-33	388	2	with	with	ADP
aji-33	388	3	protein	protein	NOUN
aji-33	388	4	s	s	PART
aji-33	388	5	(	(	PUNCT
aji-33	388	6	ps	ps	NOUN
aji-33	388	7	)	)	PUNCT
aji-33	388	8	,	,	PUNCT
aji-33	388	9	apc	apc	PROPN
aji-33	388	10	may	may	AUX
aji-33	388	11	also	also	ADV
aji-33	388	12	increase	increase	VERB
aji-33	388	13	fibrinolytic	fibrinolytic	ADJ
aji-33	388	14	activity	activity	NOUN
aji-33	388	15	,	,	PUNCT
aji-33	388	16	by	by	ADP
aji-33	388	17	neutralizing	neutralize	VERB
aji-33	388	18	plasminogen	plasminogen	NOUN
aji-33	388	19	activator	activator	NOUN
aji-33	388	20	inhibitor	inhibitor	NOUN
aji-33	388	21	1	1	NUM
aji-33	388	22	(	(	PUNCT
aji-33	388	23	pai-1	pai-1	NUM
aji-33	388	24	)	)	PUNCT
aji-33	388	25	.	.	PUNCT
aji-33	389	1	this	this	PRON
aji-33	389	2	results	result	VERB
aji-33	389	3	in	in	ADP
aji-33	389	4	a	a	DET
aji-33	389	5	hypercoagulable	hypercoagulable	ADJ
aji-33	389	6	state	state	NOUN
aji-33	389	7	.	.	PUNCT
aji-33	390	1	pro	pro	ADJ
aji-33	390	2	-	-	ADJ
aji-33	390	3	inflammatory	inflammatory	ADJ
aji-33	390	4	cellular	cellular	ADJ
aji-33	390	5	effects	effect	NOUN
aji-33	390	6	of	of	ADP
aji-33	390	7	coagulation	coagulation	NOUN
aji-33	390	8	proteases	protease	NOUN
aji-33	390	9	as	as	ADV
aji-33	390	10	well	well	ADV
aji-33	390	11	as	as	ADP
aji-33	390	12	the	the	DET
aji-33	390	13	anti	anti	ADJ
aji-33	390	14	-	-	ADJ
aji-33	390	15	inflammatory	inflammatory	ADJ
aji-33	390	16	effects	effect	NOUN
aji-33	390	17	of	of	ADP
aji-33	390	18	apc	apc	PROPN
aji-33	390	19	/	/	SYM
aji-33	390	20	epcr	epcr	PROPN
aji-33	390	21	are	be	AUX
aji-33	390	22	mediated	mediate	VERB
aji-33	390	23	by	by	ADP
aji-33	390	24	signalling	signal	VERB
aji-33	390	25	via	via	ADP
aji-33	390	26	protease	protease	NOUN
aji-33	390	27	activated	activate	VERB
aji-33	390	28	receptors	receptor	NOUN
aji-33	390	29	par	par	NOUN
aji-33	390	30	on	on	ADP
aji-33	390	31	mononuclear	mononuclear	ADJ
aji-33	390	32	cells	cell	NOUN
aji-33	390	33	,	,	PUNCT
aji-33	390	34	endothelial	endothelial	ADJ
aji-33	390	35	cells	cell	NOUN
aji-33	390	36	,	,	PUNCT
aji-33	390	37	platelets	platelet	NOUN
aji-33	390	38	,	,	PUNCT
aji-33	390	39	fibroblast	fibroblast	ADJ
aji-33	390	40	,	,	PUNCT
aji-33	390	41	and	and	CCONJ
aji-33	390	42	smooth	smooth	ADJ
aji-33	390	43	muscle	muscle	NOUN
aji-33	390	44	cells	cell	NOUN
aji-33	390	45	.	.	PUNCT
aji-33	391	1	the	the	DET
aji-33	391	2	beneficial	beneficial	ADJ
aji-33	391	3	effects	effect	NOUN
aji-33	391	4	of	of	ADP
aji-33	391	5	apc	apc	PROPN
aji-33	391	6	in	in	ADP
aji-33	391	7	sepsis	sepsis	NOUN
aji-33	391	8	are	be	AUX
aji-33	391	9	mainly	mainly	ADV
aji-33	391	10	dependent	dependent	ADJ
aji-33	391	11	on	on	ADP
aji-33	391	12	the	the	DET
aji-33	391	13	par	par	ADV
aji-33	391	14	-	-	PUNCT
aji-33	391	15	mediated	mediate	VERB
aji-33	391	16	cellprotective	cellprotective	ADJ
aji-33	391	17	properties	property	NOUN
aji-33	391	18	rather	rather	ADV
aji-33	391	19	than	than	ADP
aji-33	391	20	the	the	DET
aji-33	391	21	anticoagulant	anticoagulant	ADJ
aji-33	391	22	protease	protease	NOUN
aji-33	391	23	function	function	NOUN
aji-33	391	24	on	on	ADP
aji-33	391	25	coagulation	coagulation	NOUN
aji-33	391	26	cofactors	cofactor	NOUN
aji-33	391	27	fv	fv	ADP
aji-33	391	28	/	/	SYM
aji-33	391	29	va	va	PROPN
aji-33	391	30	and	and	CCONJ
aji-33	391	31	fviii	fviii	NOUN
aji-33	391	32	/	/	SYM
aji-33	391	33	viiia	viiia	NOUN
aji-33	391	34	.	.	PUNCT
aji-33	392	1	protein	protein	NOUN
aji-33	392	2	c	c	NOUN
aji-33	392	3	,	,	PUNCT
aji-33	392	4	which	which	PRON
aji-33	392	5	is	be	AUX
aji-33	392	6	activated	activate	VERB
aji-33	392	7	by	by	ADP
aji-33	392	8	thrombin	thrombin	NOUN
aji-33	392	9	,	,	PUNCT
aji-33	392	10	complexes	complexe	VERB
aji-33	392	11	with	with	ADP
aji-33	392	12	endothelial	endothelial	ADJ
aji-33	392	13	protein	protein	NOUN
aji-33	392	14	c	c	NOUN
aji-33	392	15	receptor	receptor	NOUN
aji-33	392	16	and	and	CCONJ
aji-33	392	17	thrombomodulin	thrombomodulin	NOUN
aji-33	392	18	and	and	CCONJ
aji-33	392	19	together	together	ADV
aji-33	392	20	with	with	ADP
aji-33	392	21	protein	protein	NOUN
aji-33	392	22	s	s	PART
aji-33	392	23	forms	form	NOUN
aji-33	392	24	the	the	DET
aji-33	392	25	activated	activate	VERB
aji-33	392	26	protein	protein	NOUN
aji-33	392	27	c	c	NOUN
aji-33	392	28	complex	complex	NOUN
aji-33	392	29	that	that	PRON
aji-33	392	30	inactivates	inactivate	VERB
aji-33	392	31	activated	activate	VERB
aji-33	392	32	coagulation	coagulation	NOUN
aji-33	392	33	factors	factor	NOUN
aji-33	392	34	v	v	ADP
aji-33	392	35	and	and	CCONJ
aji-33	392	36	viii	viii	NOUN
aji-33	392	37	.	.	PUNCT
aji-33	393	1	the	the	DET
aji-33	393	2	receptor	receptor	NOUN
aji-33	393	3	par-1	par-1	PART
aji-33	393	4	is	be	AUX
aji-33	393	5	differentially	differentially	ADV
aji-33	393	6	activated	activate	VERB
aji-33	393	7	by	by	ADP
aji-33	393	8	thrombin	thrombin	NOUN
aji-33	393	9	and	and	CCONJ
aji-33	393	10	the	the	DET
aji-33	393	11	activated	activate	VERB
aji-33	393	12	protein	protein	NOUN
aji-33	393	13	c	c	NOUN
aji-33	393	14	/	/	SYM
aji-33	393	15	epcr	epcr	ADV
aji-33	393	16	complex	complex	NOUN
aji-33	393	17	,	,	PUNCT
aji-33	393	18	resulting	result	VERB
aji-33	393	19	in	in	ADP
aji-33	393	20	antithrombotic	antithrombotic	ADJ
aji-33	393	21	and	and	CCONJ
aji-33	393	22	anti	anti	ADJ
aji-33	393	23	-	-	ADJ
aji-33	393	24	inflammatory	inflammatory	ADJ
aji-33	393	25	effects	effect	NOUN
aji-33	393	26	.	.	PUNCT
aji-33	394	1	thrombin	thrombin	NOUN
aji-33	394	2	and	and	CCONJ
aji-33	394	3	vasoactive	vasoactive	ADJ
aji-33	394	4	agents	agent	NOUN
aji-33	394	5	release	release	PROPN
aji-33	394	6	von	von	PROPN
aji-33	394	7	willebr	willebr	PROPN
aji-33	394	8	and	and	CCONJ
aji-33	394	9	factor	factor	NOUN
aji-33	394	10	as	as	ADP
aji-33	394	11	ultra	ultra	ADJ
aji-33	394	12	-	-	ADJ
aji-33	394	13	large	large	ADJ
aji-33	394	14	platelet	platelet	NOUN
aji-33	394	15	-	-	PUNCT
aji-33	394	16	binding	bind	VERB
aji-33	394	17	multimers	multimer	NOUN
aji-33	394	18	,	,	PUNCT
aji-33	394	19	which	which	PRON
aji-33	394	20	are	be	AUX
aji-33	394	21	cleaved	cleave	VERB
aji-33	394	22	by	by	ADP
aji-33	394	23	adamts13	adamts13	NOUN
aji-33	394	24	.	.	PUNCT
aji-33	395	1	platelets	platelet	NOUN
aji-33	395	2	can	can	AUX
aji-33	395	3	also	also	ADV
aji-33	395	4	facilitate	facilitate	VERB
aji-33	395	5	leukocyte	leukocyte	ADJ
aji-33	395	6	-	-	PUNCT
aji-33	395	7	endothelium	endothelium	NOUN
aji-33	395	8	interaction	interaction	NOUN
aji-33	395	9	.	.	PUNCT
aji-33	396	1	platelet	platelet	NOUN
aji-33	396	2	activation	activation	NOUN
aji-33	396	3	is	be	AUX
aji-33	396	4	prevented	prevent	VERB
aji-33	396	5	by	by	ADP
aji-33	396	6	nitric	nitric	ADJ
aji-33	396	7	oxide	oxide	NOUN
aji-33	396	8	,	,	PUNCT
aji-33	396	9	prostacyclin	prostacyclin	NOUN
aji-33	396	10	and	and	CCONJ
aji-33	396	11	exonucleotidases	exonucleotidase	NOUN
aji-33	396	12	.	.	PUNCT
aji-33	397	1	thrombin	thrombin	NOUN
aji-33	397	2	-	-	PUNCT
aji-33	397	3	cleaved	cleave	VERB
aji-33	397	4	adamts	adamts	ADJ
aji-33	397	5	disintegration	disintegration	NOUN
aji-33	397	6	of	of	ADP
aji-33	397	7	platelet	platelet	NOUN
aji-33	397	8	aggregates	aggregate	NOUN
aji-33	397	9	while	while	SCONJ
aji-33	397	10	tissue	tissue	NOUN
aji-33	397	11	-	-	PUNCT
aji-33	397	12	type	type	NOUN
aji-33	397	13	plasminogen	plasminogen	NOUN
aji-33	397	14	activator	activator	NOUN
aji-33	397	15	initiates	initiate	VERB
aji-33	397	16	fibrinolysis	fibrinolysis	NOUN
aji-33	397	17	.	.	PUNCT
aji-33	398	1	fibrin	fibrin	NOUN
aji-33	398	2	and	and	CCONJ
aji-33	398	3	products	product	NOUN
aji-33	398	4	of	of	ADP
aji-33	398	5	platelets	platelet	NOUN
aji-33	398	6	and	and	CCONJ
aji-33	398	7	inflammatory	inflammatory	ADJ
aji-33	398	8	cells	cell	NOUN
aji-33	398	9	modulate	modulate	VERB
aji-33	398	10	the	the	DET
aji-33	398	11	angiogenic	angiogenic	ADJ
aji-33	398	12	response	response	NOUN
aji-33	398	13	of	of	ADP
aji-33	398	14	endothelial	endothelial	ADJ
aji-33	398	15	cells	cell	NOUN
aji-33	398	16	and	and	CCONJ
aji-33	398	17	contribute	contribute	VERB
aji-33	398	18	to	to	ADP
aji-33	398	19	tissue	tissue	NOUN
aji-33	398	20	repair	repair	NOUN
aji-33	398	21	.	.	PUNCT
aji-33	399	1	endothelial	endothelial	ADJ
aji-33	399	2	pars	par	NOUN
aji-33	399	3	(	(	PUNCT
aji-33	399	4	protease	protease	NOUN
aji-33	399	5	activated	activate	VERB
aji-33	399	6	receptors	receptor	NOUN
aji-33	399	7	)	)	PUNCT
aji-33	399	8	participate	participate	VERB
aji-33	399	9	in	in	ADP
aji-33	399	10	the	the	DET
aji-33	399	11	regulation	regulation	NOUN
aji-33	399	12	of	of	ADP
aji-33	399	13	vascular	vascular	ADJ
aji-33	399	14	tone	tone	NOUN
aji-33	399	15	and	and	CCONJ
aji-33	399	16	permeability	permeability	NOUN
aji-33	399	17	.	.	PUNCT
aji-33	400	1	in	in	ADP
aji-33	400	2	endothelial	endothelial	ADJ
aji-33	400	3	cells	cell	NOUN
aji-33	400	4	,	,	PUNCT
aji-33	400	5	pars	par	NOUN
aji-33	400	6	play	play	VERB
aji-33	400	7	a	a	DET
aji-33	400	8	key	key	ADJ
aji-33	400	9	role	role	NOUN
aji-33	400	10	in	in	ADP
aji-33	400	11	promotion	promotion	NOUN
aji-33	400	12	vascular	vascular	ADJ
aji-33	400	13	barrier	barrier	NOUN
aji-33	400	14	function	function	NOUN
aji-33	400	15	as	as	SCONJ
aji-33	400	16	they	they	PRON
aji-33	400	17	provide	provide	VERB
aji-33	400	18	a	a	DET
aji-33	400	19	positive	positive	ADJ
aji-33	400	20	signals	signal	NOUN
aji-33	400	21	for	for	ADP
aji-33	400	22	endothelial	endothelial	ADJ
aji-33	400	23	adhesion	adhesion	NOUN
aji-33	400	24	molecules	molecule	NOUN
aji-33	400	25	(	(	PUNCT
aji-33	400	26	vascular	vascular	ADJ
aji-33	400	27	cell	cell	NOUN
aji-33	400	28	adhesion	adhesion	NOUN
aji-33	400	29	molecule-1	molecule-1	PROPN
aji-33	400	30	(	(	PUNCT
aji-33	400	31	vcam-1	vcam-1	NOUN
aji-33	400	32	)	)	PUNCT
aji-33	400	33	,	,	PUNCT
aji-33	400	34	intercellular	intercellular	ADJ
aji-33	400	35	adhesion	adhesion	NOUN
aji-33	400	36	molecule-1(icam-1	molecule-1(icam-1	NOUN
aji-33	400	37	)	)	PUNCT
aji-33	400	38	,	,	PUNCT
aji-33	400	39	and	and	CCONJ
aji-33	400	40	e	e	X
aji-33	400	41	-	-	NOUN
aji-33	400	42	selectin	selectin	ADJ
aji-33	400	43	[	[	X
aji-33	400	44	53	53	NUM
aji-33	400	45	]	]	PUNCT
aji-33	400	46	.	.	PUNCT
aji-33	401	1	pars	par	NOUN
aji-33	401	2	contribute	contribute	VERB
aji-33	401	3	to	to	ADP
aji-33	401	4	the	the	DET
aji-33	401	5	pro	pro	ADJ
aji-33	401	6	-	-	ADJ
aji-33	401	7	inflammatory	inflammatory	ADJ
aji-33	401	8	response	response	NOUN
aji-33	401	9	.	.	PUNCT
aji-33	402	1	for	for	ADP
aji-33	402	2	example	example	NOUN
aji-33	402	3	par4	par4	NOUN
aji-33	402	4	induces	induce	VERB
aji-33	402	5	leukocyte	leukocyte	NOUN
aji-33	402	6	migration	migration	NOUN
aji-33	402	7	and	and	CCONJ
aji-33	402	8	par2	par2	PROPN
aji-33	402	9	helps	help	VERB
aji-33	402	10	macrophages	macrophage	NOUN
aji-33	402	11	to	to	PART
aji-33	402	12	produce	produce	VERB
aji-33	402	13	cytokines	cytokine	NOUN
aji-33	402	14	such	such	ADJ
aji-33	402	15	as	as	ADP
aji-33	402	16	interleukin-8	interleukin-8	NUM
aji-33	402	17	(	(	PUNCT
aji-33	402	18	il-8	il-8	NOUN
aji-33	402	19	)	)	PUNCT
aji-33	402	20	.	.	PUNCT
aji-33	403	1	activation	activation	NOUN
aji-33	403	2	of	of	ADP
aji-33	403	3	pars	par	NOUN
aji-33	403	4	alternatively	alternatively	ADV
aji-33	403	5	lead	lead	VERB
aji-33	403	6	to	to	ADP
aji-33	403	7	the	the	DET
aji-33	403	8	transactivation	transactivation	NOUN
aji-33	403	9	of	of	ADP
aji-33	403	10	and	and	CCONJ
aji-33	403	11	signalling	signal	VERB
aji-33	403	12	through	through	ADP
aji-33	403	13	receptors	receptor	NOUN
aji-33	403	14	such	such	ADJ
aji-33	403	15	as	as	ADP
aji-33	403	16	colocalized	colocalized	ADJ
aji-33	403	17	pars	par	NOUN
aji-33	403	18	,	,	PUNCT
aji-33	403	19	ion	ion	NOUN
aji-33	403	20	channels	channel	NOUN
aji-33	403	21	,	,	PUNCT
aji-33	403	22	and	and	CCONJ
aji-33	403	23	toll	toll	NOUN
aji-33	403	24	-	-	PUNCT
aji-33	403	25	like	like	ADJ
aji-33	403	26	receptors	receptor	NOUN
aji-33	403	27	.	.	PUNCT
aji-33	404	1	4.1.6	4.1.6	NUM
aji-33	404	2	role	role	NOUN
aji-33	404	3	of	of	ADP
aji-33	404	4	other	other	ADJ
aji-33	404	5	elements	element	NOUN
aji-33	404	6	of	of	ADP
aji-33	404	7	innate	innate	ADJ
aji-33	404	8	immunity	immunity	NOUN
aji-33	404	9	4.1.6.1	4.1.6.1	NUM
aji-33	404	10	role	role	NOUN
aji-33	404	11	of	of	ADP
aji-33	404	12	the	the	DET
aji-33	404	13	interferons	interferon	NOUN
aji-33	404	14	interferons(ifns	interferons(ifns	PROPN
aji-33	404	15	)	)	PUNCT
aji-33	404	16	are	be	AUX
aji-33	404	17	a	a	DET
aji-33	404	18	group	group	NOUN
aji-33	404	19	of	of	ADP
aji-33	404	20	signalling	signal	VERB
aji-33	404	21	proteins	protein	NOUN
aji-33	404	22	made	make	VERB
aji-33	404	23	and	and	CCONJ
aji-33	404	24	released	release	VERB
aji-33	404	25	by	by	ADP
aji-33	404	26	host	host	NOUN
aji-33	404	27	cells	cell	NOUN
aji-33	404	28	in	in	ADP
aji-33	404	29	response	response	NOUN
aji-33	404	30	to	to	ADP
aji-33	404	31	the	the	DET
aji-33	404	32	presence	presence	NOUN
aji-33	404	33	of	of	ADP
aji-33	404	34	several	several	ADJ
aji-33	404	35	viruses	virus	NOUN
aji-33	404	36	.	.	PUNCT
aji-33	405	1	type	type	NOUN
aji-33	405	2	i	i	PRON
aji-33	405	3	interferons	interferon	VERB
aji-33	405	4	(	(	PUNCT
aji-33	405	5	ifn	ifn	NOUN
aji-33	405	6	-	-	PUNCT
aji-33	405	7	alpha	alpha	NOUN
aji-33	405	8	and	and	CCONJ
aji-33	405	9	ifnbeta	ifnbeta	NOUN
aji-33	405	10	)	)	PUNCT
aji-33	405	11	are	be	AUX
aji-33	405	12	secreted	secrete	VERB
aji-33	405	13	by	by	ADP
aji-33	405	14	virus	virus	NOUN
aji-33	405	15	-	-	PUNCT
aji-33	405	16	infected	infect	VERB
aji-33	405	17	cells	cell	NOUN
aji-33	405	18	while	while	SCONJ
aji-33	405	19	type	type	NOUN
aji-33	405	20	ii	ii	PROPN
aji-33	405	21	,	,	PUNCT
aji-33	405	22	immune	immune	ADJ
aji-33	405	23	or	or	CCONJ
aji-33	405	24	gamma	gamma	PROPN
aji-33	405	25	interferon	interferon	NOUN
aji-33	405	26	(	(	PUNCT
aji-33	405	27	ifn	ifn	PROPN
aji-33	405	28	-	-	PUNCT
aji-33	405	29	gamma	gamma	NOUN
aji-33	405	30	)	)	PUNCT
aji-33	405	31	is	be	AUX
aji-33	405	32	mainly	mainly	ADV
aji-33	405	33	secreted	secrete	VERB
aji-33	405	34	by	by	ADP
aji-33	405	35	components	component	NOUN
aji-33	405	36	of	of	ADP
aji-33	405	37	both	both	PRON
aji-33	405	38	innate	innate	ADJ
aji-33	405	39	and	and	CCONJ
aji-33	405	40	adaptive	adaptive	ADJ
aji-33	405	41	immunity	immunity	NOUN
aji-33	405	42	t	t	NOUN
aji-33	405	43	cells	cell	NOUN
aji-33	405	44	(	(	PUNCT
aji-33	405	45	of	of	ADP
aji-33	405	46	adaptive	adaptive	ADJ
aji-33	405	47	immunity	immunity	NOUN
aji-33	405	48	)	)	PUNCT
aji-33	405	49	,	,	PUNCT
aji-33	405	50	natural	natural	ADJ
aji-33	405	51	killer	killer	NOUN
aji-33	405	52	(	(	PUNCT
aji-33	405	53	nk	nk	PROPN
aji-33	405	54	)	)	PUNCT
aji-33	405	55	cells	cell	NOUN
aji-33	405	56	and	and	CCONJ
aji-33	405	57	macrophages	macrophage	NOUN
aji-33	405	58	(	(	PUNCT
aji-33	405	59	of	of	ADP
aji-33	405	60	innate	innate	ADJ
aji-33	405	61	immunity	immunity	NOUN
aji-33	405	62	)	)	PUNCT
aji-33	405	63	.	.	PUNCT
aji-33	406	1	ifnγ	ifnγ	NOUN
aji-33	406	2	,	,	PUNCT
aji-33	406	3	a	a	DET
aji-33	406	4	cytokine	cytokine	NOUN
aji-33	406	5	which	which	PRON
aji-33	406	6	is	be	AUX
aji-33	406	7	crucial	crucial	ADJ
aji-33	406	8	for	for	SCONJ
aji-33	406	9	innate	innate	ADJ
aji-33	406	10	and	and	CCONJ
aji-33	406	11	adaptive	adaptive	ADJ
aji-33	406	12	immunity	immunity	NOUN
aji-33	406	13	against	against	ADP
aji-33	406	14	many	many	ADJ
aji-33	406	15	pathogens	pathogen	NOUN
aji-33	406	16	is	be	AUX
aji-33	406	17	produced	produce	VERB
aji-33	406	18	:	:	PUNCT
aji-33	406	19	1	1	X
aji-33	406	20	.	.	X
aji-33	407	1	as	as	ADP
aji-33	407	2	a	a	DET
aji-33	407	3	part	part	NOUN
aji-33	407	4	of	of	ADP
aji-33	407	5	the	the	DET
aji-33	407	6	innate	innate	ADJ
aji-33	407	7	immune	immune	ADJ
aji-33	407	8	response	response	NOUN
aji-33	407	9	:	:	PUNCT
aji-33	407	10	natural	natural	ADJ
aji-33	407	11	killer	killer	NOUN
aji-33	407	12	(	(	PUNCT
aji-33	407	13	nk	nk	PROPN
aji-33	407	14	)	)	PUNCT
aji-33	407	15	natural	natural	ADJ
aji-33	407	16	killer	killer	NOUN
aji-33	407	17	t	t	PROPN
aji-33	407	18	(	(	PUNCT
aji-33	407	19	nkt	nkt	PROPN
aji-33	407	20	)	)	PUNCT
aji-33	407	21	cells	cell	NOUN
aji-33	407	22	mucosal	mucosal	VERB
aji-33	407	23	epithelial	epithelial	ADJ
aji-33	407	24	cells	cell	NOUN
aji-33	407	25	,	,	PUNCT
aji-33	407	26	macrophages	macrophage	NOUN
aji-33	407	27	innate	innate	ADJ
aji-33	407	28	lymphoid	lymphoid	ADJ
aji-33	407	29	cells(ilc	cells(ilc	NOUN
aji-33	407	30	)	)	PUNCT
aji-33	407	31	produce	produce	VERB
aji-33	407	32	it	it	PRON
aji-33	407	33	.	.	PUNCT
aji-33	408	1	2	2	X
aji-33	408	2	.	.	X
aji-33	408	3	as	as	ADP
aji-33	408	4	a	a	DET
aji-33	408	5	part	part	NOUN
aji-33	408	6	of	of	ADP
aji-33	408	7	adaptive	adaptive	ADJ
aji-33	408	8	immunity	immunity	NOUN
aji-33	408	9	:	:	PUNCT
aji-33	408	10	cd4	cd4	PROPN
aji-33	408	11	th1	th1	PROPN
aji-33	408	12	cells	cell	NOUN
aji-33	408	13	,	,	PUNCT
aji-33	408	14	cd8	cd8	PROPN
aji-33	408	15	cytotoxic	cytotoxic	ADJ
aji-33	408	16	t	t	PROPN
aji-33	408	17	lymphocyte	lymphocyte	NOUN
aji-33	408	18	(	(	PUNCT
aji-33	408	19	ctl	ctl	PROPN
aji-33	408	20	)	)	PUNCT
aji-33	408	21	produce	produce	VERB
aji-33	408	22	it	it	PRON
aji-33	408	23	.	.	PUNCT
aji-33	409	1	4.1.7	4.1.7	NUM
aji-33	409	2	functions	function	NOUN
aji-33	409	3	it	it	PRON
aji-33	409	4	serves	serve	VERB
aji-33	409	5			DET
aji-33	409	6	macrophage	macrophage	ADJ
aji-33	409	7	activation	activation	NOUN
aji-33	409	8	increases	increase	VERB
aji-33	409	9	their	their	PRON
aji-33	409	10	antigen	antigen	ADJ
aji-33	409	11	presentation	presentation	NOUN
aji-33	409	12	and	and	CCONJ
aji-33	409	13	lysosome	lysosome	NOUN
aji-33	409	14	activity	activity	NOUN
aji-33	409	15	.	.	PUNCT
aji-33	410	1			NOUN
aji-33	410	2	increased	increase	VERB
aji-33	410	3	expression	expression	NOUN
aji-33	410	4	of	of	ADP
aji-33	410	5	class	class	NOUN
aji-33	410	6	i	i	PROPN
aji-33	410	7	and	and	CCONJ
aji-33	410	8	class	class	PROPN
aji-33	410	9	ii	ii	PROPN
aji-33	410	10	mhc	mhc	PROPN
aji-33	410	11	molecules	molecule	NOUN
aji-33	410	12	.	.	PUNCT
aji-33	411	1			X
aji-33	411	2	increased	increase	VERB
aji-33	411	3	expression	expression	NOUN
aji-33	411	4	of	of	ADP
aji-33	411	5	apcs	apc	NOUN
aji-33	411	6	(	(	PUNCT
aji-33	411	7	antigenpresenting	antigenpresente	VERB
aji-33	411	8	cells	cell	NOUN
aji-33	411	9	)	)	PUNCT
aji-33	411	10	through	through	ADP
aji-33	411	11	induction	induction	NOUN
aji-33	411	12	of	of	ADP
aji-33	411	13	antigen	antigen	ADJ
aji-33	411	14	processing	processing	NOUN
aji-33	411	15	genes	gene	NOUN
aji-33	411	16	,	,	PUNCT
aji-33	411	17	including	include	VERB
aji-33	411	18	subunits	subunit	NOUN
aji-33	411	19	of	of	ADP
aji-33	411	20	the	the	DET
aji-33	411	21	immunoproteasome	immunoproteasome	NOUN
aji-33	411	22	(	(	PUNCT
aji-33	411	23	mecl1	mecl1	NOUN
aji-33	411	24	,	,	PUNCT
aji-33	411	25	lmp2	lmp2	NOUN
aji-33	411	26	,	,	PUNCT
aji-33	411	27	lmp7	lmp7	PROPN
aji-33	411	28	)	)	PUNCT
aji-33	411	29	,	,	PUNCT
aji-33	411	30	tap	tap	NOUN
aji-33	411	31	and	and	CCONJ
aji-33	411	32	eraap	eraap	ADJ
aji-33	411	33	and	and	CCONJ
aji-33	411	34	direct	direct	ADJ
aji-33	411	35	upregulation	upregulation	NOUN
aji-33	411	36	of	of	ADP
aji-33	411	37	mhc	mhc	PROPN
aji-33	411	38	heavy	heavy	ADJ
aji-33	411	39	chains	chain	NOUN
aji-33	411	40	and	and	CCONJ
aji-33	411	41	b2	b2	NOUN
aji-33	411	42	-	-	PUNCT
aji-33	411	43	microglobulin	microglobulin	PROPN
aji-33	411	44	itself	itself	PRON
aji-33	411	45	.	.	PUNCT
aji-33	412	1			PRON
aji-33	412	2	role	role	NOUN
aji-33	412	3	in	in	ADP
aji-33	412	4	macrophagepolymorphism	macrophagepolymorphism	NOUN
aji-33	412	5	:	:	PUNCT
aji-33	412	6	m1	m1	NOUN
aji-33	412	7	macrophages	macrophage	NOUN
aji-33	412	8	are	be	AUX
aji-33	412	9	stimulated	stimulate	VERB
aji-33	412	10	by	by	ADP
aji-33	412	11	interferon	interferon	NOUN
aji-33	412	12	(	(	PUNCT
aji-33	412	13	ifn)-γ	ifn)-γ	NOUN
aji-33	412	14	which	which	PRON
aji-33	412	15	secrete	secrete	VERB
aji-33	412	16	proinflammatory	proinflammatory	ADJ
aji-33	412	17	cytokines	cytokine	NOUN
aji-33	412	18	(	(	PUNCT
aji-33	412	19	like	like	ADP
aji-33	412	20	tnf	tnf	PROPN
aji-33	412	21	-	-	PUNCT
aji-33	412	22	α	α	PROPN
aji-33	412	23	,	,	PUNCT
aji-33	412	24	il-1β	il-1β	PROPN
aji-33	412	25	,	,	PUNCT
aji-33	412	26	il-12	il-12	NOUN
aji-33	412	27	,	,	PUNCT
aji-33	412	28	il-18	il-18	NUM
aji-33	412	29	)	)	PUNCT
aji-33	412	30	prasad	prasad	PROPN
aji-33	412	31	;	;	PUNCT
aji-33	412	32	aji	aji	NOUN
aji-33	412	33	,	,	PUNCT
aji-33	412	34	3(1	3(1	NUM
aji-33	412	35	):	):	PUNCT
aji-33	412	36	233	233	NUM
aji-33	412	37	-	-	SYM
aji-33	412	38	252	252	NUM
aji-33	412	39	,	,	PUNCT
aji-33	412	40	2020	2020	NUM
aji-33	412	41	;	;	PUNCT
aji-33	412	42	article	article	NOUN
aji-33	412	43	no.aji.58422	no.aji.58422	NOUN
aji-33	412	44	243	243	NUM
aji-33	412	45	and	and	CCONJ
aji-33	412	46	the	the	DET
aji-33	412	47	chemokines	chemokine	NOUN
aji-33	412	48	.	.	PUNCT
aji-33	413	1	(	(	PUNCT
aji-33	413	2	like	like	ADP
aji-33	413	3	ccl15	ccl15	ADJ
aji-33	413	4	,	,	PUNCT
aji-33	413	5	ccl20	ccl20	NOUN
aji-33	413	6	,	,	PUNCT
aji-33	413	7	cxcl8	cxcl8	NOUN
aji-33	413	8	-	-	PUNCT
aji-33	413	9	11	11	NUM
aji-33	413	10	and	and	CCONJ
aji-33	413	11	cxcl13	cxcl13	NOUN
aji-33	413	12	)	)	PUNCT
aji-33	413	13	.	.	PUNCT
aji-33	414	1			PROPN
aji-33	414	2	antiviral	antiviral	NOUN
aji-33	414	3	(	(	PUNCT
aji-33	414	4	replicatory	replicatory	NOUN
aji-33	414	5	)	)	PUNCT
aji-33	414	6	,	,	PUNCT
aji-33	414	7	immuno	immuno	ADJ
aji-33	414	8	-	-	ADJ
aji-33	414	9	regulatory	regulatory	ADJ
aji-33	414	10	,	,	PUNCT
aji-33	414	11	and	and	CCONJ
aji-33	414	12	anti	anti	ADJ
aji-33	414	13	-	-	ADJ
aji-33	414	14	tumour	tumour	ADJ
aji-33	414	15	properties	property	NOUN
aji-33	414	16	[	[	X
aji-33	414	17	19	19	NUM
aji-33	414	18	]	]	PUNCT
aji-33	414	19	.	.	PUNCT
aji-33	415	1			NOUN
aji-33	415	2	aberrant	aberrant	ADJ
aji-33	415	3	ifnγ	ifnγ	NOUN
aji-33	415	4	expression	expression	NOUN
aji-33	415	5	causes	cause	VERB
aji-33	415	6	number	number	NOUN
aji-33	415	7	or	or	CCONJ
aji-33	415	8	autoimmune	autoimmune	ADJ
aji-33	415	9	diseases	disease	NOUN
aji-33	415	10	.	.	PUNCT
aji-33	416	1			PRON
aji-33	416	2	activates	activate	VERB
aji-33	416	3	inducible	inducible	ADJ
aji-33	416	4	nitric	nitric	ADJ
aji-33	416	5	oxide	oxide	NOUN
aji-33	416	6	synthase	synthase	NOUN
aji-33	416	7	(	(	PUNCT
aji-33	416	8	inos	ino	NOUN
aji-33	416	9	)	)	PUNCT
aji-33	416	10	.	.	PUNCT
aji-33	417	1			NOUN
aji-33	417	2	induces	induce	VERB
aji-33	417	3	production	production	NOUN
aji-33	417	4	of	of	ADP
aji-33	417	5	igg2a	igg2a	PROPN
aji-33	417	6	and	and	CCONJ
aji-33	417	7	igg3	igg3	NOUN
aji-33	417	8	from	from	ADP
aji-33	417	9	activated	activate	VERB
aji-33	417	10	plasma	plasma	NOUN
aji-33	417	11	b	b	NOUN
aji-33	417	12	cell	cell	NOUN
aji-33	417	13	.	.	PUNCT
aji-33	418	1			NOUN
aji-33	418	2	promotes	promote	VERB
aji-33	418	3	adhesion	adhesion	NOUN
aji-33	418	4	and	and	CCONJ
aji-33	418	5	binding	bind	VERB
aji-33	418	6	required	require	VERB
aji-33	418	7	for	for	ADP
aji-33	418	8	leukocyte	leukocyte	NOUN
aji-33	418	9	migration	migration	NOUN
aji-33	418	10	.	.	PUNCT
aji-33	419	1			NOUN
aji-33	419	2	primes	prime	NOUN
aji-33	419	3	alveolar	alveolar	ADJ
aji-33	419	4	macrophages	macrophage	NOUN
aji-33	419	5	against	against	ADP
aji-33	419	6	secondary	secondary	ADJ
aji-33	419	7	bacterial	bacterial	ADJ
aji-33	419	8	infections	infection	NOUN
aji-33	419	9	.	.	PUNCT
aji-33	420	1	how	how	SCONJ
aji-33	420	2	ifnγ	ifnγ	NOUN
aji-33	420	3	exerts	exert	VERB
aji-33	420	4	its	its	PRON
aji-33	420	5	cellular	cellular	ADJ
aji-33	420	6	responses	response	NOUN
aji-33	420	7	?	?	PUNCT
aji-33	421	1	1	1	X
aji-33	421	2	.	.	X
aji-33	421	3	it	it	PRON
aji-33	421	4	interacts	interact	VERB
aji-33	421	5	with	with	ADP
aji-33	421	6	interferon	interferon	ADJ
aji-33	421	7	gamma	gamma	NOUN
aji-33	421	8	receptor	receptor	NOUN
aji-33	421	9	1	1	NUM
aji-33	421	10	(	(	PUNCT
aji-33	421	11	ifngr1	ifngr1	PROPN
aji-33	421	12	)	)	PUNCT
aji-33	421	13	and	and	CCONJ
aji-33	421	14	interferon	interferon	ADJ
aji-33	421	15	gamma	gamma	NOUN
aji-33	421	16	receptor	receptor	PROPN
aji-33	421	17	2(ifngr2	2(ifngr2	NUM
aji-33	421	18	)	)	PUNCT
aji-33	421	19	.	.	PUNCT
aji-33	422	1	2	2	X
aji-33	422	2	.	.	X
aji-33	422	3	binding	bind	VERB
aji-33	422	4	activates	activate	VERB
aji-33	422	5	jak	jak	PROPN
aji-33	422	6	-	-	PUNCT
aji-33	422	7	stat	stat	PROPN
aji-33	422	8	pathway	pathway	NOUN
aji-33	422	9	.	.	PUNCT
aji-33	423	1	3	3	X
aji-33	423	2	.	.	X
aji-33	423	3	ifnγ	ifnγ	NOUN
aji-33	423	4	also	also	ADV
aji-33	423	5	binds	bind	VERB
aji-33	423	6	to	to	ADP
aji-33	423	7	the	the	DET
aji-33	423	8	glycosaminogly	glycosaminogly	NOUN
aji-33	423	9	can	can	AUX
aji-33	423	10	heparan	heparan	ADJ
aji-33	423	11	sulphate	sulphate	NOUN
aji-33	423	12	(	(	PUNCT
aji-33	423	13	hs	hs	X
aji-33	423	14	)	)	PUNCT
aji-33	423	15	and	and	CCONJ
aji-33	423	16	inhibits	inhibit	VERB
aji-33	423	17	its	its	PRON
aji-33	423	18	biological	biological	ADJ
aji-33	423	19	activity	activity	NOUN
aji-33	423	20	.	.	PUNCT
aji-33	424	1	4	4	X
aji-33	424	2	.	.	X
aji-33	424	3	promotes	promote	VERB
aji-33	424	4	nk	nk	PROPN
aji-33	424	5	cell	cell	NOUN
aji-33	424	6	activity	activity	NOUN
aji-33	424	7	.	.	PUNCT
aji-33	425	1	ifn	ifn	PROPN
aji-33	425	2	-	-	PUNCT
aji-33	425	3	α	α	PROPN
aji-33	425	4	has	have	VERB
aji-33	425	5	a	a	DET
aji-33	425	6	general	general	ADJ
aji-33	425	7	inflammatory	inflammatory	ADJ
aji-33	425	8	action	action	NOUN
aji-33	425	9	which	which	PRON
aji-33	425	10	skews	skew	VERB
aji-33	425	11	the	the	DET
aji-33	425	12	immune	immune	ADJ
aji-33	425	13	response	response	NOUN
aji-33	425	14	towards	towards	ADP
aji-33	425	15	a	a	DET
aji-33	425	16	th1	th1	NOUN
aji-33	425	17	profile	profile	NOUN
aji-33	425	18	,	,	PUNCT
aji-33	425	19	which	which	PRON
aji-33	425	20	leads	lead	VERB
aji-33	425	21	to	to	ADP
aji-33	425	22	induction	induction	NOUN
aji-33	425	23	of	of	ADP
aji-33	425	24	classically	classically	ADV
aji-33	425	25	activated	activate	VERB
aji-33	425	26	m1	m1	PROPN
aji-33	425	27	macrophages.(see	macrophages.(see	PROPN
aji-33	425	28	macrophage	macrophage	ADJ
aji-33	425	29	polymorphism	polymorphism	NOUN
aji-33	425	30	below	below	ADP
aji-33	425	31	)	)	PUNCT
aji-33	426	1	1	1	X
aji-33	426	2	.	.	PUNCT
aji-33	427	1	ifn	ifn	PROPN
aji-33	427	2	α	α	PROPN
aji-33	427	3	functions	function	NOUN
aji-33	427	4	1	1	NUM
aji-33	427	5	.	.	PUNCT
aji-33	428	1	ifn	ifn	PROPN
aji-33	428	2	-	-	PUNCT
aji-33	428	3	α8	α8	NOUN
aji-33	428	4	enhances	enhance	VERB
aji-33	428	5	the	the	DET
aji-33	428	6	proliferation	proliferation	NOUN
aji-33	428	7	of	of	ADP
aji-33	428	8	human	human	PROPN
aji-33	428	9	b	b	PROPN
aji-33	428	10	cells	cell	NOUN
aji-33	428	11	,	,	PUNCT
aji-33	428	12	and	and	CCONJ
aji-33	428	13	activates	activate	VERB
aji-33	428	14	nk	nk	PROPN
aji-33	428	15	cells	cell	NOUN
aji-33	428	16	.	.	PUNCT
aji-33	429	1	the	the	DET
aji-33	429	2	subtypes	subtype	NOUN
aji-33	429	3	α10	α10	NOUN
aji-33	429	4	and	and	CCONJ
aji-33	429	5	α2	α2	ADJ
aji-33	429	6	,	,	PUNCT
aji-33	429	7	and	and	CCONJ
aji-33	429	8	α8	α8	NOUN
aji-33	429	9	,	,	PUNCT
aji-33	429	10	are	be	AUX
aji-33	429	11	the	the	DET
aji-33	429	12	most	most	ADV
aji-33	429	13	efficient	efficient	ADJ
aji-33	429	14	nk	nk	PROPN
aji-33	429	15	cell	cell	NOUN
aji-33	429	16	activators	activator	NOUN
aji-33	429	17	.	.	PUNCT
aji-33	430	1	2	2	X
aji-33	430	2	.	.	X
aji-33	430	3	subtypes	subtype	NOUN
aji-33	430	4	α21	α21	VERB
aji-33	430	5	and	and	CCONJ
aji-33	430	6	α2	α2	PROPN
aji-33	430	7	enhance	enhance	VERB
aji-33	430	8	the	the	DET
aji-33	430	9	expression	expression	NOUN
aji-33	430	10	of	of	ADP
aji-33	430	11	ifn	ifn	PROPN
aji-33	430	12	-	-	PUNCT
aji-33	430	13	gamma	gamma	NOUN
aji-33	430	14	inducible	inducible	ADJ
aji-33	430	15	protein-10	protein-10	PROPN
aji-33	430	16	(	(	PUNCT
aji-33	430	17	ip10),a	ip10),a	PROPN
aji-33	430	18	chemokine	chemokine	PROPN
aji-33	430	19	,	,	PUNCT
aji-33	430	20	that	that	PRON
aji-33	430	21	promotes	promote	VERB
aji-33	430	22	th1	th1	NOUN
aji-33	430	23	inflammatory	inflammatory	ADJ
aji-33	430	24	response	response	NOUN
aji-33	430	25	.	.	PUNCT
aji-33	431	1	in	in	ADP
aji-33	431	2	dendritic	dendritic	ADJ
aji-33	431	3	cells	cell	NOUN
aji-33	431	4	.	.	PUNCT
aji-33	432	1	3	3	X
aji-33	432	2	.	.	X
aji-33	432	3	ifn	ifn	PROPN
aji-33	432	4	-	-	PUNCT
aji-33	432	5	α1	α1	PROPN
aji-33	432	6	causes	cause	NOUN
aji-33	432	7	increased	increase	VERB
aji-33	432	8	hla	hla	PROPN
aji-33	432	9	-	-	PUNCT
aji-33	432	10	ii	ii	NOUN
aji-33	432	11	expression	expression	NOUN
aji-33	432	12	and	and	CCONJ
aji-33	432	13	can	can	AUX
aji-33	432	14	directly	directly	ADV
aji-33	432	15	inhibit	inhibit	VERB
aji-33	432	16	tumour	tumour	NOUN
aji-33	432	17	cell	cell	NOUN
aji-33	432	18	growth	growth	NOUN
aji-33	432	19	in	in	ADP
aji-33	432	20	vitro	vitro	X
aji-33	432	21	.	.	PUNCT
aji-33	433	1	4	4	X
aji-33	433	2	.	.	X
aji-33	433	3	subtype	subtype	NOUN
aji-33	433	4	α2	α2	ADJ
aji-33	433	5	increases	increase	VERB
aji-33	433	6	the	the	DET
aji-33	433	7	expression	expression	NOUN
aji-33	433	8	of	of	ADP
aji-33	433	9	hla	hla	PROPN
aji-33	433	10	-	-	PUNCT
aji-33	433	11	i	i	NOUN
aji-33	433	12	molecules	molecule	NOUN
aji-33	433	13	,	,	PUNCT
aji-33	433	14	which	which	PRON
aji-33	433	15	correlates	correlate	VERB
aji-33	433	16	with	with	ADP
aji-33	433	17	ifn	ifn	PROPN
aji-33	433	18	-	-	PUNCT
aji-33	433	19	α	α	NOUN
aji-33	433	20	-	-	PUNCT
aji-33	433	21	mediated	mediate	VERB
aji-33	433	22	activation	activation	NOUN
aji-33	433	23	of	of	ADP
aji-33	433	24	memory	memory	NOUN
aji-33	433	25	cd8	cd8	PROPN
aji-33	433	26	cells	cell	NOUN
aji-33	433	27	and	and	CCONJ
aji-33	433	28	increased	increase	VERB
aji-33	433	29	catalytic	catalytic	ADJ
aji-33	433	30	action	action	NOUN
aji-33	433	31	against	against	ADP
aji-33	433	32	virally	virally	ADV
aji-33	433	33	infected	infect	VERB
aji-33	433	34	cells	cell	NOUN
aji-33	433	35	and	and	CCONJ
aji-33	433	36	tumour	tumour	NOUN
aji-33	433	37	cells	cell	NOUN
aji-33	433	38	(	(	PUNCT
aji-33	433	39	via	via	ADP
aji-33	433	40	cytotoxic	cytotoxic	ADJ
aji-33	433	41	cd8	cd8	PROPN
aji-33	433	42	cells	cell	NOUN
aji-33	433	43	)	)	PUNCT
aji-33	433	44	.	.	PUNCT
aji-33	434	1	interferon	interferon	ADJ
aji-33	434	2	beta	beta	NOUN
aji-33	434	3	:	:	PUNCT
aji-33	434	4	it	it	PRON
aji-33	434	5	is	be	AUX
aji-33	434	6	released	release	VERB
aji-33	434	7	at	at	ADP
aji-33	434	8	the	the	DET
aji-33	434	9	end	end	NOUN
aji-33	434	10	of	of	ADP
aji-33	434	11	an	an	DET
aji-33	434	12	immune	immune	ADJ
aji-33	434	13	attack	attack	NOUN
aji-33	434	14	,	,	PUNCT
aji-33	434	15	blocks	block	VERB
aji-33	434	16	the	the	DET
aji-33	434	17	action	action	NOUN
aji-33	434	18	of	of	ADP
aji-33	434	19	gamma	gamma	PROPN
aji-33	434	20	interferon	interferon	NOUN
aji-33	434	21	and	and	CCONJ
aji-33	434	22	helps	help	VERB
aji-33	434	23	to	to	PART
aji-33	434	24	reduce	reduce	VERB
aji-33	434	25	inflammation	inflammation	NOUN
aji-33	434	26	and	and	CCONJ
aji-33	434	27	the	the	DET
aji-33	434	28	body	body	NOUN
aji-33	434	29	's	's	PART
aji-33	434	30	immune	immune	ADJ
aji-33	434	31	reaction	reaction	NOUN
aji-33	434	32	.	.	PUNCT
aji-33	435	1	role	role	NOUN
aji-33	435	2	of	of	ADP
aji-33	435	3	other	other	ADJ
aji-33	435	4	important	important	ADJ
aji-33	435	5	innate	innate	ADJ
aji-33	435	6	cellular	cellular	ADJ
aji-33	435	7	elements	element	NOUN
aji-33	435	8	:	:	PUNCT
aji-33	435	9	these	these	PRON
aji-33	435	10	are	be	AUX
aji-33	435	11	presented	present	VERB
aji-33	435	12	in	in	ADP
aji-33	435	13	appendix	appendix	ADJ
aji-33	435	14	4	4	NUM
aji-33	435	15			NOUN
aji-33	435	16	role	role	NOUN
aji-33	435	17	of	of	ADP
aji-33	435	18	adoptive	adoptive	ADJ
aji-33	435	19	immunity	immunity	NOUN
aji-33	435	20	in	in	ADP
aji-33	435	21	covid	covid	PROPN
aji-33	435	22	lung	lung	PROPN
aji-33	435	23	pathology	pathology	PROPN
aji-33	435	24	:	:	PUNCT
aji-33	436	1	cd8	cd8	PROPN
aji-33	436	2	+	+	PROPN
aji-33	436	3	t	t	PROPN
aji-33	436	4	cells	cell	NOUN
aji-33	436	5	and	and	CCONJ
aji-33	436	6	cd	cd	PROPN
aji-33	436	7	4	4	NUM
aji-33	436	8	+	+	NOUN
aji-33	436	9	at	at	ADP
aji-33	436	10	cells	cell	NOUN
aji-33	436	11	:	:	PUNCT
aji-33	436	12	the	the	DET
aji-33	436	13	autopsy	autopsy	ADJ
aji-33	436	14	findings	finding	NOUN
aji-33	436	15	considered	consider	VERB
aji-33	436	16	above	above	ADV
aji-33	436	17	,	,	PUNCT
aji-33	436	18	showed	show	VERB
aji-33	436	19	that	that	SCONJ
aji-33	436	20	cd8+and	cd8+and	PUNCT
aji-33	436	21	cd4	cd4	PROPN
aji-33	436	22	+	+	NOUN
aji-33	436	23	cells	cell	NOUN
aji-33	436	24	in	in	ADP
aji-33	436	25	the	the	DET
aji-33	436	26	lung	lung	NOUN
aji-33	436	27	tissue	tissue	NOUN
aji-33	436	28	interstetium	interstetium	NOUN
aji-33	436	29	.	.	PUNCT
aji-33	437	1	cd	cd	PROPN
aji-33	437	2	8	8	NUM
aji-33	438	1	+	+	SYM
aji-33	438	2	cd8	cd8	PROPN
aji-33	438	3	+	+	PROPN
aji-33	438	4	t	t	NOUN
aji-33	438	5	cells	cell	NOUN
aji-33	438	6	directly	directly	ADV
aji-33	438	7	kill	kill	VERB
aji-33	438	8	the	the	DET
aji-33	438	9	virus	virus	NOUN
aji-33	438	10	upon	upon	SCONJ
aji-33	438	11	stimulation	stimulation	NOUN
aji-33	438	12	.	.	PUNCT
aji-33	439	1	cd	cd	PROPN
aji-33	439	2	4	4	NUM
aji-33	439	3	+	+	NUM
aji-33	439	4	cells	cell	NOUN
aji-33	439	5	helps	help	VERB
aji-33	439	6	to	to	PART
aji-33	439	7	secrete	secrete	VERB
aji-33	439	8	antibodies	antibody	NOUN
aji-33	439	9	which	which	PRON
aji-33	439	10	have	have	VERB
aji-33	439	11	diverse	diverse	ADJ
aji-33	439	12	actions	action	NOUN
aji-33	439	13	.	.	PUNCT
aji-33	440	1	ali	ali	PROPN
aji-33	440	2	ganji	ganji	PROPN
aji-33	440	3	et	et	PROPN
aji-33	440	4	al	al	PROPN
aji-33	440	5	.	.	PUNCT
aji-33	441	1	[	[	X
aji-33	441	2	53	53	NUM
aji-33	441	3	]	]	PUNCT
aji-33	441	4	have	have	AUX
aji-33	441	5	shown	show	VERB
aji-33	441	6	that	that	SCONJ
aji-33	441	7	cd8	cd8	PROPN
aji-33	441	8	mfi	mfi	PROPN
aji-33	441	9	increased	increase	VERB
aji-33	441	10	significantly	significantly	ADV
aji-33	441	11	in	in	ADP
aji-33	441	12	covid-19	covid-19	PROPN
aji-33	441	13	infected	infected	ADJ
aji-33	441	14	patients	patient	NOUN
aji-33	441	15	(	(	PUNCT
aji-33	441	16	p	p	X
aji-33	441	17	<	<	X
aji-33	441	18	0.05	0.05	NUM
aji-33	441	19	)	)	PUNCT
aji-33	441	20	,	,	PUNCT
aji-33	441	21	implying	imply	VERB
aji-33	441	22	increased	increase	VERB
aji-33	441	23	expression	expression	NOUN
aji-33	441	24	of	of	ADP
aji-33	441	25	cd	cd	PROPN
aji-33	441	26	8	8	NUM
aji-33	441	27	+	+	NUM
aji-33	441	28	t	t	NOUN
aji-33	441	29	cells	cell	NOUN
aji-33	441	30	.	.	PUNCT
aji-33	442	1	zheng	zheng	PROPN
aji-33	442	2	et	et	PROPN
aji-33	442	3	al	al	PROPN
aji-33	442	4	.	.	PUNCT
aji-33	443	1	[	[	X
aji-33	443	2	54	54	NUM
aji-33	443	3	]	]	PUNCT
aji-33	443	4	found	find	VERB
aji-33	443	5	that	that	SCONJ
aji-33	443	6	the	the	DET
aji-33	443	7	total	total	ADJ
aji-33	443	8	numbers	number	NOUN
aji-33	443	9	of	of	ADP
aji-33	443	10	t	t	NOUN
aji-33	443	11	cells	cell	NOUN
aji-33	443	12	,	,	PUNCT
aji-33	443	13	nk	nk	PROPN
aji-33	443	14	cells	cell	NOUN
aji-33	443	15	and	and	CCONJ
aji-33	443	16	ctls	ctls	PROPN
aji-33	443	17	were	be	AUX
aji-33	443	18	reduced	reduce	VERB
aji-33	443	19	in	in	ADP
aji-33	443	20	all	all	DET
aji-33	443	21	patients	patient	NOUN
aji-33	443	22	,	,	PUNCT
aji-33	443	23	with	with	ADP
aji-33	443	24	severe	severe	ADJ
aji-33	443	25	cases	case	NOUN
aji-33	443	26	of	of	ADP
aji-33	443	27	covid	covid	PROPN
aji-33	443	28	19	19	NUM
aji-33	443	29	having	have	VERB
aji-33	443	30	significantly	significantly	ADV
aji-33	443	31	lower	low	ADJ
aji-33	443	32	proportions	proportion	NOUN
aji-33	443	33	than	than	ADP
aji-33	443	34	those	those	PRON
aji-33	443	35	seen	see	VERB
aji-33	443	36	in	in	ADP
aji-33	443	37	mild	mild	ADJ
aji-33	443	38	cases	case	NOUN
aji-33	443	39	.	.	PUNCT
aji-33	444	1	cd8	cd8	PROPN
aji-33	444	2	+	+	PROPN
aji-33	444	3	t	t	PROPN
aji-33	444	4	and	and	CCONJ
aji-33	444	5	nk	nk	PROPN
aji-33	444	6	cells	cell	NOUN
aji-33	444	7	from	from	ADP
aji-33	444	8	covid-19	covid-19	PROPN
aji-33	444	9	patients	patient	NOUN
aji-33	444	10	had	have	VERB
aji-33	444	11	increased	increase	VERB
aji-33	444	12	expression	expression	NOUN
aji-33	444	13	of	of	ADP
aji-33	444	14	the	the	DET
aji-33	444	15	inhibitory	inhibitory	ADJ
aji-33	444	16	receptor	receptor	NOUN
aji-33	444	17	nkg2a	nkg2a	NOUN
aji-33	444	18	.	.	PUNCT
aji-33	445	1	furthermore	furthermore	ADV
aji-33	445	2	,	,	PUNCT
aji-33	445	3	cells	cell	NOUN
aji-33	445	4	expressing	express	VERB
aji-33	445	5	nkg2a	nkg2a	NUM
aji-33	445	6	had	have	AUX
aji-33	445	7	diminished	diminish	VERB
aji-33	445	8	production	production	NOUN
aji-33	445	9	of	of	ADP
aji-33	445	10	cd107a	cd107a	PROPN
aji-33	445	11	,	,	PUNCT
aji-33	445	12	ifn	ifn	PROPN
aji-33	445	13	-	-	PUNCT
aji-33	445	14	γ	γ	NOUN
aji-33	445	15	,	,	PUNCT
aji-33	445	16	il-2	il-2	PROPN
aji-33	445	17	,	,	PUNCT
aji-33	445	18	tnf	tnf	PROPN
aji-33	445	19	-	-	PUNCT
aji-33	445	20	α	α	PROPN
aji-33	445	21	and	and	CCONJ
aji-33	445	22	granzyme	granzyme	PROPN
aji-33	445	23	b.	b.	PROPN
aji-33	446	1	these	these	DET
aji-33	446	2	findings	finding	NOUN
aji-33	446	3	suggest	suggest	VERB
aji-33	446	4	functional	functional	ADJ
aji-33	446	5	exhaustion	exhaustion	NOUN
aji-33	446	6	of	of	ADP
aji-33	446	7	nk	nk	PROPN
aji-33	446	8	and	and	CCONJ
aji-33	446	9	cd8	cd8	PROPN
aji-33	446	10	+	+	PROPN
aji-33	446	11	t	t	NOUN
aji-33	446	12	cells	cell	NOUN
aji-33	446	13	and	and	CCONJ
aji-33	446	14	inhibition	inhibition	NOUN
aji-33	446	15	of	of	ADP
aji-33	446	16	antiviral	antiviral	ADJ
aji-33	446	17	immunity	immunity	NOUN
aji-33	446	18	during	during	ADP
aji-33	446	19	sars	sar	NOUN
aji-33	446	20	-	-	PUNCT
aji-33	446	21	cov-2	cov-2	PART
aji-33	446	22	infection	infection	NOUN
aji-33	446	23	.	.	PUNCT
aji-33	447	1	it	it	PRON
aji-33	447	2	was	be	AUX
aji-33	447	3	opined	opine	VERB
aji-33	447	4	that	that	SCONJ
aji-33	447	5	down	down	ADP
aji-33	447	6	regulation	regulation	NOUN
aji-33	447	7	of	of	ADP
aji-33	447	8	nkg2a	nkg2a	NUM
aji-33	447	9	may	may	AUX
aji-33	447	10	be	be	AUX
aji-33	447	11	crucial	crucial	ADJ
aji-33	447	12	for	for	ADP
aji-33	447	13	disease	disease	NOUN
aji-33	447	14	control	control	NOUN
aji-33	447	15	.	.	PUNCT
aji-33	448	1			PRON
aji-33	448	2	helper	helper	NOUN
aji-33	448	3	t	t	PROPN
aji-33	448	4	cells	cell	NOUN
aji-33	448	5	:	:	PUNCT
aji-33	448	6	type	type	NOUN
aji-33	448	7	1	1	NUM
aji-33	448	8	helper	helper	NOUN
aji-33	448	9	(	(	PUNCT
aji-33	448	10	th1	th1	NOUN
aji-33	448	11	)	)	PUNCT
aji-33	448	12	,	,	PUNCT
aji-33	448	13	cells	cell	NOUN
aji-33	448	14	produce	produce	VERB
aji-33	448	15	interleukin	interleukin	NOUN
aji-33	448	16	(	(	PUNCT
aji-33	448	17	il)-2	il)-2	NOUN
aji-33	448	18	,	,	PUNCT
aji-33	448	19	gammainterferon	gammainterferon	X
aji-33	448	20	(	(	PUNCT
aji-33	448	21	ifn	ifn	NOUN
aji-33	448	22	-	-	PUNCT
aji-33	448	23	gamma	gamma	NOUN
aji-33	448	24	)	)	PUNCT
aji-33	448	25	and	and	CCONJ
aji-33	448	26	tumour	tumour	NOUN
aji-33	448	27	necrosis	necrosis	NOUN
aji-33	448	28	factor	factor	NOUN
aji-33	448	29	-	-	PUNCT
aji-33	448	30	beta	beta	NOUN
aji-33	448	31	,	,	PUNCT
aji-33	448	32	(	(	PUNCT
aji-33	448	33	pro	pro	ADJ
aji-33	448	34	-	-	ADJ
aji-33	448	35	inflammatory	inflammatory	ADJ
aji-33	448	36	)	)	PUNCT
aji-33	448	37	.	.	PUNCT
aji-33	449	1	th1	th1	PROPN
aji-33	449	2	activate	activate	VERB
aji-33	449	3	classically	classically	ADV
aji-33	449	4	activated	activate	VERB
aji-33	449	5	m1	m1	NOUN
aji-33	449	6	macrophages	macrophage	NOUN
aji-33	449	7	.	.	PUNCT
aji-33	450	1	cells	cell	NOUN
aji-33	450	2	are	be	AUX
aji-33	450	3	cytotoxic	cytotoxic	ADJ
aji-33	450	4	and	and	CCONJ
aji-33	450	5	hence	hence	ADV
aji-33	450	6	kill	kill	VERB
aji-33	450	7	the	the	DET
aji-33	450	8	virus	virus	NOUN
aji-33	450	9	laden	laden	PROPN
aji-33	450	10	cells	cell	NOUN
aji-33	450	11	,	,	PUNCT
aji-33	450	12	when	when	SCONJ
aji-33	450	13	activated	activate	VERB
aji-33	450	14	.	.	PUNCT
aji-33	451	1	the	the	DET
aji-33	451	2	zcd4+cells	zcd4+cells	PROPN
aji-33	451	3	helps	help	VERB
aji-33	451	4	to	to	PART
aji-33	451	5	stimulate	stimulate	VERB
aji-33	451	6	b	b	NUM
aji-33	451	7	-	-	PUNCT
aji-33	451	8	cell	cell	NOUN
aji-33	451	9	function	function	NOUN
aji-33	451	10	.	.	PUNCT
aji-33	452	1	type	type	NOUN
aji-33	452	2	2	2	NUM
aji-33	452	3	helper	helper	NOUN
aji-33	452	4	(	(	PUNCT
aji-33	452	5	th2	th2	PROPN
aji-33	452	6	)	)	PUNCT
aji-33	452	7	cells	cell	NOUN
aji-33	452	8	express	express	VERB
aji-33	452	9	il-4	il-4	NOUN
aji-33	452	10	,	,	PUNCT
aji-33	452	11	il-5	il-5	PROPN
aji-33	452	12	,	,	PUNCT
aji-33	452	13	il-6	il-6	NOUN
aji-33	452	14	and	and	CCONJ
aji-33	452	15	il-10	il-10	PRON
aji-33	452	16	(	(	PUNCT
aji-33	452	17	anti	anti	ADJ
aji-33	452	18	-	-	ADJ
aji-33	452	19	inflammatory	inflammatory	ADJ
aji-33	452	20	)	)	PUNCT
aji-33	452	21	.	.	PUNCT
aji-33	453	1	th2	th2	PROPN
aji-33	453	2	cells	cell	NOUN
aji-33	453	3	activate	activate	AUX
aji-33	453	4	alternately	alternately	ADV
aji-33	453	5	activate	activate	VERB
aji-33	453	6	m2	m2	PROPN
aji-33	453	7	macrophages	macrophage	NOUN
aji-33	453	8	.	.	PUNCT
aji-33	454	1	role	role	NOUN
aji-33	454	2	of	of	ADP
aji-33	454	3	complement	complement	NOUN
aji-33	454	4	in	in	ADP
aji-33	454	5	adaptive	adaptive	ADJ
aji-33	454	6	immunity	immunity	NOUN
aji-33	454	7	:	:	PUNCT
aji-33	454	8	the	the	DET
aji-33	454	9	classical	classical	ADJ
aji-33	454	10	complement	complement	NOUN
aji-33	454	11	pathway	pathway	NOUN
aji-33	454	12	is	be	AUX
aji-33	454	13	activated	activate	VERB
aji-33	454	14	by	by	ADP
aji-33	454	15	the	the	DET
aji-33	454	16	virus	virus	NOUN
aji-33	454	17	in	in	ADP
aji-33	454	18	adaptive	adaptive	ADJ
aji-33	454	19	immune	immune	ADJ
aji-33	454	20	cells	cell	NOUN
aji-33	454	21	.it	.it	PUNCT
aji-33	455	1	takes	take	VERB
aji-33	455	2	part	part	NOUN
aji-33	455	3	in	in	ADP
aji-33	455	4	mac	mac	PROPN
aji-33	455	5	induced	induce	VERB
aji-33	455	6	cell	cell	NOUN
aji-33	455	7	lysis	lysis	NOUN
aji-33	455	8	by	by	ADP
aji-33	455	9	itself	itself	PRON
aji-33	455	10	.	.	PUNCT
aji-33	456	1	also	also	ADV
aji-33	456	2	it	it	PRON
aji-33	456	3	acts	act	VERB
aji-33	456	4	through	through	ADP
aji-33	456	5	potentiation	potentiation	NOUN
aji-33	456	6	loop	loop	NOUN
aji-33	456	7	in	in	ADP
aji-33	456	8	producing	produce	VERB
aji-33	456	9	3cb	3cb	ADJ
aji-33	456	10	and	and	CCONJ
aji-33	456	11	classical	classical	ADJ
aji-33	456	12	3c	3c	NUM
aji-33	456	13	esterase	esterase	NOUN
aji-33	456	14	.	.	PUNCT
aji-33	457	1	its	its	PRON
aji-33	457	2	role	role	NOUN
aji-33	457	3	in	in	ADP
aji-33	457	4	complement	complement	NOUN
aji-33	457	5	mediated	mediate	VERB
aji-33	457	6	phagocytosis	phagocytosis	NOUN
aji-33	457	7	and	and	CCONJ
aji-33	457	8	complement	complement	NOUN
aji-33	457	9	mediated	mediate	VERB
aji-33	457	10	cytotoxicity	cytotoxicity	NOUN
aji-33	457	11	,	,	PUNCT
aji-33	457	12	as	as	SCONJ
aji-33	457	13	already	already	ADV
aji-33	457	14	seen	see	VERB
aji-33	457	15	above	above	ADV
aji-33	457	16	.	.	PUNCT
aji-33	458	1	prasad	prasad	PROPN
aji-33	458	2	;	;	PUNCT
aji-33	458	3	aji	aji	NOUN
aji-33	458	4	,	,	PUNCT
aji-33	458	5	3(1	3(1	NUM
aji-33	458	6	):	):	PUNCT
aji-33	458	7	233	233	NUM
aji-33	458	8	-	-	SYM
aji-33	458	9	252	252	NUM
aji-33	458	10	,	,	PUNCT
aji-33	458	11	2020	2020	NUM
aji-33	458	12	;	;	PUNCT
aji-33	458	13	article	article	NOUN
aji-33	458	14	no.aji.58422	no.aji.58422	NOUN
aji-33	458	15	244	244	NUM
aji-33	458	16	the	the	DET
aji-33	458	17	central	central	ADJ
aji-33	458	18	role	role	NOUN
aji-33	458	19	of	of	ADP
aji-33	458	20	alveolar	alveolar	ADJ
aji-33	458	21	macrophages	macrophage	NOUN
aji-33	458	22	(	(	PUNCT
aji-33	458	23	am	be	AUX
aji-33	458	24	):	):	PUNCT
aji-33	458	25			X
aji-33	458	26	under	under	ADP
aji-33	458	27	physiological	physiological	ADJ
aji-33	458	28	conditions	condition	NOUN
aji-33	458	29	the	the	DET
aji-33	458	30	expression	expression	NOUN
aji-33	458	31	of	of	ADP
aji-33	458	32	the	the	DET
aji-33	458	33	phagocytic	phagocytic	ADJ
aji-33	458	34	receptor	receptor	NOUN
aji-33	458	35	macrophage	macrophage	NOUN
aji-33	458	36	1	1	NUM
aji-33	458	37	antigen	antigen	NOUN
aji-33	458	38	(	(	PUNCT
aji-33	458	39	mac-1	mac-1	NOUN
aji-33	458	40	)	)	PUNCT
aji-33	458	41	keeps	keep	VERB
aji-33	458	42	the	the	DET
aji-33	458	43	ams	am	NOUN
aji-33	458	44	down	down	ADV
aji-33	458	45	-	-	PUNCT
aji-33	458	46	regulated	regulate	VERB
aji-33	458	47	,	,	PUNCT
aji-33	458	48	to	to	PART
aji-33	458	49	prevent	prevent	VERB
aji-33	458	50	damage	damage	NOUN
aji-33	458	51	of	of	ADP
aji-33	458	52	body	body	NOUN
aji-33	458	53	tissues	tissue	NOUN
aji-33	458	54	from	from	ADP
aji-33	458	55	the	the	DET
aji-33	458	56	activated	activate	VERB
aji-33	458	57	ams	am	NOUN
aji-33	458	58	.	.	PUNCT
aji-33	459	1			X
aji-33	460	1	the	the	DET
aji-33	460	2	adaptive	adaptive	ADJ
aji-33	460	3	immunity	immunity	NOUN
aji-33	460	4	is	be	AUX
aji-33	460	5	suppressed	suppress	VERB
aji-33	460	6	through	through	ADP
aji-33	460	7	am	am	NOUN
aji-33	460	8	's	's	PART
aji-33	460	9	effects	effect	NOUN
aji-33	460	10	on	on	ADP
aji-33	460	11	interstitial	interstitial	ADJ
aji-33	460	12	dendritic	dendritic	ADJ
aji-33	460	13	cells	cell	NOUN
aji-33	460	14	,	,	PUNCT
aji-33	460	15	b	b	X
aji-33	460	16	-	-	PUNCT
aji-33	460	17	cells	cell	NOUN
aji-33	460	18	and	and	CCONJ
aji-33	460	19	t	t	NOUN
aji-33	460	20	-	-	PUNCT
aji-33	460	21	cells	cell	NOUN
aji-33	460	22	.	.	PUNCT
aji-33	461	1			PUNCT
aji-33	461	2	the	the	DET
aji-33	461	3	macrophage	macrophage	NOUN
aji-33	461	4	performs	perform	VERB
aji-33	461	5	the	the	DET
aji-33	461	6	phagocytic	phagocytic	ADJ
aji-33	461	7	function	function	NOUN
aji-33	461	8	,	,	PUNCT
aji-33	461	9	both	both	DET
aji-33	461	10	igg	igg	PROPN
aji-33	461	11	mediated(through	mediated(through	PROPN
aji-33	461	12	fcy	fcy	PROPN
aji-33	461	13	.receptor)and	.receptor)and	PUNCT
aji-33	462	1	complement	complement	VERB
aji-33	462	2	mediated,(through	mediated,(through	PROPN
aji-33	462	3	cr1,cr2	cr1,cr2	PROPN
aji-33	462	4	and	and	CCONJ
aji-33	462	5	cr3	cr3	NOUN
aji-33	462	6	receptors	receptor	NOUN
aji-33	462	7	)	)	PUNCT
aji-33	462	8	.	.	PUNCT
aji-33	463	1			PROPN
aji-33	463	2	can	can	AUX
aji-33	463	3	cause	cause	VERB
aji-33	463	4	tissue	tissue	NOUN
aji-33	463	5	damage	damage	NOUN
aji-33	463	6	through	through	ADP
aji-33	463	7	pr	pr	X
aji-33	463	8	inflammatory	inflammatory	ADJ
aji-33	463	9	cytokines	cytokine	NOUN
aji-33	463	10	(	(	PUNCT
aji-33	463	11	mediated	mediate	VERB
aji-33	463	12	by	by	ADP
aji-33	463	13	m1	m1	PROPN
aji-33	463	14	macrophages	macrophage	NOUN
aji-33	463	15	)	)	PUNCT
aji-33	463	16	can	can	AUX
aji-33	463	17	exert	exert	VERB
aji-33	463	18	anti	anti	ADJ
aji-33	463	19	inflammatory	inflammatory	ADJ
aji-33	463	20	effect	effect	NOUN
aji-33	463	21	with	with	ADP
aji-33	463	22	antiinflammatory	antiinflammatory	NOUN
aji-33	463	23	cytokines	cytokine	NOUN
aji-33	463	24	as	as	ADV
aji-33	463	25	well	well	ADV
aji-33	463	26	as	as	ADP
aji-33	463	27	healing	healing	NOUN
aji-33	463	28	of	of	ADP
aji-33	463	29	damaged	damage	VERB
aji-33	463	30	tissues	tissue	NOUN
aji-33	463	31	by	by	ADP
aji-33	463	32	fibrosis	fibrosis	NOUN
aji-33	463	33	(	(	PUNCT
aji-33	463	34	through	through	ADP
aji-33	463	35	m2	m2	PROPN
aji-33	463	36	type	type	NOUN
aji-33	463	37	macrophages	macrophage	NOUN
aji-33	463	38	.	.	PUNCT
aji-33	463	39	)	)	PUNCT
aji-33	464	1			NOUN
aji-33	464	2	play	play	VERB
aji-33	464	3	role	role	NOUN
aji-33	464	4	as	as	ADP
aji-33	464	5	antigen	antigen	ADJ
aji-33	464	6	presentation	presentation	NOUN
aji-33	464	7	cells	cell	NOUN
aji-33	464	8	(	(	PUNCT
aji-33	464	9	arc	arc	NOUN
aji-33	464	10	)	)	PUNCT
aji-33	464	11	and	and	CCONJ
aji-33	464	12	recognizes	recognize	VERB
aji-33	464	13	pamps	pamp	NOUN
aji-33	464	14	of	of	ADP
aji-33	464	15	the	the	DET
aji-33	464	16	virus	virus	NOUN
aji-33	464	17	with	with	ADP
aji-33	464	18	the	the	DET
aji-33	464	19	prr	prr	NOUN
aji-33	464	20	,	,	PUNCT
aji-33	464	21	on	on	ADP
aji-33	464	22	its	its	PRON
aji-33	464	23	surface	surface	NOUN
aji-33	464	24	,	,	PUNCT
aji-33	464	25	in	in	ADP
aji-33	464	26	conjunction	conjunction	NOUN
aji-33	464	27	with	with	ADP
aji-33	464	28	mhc	mhc	PROPN
aji-33	464	29	class	class	NOUN
aji-33	464	30	2	2	NUM
aji-33	464	31	molecules	molecule	NOUN
aji-33	464	32	.	.	PUNCT
aji-33	465	1			X
aji-33	465	2	it	it	PRON
aji-33	465	3	controls	control	VERB
aji-33	465	4	through	through	ADP
aji-33	465	5	,	,	PUNCT
aji-33	465	6	inos(inducible	inos(inducible	ADJ
aji-33	465	7	nitric	nitric	ADJ
aji-33	465	8	oxide	oxide	NOUN
aji-33	465	9	synthase	synthase	NOUN
aji-33	465	10	)	)	PUNCT
aji-33	465	11	,	,	PUNCT
aji-33	465	12	the	the	DET
aji-33	465	13	differentiation	differentiation	NOUN
aji-33	465	14	and	and	CCONJ
aji-33	465	15	maturation	maturation	NOUN
aji-33	465	16	of	of	ADP
aji-33	465	17	dendritic	dendritic	ADJ
aji-33	465	18	cells	cell	NOUN
aji-33	465	19	through	through	ADV
aji-33	465	20	.	.	PUNCT
aji-33	466	1	inhibition	inhibition	NOUN
aji-33	466	2	of	of	ADP
aji-33	466	3	the	the	DET
aji-33	466	4	granulocyte	granulocyte	ADJ
aji-33	466	5	-	-	PUNCT
aji-33	466	6	macrophage	macrophage	ADJ
aji-33	466	7	colony	colony	NOUN
aji-33	466	8	-	-	PUNCT
aji-33	466	9	stimulating	stimulate	VERB
aji-33	466	10	factor	factor	NOUN
aji-33	466	11	(	(	PUNCT
aji-33	466	12	gm	gm	PROPN
aji-33	466	13	-	-	PUNCT
aji-33	466	14	csf)and	csf)and	PROPN
aji-33	466	15	tnf	tnf	PROPN
aji-33	466	16	-	-	PUNCT
aji-33	466	17	alpha	alpha	NOUN
aji-33	466	18	-	-	PUNCT
aji-33	466	19	mediated	mediate	VERB
aji-33	466	20	mechanisms	mechanism	NOUN
aji-33	466	21	.	.	PUNCT
aji-33	467	1			PROPN
aji-33	467	2	through	through	ADP
aji-33	467	3	il	il	PROPN
aji-33	467	4	4	4	NUM
aji-33	467	5	and	and	CCONJ
aji-33	467	6	il10	il10	PROPN
aji-33	467	7	,	,	PUNCT
aji-33	467	8	it	it	PRON
aji-33	467	9	causes	cause	VERB
aji-33	467	10	the	the	DET
aji-33	467	11	reduced	reduce	VERB
aji-33	467	12	production	production	NOUN
aji-33	467	13	of	of	ADP
aji-33	467	14	metalloproteinases	metalloproteinase	NOUN
aji-33	467	15	(	(	PUNCT
aji-33	467	16	endopeptidases	endopeptidase	NOUN
aji-33	467	17	which	which	PRON
aji-33	467	18	break	break	VERB
aji-33	467	19	down	down	ADP
aji-33	467	20	collagen	collagen	NOUN
aji-33	467	21	and	and	CCONJ
aji-33	467	22	other	other	ADJ
aji-33	467	23	extracellular	extracellular	ADJ
aji-33	467	24	proteins	protein	NOUN
aji-33	467	25	)	)	PUNCT
aji-33	467	26	by	by	ADP
aji-33	467	27	human	human	ADJ
aji-33	467	28	ams	am	NOUN
aji-33	467	29	.	.	PUNCT
aji-33	468	1			PROPN
aji-33	468	2	causes	cause	VERB
aji-33	468	3	differentiation	differentiation	NOUN
aji-33	468	4	of	of	ADP
aji-33	468	5	naïve	naïve	ADJ
aji-33	468	6	cd4	cd4	PROPN
aji-33	468	7	-	-	PUNCT
aji-33	468	8	t	t	NOUN
aji-33	468	9	cells	cell	NOUN
aji-33	468	10	into	into	ADP
aji-33	468	11	mature	mature	ADJ
aji-33	468	12	th2	th2	PROPN
aji-33	468	13	type	type	NOUN
aji-33	468	14	cells	cell	NOUN
aji-33	468	15	.	.	PUNCT
aji-33	469	1			PROPN
aji-33	469	2	il4	il4	PROPN
aji-33	469	3	enhances	enhance	VERB
aji-33	469	4	mhc	mhc	PROPN
aji-33	469	5	class	class	PROPN
aji-33	469	6	ii	ii	PROPN
aji-33	469	7	antigen	antigen	NOUN
aji-33	469	8	and	and	CCONJ
aji-33	469	9	mac-1(surface	mac-1(surface	VERB
aji-33	469	10	receptor	receptor	NOUN
aji-33	469	11	as	as	ADP
aji-33	469	12	part	part	NOUN
aji-33	469	13	of	of	ADP
aji-33	469	14	innate	innate	ADJ
aji-33	469	15	complement	complement	NOUN
aji-33	469	16	system	system	NOUN
aji-33	469	17	)	)	PUNCT
aji-33	469	18	expression	expression	NOUN
aji-33	469	19	,	,	PUNCT
aji-33	469	20	thus	thus	ADV
aji-33	469	21	promoting	promote	VERB
aji-33	469	22	phagocytosis	phagocytosis	NOUN
aji-33	469	23	.	.	PUNCT
aji-33	470	1			PUNCT
aji-33	471	1	il10	il10	PROPN
aji-33	471	2	inhibits	inhibit	VERB
aji-33	471	3	the	the	DET
aji-33	471	4	secretion	secretion	NOUN
aji-33	471	5	of	of	ADP
aji-33	471	6	proinflammatory	proinflammatory	ADJ
aji-33	471	7	cytokines	cytokine	NOUN
aji-33	471	8	tnf	tnf	NOUN
aji-33	471	9	-	-	PUNCT
aji-33	471	10	alpha	alpha	NOUN
aji-33	471	11	and	and	CCONJ
aji-33	471	12	inf	inf	NOUN
aji-33	471	13	-	-	PUNCT
aji-33	471	14	gamma	gamma	NOUN
aji-33	471	15	,	,	PUNCT
aji-33	471	16	thus	thus	ADV
aji-33	471	17	suppressing	suppress	VERB
aji-33	471	18	the	the	DET
aji-33	471	19	proliferation	proliferation	NOUN
aji-33	471	20	of	of	ADP
aji-33	471	21	t	t	PROPN
aji-33	471	22	-	-	PUNCT
aji-33	471	23	cells	cell	NOUN
aji-33	471	24	,	,	PUNCT
aji-33	471	25	nk	nk	PROPN
aji-33	471	26	cells	cell	NOUN
aji-33	471	27	,	,	PUNCT
aji-33	471	28	and	and	CCONJ
aji-33	471	29	am	be	AUX
aji-33	471	30	.	.	PUNCT
aji-33	471	31			PUNCT
aji-33	471	32	by	by	ADP
aji-33	471	33	similar	similar	ADJ
aji-33	471	34	immunomodulation	immunomodulation	NOUN
aji-33	471	35	mechanisms	mechanism	NOUN
aji-33	471	36	to	to	ADP
aji-33	471	37	tgf	tgf	PROPN
aji-33	471	38	-	-	PUNCT
aji-33	471	39	β	β	NOUN
aji-33	471	40	.	.	PUNCT
aji-33	471	41	il-10reduces	il-10reduce	VERB
aji-33	471	42	the	the	DET
aji-33	471	43	rate	rate	NOUN
aji-33	471	44	of	of	ADP
aji-33	471	45	apoptosis	apoptosis	NOUN
aji-33	471	46	.	.	PUNCT
aji-33	472	1	indirectly	indirectly	ADV
aji-33	472	2	enhancing	enhance	VERB
aji-33	472	3	alveolar	alveolar	ADJ
aji-33	472	4	macrophage	macrophage	NOUN
aji-33	472	5	-	-	PUNCT
aji-33	472	6	mediated	mediate	VERB
aji-33	472	7	inhibition	inhibition	NOUN
aji-33	472	8	of	of	ADP
aji-33	472	9	t	t	NOUN
aji-33	472	10	-	-	PUNCT
aji-33	472	11	cell	cell	NOUN
aji-33	472	12	proliferation	proliferation	NOUN
aji-33	472	13	.	.	PUNCT
aji-33	473	1	alveolar	alveolar	ADJ
aji-33	473	2	macrophages	macrophage	NOUN
aji-33	473	3	induce	induce	VERB
aji-33	473	4	expression	expression	NOUN
aji-33	473	5	of	of	ADP
aji-33	473	6	the	the	DET
aji-33	473	7	αvβ6	αvβ6	NOUN
aji-33	473	8	integrins	integrin	VERB
aji-33	473	9	,	,	PUNCT
aji-33	473	10	the	the	DET
aji-33	473	11	cell	cell	NOUN
aji-33	473	12	-	-	PUNCT
aji-33	473	13	surface	surface	NOUN
aji-33	473	14	receptors	receptor	NOUN
aji-33	473	15	,	,	PUNCT
aji-33	473	16	activate	activate	VERB
aji-33	473	17	tgf	tgf	PROPN
aji-33	473	18	-	-	PUNCT
aji-33	473	19	β	β	NOUN
aji-33	473	20	.	.	PUNCT
aji-33	474	1			NOUN
aji-33	474	2	tgfβ	tgfβ	PROPN
aji-33	474	3	tightly	tightly	ADV
aji-33	474	4	regulates	regulate	VERB
aji-33	474	5	antiinflammatory	antiinflammatory	NOUN
aji-33	474	6	activity	activity	NOUN
aji-33	474	7	by	by	ADP
aji-33	474	8	suppressing	suppress	VERB
aji-33	474	9	proinflammatory	proinflammatory	ADJ
aji-33	474	10	cytokine	cytokine	NOUN
aji-33	474	11	production	production	NOUN
aji-33	474	12	,	,	PUNCT
aji-33	474	13	thereby	thereby	ADV
aji-33	474	14	inhibiting	inhibit	VERB
aji-33	474	15	t	t	NOUN
aji-33	474	16	-	-	PUNCT
aji-33	474	17	lymphocyte	lymphocyte	NOUN
aji-33	474	18	function	function	NOUN
aji-33	474	19	.	.	PUNCT
aji-33	475	1			X
aji-33	475	2	this	this	PRON
aji-33	475	3	induces	induce	VERB
aji-33	475	4	a	a	DET
aji-33	475	5	downstream	downstream	ADJ
aji-33	475	6	signalling	signal	VERB
aji-33	475	7	cascade	cascade	NOUN
aji-33	475	8	leading	lead	VERB
aji-33	475	9	to	to	ADP
aji-33	475	10	transcription	transcription	NOUN
aji-33	475	11	factors	factor	NOUN
aji-33	475	12	,	,	PUNCT
aji-33	475	13	regulating	regulate	VERB
aji-33	475	14	the	the	DET
aji-33	475	15	expression	expression	NOUN
aji-33	475	16	of	of	ADP
aji-33	475	17	tgf	tgf	PROPN
aji-33	475	18	-	-	PUNCT
aji-33	475	19	β	β	NOUN
aji-33	475	20	target	target	NOUN
aji-33	475	21	genes	gene	NOUN
aji-33	475	22			NOUN
aji-33	475	23	important	important	ADJ
aji-33	475	24	inhibitor	inhibitor	NOUN
aji-33	475	25	receptors	receptor	NOUN
aji-33	475	26	of	of	ADP
aji-33	475	27	ams	am	NOUN
aji-33	475	28	include	include	VERB
aji-33	475	29	tim-3	tim-3	NUM
aji-33	475	30	,	,	PUNCT
aji-33	475	31	pd-1	pd-1	ADV
aji-33	475	32	,	,	PUNCT
aji-33	475	33	cd32b	cd32b	NOUN
aji-33	475	34	,	,	PUNCT
aji-33	475	35	and	and	CCONJ
aji-33	475	36	cd200r	cd200r	NOUN
aji-33	475	37	.	.	PUNCT
aji-33	476	1	the	the	DET
aji-33	476	2	pathways	pathway	NOUN
aji-33	476	3	by	by	ADP
aji-33	476	4	which	which	PRON
aji-33	476	5	macrophages	macrophage	NOUN
aji-33	476	6	are	be	AUX
aji-33	476	7	activated	activate	VERB
aji-33	476	8	and	and	CCONJ
aji-33	476	9	deactivated	deactivate	VERB
aji-33	476	10	are	be	AUX
aji-33	476	11	shown	show	VERB
aji-33	476	12	in	in	ADP
aji-33	476	13	table	table	NOUN
aji-33	476	14	1	1	NUM
aji-33	476	15	below	below	ADV
aji-33	476	16	.	.	PUNCT
aji-33	477	1	macrophage	macrophage	ADJ
aji-33	477	2	polymorphism	polymorphism	NOUN
aji-33	477	3	:	:	PUNCT
aji-33	477	4	the	the	DET
aji-33	477	5	alveolar	alveolar	ADJ
aji-33	477	6	macrophages	macrophage	NOUN
aji-33	477	7	(	(	PUNCT
aji-33	477	8	am	be	AUX
aji-33	477	9	)	)	PUNCT
aji-33	477	10	exist	exist	VERB
aji-33	477	11	as	as	ADP
aji-33	477	12	two	two	NUM
aji-33	477	13	phenotypes	phenotype	NOUN
aji-33	477	14	,	,	PUNCT
aji-33	477	15	m1	m1	PROPN
aji-33	477	16	and	and	CCONJ
aji-33	477	17	m2	m2	PROPN
aji-33	477	18	macrophages	macrophage	NOUN
aji-33	477	19	,	,	PUNCT
aji-33	477	20	which	which	PRON
aji-33	477	21	have	have	VERB
aji-33	477	22	different	different	ADJ
aji-33	477	23	means	mean	NOUN
aji-33	477	24	of	of	ADP
aji-33	477	25	stimulation	stimulation	NOUN
aji-33	477	26	,	,	PUNCT
aji-33	477	27	express	express	VERB
aji-33	477	28	different	different	ADJ
aji-33	477	29	kinds	kind	NOUN
aji-33	477	30	of	of	ADP
aji-33	477	31	cytokines	cytokine	NOUN
aji-33	477	32	and	and	CCONJ
aji-33	477	33	chemokines	chemokine	NOUN
aji-33	477	34	and	and	CCONJ
aji-33	477	35	have	have	VERB
aji-33	477	36	opposite	opposite	ADJ
aji-33	477	37	physiological	physiological	ADJ
aji-33	477	38	actions	action	NOUN
aji-33	477	39	.	.	PUNCT
aji-33	478	1	the	the	DET
aji-33	478	2	m1	m1	PROPN
aji-33	478	3	macrophages	macrophage	NOUN
aji-33	478	4	are	be	AUX
aji-33	478	5	pr	pr	NOUN
aji-33	478	6	inflammatory	inflammatory	ADJ
aji-33	478	7	and	and	CCONJ
aji-33	478	8	m2	m2	PROPN
aji-33	478	9	are	be	AUX
aji-33	478	10	not	not	PART
aji-33	478	11	only	only	ADV
aji-33	478	12	anti	anti	ADJ
aji-33	478	13	inflammatory	inflammatory	ADJ
aji-33	478	14	in	in	ADP
aji-33	478	15	function	function	NOUN
aji-33	478	16	,	,	PUNCT
aji-33	478	17	but	but	CCONJ
aji-33	478	18	also	also	ADV
aji-33	478	19	have	have	VERB
aji-33	478	20	action	action	NOUN
aji-33	478	21	on	on	ADP
aji-33	478	22	extracellular	extracellular	ADJ
aji-33	478	23	matrix	matrix	NOUN
aji-33	478	24	promoting	promote	VERB
aji-33	478	25	healing	healing	NOUN
aji-33	478	26	by	by	ADP
aji-33	478	27	stimulating	stimulate	VERB
aji-33	478	28	collagen	collagen	NOUN
aji-33	478	29	fibres	fibre	NOUN
aji-33	478	30	,	,	PUNCT
aji-33	478	31	leading	lead	VERB
aji-33	478	32	to	to	ADP
aji-33	478	33	fibrosis	fibrosis	NOUN
aji-33	478	34	.	.	PUNCT
aji-33	479	1	m2	m2	PROPN
aji-33	479	2	macrophages	macrophage	NOUN
aji-33	479	3	have	have	VERB
aji-33	479	4	3	3	NUM
aji-33	479	5	,	,	PUNCT
aji-33	479	6	m2b	m2b	NOUN
aji-33	479	7	and	and	CCONJ
aji-33	479	8	m2c	m2c	PROPN
aji-33	479	9	.	.	PUNCT
aji-33	480	1	the	the	DET
aji-33	480	2	salient	salient	ADJ
aji-33	480	3	points	point	NOUN
aji-33	480	4	of	of	ADP
aji-33	480	5	both	both	CCONJ
aji-33	480	6	the	the	DET
aji-33	480	7	phenotypes	phenotype	NOUN
aji-33	480	8	and	and	CCONJ
aji-33	480	9	the	the	DET
aji-33	480	10	sub	sub	NOUN
aji-33	480	11	-	-	NOUN
aji-33	480	12	types	type	NOUN
aji-33	480	13	are	be	AUX
aji-33	480	14	shown	show	VERB
aji-33	480	15	in	in	ADP
aji-33	480	16	table	table	NOUN
aji-33	480	17	3	3	NUM
aji-33	480	18	.	.	PUNCT
aji-33	480	19	table	table	NOUN
aji-33	480	20	1	1	NUM
aji-33	480	21	.	.	PUNCT
aji-33	480	22	activation	activation	NOUN
aji-33	480	23	of	of	ADP
aji-33	480	24	amsequence	amsequence	NOUN
aji-33	480	25	of	of	ADP
aji-33	480	26	events	event	NOUN
aji-33	480	27	1	1	NUM
aji-33	480	28	.	.	PUNCT
aji-33	481	1	binding	bind	VERB
aji-33	481	2	of	of	ADP
aji-33	481	3	pamps	pamp	NOUN
aji-33	481	4	to	to	ADP
aji-33	481	5	tlrs.(prps	tlrs.(prp	NOUN
aji-33	481	6	)	)	PUNCT
aji-33	481	7	2	2	NUM
aji-33	481	8	.	.	PUNCT
aji-33	481	9	actin	actin	NOUN
aji-33	481	10	polymerization	polymerization	NOUN
aji-33	481	11	(	(	PUNCT
aji-33	481	12	in	in	ADP
aji-33	481	13	alveolar	alveolar	ADJ
aji-33	481	14	macrophages	macrophage	NOUN
aji-33	481	15	)	)	PUNCT
aji-33	481	16	.	.	PUNCT
aji-33	482	1	3	3	X
aji-33	482	2	.	.	X
aji-33	482	3	suppression	suppression	NOUN
aji-33	482	4	of	of	ADP
aji-33	482	5	integrin	integrin	NOUN
aji-33	482	6	expression	expression	NOUN
aji-33	482	7	4	4	NUM
aji-33	482	8	.	.	PUNCT
aji-33	482	9	deactivation	deactivation	NOUN
aji-33	482	10	of	of	ADP
aji-33	482	11	tgf	tgf	PROPN
aji-33	482	12	-	-	PUNCT
aji-33	482	13	β	β	PROPN
aji-33	482	14	and	and	CCONJ
aji-33	482	15	the	the	DET
aji-33	482	16	down	down	ADJ
aji-33	482	17	regulation	regulation	NOUN
aji-33	482	18	of	of	ADP
aji-33	482	19	the	the	DET
aji-33	482	20	basal	basal	ADJ
aji-33	482	21	phosphorylation	phosphorylation	NOUN
aji-33	482	22	level	level	NOUN
aji-33	482	23	of	of	ADP
aji-33	482	24	smad	smad	PROPN
aji-33	482	25	2/3	2/3	NUM
aji-33	482	26	;	;	PUNCT
aji-33	482	27	5	5	NUM
aji-33	482	28	.	.	NOUN
aji-33	482	29	activation	activation	NOUN
aji-33	482	30	and	and	CCONJ
aji-33	482	31	detachment	detachment	NOUN
aji-33	482	32	of	of	ADP
aji-33	482	33	alveolar	alveolar	ADJ
aji-33	482	34	macrophages	macrophage	NOUN
aji-33	482	35	from	from	ADP
aji-33	482	36	the	the	DET
aji-33	482	37	alveolar	alveolar	ADJ
aji-33	482	38	epithelial	epithelial	ADJ
aji-33	482	39	cells	cell	NOUN
aji-33	482	40	6	6	NUM
aji-33	482	41	.	.	PUNCT
aji-33	483	1	macrophages	macrophage	NOUN
aji-33	483	2	become	become	AUX
aji-33	483	3	primed	prime	VERB
aji-33	483	4	(	(	PUNCT
aji-33	483	5	by	by	ADP
aji-33	483	6	ifn	ifn	PROPN
aji-33	483	7	-	-	PUNCT
aji-33	483	8	γ	γ	X
aji-33	483	9	and	and	CCONJ
aji-33	483	10	tnf	tnf	PROPN
aji-33	483	11	-	-	PUNCT
aji-33	483	12	α	α	NOUN
aji-33	483	13	)	)	PUNCT
aji-33	483	14	7	7	NUM
aji-33	483	15	.	.	NOUN
aji-33	483	16	phagocytosis	phagocytosis	NOUN
aji-33	483	17	and	and	CCONJ
aji-33	483	18	secretion	secretion	NOUN
aji-33	483	19	of	of	ADP
aji-33	483	20	proinflammatory	proinflammatory	ADJ
aji-33	483	21	cytokines	cytokine	NOUN
aji-33	483	22	(	(	PUNCT
aji-33	483	23	tnf	tnf	PROPN
aji-33	483	24	-	-	PUNCT
aji-33	483	25	α	α	PROPN
aji-33	483	26	and	and	CCONJ
aji-33	483	27	il-6	il-6	NUM
aji-33	483	28	)	)	PUNCT
aji-33	483	29	8	8	NUM
aji-33	483	30	.	.	PUNCT
aji-33	484	1	the	the	DET
aji-33	484	2	ros	ros	PROPN
aji-33	484	3	(	(	PUNCT
aji-33	484	4	reactive	reactive	ADJ
aji-33	484	5	oxygen	oxygen	NOUN
aji-33	484	6	species	specie	NOUN
aji-33	484	7	)	)	PUNCT
aji-33	484	8	produced	produce	VERB
aji-33	484	9	by	by	ADP
aji-33	484	10	respiratory	respiratory	ADJ
aji-33	484	11	burst	burst	NOUN
aji-33	484	12	.	.	PUNCT
aji-33	485	1	9	9	X
aji-33	485	2	.	.	X
aji-33	485	3	oxidative	oxidative	ADJ
aji-33	485	4	damage	damage	NOUN
aji-33	485	5	to	to	ADP
aji-33	485	6	lung	lung	NOUN
aji-33	485	7	tissue	tissue	NOUN
aji-33	485	8	.	.	PUNCT
aji-33	486	1	10	10	NUM
aji-33	486	2	.	.	X
aji-33	486	3	positive	positive	ADJ
aji-33	486	4	feedback	feedback	NOUN
aji-33	486	5	effect	effect	NOUN
aji-33	486	6	-enhancement	-enhancement	ADJ
aji-33	486	7	of	of	ADP
aji-33	486	8	production	production	NOUN
aji-33	486	9	of	of	ADP
aji-33	486	10	tnf	tnf	PROPN
aji-33	486	11	-	-	PUNCT
aji-33	486	12	α	α	NOUN
aji-33	486	13	by	by	ADP
aji-33	486	14	macrophages	macrophage	NOUN
aji-33	486	15	(	(	PUNCT
aji-33	486	16	step	step	NOUN
aji-33	486	17	7	7	NUM
aji-33	486	18	)	)	PUNCT
aji-33	486	19	.	.	PUNCT
aji-33	487	1	prasad	prasad	PROPN
aji-33	487	2	;	;	PUNCT
aji-33	487	3	aji	aji	NOUN
aji-33	487	4	,	,	PUNCT
aji-33	487	5	3(1	3(1	NUM
aji-33	487	6	):	):	PUNCT
aji-33	487	7	233	233	NUM
aji-33	487	8	-	-	SYM
aji-33	487	9	252	252	NUM
aji-33	487	10	,	,	PUNCT
aji-33	487	11	2020	2020	NUM
aji-33	487	12	;	;	PUNCT
aji-33	487	13	article	article	NOUN
aji-33	487	14	no.aji.58422	no.aji.58422	NOUN
aji-33	487	15	245	245	NUM
aji-33	487	16	table	table	NOUN
aji-33	487	17	2	2	NUM
aji-33	487	18	.	.	PUNCT
aji-33	487	19	deactivation	deactivation	NOUN
aji-33	487	20	of	of	ADP
aji-33	487	21	ams	am	NOUN
aji-33	487	22	sequence	sequence	NOUN
aji-33	487	23	of	of	ADP
aji-33	487	24	events	event	NOUN
aji-33	487	25	1	1	NUM
aji-33	487	26	.	.	PUNCT
aji-33	487	27	secretion	secretion	NOUN
aji-33	487	28	of	of	ADP
aji-33	487	29	ifnγ	ifnγ	NOUN
aji-33	487	30	by	by	ADP
aji-33	487	31	activated	activated	ADJ
aji-33	487	32	lymphocytes	lymphocyte	NOUN
aji-33	487	33	.	.	PUNCT
aji-33	488	1	2	2	X
aji-33	488	2	.	.	X
aji-33	488	3	stimulation	stimulation	NOUN
aji-33	488	4	of	of	ADP
aji-33	488	5	the	the	DET
aji-33	488	6	production	production	NOUN
aji-33	488	7	of	of	ADP
aji-33	488	8	matrix	matrix	NOUN
aji-33	488	9	metalloproteinase	metalloproteinase	NOUN
aji-33	488	10	mmp-9	mmp-9	NOUN
aji-33	488	11	by	by	ADP
aji-33	488	12	macrophages	macrophage	NOUN
aji-33	488	13	.	.	PUNCT
aji-33	489	1	3	3	X
aji-33	489	2	.	.	NOUN
aji-33	489	3	mmp-9	mmp-9	NOUN
aji-33	489	4	activates	activate	VERB
aji-33	489	5	latent	latent	PROPN
aji-33	489	6	tgf	tgf	PROPN
aji-33	489	7	-	-	PUNCT
aji-33	489	8	β	β	NOUN
aji-33	489	9	.	.	PROPN
aji-33	490	1	4	4	X
aji-33	490	2	.	.	NOUN
aji-33	490	3	reduced	reduce	VERB
aji-33	490	4	expression	expression	NOUN
aji-33	490	5	of	of	ADP
aji-33	490	6	αvβ6	αvβ6	PROPN
aji-33	490	7	integrins	integrin	VERB
aji-33	490	8	on	on	ADP
aji-33	490	9	alveolar	alveolar	ADJ
aji-33	490	10	epithelial	epithelial	ADJ
aji-33	490	11	cells	cell	NOUN
aji-33	490	12	.	.	PUNCT
aji-33	491	1	5	5	X
aji-33	491	2	.	.	X
aji-33	491	3	return	return	NOUN
aji-33	491	4	of	of	ADP
aji-33	491	5	the	the	DET
aji-33	491	6	alveolar	alveolar	ADJ
aji-33	491	7	macrophage	macrophage	NOUN
aji-33	491	8	to	to	ADP
aji-33	491	9	a	a	DET
aji-33	491	10	resting	rest	VERB
aji-33	491	11	state	state	NOUN
aji-33	491	12	*	*	PUNCT
aji-33	491	13	ams	am	NOUN
aji-33	491	14	have	have	AUX
aji-33	491	15	been	be	AUX
aji-33	491	16	reported	report	VERB
aji-33	491	17	to	to	PART
aji-33	491	18	produce	produce	VERB
aji-33	491	19	mmp-9	mmp-9	NOUN
aji-33	491	20	partly	partly	ADV
aji-33	491	21	via	via	ADP
aji-33	491	22	pge2	pge2	NOUN
aji-33	491	23	-	-	PUNCT
aji-33	491	24	dependent	dependent	ADJ
aji-33	491	25	pka	pka	PROPN
aji-33	491	26	signaling	signal	VERB
aji-33	491	27	pathways	pathway	NOUN
aji-33	491	28	,	,	PUNCT
aji-33	491	29	which	which	PRON
aji-33	491	30	are	be	AUX
aji-33	491	31	the	the	DET
aji-33	491	32	pathways	pathway	NOUN
aji-33	491	33	involved	involve	VERB
aji-33	491	34	in	in	ADP
aji-33	491	35	the	the	DET
aji-33	491	36	inhibition	inhibition	NOUN
aji-33	491	37	of	of	ADP
aji-33	491	38	phagocytosis	phagocytosis	NOUN
aji-33	491	39	.	.	PUNCT
aji-33	492	1	*	*	PUNCT
aji-33	492	2	*	*	PUNCT
aji-33	492	3	activation	activation	NOUN
aji-33	492	4	of	of	ADP
aji-33	492	5	tgf	tgf	PROPN
aji-33	492	6	-	-	PUNCT
aji-33	492	7	β	β	PROPN
aji-33	492	8	is	be	AUX
aji-33	492	9	also	also	ADV
aji-33	492	10	advantageous	advantageous	ADJ
aji-33	492	11	because	because	SCONJ
aji-33	492	12	its	its	PRON
aji-33	492	13	production	production	NOUN
aji-33	492	14	stimulates	stimulate	VERB
aji-33	492	15	collagen	collagen	NOUN
aji-33	492	16	synthesis	synthesis	NOUN
aji-33	492	17	in	in	ADP
aji-33	492	18	interstitial	interstitial	ADJ
aji-33	492	19	fibroblasts	fibroblast	NOUN
aji-33	492	20	,	,	PUNCT
aji-33	492	21	which	which	PRON
aji-33	492	22	is	be	AUX
aji-33	492	23	necessary	necessary	ADJ
aji-33	492	24	for	for	ADP
aji-33	492	25	restoring	restore	VERB
aji-33	492	26	alveolar	alveolar	ADJ
aji-33	492	27	wall	wall	NOUN
aji-33	492	28	architecture	architecture	NOUN
aji-33	492	29	.	.	PUNCT
aji-33	493	1	table	table	NOUN
aji-33	493	2	3	3	NUM
aji-33	493	3	.	.	PUNCT
aji-33	494	1	different	different	ADJ
aji-33	494	2	polymorphic	polymorphic	ADJ
aji-33	494	3	types	type	NOUN
aji-33	494	4	of	of	ADP
aji-33	494	5	macrophage	macrophage	ADJ
aji-33	494	6	type	type	NOUN
aji-33	494	7	of	of	ADP
aji-33	494	8	macrophage	macrophage	NOUN
aji-33	494	9	stimulated	stimulate	VERB
aji-33	494	10	by	by	ADP
aji-33	494	11	express	express	ADJ
aji-33	494	12	functions	function	NOUN
aji-33	494	13	m1	m1	NOUN
aji-33	494	14	macrophages	macrophage	NOUN
aji-33	494	15	(	(	PUNCT
aji-33	494	16	classically	classically	ADV
aji-33	494	17	activated	activate	VERB
aji-33	494	18	)	)	PUNCT
aji-33	494	19	1.lps	1.lps	ADP
aji-33	494	20	2	2	NUM
aji-33	494	21	.	.	PUNCT
aji-33	495	1	th1	th1	NOUN
aji-33	495	2	cytokines	cytokine	NOUN
aji-33	495	3	(	(	PUNCT
aji-33	495	4	ifn	ifn	NOUN
aji-33	495	5	-	-	PUNCT
aji-33	495	6	γ	γ	NOUN
aji-33	495	7	,	,	PUNCT
aji-33	495	8	il-2	il-2	PROPN
aji-33	495	9	,	,	PUNCT
aji-33	495	10	il-12	il-12	NOUN
aji-33	495	11	,	,	PUNCT
aji-33	495	12	il18	il18	PROPN
aji-33	495	13	and	and	CCONJ
aji-33	495	14	tnf	tnf	PROPN
aji-33	495	15	-	-	PUNCT
aji-33	495	16	β	β	NOUN
aji-33	495	17	)	)	PUNCT
aji-33	495	18	3.gmcgo	3.gmcgo	NUM
aji-33	495	19	(	(	PUNCT
aji-33	495	20	tnf-	tnf-	INTJ
aji-33	495	21	)	)	PUNCT
aji-33	495	22	α	α	NOUN
aji-33	495	23	,	,	PUNCT
aji-33	495	24	il-1	il-1	ADP
aji-33	495	25	,	,	PUNCT
aji-33	495	26	il-6	il-6	NOUN
aji-33	495	27	,	,	PUNCT
aji-33	495	28	and	and	CCONJ
aji-33	495	29	il-12	il-12	NOUN
aji-33	495	30	,	,	PUNCT
aji-33	495	31	and	and	CCONJ
aji-33	495	32	type	type	NOUN
aji-33	495	33	i	i	PRON
aji-33	495	34	interferons	interferon	VERB
aji-33	495	35	(	(	PUNCT
aji-33	495	36	ifn	ifn	PROPN
aji-33	495	37	)	)	PUNCT
aji-33	495	38	th1	th1	NOUN
aji-33	495	39	cell	cell	NOUN
aji-33	495	40	-	-	PUNCT
aji-33	495	41	attracting	attract	VERB
aji-33	495	42	chemokines	chemokine	NOUN
aji-33	495	43	(	(	PUNCT
aji-33	495	44	ccl5	ccl5	PROPN
aji-33	495	45	cxcl9	cxcl9	NOUN
aji-33	495	46	and	and	CCONJ
aji-33	495	47	cxcl10	cxcl10	NOUN
aji-33	495	48	)	)	PUNCT
aji-33	495	49	(	(	PUNCT
aji-33	495	50	(	(	PUNCT
aji-33	495	51	rantes	rante	NOUN
aji-33	495	52	)	)	PUNCT
aji-33	495	53	pro	pro	ADJ
aji-33	495	54	-	-	ADJ
aji-33	495	55	inflammatory	inflammatory	ADJ
aji-33	495	56	m2	m2	PROPN
aji-33	495	57	macrophages	macrophage	NOUN
aji-33	495	58	(	(	PUNCT
aji-33	495	59	alternatively	alternatively	ADV
aji-33	495	60	activated	activate	VERB
aji-33	495	61	macrophages	macrophage	NOUN
aji-33	495	62	(	(	PUNCT
aji-33	495	63	aams	aam	NOUN
aji-33	495	64	)	)	PUNCT
aji-33	495	65	1.th2	1.th2	NUM
aji-33	495	66	cytokines	cytokine	NOUN
aji-33	495	67	including	include	VERB
aji-33	495	68	(	(	PUNCT
aji-33	495	69	il-4	il-4	X
aji-33	495	70	,	,	PUNCT
aji-33	495	71	il-5	il-5	PROPN
aji-33	495	72	,	,	PUNCT
aji-33	495	73	il-6	il-6	PRON
aji-33	495	74	,	,	PUNCT
aji-33	495	75	and	and	CCONJ
aji-33	495	76	il-10	il-10	PRON
aji-33	495	77	)	)	PUNCT
aji-33	495	78	2	2	NUM
aji-33	495	79	.	.	X
aji-33	496	1	m	m	NOUN
aji-33	496	2	-	-	PUNCT
aji-33	496	3	csf	csf	ADJ
aji-33	496	4	1	1	NUM
aji-33	496	5	.	.	NOUN
aji-33	496	6	scavenging	scavenge	VERB
aji-33	496	7	receptors	receptor	NOUN
aji-33	496	8	2	2	NUM
aji-33	496	9	.	.	PUNCT
aji-33	497	1	mannose	mannose	NOUN
aji-33	497	2	and	and	CCONJ
aji-33	497	3	galactose	galactose	ADJ
aji-33	497	4	receptors	receptor	NOUN
aji-33	497	5	.	.	PUNCT
aji-33	498	1	3	3	X
aji-33	498	2	.	.	X
aji-33	498	3	secrete	secrete	NOUN
aji-33	498	4	high	high	ADJ
aji-33	498	5	amount	amount	NOUN
aji-33	498	6	of	of	ADP
aji-33	498	7	il-10	il-10	PRON
aji-33	498	8	4	4	X
aji-33	498	9	.	.	X
aji-33	498	10	express	express	VERB
aji-33	498	11	higher	high	ADJ
aji-33	498	12	levels	level	NOUN
aji-33	498	13	of	of	ADP
aji-33	498	14	the	the	DET
aji-33	498	15	il-1	il-1	X
aji-33	498	16	decoy	decoy	NOUN
aji-33	498	17	receptor	receptor	NOUN
aji-33	498	18	and	and	CCONJ
aji-33	498	19	il-1ra	il-1ra	NOUN
aji-33	498	20	5	5	NUM
aji-33	498	21	.	.	PUNCT
aji-33	498	22	express	express	VERB
aji-33	498	23	the	the	DET
aji-33	498	24	chemokines	chemokine	NOUN
aji-33	498	25	ccl17	ccl17	VERB
aji-33	498	26	,	,	PUNCT
aji-33	498	27	ccl22	ccl22	PROPN
aji-33	498	28	and	and	CCONJ
aji-33	498	29	ccl24	ccl24	PROPN
aji-33	498	30	1	1	NUM
aji-33	498	31	.	.	PUNCT
aji-33	499	1	anti	anti	ADJ
aji-33	499	2	-	-	ADJ
aji-33	499	3	inflammatory	inflammatory	ADJ
aji-33	499	4	action	action	NOUN
aji-33	499	5	2	2	NUM
aji-33	499	6	.	.	PUNCT
aji-33	499	7	higher	high	ADJ
aji-33	499	8	phagocytic	phagocytic	ADJ
aji-33	499	9	activity	activity	NOUN
aji-33	499	10	3.promotetissue	3.promotetissue	NUM
aji-33	499	11	remodelling	remodelling	NOUN
aji-33	499	12	,	,	PUNCT
aji-33	499	13	4.vasculogenesis	4.vasculogenesis	NUM
aji-33	499	14	5	5	NUM
aji-33	499	15	.	.	PUNCT
aji-33	500	1	tumour	tumour	NOUN
aji-33	500	2	progression	progression	NOUN
aji-33	500	3	m2	m2	PROPN
aji-33	500	4	a	a	DET
aji-33	500	5	macrophages	macrophage	NOUN
aji-33	500	6	il-4	il-4	X
aji-33	500	7	and	and	CCONJ
aji-33	500	8	il-13	il-13	ADP
aji-33	500	9	1	1	X
aji-33	500	10	.	.	PUNCT
aji-33	500	11	upregulate	upregulate	VERB
aji-33	500	12	expression	expression	NOUN
aji-33	500	13	of	of	ADP
aji-33	500	14	arginase-1	arginase-1	PROPN
aji-33	500	15	,	,	PUNCT
aji-33	500	16	mannose	mannose	NOUN
aji-33	500	17	receptor	receptor	NOUN
aji-33	500	18	mrc1	mrc1	PROPN
aji-33	500	19	(	(	PUNCT
aji-33	500	20	cd206	cd206	PROPN
aji-33	500	21	)	)	PUNCT
aji-33	500	22	,	,	PUNCT
aji-33	500	23	2	2	X
aji-33	500	24	.	.	PUNCT
aji-33	500	25	antigen	antigen	ADJ
aji-33	500	26	presentation	presentation	NOUN
aji-33	500	27	by	by	ADP
aji-33	500	28	 	 	SPACE
aji-33	500	29	mhc	mhc	PROPN
aji-33	500	30	ii	ii	PROPN
aji-33	500	31	 	 	SPACE
aji-33	500	32	systemof	systemof	VERB
aji-33	500	33	il-10	il-10	X
aji-33	500	34	and	and	CCONJ
aji-33	500	35	tgf	tgf	PROPN
aji-33	500	36	.	.	PUNCT
aji-33	501	1	anti	anti	ADJ
aji-33	501	2	-	-	ADJ
aji-33	501	3	inflammatory	inflammatory	ADJ
aji-33	501	4	m2	m2	PROPN
aji-33	501	5	b	b	PROPN
aji-33	501	6	macrophages	macrophage	NOUN
aji-33	501	7	immune	immune	ADJ
aji-33	501	8	complexes	complex	NOUN
aji-33	501	9	  	  	SPACE
aji-33	501	10	lps	lps	PROPN
aji-33	501	11	il-1	il-1	PROPN
aji-33	501	12	,	,	PUNCT
aji-33	501	13	il-6	il-6	NUM
aji-33	501	14	,	,	PUNCT
aji-33	501	15	il-10	il-10	PRON
aji-33	501	16	,	,	PUNCT
aji-33	501	17	tnf	tnf	PROPN
aji-33	501	18	anti	anti	ADJ
aji-33	501	19	-	-	ADJ
aji-33	501	20	inflammatory	inflammatory	ADJ
aji-33	501	21	m2	m2	PROPN
aji-33	501	22	c	c	NOUN
aji-33	501	23	macrophages	macrophage	NOUN
aji-33	501	24	il-10	il-10	PRON
aji-33	501	25	,	,	PUNCT
aji-33	501	26	  	  	SPACE
aji-33	501	27	transforming	transform	VERB
aji-33	501	28	growth	growth	NOUN
aji-33	501	29	factor	factor	NOUN
aji-33	501	30	beta	beta	NOUN
aji-33	501	31	 	 	SPACE
aji-33	501	32	(	(	PUNCT
aji-33	501	33	tgf	tgf	PROPN
aji-33	501	34	)	)	PUNCT
aji-33	501	35	and	and	CCONJ
aji-33	501	36	 	 	SPACE
aji-33	501	37	glucocorticoids	glucocorticoid	NOUN
aji-33	501	38	,	,	PUNCT
aji-33	501	39	il-10	il-10	PRON
aji-33	501	40	and	and	CCONJ
aji-33	501	41	tgfβ	tgfβ	ADJ
aji-33	501	42	suppression	suppression	NOUN
aji-33	501	43	of	of	ADP
aji-33	501	44	inflammatory	inflammatory	ADJ
aji-33	501	45	response	response	NOUN
aji-33	501	46	5	5	NUM
aji-33	501	47	.	.	PUNCT
aji-33	502	1	summary	summary	VERB
aji-33	502	2	the	the	DET
aji-33	502	3	elusive	elusive	ADJ
aji-33	502	4	pathology	pathology	NOUN
aji-33	502	5	of	of	ADP
aji-33	502	6	covid	covid	PROPN
aji-33	502	7	19	19	NUM
aji-33	502	8	lung	lung	NOUN
aji-33	502	9	disease	disease	NOUN
aji-33	502	10	is	be	AUX
aji-33	502	11	dueto	dueto	VERB
aji-33	502	12	its	its	PRON
aji-33	502	13	protean	protean	ADJ
aji-33	502	14	and	and	CCONJ
aji-33	502	15	varied	varied	ADJ
aji-33	502	16	manifestations	manifestation	NOUN
aji-33	502	17	.	.	PUNCT
aji-33	503	1	thus	thus	ADV
aji-33	503	2	it	it	PRON
aji-33	503	3	might	might	AUX
aji-33	503	4	resemble	resemble	VERB
aji-33	503	5	from	from	ADP
aji-33	503	6	consolidation	consolidation	NOUN
aji-33	503	7	/pulmonary	/pulmonary	PUNCT
aji-33	503	8	oedema/	oedema/	NUM
aji-33	503	9	ards	ard	NOUN
aji-33	503	10	or	or	CCONJ
aji-33	503	11	cytokinestorm	cytokinestorm	NOUN
aji-33	503	12	;	;	PUNCT
aji-33	503	13	yetit	yetit	NOUN
aji-33	503	14	is	be	AUX
aji-33	503	15	distinct	distinct	ADJ
aji-33	503	16	from	from	ADP
aji-33	503	17	each	each	PRON
aji-33	503	18	of	of	ADP
aji-33	503	19	these	these	DET
aji-33	503	20	specific	specific	ADJ
aji-33	503	21	syndromes	syndrome	NOUN
aji-33	503	22	.	.	PUNCT
aji-33	504	1	in	in	ADP
aji-33	504	2	fact	fact	NOUN
aji-33	504	3	covid	covid	PROPN
aji-33	504	4	lung	lung	PROPN
aji-33	504	5	pathology	pathology	PROPN
aji-33	504	6	resemblesa	resemblesa	NOUN
aji-33	504	7	mixture	mixture	NOUN
aji-33	504	8	of	of	ADP
aji-33	504	9	all	all	DET
aji-33	504	10	theseindividual	theseindividual	ADJ
aji-33	504	11	entities.alveolitis	entities.alveolitis	PROPN
aji-33	504	12	due	due	ADP
aji-33	504	13	to	to	ADP
aji-33	504	14	inflammatory	inflammatory	ADJ
aji-33	504	15	cytokines	cytokine	NOUN
aji-33	504	16	explains	explain	VERB
aji-33	504	17	the	the	DET
aji-33	504	18	consolidation	consolidation	NOUN
aji-33	504	19	finding	finding	NOUN
aji-33	504	20	.	.	PUNCT
aji-33	505	1	damage	damage	NOUN
aji-33	505	2	to	to	ADP
aji-33	505	3	capillaries	capillary	NOUN
aji-33	505	4	with	with	ADP
aji-33	505	5	consequent	consequent	ADJ
aji-33	505	6	seepage	seepage	NOUN
aji-33	505	7	of	of	ADP
aji-33	505	8	translate	translate	NOUN
aji-33	505	9	explains	explain	VERB
aji-33	505	10	the	the	DET
aji-33	505	11	pulmonary	pulmonary	ADJ
aji-33	505	12	oedema	oedema	NOUN
aji-33	505	13	like	like	ADP
aji-33	505	14	component	component	NOUN
aji-33	505	15	.	.	PUNCT
aji-33	506	1	this	this	PRON
aji-33	506	2	in	in	ADP
aji-33	506	3	combination	combination	NOUN
aji-33	506	4	with	with	ADP
aji-33	506	5	interstitial	interstitial	ADJ
aji-33	506	6	fibrosis	fibrosis	NOUN
aji-33	506	7	formed	form	VERB
aji-33	506	8	due	due	ADP
aji-33	506	9	to	to	ADP
aji-33	506	10	m2	m2	PROPN
aji-33	506	11	macrophage	macrophage	NOUN
aji-33	506	12	2	2	NUM
aji-33	506	13	,	,	PUNCT
aji-33	506	14	with	with	ADP
aji-33	506	15	resultant	resultant	NOUN
aji-33	506	16	hypoxia	hypoxia	NOUN
aji-33	506	17	might	might	AUX
aji-33	506	18	explain	explain	VERB
aji-33	506	19	the	the	DET
aji-33	506	20	ards	ard	NOUN
aji-33	506	21	-	-	PUNCT
aji-33	506	22	like	like	ADJ
aji-33	506	23	picture	picture	NOUN
aji-33	506	24	.	.	PUNCT
aji-33	507	1	the	the	DET
aji-33	507	2	terminal	terminal	ADJ
aji-33	507	3	events	event	NOUN
aji-33	507	4	of	of	ADP
aji-33	507	5	disseminated	disseminate	VERB
aji-33	507	6	intravascular	intravascular	ADJ
aji-33	507	7	coagulation	coagulation	NOUN
aji-33	507	8	(	(	PUNCT
aji-33	507	9	dic	dic	ADJ
aji-33	507	10	)	)	PUNCT
aji-33	507	11	and	and	CCONJ
aji-33	507	12	multi	multi	ADJ
aji-33	507	13	organ	organ	NOUN
aji-33	507	14	dysfunction	dysfunction	NOUN
aji-33	507	15	prasad	prasad	NOUN
aji-33	507	16	;	;	PUNCT
aji-33	507	17	aji	aji	NOUN
aji-33	507	18	,	,	PUNCT
aji-33	507	19	3(1	3(1	NUM
aji-33	507	20	):	):	PUNCT
aji-33	507	21	233	233	NUM
aji-33	507	22	-	-	SYM
aji-33	507	23	252	252	NUM
aji-33	507	24	,	,	PUNCT
aji-33	507	25	2020	2020	NUM
aji-33	507	26	;	;	PUNCT
aji-33	507	27	article	article	NOUN
aji-33	507	28	no.aji.58422	no.aji.58422	NOUN
aji-33	507	29	246	246	NUM
aji-33	507	30	(	(	PUNCT
aji-33	507	31	mod	mod	PROPN
aji-33	507	32	)	)	PUNCT
aji-33	507	33	,	,	PUNCT
aji-33	507	34	which	which	PRON
aji-33	507	35	is	be	AUX
aji-33	507	36	a	a	DET
aji-33	507	37	common	common	ADJ
aji-33	507	38	pathway	pathway	NOUN
aji-33	507	39	for	for	ADP
aji-33	507	40	severe	severe	ADJ
aji-33	507	41	sepsis	sepsis	NOUN
aji-33	507	42	or	or	CCONJ
aji-33	507	43	cytokine	cytokine	VERB
aji-33	507	44	storm	storm	NOUN
aji-33	507	45	like	like	ADP
aji-33	507	46	picture	picture	NOUN
aji-33	507	47	seen	see	VERB
aji-33	507	48	in	in	ADP
aji-33	507	49	a	a	DET
aji-33	507	50	few	few	ADJ
aji-33	507	51	covid	covid	NOUN
aji-33	507	52	19	19	NUM
aji-33	507	53	patients	patient	NOUN
aji-33	507	54	which	which	PRON
aji-33	507	55	contributed	contribute	VERB
aji-33	507	56	to	to	ADP
aji-33	507	57	the	the	DET
aji-33	507	58	overall	overall	ADJ
aji-33	507	59	mortality	mortality	NOUN
aji-33	507	60	due	due	ADP
aji-33	507	61	to	to	PART
aji-33	507	62	covid	covid	VERB
aji-33	507	63	19.the	19.the	DET
aji-33	507	64	failure	failure	NOUN
aji-33	507	65	to	to	ADP
aji-33	507	66	pin	pin	VERB
aji-33	507	67	point	point	NOUN
aji-33	507	68	to	to	ADP
aji-33	507	69	single	single	ADJ
aji-33	507	70	pathology	pathology	NOUN
aji-33	507	71	,	,	PUNCT
aji-33	507	72	perhaps	perhaps	ADV
aji-33	507	73	is	be	AUX
aji-33	507	74	due	due	ADJ
aji-33	507	75	to	to	ADP
aji-33	507	76	this	this	DET
aji-33	507	77	fact	fact	NOUN
aji-33	507	78	.	.	PUNCT
aji-33	508	1	further	far	ADV
aji-33	508	2	the	the	DET
aji-33	508	3	simultaneous	simultaneous	ADJ
aji-33	508	4	occurrence	occurrence	NOUN
aji-33	508	5	of	of	ADP
aji-33	508	6	thrombotic	thrombotic	ADJ
aji-33	508	7	and	and	CCONJ
aji-33	508	8	haemorrhage	haemorrhage	NOUN
aji-33	508	9	,	,	PUNCT
aji-33	508	10	seen	see	VERB
aji-33	508	11	in	in	ADP
aji-33	508	12	covid	covid	PROPN
aji-33	508	13	lung	lung	PROPN
aji-33	508	14	,	,	PUNCT
aji-33	508	15	suggests	suggest	VERB
aji-33	508	16	a	a	DET
aji-33	508	17	range	range	NOUN
aji-33	508	18	of	of	ADP
aji-33	508	19	diseases	disease	NOUN
aji-33	508	20	such	such	ADJ
aji-33	508	21	as	as	ADP
aji-33	508	22	activation	activation	NOUN
aji-33	508	23	of	of	ADP
aji-33	508	24	simple	simple	ADJ
aji-33	508	25	coagulation	coagulation	NOUN
aji-33	508	26	cascadeand	cascadeand	NOUN
aji-33	508	27	subsequent	subsequent	ADJ
aji-33	508	28	fibrinolysis	fibrinolysis	NOUN
aji-33	508	29	,	,	PUNCT
aji-33	508	30	small	small	ADJ
aji-33	508	31	vessel	vessel	NOUN
aji-33	508	32	vasculitis	vasculitis	PROPN
aji-33	508	33	to	to	ADP
aji-33	508	34	thrombotic	thrombotic	ADJ
aji-33	508	35	thrombocytopenia	thrombocytopenia	PROPN
aji-33	508	36	.	.	PUNCT
aji-33	509	1	simple	simple	ADJ
aji-33	509	2	coagulation	coagulation	NOUN
aji-33	509	3	cascade	cascade	NOUN
aji-33	509	4	activation/	activation/	NUM
aji-33	509	5	fibrinolysis	fibrinolysis	NOUN
aji-33	509	6	,	,	PUNCT
aji-33	509	7	can	can	AUX
aji-33	509	8	not	not	PART
aji-33	509	9	explain	explain	VERB
aji-33	509	10	either	either	CCONJ
aji-33	509	11	the	the	DET
aji-33	509	12	presence	presence	NOUN
aji-33	509	13	of	of	ADP
aji-33	509	14	immune	immune	ADJ
aji-33	509	15	cells	cell	NOUN
aji-33	509	16	like	like	ADP
aji-33	509	17	cd8	cd8	PROPN
aji-33	509	18	+	+	PROPN
aji-33	509	19	and	and	CCONJ
aji-33	509	20	cd4	cd4	PROPN
aji-33	509	21	+	+	NOUN
aji-33	509	22	cells	cell	NOUN
aji-33	509	23	nor	nor	CCONJ
aji-33	509	24	the	the	DET
aji-33	509	25	consolidation	consolidation	NOUN
aji-33	509	26	/	/	SYM
aji-33	509	27	fibrosis	fibrosis	NOUN
aji-33	509	28	component	component	NOUN
aji-33	509	29	.	.	PUNCT
aji-33	510	1	small	small	ADJ
aji-33	510	2	vessel	vessel	NOUN
aji-33	510	3	vasculitis(capillaritis	vasculitis(capillaritis	PROPN
aji-33	510	4	)	)	PUNCT
aji-33	510	5	/	/	SYM
aji-33	510	6	luecocytoclastic	luecocytoclastic	ADJ
aji-33	510	7	/	/	SYM
aji-33	510	8	hypersensitive	hypersensitive	ADJ
aji-33	510	9	angiitis	angiitis	ADV
aji-33	510	10	is	be	AUX
aji-33	510	11	a	a	DET
aji-33	510	12	systemic	systemic	ADJ
aji-33	510	13	disease	disease	NOUN
aji-33	510	14	and	and	CCONJ
aji-33	510	15	the	the	DET
aji-33	510	16	specific	specific	ADJ
aji-33	510	17	histological	histological	ADJ
aji-33	510	18	features	feature	NOUN
aji-33	510	19	like	like	ADP
aji-33	510	20	leukocyteclasia	leukocyteclasia	NOUN
aji-33	510	21	(	(	PUNCT
aji-33	510	22	a	a	DET
aji-33	510	23	process	process	NOUN
aji-33	510	24	in	in	ADP
aji-33	510	25	which	which	PRON
aji-33	510	26	the	the	DET
aji-33	510	27	neutrophils	neutrophil	NOUN
aji-33	510	28	are	be	AUX
aji-33	510	29	destroyed	destroy	VERB
aji-33	510	30	leading	lead	VERB
aji-33	510	31	to	to	ADP
aji-33	510	32	debris	debris	NOUN
aji-33	510	33	collection	collection	NOUN
aji-33	510	34	)	)	PUNCT
aji-33	510	35	is	be	AUX
aji-33	510	36	not	not	PART
aji-33	510	37	demonstrated	demonstrate	VERB
aji-33	510	38	,	,	PUNCT
aji-33	510	39	in	in	ADP
aji-33	510	40	the	the	DET
aji-33	510	41	autopsy	autopsy	ADJ
aji-33	510	42	findings	finding	NOUN
aji-33	510	43	of	of	ADP
aji-33	510	44	covid	covid	PROPN
aji-33	510	45	19	19	NUM
aji-33	510	46	.	.	PUNCT
aji-33	511	1	further	far	ADV
aji-33	511	2	it	it	PRON
aji-33	511	3	is	be	AUX
aji-33	511	4	either	either	CCONJ
aji-33	511	5	due	due	ADJ
aji-33	511	6	to	to	ADP
aji-33	511	7	drug	drug	NOUN
aji-33	511	8	induced	induce	VERB
aji-33	511	9	allergy	allergy	NOUN
aji-33	511	10	or	or	CCONJ
aji-33	511	11	idiopathic	idiopathic	ADJ
aji-33	511	12	.	.	PUNCT
aji-33	512	1	thethhrombotic	thethhrombotic	ADJ
aji-33	512	2	phenomena	phenomenon	NOUN
aji-33	512	3	are	be	AUX
aji-33	512	4	not	not	PART
aji-33	512	5	a	a	DET
aji-33	512	6	feature	feature	NOUN
aji-33	512	7	of	of	ADP
aji-33	512	8	small	small	ADJ
aji-33	512	9	vessel	vessel	NOUN
aji-33	512	10	vasculitis	vasculitis	PROPN
aji-33	512	11	.	.	PUNCT
aji-33	513	1	the	the	DET
aji-33	513	2	acute	acute	ADJ
aji-33	513	3	nature	nature	NOUN
aji-33	513	4	and	and	CCONJ
aji-33	513	5	non	non	ADJ
aji-33	513	6	involvement	involvement	NOUN
aji-33	513	7	of	of	ADP
aji-33	513	8	medium	medium	ADJ
aji-33	513	9	sized	sized	ADJ
aji-33	513	10	blood	blood	NOUN
aji-33	513	11	vessels	vessel	NOUN
aji-33	513	12	and	and	CCONJ
aji-33	513	13	absent	absent	ADJ
aji-33	513	14	fibroid	fibroid	ADJ
aji-33	513	15	necrosis	necrosis	NOUN
aji-33	513	16	are	be	AUX
aji-33	513	17	points	point	NOUN
aji-33	513	18	wagnersgranulomatosis	wagnersgranulomatosis	NOUN
aji-33	513	19	a	a	DET
aji-33	513	20	non	non	ADJ
aji-33	513	21	possibility	possibility	NOUN
aji-33	513	22	.	.	PUNCT
aji-33	514	1	the	the	DET
aji-33	514	2	absence	absence	NOUN
aji-33	514	3	of	of	ADP
aji-33	514	4	haemoptysis	haemoptysis	NOUN
aji-33	514	5	even	even	ADV
aji-33	514	6	though	though	ADV
aji-33	514	7	,	,	PUNCT
aji-33	514	8	patchyhaemorrhages	patchyhaemorrhage	NOUN
aji-33	514	9	are	be	AUX
aji-33	514	10	seen	see	VERB
aji-33	514	11	on	on	ADP
aji-33	514	12	gross	gross	ADJ
aji-33	514	13	as	as	ADV
aji-33	514	14	well	well	ADV
aji-33	514	15	as	as	ADP
aji-33	514	16	microscopic	microscopic	ADJ
aji-33	514	17	autopsy	autopsy	ADJ
aji-33	514	18	findings	finding	NOUN
aji-33	514	19	indicates	indicate	VERB
aji-33	514	20	that	that	SCONJ
aji-33	514	21	the	the	DET
aji-33	514	22	bleeding	bleeding	NOUN
aji-33	514	23	is	be	AUX
aji-33	514	24	not	not	PART
aji-33	514	25	substantially	substantially	ADV
aji-33	514	26	enough	enough	ADJ
aji-33	514	27	to	to	PART
aji-33	514	28	give	give	VERB
aji-33	514	29	rise	rise	NOUN
aji-33	514	30	to	to	ADP
aji-33	514	31	clinically	clinically	ADV
aji-33	514	32	haemoptysis	haemoptysis	NOUN
aji-33	514	33	which	which	PRON
aji-33	514	34	distinguishes	distinguish	VERB
aji-33	514	35	covid	covid	PROPN
aji-33	514	36	lung	lung	NOUN
aji-33	514	37	disease	disease	NOUN
aji-33	514	38	from	from	ADP
aji-33	514	39	good	good	ADJ
aji-33	514	40	.	.	PUNCT
aji-33	515	1	pasture	pasture	NOUN
aji-33	515	2	's	's	PART
aji-33	515	3	syndrome	syndrome	NOUN
aji-33	515	4	the	the	DET
aji-33	515	5	haemorrhagic	haemorrhagic	ADJ
aji-33	515	6	part	part	NOUN
aji-33	515	7	is	be	AUX
aji-33	515	8	perhaps	perhaps	ADV
aji-33	515	9	due	due	ADJ
aji-33	515	10	to	to	ADP
aji-33	515	11	purpura	purpura	NOUN
aji-33	515	12	as	as	SCONJ
aji-33	515	13	supported	support	VERB
aji-33	515	14	by	by	ADP
aji-33	515	15	low	low	ADJ
aji-33	515	16	platelet	platelet	NOUN
aji-33	515	17	counts	count	NOUN
aji-33	515	18	and	and	CCONJ
aji-33	515	19	presence	presence	NOUN
aji-33	515	20	of	of	ADP
aji-33	515	21	atypical	atypical	ADJ
aji-33	515	22	megakaryocytes	megakaryocyte	NOUN
aji-33	515	23	seen	see	VERB
aji-33	515	24	in	in	ADP
aji-33	515	25	the	the	DET
aji-33	515	26	autopsy	autopsy	ADJ
aji-33	515	27	findings	finding	NOUN
aji-33	515	28	.	.	PUNCT
aji-33	516	1	this	this	PRON
aji-33	516	2	takes	take	VERB
aji-33	516	3	us	we	PRON
aji-33	516	4	to	to	ADP
aji-33	516	5	the	the	DET
aji-33	516	6	possibility	possibility	NOUN
aji-33	516	7	of	of	ADP
aji-33	516	8	thrombotic	thrombotic	ADJ
aji-33	516	9	thrombocytopenia	thrombocytopenia	NOUN
aji-33	516	10	or	or	CCONJ
aji-33	516	11	coagulative	coagulative	NOUN
aji-33	516	12	microangiopathy	microangiopathy	ADJ
aji-33	516	13	which	which	PRON
aji-33	516	14	is	be	AUX
aji-33	516	15	a	a	DET
aji-33	516	16	systemic	systemic	ADJ
aji-33	516	17	syndrome	syndrome	NOUN
aji-33	516	18	unlike	unlike	ADP
aji-33	516	19	the	the	DET
aji-33	516	20	localised	localise	VERB
aji-33	516	21	pathology	pathology	NOUN
aji-33	516	22	as	as	SCONJ
aji-33	516	23	seen	see	VERB
aji-33	516	24	in	in	ADP
aji-33	516	25	covid	covid	PROPN
aji-33	516	26	19	19	NUM
aji-33	516	27	.	.	PUNCT
aji-33	517	1	however	however	ADV
aji-33	517	2	all	all	DET
aji-33	517	3	coagulative	coagulative	NOUN
aji-33	517	4	microangiopathy	microangiopathy	NOUN
aji-33	517	5	is	be	AUX
aji-33	517	6	described	describe	VERB
aji-33	517	7	in	in	ADP
aji-33	517	8	literature	literature	NOUN
aji-33	517	9	in	in	ADP
aji-33	517	10	case	case	NOUN
aji-33	517	11	of	of	ADP
aji-33	517	12	fall	fall	NOUN
aji-33	517	13	bladder	bladder	NOUN
aji-33	517	14	,	,	PUNCT
aji-33	517	15	but	but	CCONJ
aji-33	517	16	not	not	PART
aji-33	517	17	in	in	ADP
aji-33	517	18	case	case	NOUN
aji-33	517	19	of	of	ADP
aji-33	517	20	lung	lung	NOUN
aji-33	517	21	.	.	PUNCT
aji-33	518	1	if	if	SCONJ
aji-33	518	2	it	it	PRON
aji-33	518	3	is	be	AUX
aji-33	518	4	true	true	ADJ
aji-33	518	5	,	,	PUNCT
aji-33	518	6	covid	covid	PROPN
aji-33	518	7	19	19	NUM
aji-33	518	8	is	be	AUX
aji-33	518	9	the	the	DET
aji-33	518	10	first	first	ADJ
aji-33	518	11	ever	ever	ADJ
aji-33	518	12	disease	disease	NOUN
aji-33	518	13	to	to	PART
aji-33	518	14	cause	cause	VERB
aji-33	518	15	such	such	ADJ
aji-33	518	16	"	"	PUNCT
aji-33	518	17	localised	localised	ADJ
aji-33	518	18	coagulative	coagulative	NOUN
aji-33	518	19	microangiopathy	microangiopathy	PROPN
aji-33	518	20	.	.	PUNCT
aji-33	519	1	disseminated	disseminate	VERB
aji-33	519	2	intravascular	intravascular	ADJ
aji-33	519	3	coagulation	coagulation	NOUN
aji-33	519	4	is	be	AUX
aji-33	519	5	a	a	DET
aji-33	519	6	serious	serious	ADJ
aji-33	519	7	condition	condition	NOUN
aji-33	519	8	that	that	PRON
aji-33	519	9	may	may	AUX
aji-33	519	10	explain	explain	VERB
aji-33	519	11	both	both	CCONJ
aji-33	519	12	the	the	DET
aji-33	519	13	observed	observe	VERB
aji-33	519	14	pathological	pathological	ADJ
aji-33	519	15	entities	entity	NOUN
aji-33	519	16	,	,	PUNCT
aji-33	519	17	but	but	CCONJ
aji-33	519	18	its	its	PRON
aji-33	519	19	protean	protean	ADJ
aji-33	519	20	manifestation	manifestation	NOUN
aji-33	519	21	are	be	AUX
aji-33	519	22	not	not	PART
aji-33	519	23	discernible	discernible	ADJ
aji-33	519	24	in	in	ADP
aji-33	519	25	routine	routine	ADJ
aji-33	519	26	cases	case	NOUN
aji-33	519	27	except	except	SCONJ
aji-33	519	28	the	the	DET
aji-33	519	29	seriously	seriously	ADV
aji-33	519	30	terminally	terminally	ADV
aji-33	519	31	ill	ill	ADJ
aji-33	519	32	patients	patient	NOUN
aji-33	519	33	distained	distaine	VERB
aji-33	519	34	for	for	ADP
aji-33	519	35	mod(multiorgan	mod(multiorgan	VERB
aji-33	519	36	dysfunction	dysfunction	NOUN
aji-33	519	37	)	)	PUNCT
aji-33	519	38	.	.	PUNCT
aji-33	520	1	the	the	DET
aji-33	520	2	elusiveness	elusiveness	NOUN
aji-33	520	3	of	of	ADP
aji-33	520	4	covid	covid	PROPN
aji-33	520	5	19	19	NUM
aji-33	520	6	lung	lung	NOUN
aji-33	520	7	pathogenesis	pathogenesis	NOUN
aji-33	520	8	could	could	AUX
aji-33	520	9	be	be	AUX
aji-33	520	10	due	due	ADJ
aji-33	520	11	the	the	DET
aji-33	520	12	culmination	culmination	NOUN
aji-33	520	13	of	of	ADP
aji-33	520	14	more	more	ADJ
aji-33	520	15	than	than	ADP
aji-33	520	16	one	one	NUM
aji-33	520	17	pathogenic	pathogenic	ADJ
aji-33	520	18	pathway	pathway	NOUN
aji-33	520	19	.	.	PUNCT
aji-33	521	1	the	the	DET
aji-33	521	2	different	different	ADJ
aji-33	521	3	pathways	pathway	NOUN
aji-33	521	4	explaining	explain	VERB
aji-33	521	5	the	the	DET
aji-33	521	6	interstitial	interstitial	ADJ
aji-33	521	7	fibrosis	fibrosis	NOUN
aji-33	521	8	and	and	CCONJ
aji-33	521	9	vascular	vascular	ADJ
aji-33	521	10	changes	change	NOUN
aji-33	521	11	already	already	ADV
aji-33	521	12	seen	see	VERB
aji-33	521	13	bear	bear	NOUN
aji-33	521	14	testimony	testimony	NOUN
aji-33	521	15	to	to	ADP
aji-33	521	16	this	this	DET
aji-33	521	17	fact	fact	NOUN
aji-33	521	18	.	.	PUNCT
aji-33	522	1	while	while	SCONJ
aji-33	522	2	the	the	DET
aji-33	522	3	effector	effector	NOUN
aji-33	522	4	cells	cell	NOUN
aji-33	522	5	(	(	PUNCT
aji-33	522	6	macrophages	macrophage	NOUN
aji-33	522	7	,	,	PUNCT
aji-33	522	8	and	and	CCONJ
aji-33	522	9	other	other	ADJ
aji-33	522	10	phagocytes	phagocytes	PROPN
aji-33	522	11	,	,	PUNCT
aji-33	522	12	nkcells	nkcell	NOUN
aji-33	522	13	,	,	PUNCT
aji-33	522	14	nak	nak	NOUN
aji-33	522	15	cells	cell	NOUN
aji-33	522	16	and	and	CCONJ
aji-33	522	17	dendritic	dendritic	ADJ
aji-33	522	18	cells	cell	NOUN
aji-33	522	19	etc)do	etc)do	NOUN
aji-33	522	20	deliver	deliver	VERB
aji-33	522	21	the	the	DET
aji-33	522	22	final	final	ADJ
aji-33	522	23	blow	blow	NOUN
aji-33	522	24	,	,	PUNCT
aji-33	522	25	nevertheless	nevertheless	ADV
aji-33	522	26	the	the	DET
aji-33	522	27	role	role	NOUN
aji-33	522	28	played	play	VERB
aji-33	522	29	by	by	ADP
aji-33	522	30	other	other	ADJ
aji-33	522	31	elements	element	NOUN
aji-33	522	32	of	of	ADP
aji-33	522	33	both	both	DET
aji-33	522	34	innate	innate	ADJ
aji-33	522	35	as	as	ADV
aji-33	522	36	well	well	ADV
aji-33	522	37	as	as	ADP
aji-33	522	38	acquired	acquire	VERB
aji-33	522	39	immunity(like	immunity(like	PROPN
aji-33	522	40	antibody	antibody	NOUN
aji-33	522	41	classes	class	NOUN
aji-33	522	42	,	,	PUNCT
aji-33	522	43	opsonins	opsonin	NOUN
aji-33	522	44	and	and	CCONJ
aji-33	522	45	complement	complement	NOUN
aji-33	522	46	etc	etc	X
aji-33	522	47	)	)	PUNCT
aji-33	522	48	can	can	AUX
aji-33	522	49	not	not	PART
aji-33	522	50	be	be	AUX
aji-33	522	51	ignored	ignore	VERB
aji-33	522	52	.	.	PUNCT
aji-33	523	1	it	it	PRON
aji-33	523	2	must	must	AUX
aji-33	523	3	be	be	AUX
aji-33	523	4	emphasized	emphasize	VERB
aji-33	523	5	that	that	SCONJ
aji-33	523	6	immunity	immunity	NOUN
aji-33	523	7	,	,	PUNCT
aji-33	523	8	innate	innate	ADJ
aji-33	523	9	or	or	CCONJ
aji-33	523	10	acquired	acquire	VERB
aji-33	523	11	can	can	AUX
aji-33	523	12	be	be	AUX
aji-33	523	13	no	no	PRON
aji-33	523	14	less	less	ADV
aji-33	523	15	damaging	damaging	ADJ
aji-33	523	16	than	than	ADP
aji-33	523	17	the	the	DET
aji-33	523	18	protection	protection	NOUN
aji-33	523	19	they	they	PRON
aji-33	523	20	offer	offer	VERB
aji-33	523	21	against	against	ADP
aji-33	523	22	the	the	DET
aji-33	523	23	invading	invade	VERB
aji-33	523	24	pathogens	pathogen	NOUN
aji-33	523	25	.	.	PUNCT
aji-33	524	1	the	the	DET
aji-33	524	2	system	system	NOUN
aji-33	524	3	has	have	VERB
aji-33	524	4	inbuilt	inbuilt	ADJ
aji-33	524	5	checks	check	NOUN
aji-33	524	6	and	and	CCONJ
aji-33	524	7	controls	control	NOUN
aji-33	524	8	,	,	PUNCT
aji-33	524	9	so	so	SCONJ
aji-33	524	10	that	that	SCONJ
aji-33	524	11	the	the	DET
aji-33	524	12	destructive	destructive	ADJ
aji-33	524	13	machinery	machinery	NOUN
aji-33	524	14	is	be	AUX
aji-33	524	15	not	not	PART
aji-33	524	16	directed	direct	VERB
aji-33	524	17	against	against	ADP
aji-33	524	18	the	the	DET
aji-33	524	19	healthy	healthy	ADJ
aji-33	524	20	host	host	NOUN
aji-33	524	21	cells	cell	NOUN
aji-33	524	22	,	,	PUNCT
aji-33	524	23	but	but	CCONJ
aji-33	524	24	are	be	AUX
aji-33	524	25	specifically	specifically	ADV
aji-33	524	26	directed	direct	VERB
aji-33	524	27	against	against	ADP
aji-33	524	28	the	the	DET
aji-33	524	29	pathogen	pathogen	NOUN
aji-33	524	30	or	or	CCONJ
aji-33	524	31	pathogen	pathogen	VERB
aji-33	524	32	infected	infect	VERB
aji-33	524	33	cell.the	cell.the	DET
aji-33	524	34	ingenuity	ingenuity	NOUN
aji-33	524	35	of	of	ADP
aji-33	524	36	the	the	DET
aji-33	524	37	pathogen	pathogen	NOUN
aji-33	524	38	to	to	PART
aji-33	524	39	sabotage	sabotage	VERB
aji-33	524	40	these	these	DET
aji-33	524	41	inbuilt	inbuilt	ADJ
aji-33	524	42	safeguards	safeguard	NOUN
aji-33	524	43	in	in	ADP
aji-33	524	44	immune	immune	ADJ
aji-33	524	45	system	system	NOUN
aji-33	524	46	to	to	PART
aji-33	524	47	farthen	farthen	VERB
aji-33	524	48	its	its	PRON
aji-33	524	49	interests	interest	NOUN
aji-33	524	50	,	,	PUNCT
aji-33	524	51	in	in	ADP
aji-33	524	52	which	which	DET
aji-33	524	53	process	process	NOUN
aji-33	524	54	,	,	PUNCT
aji-33	524	55	the	the	DET
aji-33	524	56	fallout	fallout	NOUN
aji-33	524	57	of	of	ADP
aji-33	524	58	deranged	deranged	ADJ
aji-33	524	59	defence	defence	NOUN
aji-33	524	60	mechanisms	mechanism	NOUN
aji-33	524	61	,	,	PUNCT
aji-33	524	62	trains	train	VERB
aji-33	524	63	its	its	PRON
aji-33	524	64	guns	gun	NOUN
aji-33	524	65	against	against	ADP
aji-33	524	66	host	host	NOUN
aji-33	524	67	's	's	PART
aji-33	524	68	own	own	ADJ
aji-33	524	69	tissues	tissue	NOUN
aji-33	524	70	,	,	PUNCT
aji-33	524	71	as	as	SCONJ
aji-33	524	72	already	already	ADV
aji-33	524	73	discussed	discuss	VERB
aji-33	524	74	above	above	ADV
aji-33	524	75	.	.	PUNCT
aji-33	525	1	thus	thus	ADV
aji-33	525	2	,	,	PUNCT
aji-33	525	3	foundation	foundation	NOUN
aji-33	525	4	for	for	ADP
aji-33	525	5	immune	immune	ADJ
aji-33	525	6	mediated	mediate	VERB
aji-33	525	7	injury	injury	NOUN
aji-33	525	8	,	,	PUNCT
aji-33	525	9	in	in	ADP
aji-33	525	10	covid	covid	PROPN
aji-33	525	11	19	19	NUM
aji-33	525	12	induced	induced	ADJ
aji-33	525	13	lung	lung	NOUN
aji-33	525	14	damage	damage	NOUN
aji-33	525	15	is	be	AUX
aji-33	525	16	laid	lay	VERB
aji-33	525	17	on	on	ADP
aji-33	525	18	a	a	DET
aji-33	525	19	firm	firm	ADJ
aji-33	525	20	footing	footing	NOUN
aji-33	525	21	.	.	PUNCT
aji-33	526	1	6	6	X
aji-33	526	2	.	.	X
aji-33	526	3	conclusion	conclusion	NOUN
aji-33	526	4	an	an	DET
aji-33	526	5	integrated	integrated	ADJ
aji-33	526	6	approach	approach	NOUN
aji-33	526	7	,	,	PUNCT
aji-33	526	8	taking	take	VERB
aji-33	526	9	into	into	ADP
aji-33	526	10	consideration	consideration	NOUN
aji-33	526	11	,	,	PUNCT
aji-33	526	12	all	all	DET
aji-33	526	13	the	the	DET
aji-33	526	14	available	available	ADJ
aji-33	526	15	clinical	clinical	ADJ
aji-33	526	16	,	,	PUNCT
aji-33	526	17	laboratory	laboratory	NOUN
aji-33	526	18	,	,	PUNCT
aji-33	526	19	radiological	radiological	ADJ
aji-33	526	20	and	and	CCONJ
aji-33	526	21	autopsy	autopsy	ADJ
aji-33	526	22	data	datum	NOUN
aji-33	526	23	lead	lead	VERB
aji-33	526	24	to	to	ADP
aji-33	526	25	arriving	arrive	VERB
aji-33	526	26	at	at	ADP
aji-33	526	27	a	a	DET
aji-33	526	28	possible	possible	ADJ
aji-33	526	29	mechanism	mechanism	NOUN
aji-33	526	30	underlying	underlie	VERB
aji-33	526	31	the	the	DET
aji-33	526	32	lung	lung	NOUN
aji-33	526	33	damage	damage	NOUN
aji-33	526	34	in	in	ADP
aji-33	526	35	covid	covid	PROPN
aji-33	526	36	19.the	19.the	PRON
aji-33	526	37	pathway	pathway	NOUN
aji-33	526	38	of	of	ADP
aji-33	526	39	complement	complement	NOUN
aji-33	526	40	activation	activation	NOUN
aji-33	526	41	,	,	PUNCT
aji-33	526	42	contact	contact	NOUN
aji-33	526	43	cascade	cascade	NOUN
aji-33	526	44	,	,	PUNCT
aji-33	526	45	the	the	DET
aji-33	526	46	role	role	NOUN
aji-33	526	47	of	of	ADP
aji-33	526	48	the	the	DET
aji-33	526	49	cytokines	cytokine	NOUN
aji-33	526	50	and	and	CCONJ
aji-33	526	51	the	the	DET
aji-33	526	52	role	role	NOUN
aji-33	526	53	of	of	ADP
aji-33	526	54	various	various	ADJ
aji-33	526	55	elements	element	NOUN
aji-33	526	56	of	of	ADP
aji-33	526	57	the	the	DET
aji-33	526	58	innate	innate	ADJ
aji-33	526	59	and	and	CCONJ
aji-33	526	60	adaptive	adaptive	ADJ
aji-33	526	61	immunity	immunity	NOUN
aji-33	526	62	are	be	AUX
aji-33	526	63	reviewed	review	VERB
aji-33	526	64	.	.	PUNCT
aji-33	527	1	the	the	DET
aji-33	527	2	central	central	ADJ
aji-33	527	3	role	role	NOUN
aji-33	527	4	played	play	VERB
aji-33	527	5	by	by	ADP
aji-33	527	6	the	the	DET
aji-33	527	7	macrophage	macrophage	ADJ
aji-33	527	8	polymorphism	polymorphism	NOUN
aji-33	527	9	,	,	PUNCT
aji-33	527	10	in	in	ADP
aji-33	527	11	the	the	DET
aji-33	527	12	pathogenesis	pathogenesis	NOUN
aji-33	527	13	and	and	CCONJ
aji-33	527	14	pathology	pathology	NOUN
aji-33	527	15	of	of	ADP
aji-33	527	16	the	the	DET
aji-33	527	17	covid19	covid19	NOUN
aji-33	527	18	is	be	AUX
aji-33	527	19	stressed	stress	VERB
aji-33	527	20	.	.	PUNCT
aji-33	528	1	the	the	DET
aji-33	528	2	relevance	relevance	NOUN
aji-33	528	3	of	of	ADP
aji-33	528	4	ards	ard	NOUN
aji-33	528	5	cytokine	cytokine	PROPN
aji-33	528	6	storm	storm	NOUN
aji-33	528	7	,	,	PUNCT
aji-33	528	8	the	the	DET
aji-33	528	9	small	small	ADJ
aji-33	528	10	vessel	vessel	NOUN
aji-33	528	11	vasculitis	vasculitis	PROPN
aji-33	528	12	,	,	PUNCT
aji-33	528	13	coagulative	coagulative	NOUN
aji-33	528	14	microangiopathy	microangiopathy	PROPN
aji-33	528	15	,	,	PUNCT
aji-33	528	16	disseminated	disseminate	VERB
aji-33	528	17	intravascular	intravascular	ADJ
aji-33	528	18	coagulation	coagulation	NOUN
aji-33	528	19	and	and	CCONJ
aji-33	528	20	multi	multi	ADJ
aji-33	528	21	organ	organ	NOUN
aji-33	528	22	disfunction	disfunction	NOUN
aji-33	528	23	in	in	ADP
aji-33	528	24	relation	relation	NOUN
aji-33	528	25	to	to	PART
aji-33	528	26	covid	covid	VERB
aji-33	528	27	19	19	NUM
aji-33	528	28	pathology	pathology	NOUN
aji-33	528	29	are	be	AUX
aji-33	528	30	discussed	discuss	VERB
aji-33	528	31	.	.	PUNCT
aji-33	529	1	it	it	PRON
aji-33	529	2	is	be	AUX
aji-33	529	3	also	also	ADV
aji-33	529	4	shown	show	VERB
aji-33	529	5	that	that	SCONJ
aji-33	529	6	no	no	DET
aji-33	529	7	single	single	ADJ
aji-33	529	8	mechanism	mechanism	NOUN
aji-33	529	9	could	could	AUX
aji-33	529	10	explain	explain	VERB
aji-33	529	11	the	the	DET
aji-33	529	12	whole	whole	ADJ
aji-33	529	13	gamut	gamut	NOUN
aji-33	529	14	of	of	ADP
aji-33	529	15	the	the	DET
aji-33	529	16	pathology	pathology	NOUN
aji-33	529	17	and	and	CCONJ
aji-33	529	18	pathogenesis	pathogenesis	NOUN
aji-33	529	19	of	of	ADP
aji-33	529	20	covid	covid	PROPN
aji-33	529	21	19	19	NUM
aji-33	529	22	lung	lung	NOUN
aji-33	529	23	damage	damage	NOUN
aji-33	529	24	.	.	PUNCT
aji-33	530	1	the	the	DET
aji-33	530	2	immune	immune	ADJ
aji-33	530	3	mediated	mediate	VERB
aji-33	530	4	damage	damage	NOUN
aji-33	530	5	seems	seem	VERB
aji-33	530	6	to	to	PART
aji-33	530	7	be	be	AUX
aji-33	530	8	more	more	ADV
aji-33	530	9	relevant	relevant	ADJ
aji-33	530	10	,	,	PUNCT
aji-33	530	11	rather	rather	ADV
aji-33	530	12	than	than	ADP
aji-33	530	13	the	the	DET
aji-33	530	14	infectivity	infectivity	NOUN
aji-33	530	15	of	of	ADP
aji-33	530	16	the	the	DET
aji-33	530	17	virus	virus	NOUN
aji-33	530	18	.	.	PUNCT
aji-33	531	1	it	it	PRON
aji-33	531	2	is	be	AUX
aji-33	531	3	obvious	obvious	ADJ
aji-33	531	4	that	that	SCONJ
aji-33	531	5	no	no	DET
aji-33	531	6	single	single	ADJ
aji-33	531	7	entity	entity	NOUN
aji-33	531	8	could	could	AUX
aji-33	531	9	explain	explain	VERB
aji-33	531	10	the	the	DET
aji-33	531	11	inflamatory	inflamatory	ADJ
aji-33	531	12	,	,	PUNCT
aji-33	531	13	fibrotic	fibrotic	ADJ
aji-33	531	14	and	and	CCONJ
aji-33	531	15	vascular	vascular	ADJ
aji-33	531	16	features	feature	NOUN
aji-33	531	17	observed	observe	VERB
aji-33	531	18	in	in	ADP
aji-33	531	19	the	the	DET
aji-33	531	20	lung	lung	NOUN
aji-33	531	21	of	of	ADP
aji-33	531	22	covid	covid	PROPN
aji-33	531	23	19	19	NUM
aji-33	531	24	patients	patient	NOUN
aji-33	531	25	,	,	PUNCT
aji-33	531	26	it	it	PRON
aji-33	531	27	seems	seem	VERB
aji-33	531	28	to	to	PART
aji-33	531	29	be	be	AUX
aji-33	531	30	due	due	ADJ
aji-33	531	31	to	to	ADP
aji-33	531	32	a	a	DET
aji-33	531	33	mixture	mixture	NOUN
aji-33	531	34	of	of	ADP
aji-33	531	35	different	different	ADJ
aji-33	531	36	overlapping	overlap	VERB
aji-33	531	37	immune	immune	ADJ
aji-33	531	38	mechanisms	mechanism	NOUN
aji-33	531	39	,	,	PUNCT
aji-33	531	40	resulting	result	VERB
aji-33	531	41	in	in	ADP
aji-33	531	42	evolution	evolution	NOUN
aji-33	531	43	of	of	ADP
aji-33	531	44	the	the	DET
aji-33	531	45	unique	unique	ADJ
aji-33	531	46	pathogenic	pathogenic	ADJ
aji-33	531	47	mechanism	mechanism	NOUN
aji-33	531	48	of	of	ADP
aji-33	531	49	covid	covid	PROPN
aji-33	531	50	19	19	NUM
aji-33	531	51	.	.	PUNCT
aji-33	532	1	it	it	PRON
aji-33	532	2	is	be	AUX
aji-33	532	3	perhaps	perhaps	ADV
aji-33	532	4	justifiable	justifiable	ADJ
aji-33	532	5	,	,	PUNCT
aji-33	532	6	from	from	ADP
aji-33	532	7	the	the	DET
aji-33	532	8	author	author	NOUN
aji-33	532	9	’s	’s	PART
aji-33	532	10	point	point	NOUN
aji-33	532	11	of	of	ADP
aji-33	532	12	view	view	NOUN
aji-33	532	13	to	to	PART
aji-33	532	14	call	call	VERB
aji-33	532	15	the	the	DET
aji-33	532	16	covid	covid	PROPN
aji-33	532	17	19	19	NUM
aji-33	532	18	related	relate	VERB
aji-33	532	19	lung	lung	NOUN
aji-33	532	20	damage	damage	NOUN
aji-33	532	21	as	as	ADP
aji-33	532	22	“	"	PUNCT
aji-33	532	23	acute	acute	ADJ
aji-33	532	24	immune	immune	ADJ
aji-33	532	25	mediated	mediate	VERB
aji-33	532	26	lung	lung	NOUN
aji-33	532	27	injury	injury	NOUN
aji-33	532	28	(	(	PUNCT
aji-33	532	29	aili	aili	NOUN
aji-33	532	30	)	)	PUNCT
aji-33	532	31	.	.	PUNCT
aji-33	533	1	prasad	prasad	PROPN
aji-33	533	2	;	;	PUNCT
aji-33	533	3	aji	aji	NOUN
aji-33	533	4	,	,	PUNCT
aji-33	533	5	3(1	3(1	NUM
aji-33	533	6	):	):	PUNCT
aji-33	533	7	233	233	NUM
aji-33	533	8	-	-	SYM
aji-33	533	9	252	252	NUM
aji-33	533	10	,	,	PUNCT
aji-33	533	11	2020	2020	NUM
aji-33	533	12	;	;	PUNCT
aji-33	533	13	article	article	NOUN
aji-33	533	14	no.aji.58422	no.aji.58422	NOUN
aji-33	533	15	247	247	NUM
aji-33	533	16	consent	consent	NOUN
aji-33	533	17	it	it	PRON
aji-33	533	18	is	be	AUX
aji-33	533	19	not	not	PART
aji-33	533	20	applicable	applicable	ADJ
aji-33	533	21	.	.	PUNCT
aji-33	534	1	ethical	ethical	ADJ
aji-33	534	2	approval	approval	NOUN
aji-33	534	3	it	it	PRON
aji-33	534	4	is	be	AUX
aji-33	534	5	not	not	PART
aji-33	534	6	applicable	applicable	ADJ
aji-33	534	7	.	.	PUNCT
aji-33	535	1	competing	compete	VERB
aji-33	535	2	interests	interest	NOUN
aji-33	535	3	author	author	NOUN
aji-33	535	4	has	have	AUX
aji-33	535	5	declared	declare	VERB
aji-33	535	6	that	that	SCONJ
aji-33	535	7	no	no	DET
aji-33	535	8	competing	compete	VERB
aji-33	535	9	interests	interest	NOUN
aji-33	535	10	exist	exist	VERB
aji-33	535	11	.	.	PUNCT
aji-33	536	1	references	reference	NOUN
aji-33	536	2	1	1	NUM
aji-33	536	3	.	.	PUNCT
aji-33	536	4	li	li	PROPN
aji-33	536	5	x	x	PROPN
aji-33	536	6	,	,	PUNCT
aji-33	536	7	ma	ma	PROPN
aji-33	536	8	x.	x.	PROPN
aji-33	536	9	acute	acute	PROPN
aji-33	536	10	respiratory	respiratory	ADJ
aji-33	536	11	failure	failure	NOUN
aji-33	536	12	in	in	ADP
aji-33	536	13	covid-19	covid-19	PROPN
aji-33	536	14	:	:	PUNCT
aji-33	536	15	is	be	AUX
aji-33	536	16	it	it	PRON
aji-33	536	17	“	"	PUNCT
aji-33	536	18	typical	typical	ADJ
aji-33	536	19	”	"	PUNCT
aji-33	536	20	ards	ard	NOUN
aji-33	536	21	?	?	PUNCT
aji-33	537	1	crit	crit	PROPN
aji-33	537	2	care	care	NOUN
aji-33	537	3	.	.	PUNCT
aji-33	538	1	2020;24:198	2020;24:198	X
aji-33	538	2	.	.	NOUN
aji-33	539	1	2	2	NUM
aji-33	539	2	.	.	X
aji-33	539	3	peter	peter	PROPN
aji-33	539	4	g	g	PROPN
aji-33	539	5	,	,	PUNCT
aji-33	539	6	gibson	gibson	PROPN
aji-33	539	7	,	,	PUNCT
aji-33	539	8	ling	ling	PROPN
aji-33	539	9	qin	qin	PROPN
aji-33	539	10	,	,	PUNCT
aji-33	539	11	ser	ser	NOUN
aji-33	539	12	puah	puah	PROPN
aji-33	539	13	.	.	PUNCT
aji-33	540	1	covid-19	covid-19	PROPN
aji-33	540	2	ards	ard	VERB
aji-33	540	3	:	:	PUNCT
aji-33	540	4	clinical	clinical	ADJ
aji-33	540	5	features	feature	NOUN
aji-33	540	6	and	and	CCONJ
aji-33	540	7	differences	difference	NOUN
aji-33	540	8	to	to	ADP
aji-33	540	9	“	"	PUNCT
aji-33	540	10	usual	usual	ADJ
aji-33	540	11	”	"	PUNCT
aji-33	540	12	pre	pre	ADJ
aji-33	540	13	-	-	ADJ
aji-33	540	14	covid	covid	ADJ
aji-33	540	15	ards	ard	NOUN
aji-33	540	16	.	.	PUNCT
aji-33	541	1	3	3	X
aji-33	541	2	.	.	X
aji-33	541	3	wu	wu	PROPN
aji-33	541	4	c	c	PROPN
aji-33	541	5	,	,	PUNCT
aji-33	541	6	chen	chen	PROPN
aji-33	541	7	x	x	PROPN
aji-33	541	8	,	,	PUNCT
aji-33	541	9	cai	cai	PROPN
aji-33	541	10	y	y	PROPN
aji-33	541	11	,	,	PUNCT
aji-33	541	12	xia	xia	PROPN
aji-33	541	13	j	j	PROPN
aji-33	541	14	,	,	PUNCT
aji-33	541	15	zhou	zhou	PROPN
aji-33	541	16	x	x	PROPN
aji-33	541	17	,	,	PUNCT
aji-33	541	18	xu	xu	PROPN
aji-33	541	19	s	s	PROPN
aji-33	541	20	,	,	PUNCT
aji-33	541	21	huang	huang	PROPN
aji-33	541	22	h	h	PROPN
aji-33	541	23	,	,	PUNCT
aji-33	541	24	zhang	zhang	PROPN
aji-33	541	25	l	l	PROPN
aji-33	541	26	,	,	PUNCT
aji-33	541	27	zhou	zhou	PROPN
aji-33	541	28	x	x	PROPN
aji-33	541	29	,	,	PUNCT
aji-33	541	30	du	du	PROPN
aji-33	541	31	c	c	X
aji-33	541	32	,	,	PUNCT
aji-33	541	33	zhang	zhang	PROPN
aji-33	541	34	y	y	PROPN
aji-33	541	35	,	,	PUNCT
aji-33	541	36	song	song	PROPN
aji-33	541	37	j	j	PROPN
aji-33	541	38	,	,	PUNCT
aji-33	541	39	wang	wang	PROPN
aji-33	541	40	s	s	PROPN
aji-33	541	41	,	,	PUNCT
aji-33	541	42	chao	chao	PROPN
aji-33	541	43	y	y	PROPN
aji-33	541	44	,	,	PUNCT
aji-33	541	45	yang	yang	PROPN
aji-33	541	46	z	z	PROPN
aji-33	541	47	,	,	PUNCT
aji-33	541	48	xu	xu	PROPN
aji-33	541	49	j	j	PROPN
aji-33	541	50	,	,	PUNCT
aji-33	541	51	zhou	zhou	PROPN
aji-33	541	52	x	x	PROPN
aji-33	541	53	,	,	PUNCT
aji-33	542	1	chen	chen	PROPN
aji-33	542	2	d	d	PROPN
aji-33	542	3	,	,	PUNCT
aji-33	542	4	xiong	xiong	PROPN
aji-33	542	5	w	w	PROPN
aji-33	542	6	,	,	PUNCT
aji-33	542	7	xu	xu	PROPN
aji-33	543	1	l	l	NOUN
aji-33	543	2	,	,	PUNCT
aji-33	543	3	zhou	zhou	PROPN
aji-33	543	4	f	f	PROPN
aji-33	543	5	,	,	PUNCT
aji-33	543	6	jiang	jiang	PROPN
aji-33	543	7	j	j	PROPN
aji-33	543	8	,	,	PUNCT
aji-33	543	9	bai	bai	PROPN
aji-33	543	10	c	c	PROPN
aji-33	543	11	,	,	PUNCT
aji-33	543	12	zheng	zheng	PROPN
aji-33	543	13	j	j	PROPN
aji-33	543	14	,	,	PUNCT
aji-33	543	15	song	song	ADJ
aji-33	543	16	y.	y.	PROPN
aji-33	543	17	risk	risk	NOUN
aji-33	543	18	factors	factor	NOUN
aji-33	543	19	associated	associate	VERB
aji-33	543	20	with	with	ADP
aji-33	543	21	acute	acute	ADJ
aji-33	543	22	respiratory	respiratory	ADJ
aji-33	543	23	distress	distress	NOUN
aji-33	543	24	syndrome	syndrome	NOUN
aji-33	543	25	and	and	CCONJ
aji-33	543	26	death	death	NOUN
aji-33	543	27	in	in	ADP
aji-33	543	28	patients	patient	NOUN
aji-33	543	29	with	with	ADP
aji-33	543	30	coronavirus	coronavirus	NOUN
aji-33	543	31	disease	disease	NOUN
aji-33	543	32	2019	2019	NUM
aji-33	543	33	pneumonia	pneumonia	NOUN
aji-33	543	34	in	in	ADP
aji-33	543	35	wuhan	wuhan	PROPN
aji-33	543	36	,	,	PUNCT
aji-33	543	37	china	china	PROPN
aji-33	543	38	.	.	PROPN
aji-33	544	1	jama	jama	PROPN
aji-33	544	2	intern	intern	PROPN
aji-33	544	3	med	me	VERB
aji-33	544	4	;	;	PUNCT
aji-33	544	5	2020	2020	NUM
aji-33	544	6	.	.	PUNCT
aji-33	545	1	4	4	X
aji-33	545	2	.	.	X
aji-33	545	3	puah	puah	PROPN
aji-33	545	4	sh	sh	PROPN
aji-33	545	5	.	.	PUNCT
aji-33	546	1	covid-19	covid-19	PROPN
aji-33	546	2	global	global	ADJ
aji-33	546	3	perspectives	perspective	NOUN
aji-33	546	4	.	.	PUNCT
aji-33	547	1	ats	ats	PROPN
aji-33	547	2	/	/	SYM
aji-33	547	3	apsr	apsr	PROPN
aji-33	547	4	joint	joint	ADJ
aji-33	547	5	webinar	webinar	NOUN
aji-33	547	6	.	.	PUNCT
aji-33	548	1	definition	definition	NOUN
aji-33	548	2	task	task	PROPN
aji-33	548	3	force	force	PROPN
aji-33	548	4	ards	ards	PROPN
aji-33	548	5	,	,	PUNCT
aji-33	548	6	ranieri	ranieri	PROPN
aji-33	548	7	vm	vm	PROPN
aji-33	548	8	,	,	PUNCT
aji-33	548	9	rubenfeld	rubenfeld	VERB
aji-33	548	10	gd	gd	PROPN
aji-33	548	11	,	,	PUNCT
aji-33	548	12	et	et	PROPN
aji-33	548	13	al	al	PROPN
aji-33	548	14	.	.	PUNCT
aji-33	549	1	acute	acute	ADJ
aji-33	549	2	respiratory	respiratory	ADJ
aji-33	549	3	distress	distress	NOUN
aji-33	549	4	syndrome	syndrome	NOUN
aji-33	549	5	:	:	PUNCT
aji-33	549	6	the	the	DET
aji-33	549	7	berlin	berlin	PROPN
aji-33	549	8	definition	definition	NOUN
aji-33	549	9	.	.	PUNCT
aji-33	550	1	jama	jama	PROPN
aji-33	550	2	.	.	PUNCT
aji-33	551	1	2012;307	2012;307	NUM
aji-33	551	2	:	:	PUNCT
aji-33	552	1	2526–33	2526–33	NUM
aji-33	552	2	.	.	PUNCT
aji-33	553	1	available	available	ADJ
aji-33	553	2	:	:	PUNCT
aji-33	553	3	www.apsresp.org	www.apsresp.org	X
aji-33	553	4	5	5	NUM
aji-33	553	5	.	.	PUNCT
aji-33	554	1	wang	wang	PROPN
aji-33	554	2	d	d	PROPN
aji-33	554	3	,	,	PUNCT
aji-33	554	4	hu	hu	PROPN
aji-33	554	5	b	b	PROPN
aji-33	554	6	,	,	PUNCT
aji-33	554	7	hu	hu	PROPN
aji-33	555	1	c	c	X
aji-33	555	2	,	,	PUNCT
aji-33	555	3	et	et	PROPN
aji-33	555	4	al	al	PROPN
aji-33	555	5	.	.	PROPN
aji-33	556	1	clinical	clinical	ADJ
aji-33	556	2	characteristics	characteristic	NOUN
aji-33	556	3	of	of	ADP
aji-33	556	4	138	138	NUM
aji-33	556	5	hospitalized	hospitalize	VERB
aji-33	556	6	patients	patient	NOUN
aji-33	556	7	with	with	ADP
aji-33	556	8	2019	2019	NUM
aji-33	556	9	novel	novel	ADJ
aji-33	556	10	coronavirus	coronavirus	NOUN
aji-33	556	11	-	-	PUNCT
aji-33	556	12	infected	infect	VERB
aji-33	556	13	pneumonia	pneumonia	NOUN
aji-33	556	14	in	in	ADP
aji-33	556	15	wuhan	wuhan	PROPN
aji-33	556	16	,	,	PUNCT
aji-33	556	17	china	china	PROPN
aji-33	556	18	.	.	PUNCT
aji-33	557	1	jama	jama	PROPN
aji-33	557	2	;	;	PUNCT
aji-33	557	3	2020	2020	NUM
aji-33	557	4	.	.	PUNCT
aji-33	558	1	6	6	NUM
aji-33	558	2	.	.	X
aji-33	559	1	zhou	zhou	PROPN
aji-33	559	2	f	f	PROPN
aji-33	559	3	,	,	PUNCT
aji-33	559	4	yu	yu	PROPN
aji-33	559	5	t	t	PROPN
aji-33	559	6	,	,	PUNCT
aji-33	559	7	du	du	PROPN
aji-33	559	8	r	r	PROPN
aji-33	559	9	,	,	PUNCT
aji-33	559	10	et	et	PROPN
aji-33	559	11	al	al	PROPN
aji-33	559	12	.	.	PUNCT
aji-33	560	1	clinical	clinical	ADJ
aji-33	560	2	course	course	NOUN
aji-33	560	3	and	and	CCONJ
aji-33	560	4	risk	risk	NOUN
aji-33	560	5	factors	factor	NOUN
aji-33	560	6	for	for	ADP
aji-33	560	7	mortality	mortality	NOUN
aji-33	560	8	of	of	ADP
aji-33	560	9	adult	adult	NOUN
aji-33	560	10	inpatients	inpatient	NOUN
aji-33	560	11	with	with	ADP
aji-33	560	12	covid-19	covid-19	PROPN
aji-33	560	13	in	in	ADP
aji-33	560	14	wuhan	wuhan	PROPN
aji-33	560	15	,	,	PUNCT
aji-33	560	16	china	china	PROPN
aji-33	560	17	:	:	PUNCT
aji-33	560	18	a	a	DET
aji-33	560	19	retrospective	retrospective	ADJ
aji-33	560	20	cohort	cohort	NOUN
aji-33	560	21	study	study	NOUN
aji-33	560	22	.	.	PUNCT
aji-33	561	1	lancet	lancet	PROPN
aji-33	561	2	;	;	PUNCT
aji-33	561	3	2020	2020	NUM
aji-33	561	4	.	.	PUNCT
aji-33	562	1	7	7	X
aji-33	562	2	.	.	X
aji-33	562	3	huang	huang	PROPN
aji-33	562	4	c	c	PROPN
aji-33	562	5	,	,	PUNCT
aji-33	562	6	wang	wang	PROPN
aji-33	562	7	y	y	PROPN
aji-33	562	8	,	,	PUNCT
aji-33	562	9	li	li	PROPN
aji-33	562	10	x	x	PROPN
aji-33	562	11	,	,	PUNCT
aji-33	562	12	et	et	PROPN
aji-33	562	13	al	al	PROPN
aji-33	562	14	.	.	PUNCT
aji-33	563	1	clinical	clinical	ADJ
aji-33	563	2	features	feature	NOUN
aji-33	563	3	of	of	ADP
aji-33	563	4	patients	patient	NOUN
aji-33	563	5	with	with	ADP
aji-33	563	6	2019	2019	NUM
aji-33	563	7	novel	novel	ADJ
aji-33	563	8	coronavirus	coronavirus	NOUN
aji-33	563	9	in	in	ADP
aji-33	563	10	wuhan	wuhan	PROPN
aji-33	563	11	,	,	PUNCT
aji-33	563	12	china	china	PROPN
aji-33	563	13	.	.	PUNCT
aji-33	564	1	lancet	lancet	PROPN
aji-33	564	2	.	.	PUNCT
aji-33	565	1	2020;395(10223):497–506	2020;395(10223):497–506	NOUN
aji-33	565	2	.	.	NOUN
aji-33	566	1	8	8	NUM
aji-33	566	2	.	.	X
aji-33	567	1	guan	guan	PROPN
aji-33	567	2	wj	wj	PROPN
aji-33	567	3	,	,	PUNCT
aji-33	567	4	ni	ni	PROPN
aji-33	567	5	zy	zy	PROPN
aji-33	567	6	,	,	PUNCT
aji-33	567	7	hu	hu	PROPN
aji-33	567	8	y	y	PROPN
aji-33	567	9	,	,	PUNCT
aji-33	567	10	et	et	PROPN
aji-33	567	11	al	al	PROPN
aji-33	567	12	.	.	PROPN
aji-33	568	1	clinical	clinical	ADJ
aji-33	568	2	characteristics	characteristic	NOUN
aji-33	568	3	of	of	ADP
aji-33	568	4	coronavirus	coronavirus	NOUN
aji-33	568	5	disease	disease	NOUN
aji-33	568	6	2019	2019	NUM
aji-33	568	7	in	in	ADP
aji-33	568	8	china	china	PROPN
aji-33	568	9	.	.	PUNCT
aji-33	569	1	n	n	PROPN
aji-33	569	2	engl	engl	PROPN
aji-33	569	3	j	j	PROPN
aji-33	569	4	med	med	PROPN
aji-33	569	5	;	;	PUNCT
aji-33	569	6	2020	2020	NUM
aji-33	569	7	.	.	PUNCT
aji-33	570	1	available	available	ADJ
aji-33	570	2	:	:	PUNCT
aji-33	570	3	https://doi.org/10.1056	https://doi.org/10.1056	PROPN
aji-33	570	4	/	/	SYM
aji-33	570	5	nejmoa2	nejmoa2	NOUN
aji-33	570	6	002032	002032	NUM
aji-33	570	7	9	9	X
aji-33	570	8	.	.	X
aji-33	571	1	robba	robba	PROPN
aji-33	571	2	c	c	PROPN
aji-33	571	3	,	,	PUNCT
aji-33	571	4	battaglini	battaglini	PROPN
aji-33	571	5	,	,	PUNCT
aji-33	571	6	ball	ball	NOUN
aji-33	571	7	l	l	NOUN
aji-33	571	8	,	,	PUNCT
aji-33	571	9	patroniti	patroniti	NOUN
aji-33	571	10	loconte	loconte	VERB
aji-33	571	11	m	m	VERB
aji-33	571	12	brunetti	brunetti	NOUN
aji-33	572	1	i	i	PROPN
aji-33	572	2	,	,	PUNCT
aji-33	572	3	et	et	PROPN
aji-33	572	4	al	al	PROPN
aji-33	572	5	.	.	PROPN
aji-33	572	6	distinct	distinct	ADJ
aji-33	572	7	phenotypes	phenotype	NOUN
aji-33	572	8	require	require	VERB
aji-33	572	9	distinct	distinct	ADJ
aji-33	572	10	respiratory	respiratory	ADJ
aji-33	572	11	management	management	NOUN
aji-33	572	12	strategies	strategy	NOUN
aji-33	572	13	in	in	ADP
aji-33	572	14	sever	sever	ADJ
aji-33	572	15	covid19	covid19	NOUN
aji-33	572	16	.	.	PUNCT
aji-33	573	1	respiratory	respiratory	ADJ
aji-33	573	2	physiology	physiology	NOUN
aji-33	573	3	&	&	CCONJ
aji-33	573	4	neurobiology	neurobiology	NOUN
aji-33	573	5	;	;	PUNCT
aji-33	573	6	2020	2020	NUM
aji-33	573	7	.	.	PUNCT
aji-33	574	1	10	10	NUM
aji-33	574	2	.	.	PUNCT
aji-33	574	3	gattinoni	gattinoni	PROPN
aji-33	574	4	l	l	PROPN
aji-33	574	5	,	,	PUNCT
aji-33	574	6	chiumello	chiumello	PROPN
aji-33	574	7	d	d	PROPN
aji-33	574	8	,	,	PUNCT
aji-33	574	9	rossi	rossi	PROPN
aji-33	574	10	s.	s.	PROPN
aji-33	574	11	covid19	covid19	PROPN
aji-33	574	12	pneumonia	pneumonia	PROPN
aji-33	574	13	:	:	PUNCT
aji-33	574	14	ards	ard	NOUN
aji-33	574	15	or	or	CCONJ
aji-33	574	16	not	not	PART
aji-33	574	17	?	?	PUNCT
aji-33	575	1	crit	crit	PROPN
aji-33	575	2	care	care	NOUN
aji-33	575	3	.	.	PUNCT
aji-33	576	1	2020;24:154	2020;24:154	X
aji-33	576	2	.	.	PUNCT
aji-33	577	1	11	11	NUM
aji-33	577	2	.	.	PUNCT
aji-33	578	1	xiaowei	xiaowei	PROPN
aji-33	578	2	li	li	PROPN
aji-33	578	3	,	,	PUNCT
aji-33	578	4	shemin	shemin	PROPN
aji-33	578	5	lu	lu	PROPN
aji-33	578	6	.	.	PUNCT
aji-33	579	1	molecular	molecular	ADJ
aji-33	579	2	immune	immune	ADJ
aji-33	579	3	pathogenesis	pathogenesis	NOUN
aji-33	579	4	and	and	CCONJ
aji-33	579	5	diagnosis	diagnosis	NOUN
aji-33	579	6	of	of	ADP
aji-33	579	7	covid-19	covid-19	PROPN
aji-33	579	8	journal	journal	NOUN
aji-33	579	9	of	of	ADP
aji-33	579	10	pharmaceutical	pharmaceutical	ADJ
aji-33	579	11	analysis	analysis	NOUN
aji-33	579	12	.	.	PUNCT
aji-33	580	1	2020	2020	NUM
aji-33	580	2	;	;	PUNCT
aji-33	580	3	10(2):102	10(2):102	NUM
aji-33	580	4	-	-	SYM
aji-33	580	5	108	108	NUM
aji-33	580	6	.	.	PUNCT
aji-33	581	1	12	12	NUM
aji-33	581	2	.	.	PUNCT
aji-33	582	1	chani	chani	PROPN
aji-33	582	2	mp	mp	PROPN
aji-33	582	3	.	.	PROPN
aji-33	583	1	revel	revel	VERB
aji-33	583	2	diagnostic	diagnostic	ADJ
aji-33	583	3	and	and	CCONJ
aji-33	583	4	interventional	interventional	ADJ
aji-33	583	5	imaging	imaging	NOUN
aji-33	583	6	.	.	PUNCT
aji-33	584	1	2020;101(5):263	2020;101(5):263	NUM
aji-33	584	2	-	-	SYM
aji-33	584	3	268	268	NUM
aji-33	584	4	.	.	PUNCT
aji-33	585	1	13	13	NUM
aji-33	585	2	.	.	PUNCT
aji-33	586	1	shi	shi	PROPN
aji-33	586	2	h	h	PROPN
aji-33	586	3	,	,	PUNCT
aji-33	586	4	han	han	PROPN
aji-33	586	5	x	x	PROPN
aji-33	586	6	,	,	PUNCT
aji-33	586	7	jiang	jiang	PROPN
aji-33	586	8	n.	n.	PROPN
aji-33	586	9	radiological	radiological	ADJ
aji-33	586	10	findings	finding	NOUN
aji-33	586	11	from	from	ADP
aji-33	586	12	81	81	NUM
aji-33	586	13	patients	patient	NOUN
aji-33	586	14	with	with	ADP
aji-33	586	15	covid-19	covid-19	PROPN
aji-33	586	16	pneumonia	pneumonia	NOUN
aji-33	586	17	in	in	ADP
aji-33	586	18	wuhan	wuhan	PROPN
aji-33	586	19	,	,	PUNCT
aji-33	586	20	china	china	PROPN
aji-33	586	21	:	:	PUNCT
aji-33	586	22	a	a	DET
aji-33	586	23	descriptive	descriptive	ADJ
aji-33	586	24	study	study	NOUN
aji-33	586	25	.	.	PUNCT
aji-33	587	1	lancet	lancet	PROPN
aji-33	587	2	infect	infect	PROPN
aji-33	587	3	dis	dis	PROPN
aji-33	587	4	.	.	PUNCT
aji-33	588	1	2020;20:425–434	2020;20:425–434	NUM
aji-33	588	2	.	.	PUNCT
aji-33	589	1	14	14	NUM
aji-33	589	2	.	.	PUNCT
aji-33	590	1	wei	wei	PROPN
aji-33	590	2	-	-	PROPN
aji-33	590	3	jie	jie	PROPN
aji-33	590	4	guan	guan	PROPN
aji-33	590	5	,	,	PUNCT
aji-33	590	6	et	et	PROPN
aji-33	590	7	al	al	PROPN
aji-33	590	8	.	.	PROPN
aji-33	590	9	clinical	clinical	ADJ
aji-33	590	10	characteristics	characteristic	NOUN
aji-33	590	11	of	of	ADP
aji-33	590	12	corona	corona	PROPN
aji-33	590	13	virus	virus	NOUN
aji-33	590	14	disease	disease	NOUN
aji-33	590	15	in	in	ADP
aji-33	590	16	china	china	PROPN
aji-33	590	17	n	n	PROPN
aji-33	590	18	engl	engl	PROPN
aji-33	590	19	j	j	PROPN
aji-33	590	20	med	med	PROPN
aji-33	590	21	;	;	PUNCT
aji-33	590	22	2020	2020	NUM
aji-33	590	23	.	.	PUNCT
aji-33	591	1	15	15	NUM
aji-33	591	2	.	.	X
aji-33	591	3	xu	xu	PROPN
aji-33	591	4	zhe	zhe	PROPN
aji-33	591	5	,	,	PUNCT
aji-33	591	6	lei	lei	PROPN
aji-33	591	7	shi	shi	PROPN
aji-33	591	8	,	,	PUNCT
aji-33	591	9	yijin	yijin	PROPN
aji-33	591	10	wang	wang	PROPN
aji-33	591	11	,	,	PUNCT
aji-33	591	12	jiyuan	jiyuan	PROPN
aji-33	591	13	zhang	zhang	PROPN
aji-33	591	14	,	,	PUNCT
aji-33	591	15	lei	lei	PROPN
aji-33	591	16	huang	huang	PROPN
aji-33	591	17	,	,	PUNCT
aji-33	591	18	chao	chao	PROPN
aji-33	591	19	zhang	zhang	PROPN
aji-33	591	20	,	,	PUNCT
aji-33	591	21	shuhong	shuhong	PROPN
aji-33	591	22	liu	liu	PROPN
aji-33	591	23	,	,	PUNCT
aji-33	591	24	et	et	PROPN
aji-33	591	25	al	al	PROPN
aji-33	591	26	.	.	PUNCT
aji-33	592	1	pathological	pathological	ADJ
aji-33	592	2	findings	finding	NOUN
aji-33	592	3	of	of	ADP
aji-33	592	4	covid-19	covid-19	PROPN
aji-33	592	5	associated	associate	VERB
aji-33	592	6	with	with	ADP
aji-33	592	7	acute	acute	ADJ
aji-33	592	8	respiratory	respiratory	ADJ
aji-33	592	9	distress	distress	NOUN
aji-33	592	10	syndrome	syndrome	NOUN
aji-33	592	11	.	.	PUNCT
aji-33	593	1	the	the	DET
aji-33	593	2	lancet	lancet	ADJ
aji-33	593	3	respiratory	respiratory	ADJ
aji-33	593	4	medicine	medicine	NOUN
aji-33	593	5	.	.	PUNCT
aji-33	594	1	2020;8(4):420	2020;8(4):420	X
aji-33	594	2	-	-	SYM
aji-33	594	3	422	422	NUM
aji-33	594	4	.	.	PUNCT
aji-33	595	1	16	16	NUM
aji-33	595	2	.	.	PUNCT
aji-33	596	1	joshua	joshua	PROPN
aji-33	596	2	m.	m.	PROPN
aji-33	596	3	thurman	thurman	PROPN
aji-33	596	4	,	,	PUNCT
aji-33	596	5	michael	michael	PROPN
aji-33	596	6	holers	holers	PROPN
aji-33	596	7	v.	v.	ADP
aji-33	596	8	the	the	DET
aji-33	596	9	central	central	ADJ
aji-33	596	10	role	role	NOUN
aji-33	596	11	of	of	ADP
aji-33	596	12	the	the	DET
aji-33	596	13	alternative	alternative	ADJ
aji-33	596	14	complement	complement	NOUN
aji-33	596	15	pathway	pathway	NOUN
aji-33	596	16	in	in	ADP
aji-33	596	17	human	human	ADJ
aji-33	596	18	disease	disease	NOUN
aji-33	596	19	.	.	PUNCT
aji-33	597	1	j	j	PROPN
aji-33	597	2	immunol	immunol	PROPN
aji-33	597	3	.	.	PUNCT
aji-33	598	1	2006;176	2006;176	PROPN
aji-33	598	2	.	.	PUNCT
aji-33	599	1	17	17	NUM
aji-33	599	2	.	.	PUNCT
aji-33	600	1	nilsson	nilsson	PROPN
aji-33	600	2	b	b	PROPN
aji-33	600	3	,	,	PUNCT
aji-33	600	4	nilsson	nilsson	PROPN
aji-33	600	5	ekdahl	ekdahl	PROPN
aji-33	600	6	k.	k.	PROPN
aji-33	601	1	the	the	DET
aji-33	601	2	tick	tick	NOUN
aji-33	601	3	-	-	PUNCT
aji-33	601	4	over	over	ADP
aji-33	601	5	theory	theory	NOUN
aji-33	601	6	revisited	revisit	VERB
aji-33	601	7	:	:	PUNCT
aji-33	601	8	is	be	AUX
aji-33	601	9	c3	c3	PROPN
aji-33	601	10	a	a	DET
aji-33	601	11	contact	contact	NOUN
aji-33	601	12	-	-	PUNCT
aji-33	601	13	activated	activate	VERB
aji-33	601	14	protein	protein	NOUN
aji-33	601	15	?	?	PUNCT
aji-33	602	1	immunobiology	immunobiology	NOUN
aji-33	602	2	.	.	PUNCT
aji-33	603	1	2012;217(11	2012;217(11	NUM
aji-33	603	2	):	):	PUNCT
aji-33	603	3	1106‐1110	1106‐1110	PROPN
aji-33	603	4	.	.	PUNCT
aji-33	604	1	18	18	NUM
aji-33	604	2	.	.	PUNCT
aji-33	604	3	macref	macref	PROPN
aji-33	604	4	mc	mc	PROPN
aji-33	604	5	,	,	PUNCT
aji-33	604	6	tschopp	tschopp	PROPN
aji-33	604	7	j.	j.	PROPN
aji-33	604	8	assembly	assembly	PROPN
aji-33	604	9	of	of	ADP
aji-33	604	10	macromolecular	macromolecular	PROPN
aji-33	604	11	pores	pore	NOUN
aji-33	604	12	by	by	ADP
aji-33	604	13	immune	immune	ADJ
aji-33	604	14	defense	defense	NOUN
aji-33	604	15	systems	system	NOUN
aji-33	604	16	.	.	PUNCT
aji-33	605	1	curr	curr	PROPN
aji-33	605	2	.	.	PUNCT
aji-33	606	1	opin	opin	NOUN
aji-33	606	2	.	.	PUNCT
aji-33	607	1	cell	cell	NOUN
aji-33	607	2	biol	biol	PROPN
aji-33	607	3	.	.	PUNCT
aji-33	608	1	1991;3(4	1991;3(4	NUM
aji-33	608	2	):	):	PUNCT
aji-33	608	3	710–716	710–716	NUM
aji-33	608	4	.	.	PUNCT
aji-33	609	1	19	19	NUM
aji-33	609	2	.	.	PUNCT
aji-33	610	1	conrad	conrad	PROPN
aji-33	610	2	dh	dh	PROPN
aji-33	610	3	,	,	PUNCT
aji-33	610	4	carlo	carlo	PROPN
aji-33	610	5	jr	jr	PROPN
aji-33	610	6	,	,	PUNCT
aji-33	610	7	ruddy	ruddy	VERB
aji-33	610	8	s.	s.	PROPN
aji-33	610	9	interaction	interaction	NOUN
aji-33	610	10	of	of	ADP
aji-33	610	11	beta1h	beta1h	PROPN
aji-33	610	12	globulin	globulin	NOUN
aji-33	610	13	with	with	ADP
aji-33	610	14	cellbound	cellbound	NOUN
aji-33	610	15	c3b	c3b	PROPN
aji-33	610	16	:	:	PUNCT
aji-33	610	17	quantitative	quantitative	ADJ
aji-33	610	18	analysis	analysis	NOUN
aji-33	610	19	of	of	ADP
aji-33	610	20	binding	bind	VERB
aji-33	610	21	and	and	CCONJ
aji-33	610	22	influence	influence	NOUN
aji-33	610	23	of	of	ADP
aji-33	610	24	alternative	alternative	ADJ
aji-33	610	25	pathway	pathway	NOUN
aji-33	610	26	components	component	NOUN
aji-33	610	27	on	on	ADP
aji-33	610	28	binding	bind	VERB
aji-33	610	29	.	.	PUNCT
aji-33	611	1	the	the	DET
aji-33	611	2	journal	journal	NOUN
aji-33	611	3	of	of	ADP
aji-33	611	4	experimental	experimental	ADJ
aji-33	611	5	medicine	medicine	NOUN
aji-33	611	6	.	.	PUNCT
aji-33	612	1	1978	1978	NUM
aji-33	612	2	;	;	PUNCT
aji-33	612	3	147(6):1792–1805	147(6):1792–1805	NUM
aji-33	612	4	.	.	PROPN
aji-33	612	5	20	20	NUM
aji-33	612	6	.	.	PUNCT
aji-33	613	1	weiler	weiler	PROPN
aji-33	613	2	jm	jm	PROPN
aji-33	613	3	,	,	PUNCT
aji-33	613	4	daha	daha	PROPN
aji-33	613	5	mr	mr	PROPN
aji-33	613	6	,	,	PUNCT
aji-33	613	7	austen	austen	PROPN
aji-33	613	8	kf	kf	PROPN
aji-33	613	9	,	,	PUNCT
aji-33	613	10	fearon	fearon	PROPN
aji-33	613	11	dt	dt	PROPN
aji-33	613	12	.	.	PUNCT
aji-33	614	1	control	control	NOUN
aji-33	614	2	of	of	ADP
aji-33	614	3	the	the	DET
aji-33	614	4	amplification	amplification	NOUN
aji-33	614	5	convertase	convertase	NOUN
aji-33	614	6	of	of	ADP
aji-33	614	7	complement	complement	NOUN
aji-33	614	8	by	by	ADP
aji-33	614	9	the	the	DET
aji-33	614	10	plasma	plasma	NOUN
aji-33	614	11	protein	protein	NOUN
aji-33	614	12	beta1h	beta1h	NOUN
aji-33	614	13	"	"	PUNCT
aji-33	614	14	.	.	PUNCT
aji-33	615	1	proceedings	proceeding	NOUN
aji-33	615	2	of	of	ADP
aji-33	615	3	the	the	DET
aji-33	615	4	national	national	PROPN
aji-33	615	5	academy	academy	PROPN
aji-33	615	6	of	of	ADP
aji-33	615	7	sciences	sciences	PROPN
aji-33	615	8	of	of	ADP
aji-33	615	9	the	the	DET
aji-33	615	10	united	united	PROPN
aji-33	615	11	states	states	PROPN
aji-33	615	12	of	of	ADP
aji-33	615	13	america	america	PROPN
aji-33	615	14	.	.	PUNCT
aji-33	616	1	1976;73(9):3268–72	1976;73(9):3268–72	PROPN
aji-33	616	2	.	.	PUNCT
aji-33	617	1	21	21	NUM
aji-33	617	2	.	.	PUNCT
aji-33	618	1	pangburn	pangburn	PROPN
aji-33	618	2	mk	mk	PROPN
aji-33	618	3	,	,	PUNCT
aji-33	618	4	schreiber	schreiber	PROPN
aji-33	618	5	rd	rd	PROPN
aji-33	618	6	,	,	PUNCT
aji-33	618	7	müllereberhard	müllereberhard	PROPN
aji-33	618	8	hj	hj	PROPN
aji-33	618	9	.	.	PUNCT
aji-33	619	1	human	human	PROPN
aji-33	619	2	complement	complement	PROPN
aji-33	619	3	c3b	c3b	NOUN
aji-33	619	4	inactivator	inactivator	NOUN
aji-33	619	5	:	:	PUNCT
aji-33	619	6	isolation	isolation	NOUN
aji-33	619	7	,	,	PUNCT
aji-33	619	8	characterization	characterization	NOUN
aji-33	619	9	,	,	PUNCT
aji-33	619	10	and	and	CCONJ
aji-33	619	11	demonstration	demonstration	NOUN
aji-33	619	12	of	of	ADP
aji-33	619	13	an	an	DET
aji-33	619	14	absolute	absolute	ADJ
aji-33	619	15	requirement	requirement	NOUN
aji-33	619	16	http://www.apsresp.org/	http://www.apsresp.org/	NOUN
aji-33	619	17	prasad	prasad	PROPN
aji-33	619	18	;	;	PUNCT
aji-33	619	19	aji	aji	NOUN
aji-33	619	20	,	,	PUNCT
aji-33	619	21	3(1	3(1	NUM
aji-33	619	22	):	):	PUNCT
aji-33	619	23	233	233	NUM
aji-33	619	24	-	-	SYM
aji-33	619	25	252	252	NUM
aji-33	619	26	,	,	PUNCT
aji-33	619	27	2020	2020	NUM
aji-33	619	28	;	;	PUNCT
aji-33	619	29	article	article	NOUN
aji-33	619	30	no.aji.58422	no.aji.58422	NOUN
aji-33	619	31	248	248	NUM
aji-33	619	32	for	for	ADP
aji-33	619	33	the	the	DET
aji-33	619	34	serum	serum	NOUN
aji-33	619	35	protein	protein	NOUN
aji-33	619	36	beta1h	beta1h	NOUN
aji-33	619	37	for	for	ADP
aji-33	619	38	cleavage	cleavage	NOUN
aji-33	619	39	of	of	ADP
aji-33	619	40	c3b	c3b	PROPN
aji-33	619	41	and	and	CCONJ
aji-33	619	42	c4b	c4b	PROPN
aji-33	619	43	in	in	ADP
aji-33	619	44	solution	solution	NOUN
aji-33	619	45	.	.	PUNCT
aji-33	620	1	the	the	DET
aji-33	620	2	journal	journal	NOUN
aji-33	620	3	of	of	ADP
aji-33	620	4	experimental	experimental	ADJ
aji-33	620	5	medicine	medicine	NOUN
aji-33	620	6	.	.	PUNCT
aji-33	621	1	1977;146(1):257	1977;146(1):257	X
aji-33	621	2	–	–	PUNCT
aji-33	621	3	70	70	NUM
aji-33	621	4	.	.	X
aji-33	622	1	22	22	NUM
aji-33	622	2	.	.	PUNCT
aji-33	623	1	mcrae	mcrae	PROPN
aji-33	623	2	jl	jl	PROPN
aji-33	623	3	,	,	PUNCT
aji-33	623	4	duthy	duthy	ADJ
aji-33	623	5	tg	tg	PROPN
aji-33	623	6	,	,	PUNCT
aji-33	623	7	griggs	griggs	PROPN
aji-33	623	8	km	km	PROPN
aji-33	623	9	,	,	PUNCT
aji-33	623	10	ormsby	ormsby	PROPN
aji-33	623	11	rj	rj	PROPN
aji-33	623	12	,	,	PUNCT
aji-33	623	13	cowan	cowan	PROPN
aji-33	623	14	pj	pj	PROPN
aji-33	623	15	,	,	PUNCT
aji-33	623	16	cromer	cromer	PROPN
aji-33	623	17	ba	ba	PROPN
aji-33	623	18	,	,	PUNCT
aji-33	623	19	mckinstry	mckinstry	PROPN
aji-33	623	20	wj	wj	PROPN
aji-33	623	21	,	,	PUNCT
aji-33	623	22	parker	parker	PROPN
aji-33	623	23	mw	mw	PROPN
aji-33	623	24	,	,	PUNCT
aji-33	623	25	murphy	murphy	PROPN
aji-33	623	26	bf	bf	PROPN
aji-33	623	27	,	,	PUNCT
aji-33	623	28	gordon	gordon	PROPN
aji-33	623	29	dl	dl	PROPN
aji-33	623	30	.	.	PROPN
aji-33	623	31	human	human	ADJ
aji-33	623	32	factor	factor	NOUN
aji-33	623	33	h	h	NOUN
aji-33	623	34	-	-	PUNCT
aji-33	623	35	related	relate	VERB
aji-33	623	36	protein	protein	NOUN
aji-33	623	37	5	5	NUM
aji-33	623	38	has	have	VERB
aji-33	623	39	cofactor	cofactor	NOUN
aji-33	623	40	activity	activity	NOUN
aji-33	623	41	,	,	PUNCT
aji-33	623	42	inhibits	inhibit	VERB
aji-33	623	43	c3	c3	PROPN
aji-33	623	44	convertase	convertase	PROPN
aji-33	623	45	activity	activity	NOUN
aji-33	623	46	,	,	PUNCT
aji-33	623	47	binds	bind	VERB
aji-33	623	48	heparin	heparin	ADJ
aji-33	623	49	and	and	CCONJ
aji-33	623	50	c	c	NOUN
aji-33	623	51	-	-	PUNCT
aji-33	623	52	reactive	reactive	ADJ
aji-33	623	53	protein	protein	NOUN
aji-33	623	54	,	,	PUNCT
aji-33	623	55	and	and	CCONJ
aji-33	623	56	associates	associate	NOUN
aji-33	623	57	with	with	ADP
aji-33	623	58	lipoprotein	lipoprotein	ADJ
aji-33	623	59	.	.	PUNCT
aji-33	624	1	journal	journal	NOUN
aji-33	624	2	of	of	ADP
aji-33	624	3	immunology	immunology	NOUN
aji-33	624	4	.	.	PUNCT
aji-33	625	1	2005;174(10	2005;174(10	PROPN
aji-33	625	2	):	):	PUNCT
aji-33	625	3	6250–6	6250–6	NUM
aji-33	625	4	.	.	NOUN
aji-33	625	5	23	23	NUM
aji-33	625	6	.	.	PUNCT
aji-33	626	1	butthep	butthep	PROPN
aji-33	626	2	p	p	PROPN
aji-33	626	3	,	,	PUNCT
aji-33	626	4	bunyaratvej	bunyaratvej	PROPN
aji-33	626	5	a	a	PROPN
aji-33	626	6	,	,	PUNCT
aji-33	626	7	bhamarapravati	bhamarapravati	PROPN
aji-33	626	8	n.	n.	PROPN
aji-33	626	9	dengue	dengue	PROPN
aji-33	626	10	virus	virus	NOUN
aji-33	626	11	and	and	CCONJ
aji-33	626	12	endothelial	endothelial	ADJ
aji-33	626	13	cell	cell	NOUN
aji-33	626	14	:	:	PUNCT
aji-33	626	15	a	a	DET
aji-33	626	16	related	related	ADJ
aji-33	626	17	phenomenon	phenomenon	NOUN
aji-33	626	18	to	to	ADP
aji-33	626	19	thrombocytopenia	thrombocytopenia	PROPN
aji-33	626	20	and	and	CCONJ
aji-33	626	21	granulo	granulo	PROPN
aji-33	626	22	cytopenia	cytopenia	NOUN
aji-33	626	23	in	in	ADP
aji-33	626	24	dengue	dengue	NOUN
aji-33	626	25	hemorrhagic	hemorrhagic	NOUN
aji-33	626	26	fever	fever	NOUN
aji-33	626	27	.	.	PUNCT
aji-33	627	1	southeast	southeast	ADJ
aji-33	627	2	asian	asian	PROPN
aji-33	627	3	j.	j.	PROPN
aji-33	627	4	trop	trop	PROPN
aji-33	627	5	.	.	PUNCT
aji-33	627	6	med	med	PROPN
aji-33	627	7	.	.	PUNCT
aji-33	628	1	public	public	ADJ
aji-33	628	2	health	health	NOUN
aji-33	628	3	.	.	PUNCT
aji-33	629	1	1993;24(suppl	1993;24(suppl	PROPN
aji-33	629	2	.	.	PUNCT
aji-33	630	1	1):246–249	1):246–249	X
aji-33	630	2	.	.	PUNCT
aji-33	631	1	24	24	NUM
aji-33	631	2	.	.	PUNCT
aji-33	631	3	avirutnan	avirutnan	PROPN
aji-33	631	4	p	p	NOUN
aji-33	631	5	,	,	PUNCT
aji-33	631	6	fuchs	fuchs	VERB
aji-33	631	7	a	a	PRON
aji-33	631	8	,	,	PUNCT
aji-33	631	9	hauhart	hauhart	PROPN
aji-33	631	10	re	re	NOUN
aji-33	631	11	,	,	PUNCT
aji-33	631	12	somnuke	somnuke	PROPN
aji-33	631	13	p	p	X
aji-33	631	14	,	,	PUNCT
aji-33	631	15	youn	youn	PROPN
aji-33	631	16	s	s	PROPN
aji-33	631	17	,	,	PUNCT
aji-33	631	18	diamond	diamond	PROPN
aji-33	631	19	ms	ms	PROPN
aji-33	631	20	,	,	PUNCT
aji-33	631	21	atkinson	atkinson	PROPN
aji-33	631	22	jp	jp	PROPN
aji-33	631	23	.	.	PUNCT
aji-33	632	1	antagonism	antagonism	NOUN
aji-33	632	2	of	of	ADP
aji-33	632	3	the	the	DET
aji-33	632	4	complement	complement	NOUN
aji-33	632	5	component	component	NOUN
aji-33	632	6	c4	c4	NOUN
aji-33	632	7	by	by	ADP
aji-33	632	8	flavivirus	flavivirus	PROPN
aji-33	632	9	nonstructural	nonstructural	ADJ
aji-33	632	10	protein	protein	NOUN
aji-33	632	11	ns1	ns1	PROPN
aji-33	632	12	.	.	PUNCT
aji-33	633	1	j.	j.	PROPN
aji-33	633	2	exp	exp	PROPN
aji-33	633	3	.	.	PROPN
aji-33	633	4	med	med	PROPN
aji-33	633	5	.	.	PROPN
aji-33	633	6	2010;207:793–806	2010;207:793–806	NUM
aji-33	633	7	.	.	X
aji-33	633	8	25	25	NUM
aji-33	633	9	.	.	PUNCT
aji-33	634	1	saifuddin	saifuddin	PROPN
aji-33	634	2	m	m	PROPN
aji-33	634	3	,	,	PUNCT
aji-33	634	4	parker	parker	PROPN
aji-33	634	5	cj	cj	PROPN
aji-33	634	6	,	,	PUNCT
aji-33	634	7	peeples	peeple	VERB
aji-33	634	8	me	i	PRON
aji-33	634	9	,	,	PUNCT
aji-33	634	10	gorny	gorny	PROPN
aji-33	634	11	mk	mk	PROPN
aji-33	634	12	,	,	PUNCT
aji-33	634	13	zolla	zolla	NOUN
aji-33	634	14	-	-	PUNCT
aji-33	634	15	pazner	pazner	PROPN
aji-33	634	16	s	s	NOUN
aji-33	634	17	,	,	PUNCT
aji-33	634	18	ghassemi	ghassemi	PROPN
aji-33	634	19	m	m	PROPN
aji-33	634	20	,	,	PUNCT
aji-33	634	21	rooney	rooney	PROPN
aji-33	634	22	ia	ia	PROPN
aji-33	634	23	,	,	PUNCT
aji-33	634	24	atkinson	atkinson	PROPN
aji-33	634	25	jp	jp	PROPN
aji-33	634	26	,	,	PUNCT
aji-33	634	27	spear	spear	PROPN
aji-33	634	28	gt	gt	PROPN
aji-33	634	29	.	.	PUNCT
aji-33	635	1	role	role	NOUN
aji-33	635	2	of	of	ADP
aji-33	635	3	virion	virion	NOUN
aji-33	635	4	-	-	PUNCT
aji-33	635	5	associated	associate	VERB
aji-33	635	6	glycosylphosphatidylinositol	glycosylphosphatidylinositol	NOUN
aji-33	635	7	-	-	PUNCT
aji-33	635	8	linked	link	VERB
aji-33	635	9	proteins	protein	NOUN
aji-33	635	10	cd55	cd55	PROPN
aji-33	635	11	and	and	CCONJ
aji-33	635	12	cd59	cd59	PROPN
aji-33	635	13	in	in	ADP
aji-33	635	14	complement	complement	NOUN
aji-33	635	15	resistance	resistance	NOUN
aji-33	635	16	of	of	ADP
aji-33	635	17	cell	cell	NOUN
aji-33	635	18	line	line	NOUN
aji-33	635	19	-	-	PUNCT
aji-33	635	20	derived	derive	VERB
aji-33	635	21	and	and	CCONJ
aji-33	635	22	primary	primary	ADJ
aji-33	635	23	isolates	isolate	NOUN
aji-33	635	24	of	of	ADP
aji-33	635	25	hiv-1	hiv-1	X
aji-33	635	26	.	.	PUNCT
aji-33	636	1	j.	j.	PROPN
aji-33	636	2	exp	exp	PROPN
aji-33	636	3	.	.	PROPN
aji-33	636	4	med	med	PROPN
aji-33	636	5	.	.	PROPN
aji-33	637	1	1995;182:501–509	1995;182:501–509	NUM
aji-33	637	2	.	.	PUNCT
aji-33	638	1	26	26	NUM
aji-33	638	2	.	.	X
aji-33	638	3	spear	spear	PROPN
aji-33	638	4	gt	gt	PROPN
aji-33	638	5	,	,	PUNCT
aji-33	638	6	lurain	lurain	VERB
aji-33	638	7	ns	ns	NUM
aji-33	638	8	,	,	PUNCT
aji-33	638	9	parker	parker	PROPN
aji-33	638	10	cj	cj	PROPN
aji-33	638	11	,	,	PUNCT
aji-33	638	12	ghassemi	ghassemi	PROPN
aji-33	638	13	m	m	PROPN
aji-33	638	14	,	,	PUNCT
aji-33	638	15	payne	payne	PROPN
aji-33	638	16	gh	gh	PROPN
aji-33	638	17	,	,	PUNCT
aji-33	638	18	saifuddin	saifuddin	PROPN
aji-33	638	19	m.	m.	NOUN
aji-33	638	20	host	host	NOUN
aji-33	638	21	cell	cell	NOUN
aji-33	638	22	-	-	PUNCT
aji-33	638	23	derived	derive	VERB
aji-33	638	24	complement	complement	NOUN
aji-33	638	25	control	control	NOUN
aji-33	638	26	proteins	protein	NOUN
aji-33	638	27	cd55	cd55	PROPN
aji-33	638	28	and	and	CCONJ
aji-33	638	29	cd59	cd59	PROPN
aji-33	638	30	are	be	AUX
aji-33	638	31	incorporated	incorporate	VERB
aji-33	638	32	into	into	ADP
aji-33	638	33	the	the	DET
aji-33	638	34	virions	virion	NOUN
aji-33	638	35	of	of	ADP
aji-33	638	36	two	two	NUM
aji-33	638	37	unrelated	unrelated	ADJ
aji-33	638	38	enveloped	envelop	VERB
aji-33	638	39	viruses	virus	NOUN
aji-33	638	40	.	.	PUNCT
aji-33	639	1	human	human	PROPN
aji-33	639	2	t	t	PROPN
aji-33	639	3	cell	cell	NOUN
aji-33	639	4	leukemia	leukemia	NOUN
aji-33	639	5	/	/	SYM
aji-33	639	6	lymphoma	lymphoma	NOUN
aji-33	639	7	virus	virus	NOUN
aji-33	639	8	type	type	NOUN
aji-33	639	9	i	i	PRON
aji-33	639	10	(	(	PUNCT
aji-33	639	11	htlv	htlv	PROPN
aji-33	639	12	-	-	PUNCT
aji-33	639	13	i	i	PROPN
aji-33	639	14	)	)	PUNCT
aji-33	639	15	and	and	CCONJ
aji-33	639	16	human	human	ADJ
aji-33	639	17	cytomegalovirus	cytomegalovirus	NOUN
aji-33	639	18	(	(	PUNCT
aji-33	639	19	hcmv	hcmv	NOUN
aji-33	639	20	)	)	PUNCT
aji-33	639	21	j.	j.	PROPN
aji-33	639	22	immunol	immunol	PROPN
aji-33	639	23	.	.	PUNCT
aji-33	640	1	1995;155	1995;155	NUM
aji-33	640	2	:	:	PUNCT
aji-33	640	3	4376–4381	4376–4381	NUM
aji-33	640	4	.	.	PUNCT
aji-33	641	1	27	27	NUM
aji-33	641	2	.	.	PUNCT
aji-33	642	1	datta	datta	PROPN
aji-33	642	2	pk	pk	PROPN
aji-33	642	3	,	,	PUNCT
aji-33	642	4	rappaport	rappaport	PROPN
aji-33	642	5	j.	j.	PROPN
aji-33	642	6	hiv	hiv	PROPN
aji-33	642	7	and	and	CCONJ
aji-33	642	8	complement	complement	PROPN
aji-33	642	9	:	:	PUNCT
aji-33	642	10	hijacking	hijack	VERB
aji-33	642	11	an	an	DET
aji-33	642	12	immune	immune	ADJ
aji-33	642	13	defense	defense	NOUN
aji-33	642	14	.	.	PUNCT
aji-33	643	1	biomed	biome	VERB
aji-33	643	2	.	.	PUNCT
aji-33	644	1	pharmacother	pharmacother	ADJ
aji-33	644	2	.	.	PUNCT
aji-33	645	1	2006;60	2006;60	NUM
aji-33	645	2	:	:	PUNCT
aji-33	646	1	561–568	561–568	NUM
aji-33	646	2	.	.	NOUN
aji-33	646	3	28	28	NUM
aji-33	646	4	.	.	PUNCT
aji-33	647	1	butthep	butthep	PROPN
aji-33	647	2	p	p	PROPN
aji-33	647	3	,	,	PUNCT
aji-33	647	4	bunyaratvej	bunyaratvej	PROPN
aji-33	647	5	a	a	PROPN
aji-33	647	6	,	,	PUNCT
aji-33	647	7	bhamarapravati	bhamarapravati	PROPN
aji-33	647	8	n.	n.	PROPN
aji-33	647	9	dengue	dengue	PROPN
aji-33	647	10	virus	virus	NOUN
aji-33	647	11	and	and	CCONJ
aji-33	647	12	endothelial	endothelial	ADJ
aji-33	647	13	cell	cell	NOUN
aji-33	647	14	:	:	PUNCT
aji-33	647	15	a	a	DET
aji-33	647	16	related	related	ADJ
aji-33	647	17	phenomenon	phenomenon	NOUN
aji-33	647	18	to	to	ADP
aji-33	647	19	thrombocytopenia	thrombocytopenia	PROPN
aji-33	647	20	and	and	CCONJ
aji-33	647	21	granulocytopenia	granulocytopenia	NOUN
aji-33	647	22	in	in	ADP
aji-33	647	23	dengue	dengue	NOUN
aji-33	647	24	hemorrhagic	hemorrhagic	NOUN
aji-33	647	25	fever	fever	NOUN
aji-33	647	26	.	.	PUNCT
aji-33	648	1	southeast	southeast	ADJ
aji-33	648	2	asian	asian	PROPN
aji-33	648	3	j.	j.	PROPN
aji-33	648	4	trop	trop	PROPN
aji-33	648	5	.	.	PUNCT
aji-33	648	6	med	med	PROPN
aji-33	648	7	.	.	PUNCT
aji-33	649	1	public	public	ADJ
aji-33	649	2	health	health	NOUN
aji-33	649	3	.	.	PUNCT
aji-33	650	1	1993;24(suppl	1993;24(suppl	PROPN
aji-33	650	2	.	.	PUNCT
aji-33	650	3	1	1	NUM
aji-33	650	4	)	)	PUNCT
aji-33	650	5	.	.	PUNCT
aji-33	651	1	29	29	NUM
aji-33	651	2	.	.	PUNCT
aji-33	652	1	van	van	PROPN
aji-33	652	2	dam	dam	PROPN
aji-33	652	3	-	-	PUNCT
aji-33	652	4	mieras	mieras	PROPN
aji-33	652	5	mc	mc	PROPN
aji-33	652	6	,	,	PUNCT
aji-33	652	7	muller	muller	NOUN
aji-33	652	8	ad	ad	NOUN
aji-33	652	9	,	,	PUNCT
aji-33	652	10	van	van	PROPN
aji-33	652	11	hinsbergh	hinsbergh	PROPN
aji-33	652	12	vw	vw	PROPN
aji-33	652	13	,	,	PUNCT
aji-33	652	14	mullers	mullers	PROPN
aji-33	652	15	wj	wj	PROPN
aji-33	652	16	,	,	PUNCT
aji-33	652	17	bomans	boman	NOUN
aji-33	652	18	ph	ph	VERB
aji-33	652	19	,	,	PUNCT
aji-33	652	20	bruggeman	bruggeman	NOUN
aji-33	652	21	ca	ca	NOUN
aji-33	652	22	.	.	PUNCT
aji-33	653	1	the	the	DET
aji-33	653	2	procoagulant	procoagulant	ADJ
aji-33	653	3	response	response	NOUN
aji-33	653	4	of	of	ADP
aji-33	653	5	cytomegalovirus	cytomegalovirus	NOUN
aji-33	653	6	infected	infect	VERB
aji-33	653	7	endothelial	endothelial	ADJ
aji-33	653	8	cells	cell	NOUN
aji-33	653	9	.	.	PUNCT
aji-33	654	1	thromb	thromb	NOUN
aji-33	654	2	.	.	PUNCT
aji-33	655	1	haemost	haemost	VERB
aji-33	655	2	.	.	PUNCT
aji-33	656	1	1992;68:364–370	1992;68:364–370	NUM
aji-33	656	2	.	.	PUNCT
aji-33	657	1	[	[	X
aji-33	657	2	pubmed	pubmed	X
aji-33	657	3	]	]	X
aji-33	657	4	[	[	X
aji-33	657	5	google	google	NOUN
aji-33	657	6	scholar	scholar	NOUN
aji-33	657	7	]	]	PUNCT
aji-33	657	8	30	30	NUM
aji-33	657	9	.	.	PUNCT
aji-33	658	1	renne	renne	PROPN
aji-33	658	2	t.	t.	PROPN
aji-33	658	3	the	the	DET
aji-33	658	4	procoagulant	procoagulant	NOUN
aji-33	658	5	and	and	CCONJ
aji-33	658	6	proinflammatory	proinflammatory	ADJ
aji-33	658	7	plasma	plasma	NOUN
aji-33	658	8	contact	contact	NOUN
aji-33	658	9	system	system	NOUN
aji-33	658	10	.	.	PUNCT
aji-33	659	1	semin	semin	PROPN
aji-33	659	2	.	.	PUNCT
aji-33	660	1	immunopathol	immunopathol	PROPN
aji-33	660	2	.	.	PUNCT
aji-33	661	1	2012;34:31–41	2012;34:31–41	NUM
aji-33	661	2	.	.	X
aji-33	662	1	31	31	NUM
aji-33	662	2	.	.	PUNCT
aji-33	663	1	alexander	alexander	PROPN
aji-33	663	2	h.	h.	PROPN
aji-33	663	3	sprague	sprague	PROPN
aji-33	663	4	,	,	PUNCT
aji-33	663	5	raouf	raouf	PROPN
aji-33	663	6	a.	a.	PROPN
aji-33	663	7	khalil	khalil	PROPN
aji-33	663	8	.	.	PUNCT
aji-33	664	1	inflammatory	inflammatory	ADJ
aji-33	664	2	cytokines	cytokine	NOUN
aji-33	664	3	in	in	ADP
aji-33	664	4	vascular	vascular	ADJ
aji-33	664	5	dysfunction	dysfunction	NOUN
aji-33	664	6	and	and	CCONJ
aji-33	664	7	vascular	vascular	ADJ
aji-33	664	8	disease	disease	NOUN
aji-33	664	9	.	.	PUNCT
aji-33	665	1	biochem	biochem	PROPN
aji-33	665	2	pharmacol	pharmacol	PROPN
aji-33	665	3	.	.	PUNCT
aji-33	666	1	2009;78(6):539	2009;78(6):539	NOUN
aji-33	666	2	–	–	PUNCT
aji-33	666	3	552	552	NUM
aji-33	666	4	.	.	PUNCT
aji-33	666	5	32	32	NUM
aji-33	666	6	.	.	PUNCT
aji-33	667	1	marlies	marlies	PROPN
aji-33	667	2	van	van	PROPN
aji-33	667	3	de	de	PROPN
aji-33	667	4	,	,	PUNCT
aji-33	667	5	wouwer	wouwer	NOUN
aji-33	667	6	désiré	désiré	PROPN
aji-33	667	7	colle	colle	PROPN
aji-33	667	8	,	,	PUNCT
aji-33	667	9	edward	edward	PROPN
aji-33	667	10	m.	m.	PROPN
aji-33	667	11	conway	conway	PROPN
aji-33	667	12	arteriosclerosis	arteriosclerosis	NOUN
aji-33	667	13	,	,	PUNCT
aji-33	667	14	thrombosis	thrombosis	NOUN
aji-33	667	15	and	and	CCONJ
aji-33	667	16	vascular	vascular	ADJ
aji-33	667	17	biology	biology	NOUN
aji-33	667	18	.	.	PUNCT
aji-33	668	1	2004	2004	NUM
aji-33	668	2	;	;	PUNCT
aji-33	669	1	24:1374–138	24:1374–138	NUM
aji-33	669	2	.	.	PUNCT
aji-33	670	1	33	33	NUM
aji-33	670	2	.	.	PUNCT
aji-33	671	1	muzio	muzio	PROPN
aji-33	671	2	m	m	PROPN
aji-33	671	3	,	,	PUNCT
aji-33	671	4	stockwell	stockwell	PROPN
aji-33	671	5	br	br	PROPN
aji-33	671	6	,	,	PUNCT
aji-33	671	7	stennicke	stennicke	PROPN
aji-33	671	8	hr	hr	PROPN
aji-33	671	9	,	,	PUNCT
aji-33	671	10	salvesen	salvesen	PROPN
aji-33	671	11	gs	gs	PROPN
aji-33	671	12	,	,	PUNCT
aji-33	671	13	dixit	dixit	PROPN
aji-33	671	14	vm	vm	PROPN
aji-33	671	15	.	.	PROPN
aji-33	672	1	an	an	DET
aji-33	672	2	induced	induced	ADJ
aji-33	672	3	proximity	proximity	NOUN
aji-33	672	4	model	model	NOUN
aji-33	672	5	for	for	ADP
aji-33	672	6	caspase-8	caspase-8	NOUN
aji-33	672	7	activation	activation	NOUN
aji-33	672	8	.	.	PUNCT
aji-33	673	1	j	j	PROPN
aji-33	673	2	biol	biol	PROPN
aji-33	673	3	chem	chem	NOUN
aji-33	673	4	.	.	PUNCT
aji-33	674	1	1998;273(5):2926–2930	1998;273(5):2926–2930	NUM
aji-33	674	2	.	.	NOUN
aji-33	675	1	34	34	NUM
aji-33	675	2	.	.	PUNCT
aji-33	676	1	yoshizumi	yoshizumi	PROPN
aji-33	676	2	m	m	PROPN
aji-33	676	3	,	,	PUNCT
aji-33	676	4	perrella	perrella	PROPN
aji-33	676	5	ma	ma	PROPN
aji-33	676	6	,	,	PUNCT
aji-33	676	7	burnett	burnett	PROPN
aji-33	676	8	jc	jc	PROPN
aji-33	676	9	,	,	PUNCT
aji-33	676	10	jr	jr	PROPN
aji-33	676	11	,	,	PUNCT
aji-33	676	12	lee	lee	PROPN
aji-33	676	13	me	i	PRON
aji-33	676	14	.	.	PUNCT
aji-33	677	1	tumor	tumor	NOUN
aji-33	677	2	necrosis	necrosis	NOUN
aji-33	677	3	factor	factor	NOUN
aji-33	677	4	down	down	ADV
aji-33	677	5	regulates	regulate	VERB
aji-33	677	6	an	an	DET
aji-33	677	7	endothelial	endothelial	ADJ
aji-33	677	8	nitric	nitric	ADJ
aji-33	677	9	oxide	oxide	NOUN
aji-33	677	10	synthase	synthase	NOUN
aji-33	677	11	mrna	mrna	NOUN
aji-33	677	12	by	by	ADP
aji-33	677	13	shortening	shorten	VERB
aji-33	677	14	its	its	PRON
aji-33	677	15	half	half	ADJ
aji-33	677	16	-	-	PUNCT
aji-33	677	17	life	life	NOUN
aji-33	677	18	.	.	PUNCT
aji-33	678	1	circ	circ	PROPN
aji-33	678	2	res	re	NOUN
aji-33	678	3	.	.	PUNCT
aji-33	679	1	1993;73(1):205–209	1993;73(1):205–209	NUM
aji-33	679	2	.	.	PROPN
aji-33	680	1	35	35	NUM
aji-33	680	2	.	.	PUNCT
aji-33	681	1	alma	alma	PROPN
aji-33	681	2	c	c	PROPN
aji-33	681	3	,	,	PUNCT
aji-33	681	4	meacci	meacci	PROPN
aji-33	681	5	e	e	PROPN
aji-33	681	6	,	,	PUNCT
aji-33	681	7	perrotta	perrotta	PROPN
aji-33	681	8	c	c	PROPN
aji-33	681	9	,	,	PUNCT
aji-33	681	10	bruni	bruni	PROPN
aji-33	681	11	p	p	PROPN
aji-33	681	12	,	,	PUNCT
aji-33	681	13	clementi	clementi	PROPN
aji-33	681	14	e.	e.	PROPN
aji-33	681	15	endothelial	endothelial	PROPN
aji-33	681	16	nitric	nitric	ADJ
aji-33	681	17	oxide	oxide	NOUN
aji-33	681	18	synthase	synthase	NOUN
aji-33	681	19	activation	activation	NOUN
aji-33	681	20	by	by	ADP
aji-33	681	21	tumor	tumor	NOUN
aji-33	681	22	necrosis	necrosis	NOUN
aji-33	681	23	factor	factor	NOUN
aji-33	681	24	alpha	alpha	NOUN
aji-33	681	25	through	through	ADP
aji-33	681	26	neutral	neutral	ADJ
aji-33	681	27	sphingomyelinase	sphingomyelinase	PROPN
aji-33	681	28	2	2	NUM
aji-33	681	29	,	,	PUNCT
aji-33	681	30	sphingosine	sphingosine	PROPN
aji-33	681	31	kinase	kinase	PROPN
aji-33	681	32	1	1	NUM
aji-33	681	33	and	and	CCONJ
aji-33	681	34	sphingosine	sphingosine	NOUN
aji-33	681	35	1	1	NUM
aji-33	681	36	phosphate	phosphate	NOUN
aji-33	681	37	receptors	receptor	NOUN
aji-33	681	38	:	:	PUNCT
aji-33	681	39	a	a	DET
aji-33	681	40	novel	novel	ADJ
aji-33	681	41	pathway	pathway	NOUN
aji-33	681	42	relevant	relevant	ADJ
aji-33	681	43	to	to	ADP
aji-33	681	44	the	the	DET
aji-33	681	45	pathophysiology	pathophysiology	NOUN
aji-33	681	46	of	of	ADP
aji-33	681	47	endothelium	endothelium	NOUN
aji-33	681	48	.	.	PUNCT
aji-33	682	1	arterioscler	arterioscler	PROPN
aji-33	682	2	thrombvasc	thrombvasc	PROPN
aji-33	682	3	biol	biol	PROPN
aji-33	682	4	.	.	PUNCT
aji-33	683	1	2006;26(1):99–105	2006;26(1):99–105	NUM
aji-33	683	2	.	.	PUNCT
aji-33	684	1	36	36	NUM
aji-33	684	2	.	.	PUNCT
aji-33	685	1	luscher	luscher	PROPN
aji-33	685	2	tm	tm	PROPN
aji-33	685	3	,	,	PUNCT
aji-33	685	4	steffel	steffel	ADJ
aji-33	685	5	j.	j.	PROPN
aji-33	685	6	sweet	sweet	ADJ
aji-33	685	7	and	and	CCONJ
aji-33	685	8	sour	sour	ADJ
aji-33	685	9	unraveling	unraveling	ADJ
aji-33	685	10	diabetic	diabetic	ADJ
aji-33	685	11	vascular	vascular	ADJ
aji-33	685	12	disease	disease	NOUN
aji-33	685	13	.	.	PUNCT
aji-33	686	1	circ	circ	PROPN
aji-33	686	2	res	re	NOUN
aji-33	686	3	.	.	PUNCT
aji-33	687	1	2007;102:9–1136	2007;102:9–1136	NUM
aji-33	687	2	.	.	PUNCT
aji-33	688	1	liu	liu	PROPN
aji-33	688	2	j	j	PROPN
aji-33	688	3	,	,	PUNCT
aji-33	688	4	et	et	PROPN
aji-33	688	5	al	al	PROPN
aji-33	688	6	.	.	PROPN
aji-33	688	7	c5ar	c5ar	PROPN
aji-33	688	8	,	,	PUNCT
aji-33	688	9	tnf	tnf	PROPN
aji-33	688	10	-	-	PUNCT
aji-33	688	11	alpha	alpha	NOUN
aji-33	688	12	,	,	PUNCT
aji-33	688	13	and	and	CCONJ
aji-33	688	14	fgl2	fgl2	PROPN
aji-33	688	15	contribute	contribute	VERB
aji-33	688	16	to	to	ADP
aji-33	688	17	coagulation	coagulation	NOUN
aji-33	688	18	and	and	CCONJ
aji-33	688	19	complement	complement	VERB
aji-33	688	20	activation	activation	NOUN
aji-33	688	21	in	in	ADP
aji-33	688	22	virus	virus	NOUN
aji-33	688	23	-	-	PUNCT
aji-33	688	24	induced	induce	VERB
aji-33	688	25	fulminant	fulminant	ADJ
aji-33	688	26	hepatitis	hepatitis	NOUN
aji-33	688	27	.	.	PUNCT
aji-33	689	1	j	j	PROPN
aji-33	689	2	hepatol	hepatol	ADJ
aji-33	689	3	.	.	PUNCT
aji-33	690	1	2015;62:354–362	2015;62:354–362	INTJ
aji-33	690	2	.	.	PUNCT
aji-33	691	1	doi	doi	NOUN
aji-33	691	2	:	:	PUNCT
aji-33	691	3	10.1016	10.1016	NUM
aji-33	691	4	/	/	SYM
aji-33	691	5	j.	j.	PROPN
aji-33	691	6	37	37	NUM
aji-33	691	7	.	.	PUNCT
aji-33	692	1	yamagishi	yamagishi	PROPN
aji-33	692	2	s	s	PROPN
aji-33	692	3	,	,	PUNCT
aji-33	692	4	et	et	PROPN
aji-33	692	5	al	al	PROPN
aji-33	692	6	.	.	PROPN
aji-33	692	7	decreased	decrease	VERB
aji-33	692	8	highdensity	highdensity	NOUN
aji-33	692	9	lipoprotein	lipoprotein	ADJ
aji-33	692	10	cholesterol	cholesterol	NOUN
aji-33	692	11	level	level	NOUN
aji-33	692	12	is	be	AUX
aji-33	692	13	an	an	DET
aji-33	692	14	independent	independent	ADJ
aji-33	692	15	correlate	correlate	NOUN
aji-33	692	16	of	of	ADP
aji-33	692	17	circulating	circulate	VERB
aji-33	692	18	tumor	tumor	NOUN
aji-33	692	19	necrosis	necrosis	NOUN
aji-33	692	20	factor	factor	NOUN
aji-33	692	21	-	-	PUNCT
aji-33	692	22	alpha	alpha	NOUN
aji-33	692	23	in	in	ADP
aji-33	692	24	a	a	DET
aji-33	692	25	general	general	ADJ
aji-33	692	26	population	population	NOUN
aji-33	692	27	.	.	PUNCT
aji-33	693	1	clinical	clinical	ADJ
aji-33	693	2	cardiology	cardiology	NOUN
aji-33	693	3	.	.	PUNCT
aji-33	694	1	2009;32	2009;32	NUM
aji-33	694	2	:	:	PUNCT
aji-33	694	3	e29–32	e29–32	NOUN
aji-33	694	4	.	.	PUNCT
aji-33	695	1	doi	doi	NOUN
aji-33	695	2	:	:	PUNCT
aji-33	695	3	10.1002	10.1002	NUM
aji-33	695	4	/	/	SYM
aji-33	695	5	clc.20517	clc.20517	PROPN
aji-33	695	6	38	38	NUM
aji-33	695	7	.	.	PUNCT
aji-33	696	1	yang	yang	PROPN
aji-33	696	2	g	g	PROPN
aji-33	696	3	,	,	PUNCT
aji-33	696	4	shao	shao	PROPN
aji-33	696	5	gf	gf	PROPN
aji-33	696	6	.	.	PROPN
aji-33	696	7	elevated	elevate	VERB
aji-33	696	8	serum	serum	NOUN
aji-33	696	9	il-11	il-11	ADP
aji-33	696	10	,	,	PUNCT
aji-33	696	11	tnf	tnf	PROPN
aji-33	696	12	alpha	alpha	PROPN
aji-33	696	13	,	,	PUNCT
aji-33	696	14	and	and	CCONJ
aji-33	696	15	vegf	vegf	PROPN
aji-33	696	16	expressions	expression	NOUN
aji-33	696	17	contribute	contribute	VERB
aji-33	696	18	to	to	ADP
aji-33	696	19	the	the	DET
aji-33	696	20	pathophysiology	pathophysiology	NOUN
aji-33	696	21	of	of	ADP
aji-33	696	22	hypertensive	hypertensive	ADJ
aji-33	696	23	intracerebral	intracerebral	ADJ
aji-33	696	24	hemorrhage	hemorrhage	NOUN
aji-33	696	25	(	(	PUNCT
aji-33	696	26	hich	hich	NOUN
aji-33	696	27	)	)	PUNCT
aji-33	696	28	neurol	neurol	PROPN
aji-33	696	29	sci	sci	PROPN
aji-33	696	30	.	.	PUNCT
aji-33	697	1	2016;37:1253–1259	2016;37:1253–1259	NUM
aji-33	697	2	.	.	PUNCT
aji-33	698	1	39	39	NUM
aji-33	698	2	.	.	PUNCT
aji-33	699	1	zhang	zhang	PROPN
aji-33	699	2	h	h	PROPN
aji-33	699	3	,	,	PUNCT
aji-33	699	4	et	et	PROPN
aji-33	699	5	al	al	PROPN
aji-33	699	6	.	.	PROPN
aji-33	699	7	role	role	NOUN
aji-33	699	8	of	of	ADP
aji-33	699	9	tnf	tnf	PROPN
aji-33	699	10	-	-	PUNCT
aji-33	699	11	alpha	alpha	NOUN
aji-33	699	12	in	in	ADP
aji-33	699	13	vascular	vascular	ADJ
aji-33	699	14	dysfunction	dysfunction	NOUN
aji-33	699	15	.	.	PUNCT
aji-33	700	1	clin	clin	PROPN
aji-33	700	2	sci	sci	PROPN
aji-33	700	3	(	(	PUNCT
aji-33	700	4	lond	lond	ADJ
aji-33	700	5	)	)	PUNCT
aji-33	700	6	2009	2009	NUM
aji-33	700	7	;	;	PUNCT
aji-33	700	8	116:219–230	116:219–230	NUM
aji-33	700	9	.	.	PUNCT
aji-33	701	1	https://www.ncbi.nlm.nih.gov/pubmed/1332211	https://www.ncbi.nlm.nih.gov/pubmed/1332211	PRON
aji-33	701	2	https://scholar.google.com/scholar_lookup?journal=thromb.+haemost.&title=the+procoagulant+response+of+cytomegalovirus+infected+endothelial+cells&author=m.c.+van+dam-mieras&author=a.d.+muller&author=v.w.+van+hinsbergh&author=w.j.+mullers&author=p.h.+bomans&volume=68&publication_year=1992&pages=364-370&pmid=1332211	https://scholar.google.com/scholar_lookup?journal=thromb.+haemost.&title=the+procoagulant+response+of+cytomegalovirus+infected+endothelial+cells&author=m.c.+van+dam-mieras&author=a.d.+muller&author=v.w.+van+hinsbergh&author=w.j.+mullers&author=p.h.+bomans&volume=68&publication_year=1992&pages=364-370&pmid=1332211	PROPN
aji-33	701	3	&	&	CCONJ
aji-33	701	4	prasad	prasad	PROPN
aji-33	701	5	;	;	PUNCT
aji-33	701	6	aji	aji	NOUN
aji-33	701	7	,	,	PUNCT
aji-33	701	8	3(1	3(1	NUM
aji-33	701	9	):	):	PUNCT
aji-33	701	10	233	233	NUM
aji-33	701	11	-	-	SYM
aji-33	701	12	252	252	NUM
aji-33	701	13	,	,	PUNCT
aji-33	701	14	2020	2020	NUM
aji-33	701	15	;	;	PUNCT
aji-33	701	16	article	article	NOUN
aji-33	701	17	no.aji.58422	no.aji.58422	NOUN
aji-33	701	18	249	249	NUM
aji-33	701	19	40	40	NUM
aji-33	701	20	.	.	PUNCT
aji-33	702	1	pober	pober	PROPN
aji-33	702	2	js	js	PROPN
aji-33	702	3	.	.	PUNCT
aji-33	703	1	effects	effect	NOUN
aji-33	703	2	of	of	ADP
aji-33	703	3	tumour	tumour	NOUN
aji-33	703	4	necrosis	necrosis	NOUN
aji-33	703	5	factor	factor	NOUN
aji-33	703	6	and	and	CCONJ
aji-33	703	7	related	related	ADJ
aji-33	703	8	cytokines	cytokine	NOUN
aji-33	703	9	on	on	ADP
aji-33	703	10	vascular	vascular	ADJ
aji-33	703	11	endothelial	endothelial	ADJ
aji-33	703	12	cells	cell	NOUN
aji-33	703	13	.	.	PUNCT
aji-33	704	1	ciba	ciba	PROPN
aji-33	704	2	found	find	VERB
aji-33	704	3	symp	symp	NOUN
aji-33	704	4	.	.	PUNCT
aji-33	705	1	1987	1987	NUM
aji-33	705	2	;	;	PUNCT
aji-33	706	1	131:170–184	131:170–184	X
aji-33	706	2	.	.	PUNCT
aji-33	707	1	41	41	NUM
aji-33	707	2	.	.	PUNCT
aji-33	708	1	zelová	zelová	PROPN
aji-33	708	2	h	h	PROPN
aji-33	708	3	,	,	PUNCT
aji-33	708	4	hošek	hošek	NOUN
aji-33	708	5	j.	j.	PROPN
aji-33	708	6	tnf	tnf	PROPN
aji-33	708	7	-	-	PUNCT
aji-33	708	8	alpha	alpha	NOUN
aji-33	708	9	signalling	signalling	NOUN
aji-33	708	10	and	and	CCONJ
aji-33	708	11	inflammation	inflammation	NOUN
aji-33	708	12	:	:	PUNCT
aji-33	708	13	interactions	interaction	NOUN
aji-33	708	14	between	between	ADP
aji-33	708	15	old	old	ADJ
aji-33	708	16	acquaintances	acquaintance	NOUN
aji-33	708	17	.	.	PUNCT
aji-33	709	1	inflamm	inflamm	PROPN
aji-33	709	2	res	res	PROPN
aji-33	709	3	.	.	PUNCT
aji-33	710	1	2013;62	2013;62	NUM
aji-33	710	2	:	:	PUNCT
aji-33	711	1	641–651	641–651	NUM
aji-33	711	2	.	.	PUNCT
aji-33	711	3	nikoletopoulou	nikoletopoulou	ADJ
aji-33	711	4	v	v	NOUN
aji-33	711	5	,	,	PUNCT
aji-33	711	6	markaki	markaki	PROPN
aji-33	711	7	m	m	PROPN
aji-33	711	8	,	,	PUNCT
aji-33	711	9	palikaras	palikaras	PROPN
aji-33	711	10	k	k	PROPN
aji-33	711	11	,	,	PUNCT
aji-33	711	12	tavernarakis	tavernarakis	PROPN
aji-33	711	13	n.	n.	PROPN
aji-33	711	14	crosstalk	crosstalk	NOUN
aji-33	711	15	between	between	ADP
aji-33	711	16	apoptosis	apoptosis	NOUN
aji-33	711	17	,	,	PUNCT
aji-33	711	18	necrosis	necrosis	NOUN
aji-33	711	19	and	and	CCONJ
aji-33	711	20	autophagy	autophagy	NOUN
aji-33	711	21	.	.	PUNCT
aji-33	712	1	biochim	biochim	PROPN
aji-33	712	2	biophys	biophy	NOUN
aji-33	712	3	acta	acta	PROPN
aji-33	712	4	.	.	PUNCT
aji-33	713	1	2013	2013	NUM
aji-33	713	2	;	;	PUNCT
aji-33	713	3	1833:3448–3459	1833:3448–3459	NUM
aji-33	713	4	.	.	PUNCT
aji-33	714	1	42	42	NUM
aji-33	714	2	.	.	PUNCT
aji-33	715	1	pignatelli	pignatelli	PROPN
aji-33	715	2	p	p	X
aji-33	715	3	,	,	PUNCT
aji-33	715	4	et	et	PROPN
aji-33	715	5	al	al	PROPN
aji-33	715	6	.	.	PROPN
aji-33	715	7	tumor	tumor	PROPN
aji-33	715	8	necrosis	necrosis	NOUN
aji-33	715	9	factoralpha	factoralpha	NOUN
aji-33	715	10	as	as	ADP
aji-33	715	11	trigger	trigger	NOUN
aji-33	715	12	of	of	ADP
aji-33	715	13	platelet	platelet	NOUN
aji-33	715	14	activation	activation	NOUN
aji-33	715	15	in	in	ADP
aji-33	715	16	patients	patient	NOUN
aji-33	715	17	with	with	ADP
aji-33	715	18	heart	heart	NOUN
aji-33	715	19	failure	failure	NOUN
aji-33	715	20	.	.	PUNCT
aji-33	716	1	blood	blood	NOUN
aji-33	716	2	.	.	PUNCT
aji-33	717	1	2005	2005	NUM
aji-33	717	2	;	;	PUNCT
aji-33	717	3	106:1992–1994	106:1992–1994	NUM
aji-33	717	4	.	.	PUNCT
aji-33	718	1	doi	doi	NOUN
aji-33	718	2	:	:	PUNCT
aji-33	718	3	10.1182	10.1182	NUM
aji-33	718	4	/	/	SYM
aji-33	718	5	blood-2005	blood-2005	NOUN
aji-33	718	6	-	-	PUNCT
aji-33	718	7	03	03	NUM
aji-33	718	8	-	-	SYM
aji-33	718	9	1247	1247	NUM
aji-33	718	10	43	43	NUM
aji-33	718	11	.	.	PUNCT
aji-33	719	1	pignatelli	pignatelli	PROPN
aji-33	719	2	p	p	X
aji-33	719	3	,	,	PUNCT
aji-33	719	4	et	et	PROPN
aji-33	719	5	al	al	PROPN
aji-33	719	6	.	.	PUNCT
aji-33	720	1	tumour	tumour	NOUN
aji-33	720	2	necrosis	necrosis	NOUN
aji-33	720	3	factor	factor	NOUN
aji-33	720	4	alpha	alpha	NOUN
aji-33	720	5	upregulates	upregulate	VERB
aji-33	720	6	platelet	platelet	NOUN
aji-33	720	7	cd40l	cd40l	NOUN
aji-33	720	8	in	in	ADP
aji-33	720	9	patients	patient	NOUN
aji-33	720	10	with	with	ADP
aji-33	720	11	heart	heart	NOUN
aji-33	720	12	failure	failure	NOUN
aji-33	720	13	.	.	PUNCT
aji-33	721	1	cardiovasc	cardiovasc	PROPN
aji-33	721	2	res	re	NOUN
aji-33	721	3	.	.	PUNCT
aji-33	722	1	2008;78:515–522	2008;78:515–522	NOUN
aji-33	722	2	.	.	PUNCT
aji-33	723	1	44	44	NUM
aji-33	723	2	.	.	PUNCT
aji-33	724	1	lapin	lapin	PROPN
aji-33	724	2	zj	zj	PROPN
aji-33	724	3	,	,	PUNCT
aji-33	724	4	hoppener	hoppener	NOUN
aji-33	724	5	c	c	NOUN
aji-33	724	6	,	,	PUNCT
aji-33	724	7	gelbard	gelbard	ADJ
aji-33	724	8	ha	ha	INTJ
aji-33	724	9	,	,	PUNCT
aji-33	724	10	novotny	novotny	PROPN
aji-33	724	11	l.	l.	PROPN
aji-33	724	12	near	near	ADP
aji-33	724	13	-	-	PUNCT
aji-33	724	14	field	field	NOUN
aji-33	724	15	quantification	quantification	NOUN
aji-33	724	16	of	of	ADP
aji-33	724	17	complement	complement	NOUN
aji-33	724	18	receptor	receptor	NOUN
aji-33	724	19	1	1	NUM
aji-33	724	20	(	(	PUNCT
aji-33	724	21	cr1	cr1	PROPN
aji-33	724	22	/	/	SYM
aji-33	724	23	cd35	cd35	PROPN
aji-33	724	24	)	)	PUNCT
aji-33	724	25	protein	protein	NOUN
aji-33	724	26	clustering	cluster	VERB
aji-33	724	27	in	in	ADP
aji-33	724	28	human	human	ADJ
aji-33	724	29	erythrocytes	erythrocyte	NOUN
aji-33	724	30	.	.	PUNCT
aji-33	725	1	j	j	PROPN
aji-33	725	2	neuroimmune	neuroimmune	PROPN
aji-33	725	3	pharmacol	pharmacol	PROPN
aji-33	725	4	.	.	PUNCT
aji-33	726	1	2012;7:539	2012;7:539	NUM
aji-33	726	2	–	–	PUNCT
aji-33	726	3	543	543	NUM
aji-33	726	4	.	.	NUM
aji-33	726	5	45	45	NUM
aji-33	726	6	.	.	PUNCT
aji-33	727	1	pascual	pascual	PROPN
aji-33	727	2	m	m	PROPN
aji-33	727	3	,	,	PUNCT
aji-33	727	4	schifferli	schifferli	PROPN
aji-33	727	5	ja	ja	PROPN
aji-33	727	6	.	.	PUNCT
aji-33	728	1	the	the	DET
aji-33	728	2	binding	binding	NOUN
aji-33	728	3	of	of	ADP
aji-33	728	4	immune	immune	ADJ
aji-33	728	5	complexes	complex	NOUN
aji-33	728	6	by	by	ADP
aji-33	728	7	the	the	DET
aji-33	728	8	erythrocyte	erythrocyte	NOUN
aji-33	728	9	complement	complement	NOUN
aji-33	728	10	receptor	receptor	NOUN
aji-33	728	11	1	1	NUM
aji-33	728	12	(	(	PUNCT
aji-33	728	13	cr1	cr1	NOUN
aji-33	728	14	)	)	PUNCT
aji-33	728	15	immunopharmacology	immunopharmacology	NOUN
aji-33	728	16	.	.	PUNCT
aji-33	729	1	1992;24:101–106	1992;24:101–106	NUM
aji-33	729	2	.	.	PUNCT
aji-33	730	1	46	46	NUM
aji-33	730	2	.	.	PUNCT
aji-33	731	1	meulenbroek	meulenbroek	VERB
aji-33	731	2	em	em	PRON
aji-33	731	3	,	,	PUNCT
aji-33	731	4	wouters	wouters	PROPN
aji-33	731	5	d	d	PROPN
aji-33	731	6	,	,	PUNCT
aji-33	731	7	zeerleder	zeerleder	PROPN
aji-33	731	8	s.	s.	PROPN
aji-33	731	9	methods	method	NOUN
aji-33	731	10	for	for	ADP
aji-33	731	11	quantitative	quantitative	ADJ
aji-33	731	12	detection	detection	NOUN
aji-33	731	13	of	of	ADP
aji-33	731	14	antibody	antibody	NOUN
aji-33	731	15	-	-	PUNCT
aji-33	731	16	induced	induce	VERB
aji-33	731	17	complement	complement	NOUN
aji-33	731	18	activation	activation	NOUN
aji-33	731	19	on	on	ADP
aji-33	731	20	red	red	ADJ
aji-33	731	21	blood	blood	NOUN
aji-33	731	22	cells	cell	NOUN
aji-33	731	23	.	.	PUNCT
aji-33	732	1	j	j	PROPN
aji-33	732	2	vis	vis	X
aji-33	732	3	exp	exp	PROPN
aji-33	732	4	.	.	PROPN
aji-33	732	5	2014	2014	NUM
aji-33	732	6	;	;	PUNCT
aji-33	732	7	e51161	e51161	VERB
aji-33	732	8	.	.	PROPN
aji-33	732	9	47	47	NUM
aji-33	732	10	.	.	PUNCT
aji-33	733	1	patzelt	patzelt	PROPN
aji-33	733	2	j	j	NOUN
aji-33	733	3	,	,	PUNCT
aji-33	733	4	verschoor	verschoor	VERB
aji-33	733	5	a	a	PRON
aji-33	733	6	,	,	PUNCT
aji-33	733	7	langer	langer	PROPN
aji-33	733	8	hf	hf	NOUN
aji-33	733	9	.	.	PUNCT
aji-33	734	1	platelets	platelet	NOUN
aji-33	734	2	and	and	CCONJ
aji-33	734	3	the	the	DET
aji-33	734	4	complement	complement	NOUN
aji-33	734	5	cascade	cascade	NOUN
aji-33	734	6	in	in	ADP
aji-33	734	7	atherosclerosis	atherosclerosis	NOUN
aji-33	734	8	.	.	PUNCT
aji-33	735	1	front	front	ADJ
aji-33	735	2	physiol	physiol	PROPN
aji-33	735	3	.	.	PUNCT
aji-33	736	1	2015;6:49	2015;6:49	ADJ
aji-33	736	2	.	.	PUNCT
aji-33	737	1	doi	doi	NOUN
aji-33	737	2	:	:	PUNCT
aji-33	737	3	10.3389	10.3389	NUM
aji-33	737	4	/	/	SYM
aji-33	737	5	fphys.2015.00049	fphys.2015.00049	PROPN
aji-33	737	6	48	48	NUM
aji-33	737	7	.	.	PUNCT
aji-33	738	1	hamad	hamad	PROPN
aji-33	738	2	oa	oa	PROPN
aji-33	738	3	,	,	PUNCT
aji-33	738	4	et	et	PROPN
aji-33	738	5	al	al	PROPN
aji-33	738	6	.	.	PROPN
aji-33	739	1	complement	complement	NOUN
aji-33	739	2	activation	activation	NOUN
aji-33	739	3	triggered	trigger	VERB
aji-33	739	4	by	by	ADP
aji-33	739	5	chondroitin	chondroitin	NOUN
aji-33	739	6	sulfate	sulfate	NOUN
aji-33	739	7	released	release	VERB
aji-33	739	8	by	by	ADP
aji-33	739	9	thrombin	thrombin	NOUN
aji-33	739	10	receptor	receptor	NOUN
aji-33	739	11	-	-	PUNCT
aji-33	739	12	activated	activate	VERB
aji-33	739	13	platelets	platelet	NOUN
aji-33	739	14	.	.	PUNCT
aji-33	740	1	j	j	PROPN
aji-33	740	2	thromb	thromb	PROPN
aji-33	740	3	haemost	haemost	VERB
aji-33	740	4	.	.	PUNCT
aji-33	741	1	2008;6:1413–1421	2008;6:1413–1421	X
aji-33	741	2	.	.	PUNCT
aji-33	741	3	49	49	NUM
aji-33	741	4	.	.	PUNCT
aji-33	742	1	martel	martel	NOUN
aji-33	742	2	c	c	X
aji-33	742	3	,	,	PUNCT
aji-33	742	4	et	et	PROPN
aji-33	742	5	al	al	PROPN
aji-33	742	6	.	.	PUNCT
aji-33	742	7	requirements	requirement	NOUN
aji-33	742	8	for	for	ADP
aji-33	742	9	membrane	membrane	NOUN
aji-33	742	10	attack	attack	NOUN
aji-33	742	11	complex	complex	ADJ
aji-33	742	12	formation	formation	NOUN
aji-33	742	13	and	and	CCONJ
aji-33	742	14	anaphylatoxins	anaphylatoxin	NOUN
aji-33	742	15	binding	bind	VERB
aji-33	742	16	to	to	ADP
aji-33	742	17	collagenactivated	collagenactivated	ADJ
aji-33	742	18	platelets	platelet	NOUN
aji-33	742	19	.	.	PUNCT
aji-33	743	1	plos	plos	PROPN
aji-33	743	2	one	one	NUM
aji-33	743	3	.	.	PUNCT
aji-33	744	1	2011;6	2011;6	NUM
aji-33	744	2	:	:	PUNCT
aji-33	744	3	e18812	e18812	NOUN
aji-33	744	4	.	.	PUNCT
aji-33	744	5	doi	doi	PROPN
aji-33	744	6	:	:	PUNCT
aji-33	744	7	10.1371	10.1371	NUM
aji-33	744	8	/	/	SYM
aji-33	744	9	journal.pone	journal.pone	NOUN
aji-33	744	10	.	.	NOUN
aji-33	745	1	50	50	NUM
aji-33	745	2	.	.	PUNCT
aji-33	746	1	del	del	PROPN
aji-33	746	2	conde	conde	PROPN
aji-33	746	3	i	i	PROPN
aji-33	746	4	,	,	PUNCT
aji-33	746	5	cruz	cruz	PROPN
aji-33	746	6	ma	ma	PROPN
aji-33	746	7	,	,	PUNCT
aji-33	746	8	zhang	zhang	PROPN
aji-33	746	9	h	h	PROPN
aji-33	746	10	,	,	PUNCT
aji-33	746	11	lopez	lopez	PROPN
aji-33	746	12	ja	ja	PROPN
aji-33	746	13	,	,	PUNCT
aji-33	746	14	afshar	afshar	ADJ
aji-33	746	15	-	-	PUNCT
aji-33	746	16	kharghan	kharghan	NOUN
aji-33	746	17	v.	v.	ADP
aji-33	746	18	platelet	platelet	NOUN
aji-33	746	19	activation	activation	NOUN
aji-33	746	20	leads	lead	VERB
aji-33	746	21	to	to	ADP
aji-33	746	22	activation	activation	NOUN
aji-33	746	23	and	and	CCONJ
aji-33	746	24	propagation	propagation	NOUN
aji-33	746	25	of	of	ADP
aji-33	746	26	the	the	DET
aji-33	746	27	complement	complement	NOUN
aji-33	746	28	system	system	NOUN
aji-33	746	29	.	.	PUNCT
aji-33	747	1	j	j	PROPN
aji-33	747	2	exp	exp	NOUN
aji-33	747	3	med	med	PROPN
aji-33	747	4	.	.	PUNCT
aji-33	747	5	2005	2005	NUM
aji-33	747	6	;	;	PUNCT
aji-33	747	7	201:871–879	201:871–879	NUM
aji-33	747	8	.	.	PUNCT
aji-33	748	1	doi	doi	NOUN
aji-33	748	2	:	:	PUNCT
aji-33	748	3	10.1084	10.1084	NUM
aji-33	748	4	/	/	SYM
aji-33	748	5	jem.20041497	jem.20041497	PROPN
aji-33	748	6	51	51	NUM
aji-33	748	7	.	.	PUNCT
aji-33	749	1	verschoor	verschoor	PROPN
aji-33	749	2	a	a	PRON
aji-33	749	3	,	,	PUNCT
aji-33	749	4	et	et	PROPN
aji-33	749	5	al	al	PROPN
aji-33	749	6	.	.	PUNCT
aji-33	750	1	a	a	DET
aji-33	750	2	platelet	platelet	NOUN
aji-33	750	3	-	-	PUNCT
aji-33	750	4	mediated	mediate	VERB
aji-33	750	5	system	system	NOUN
aji-33	750	6	for	for	ADP
aji-33	750	7	shuttling	shuttle	VERB
aji-33	750	8	blood	blood	NOUN
aji-33	750	9	-	-	PUNCT
aji-33	750	10	borne	bear	VERB
aji-33	750	11	bacteria	bacteria	NOUN
aji-33	750	12	to	to	AUX
aji-33	750	13	cd8alpha+	cd8alpha+	VERB
aji-33	750	14	dendritic	dendritic	ADJ
aji-33	750	15	cells	cell	NOUN
aji-33	750	16	depends	depend	VERB
aji-33	750	17	on	on	ADP
aji-33	750	18	glycoprotein	glycoprotein	NOUN
aji-33	750	19	gpib	gpib	NOUN
aji-33	750	20	and	and	CCONJ
aji-33	750	21	complement	complement	PROPN
aji-33	750	22	c3	c3	PROPN
aji-33	750	23	.	.	PUNCT
aji-33	751	1	nat	nat	PROPN
aji-33	751	2	immunol	immunol	NOUN
aji-33	751	3	.	.	PUNCT
aji-33	752	1	2011;12:1194–1201	2011;12:1194–1201	VERB
aji-33	752	2	.	.	PUNCT
aji-33	753	1	52	52	NUM
aji-33	753	2	.	.	PUNCT
aji-33	754	1	marlies	marlies	PROPN
aji-33	754	2	van	van	PROPN
aji-33	754	3	de	de	PROPN
aji-33	754	4	wouwer	wouwer	PROPN
aji-33	754	5	désiré	désiré	VERB
aji-33	754	6	collen	collen	PROPN
aji-33	754	7	and	and	CCONJ
aji-33	754	8	edward	edward	PROPN
aji-33	754	9	m.	m.	PROPN
aji-33	754	10	conway	conway	PROPN
aji-33	754	11	thrombomodulinprotein	thrombomodulinprotein	PROPN
aji-33	755	1	c	c	PROPN
aji-33	755	2	-	-	PUNCT
aji-33	755	3	epcr	epcr	ADV
aji-33	755	4	systemintegrated	systemintegrate	VERB
aji-33	755	5	to	to	PART
aji-33	755	6	regulate	regulate	VERB
aji-33	755	7	coagulation	coagulation	NOUN
aji-33	755	8	and	and	CCONJ
aji-33	755	9	inflammation	inflammation	NOUN
aji-33	755	10	.	.	PUNCT
aji-33	756	1	arteriosclerosis	arteriosclerosis	NOUN
aji-33	756	2	,	,	PUNCT
aji-33	756	3	thrombosis	thrombosis	NOUN
aji-33	756	4	,	,	PUNCT
aji-33	756	5	and	and	CCONJ
aji-33	756	6	vascular	vascular	ADJ
aji-33	756	7	biology	biology	NOUN
aji-33	756	8	.	.	PUNCT
aji-33	757	1	2004;24:1374–13838	2004;24:1374–13838	NOUN
aji-33	757	2	.	.	PUNCT
aji-33	757	3	stearns	stearns	PROPN
aji-33	757	4	-	-	PUNCT
aji-33	757	5	kurosawa	kurosawa	PROPN
aji-33	757	6	dj	dj	PROPN
aji-33	757	7	,	,	PUNCT
aji-33	757	8	kurosawa	kurosawa	PROPN
aji-33	757	9	s	s	PROPN
aji-33	757	10	,	,	PUNCT
aji-33	757	11	mollica	mollica	PROPN
aji-33	757	12	js	js	PROPN
aji-33	757	13	,	,	PUNCT
aji-33	757	14	ferrell	ferrell	PROPN
aji-33	757	15	gl	gl	PROPN
aji-33	757	16	,	,	PUNCT
aji-33	757	17	esmon	esmon	PROPN
aji-33	757	18	ct	ct	PROPN
aji-33	757	19	.	.	PUNCT
aji-33	758	1	the	the	DET
aji-33	758	2	endothelial	endothelial	ADJ
aji-33	758	3	cell	cell	NOUN
aji-33	758	4	protein	protein	NOUN
aji-33	758	5	c	c	NOUN
aji-33	758	6	receptor	receptor	NOUN
aji-33	758	7	augments	augment	VERB
aji-33	758	8	protein	protein	NOUN
aji-33	758	9	c	c	NOUN
aji-33	758	10	activation	activation	NOUN
aji-33	758	11	by	by	ADP
aji-33	758	12	the	the	DET
aji-33	758	13	thrombin	thrombin	NOUN
aji-33	758	14	-	-	PUNCT
aji-33	758	15	thrombomodulin	thrombomodulin	NOUN
aji-33	758	16	complex	complex	NOUN
aji-33	758	17	.	.	PUNCT
aji-33	759	1	proc	proc	PROPN
aji-33	759	2	natl	natl	PROPN
aji-33	759	3	acad	acad	PROPN
aji-33	759	4	sci	sci	PROPN
aji-33	759	5	usa	usa	PROPN
aji-33	759	6	.	.	PROPN
aji-33	759	7	1996	1996	NUM
aji-33	759	8	;	;	PUNCT
aji-33	759	9	93:10212	93:10212	NUM
aji-33	759	10	–	–	PUNCT
aji-33	759	11	10216	10216	NUM
aji-33	759	12	.	.	PUNCT
aji-33	760	1	53	53	NUM
aji-33	760	2	.	.	PUNCT
aji-33	760	3	ali	ali	PROPN
aji-33	760	4	ganji	ganji	PROPN
aji-33	760	5	,	,	PUNCT
aji-33	760	6	et	et	PROPN
aji-33	760	7	al	al	PROPN
aji-33	760	8	.	.	PROPN
aji-33	760	9	increased	increase	VERB
aji-33	760	10	expression	expression	NOUN
aji-33	760	11	of	of	ADP
aji-33	760	12	cd8	cd8	PROPN
aji-33	760	13	marker	marker	NOUN
aji-33	760	14	on	on	ADP
aji-33	760	15	t	t	PROPN
aji-33	760	16	-	-	PUNCT
aji-33	760	17	cells	cell	NOUN
aji-33	760	18	in	in	ADP
aji-33	760	19	covid-19	covid-19	PROPN
aji-33	760	20	patients.blood	patients.blood	PROPN
aji-33	760	21	cells	cell	NOUN
aji-33	760	22	mol	mol	ADP
aji-33	760	23	dis	dis	PROPN
aji-33	760	24	.	.	PUNCT
aji-33	760	25	2020	2020	NUM
aji-33	760	26	;	;	PUNCT
aji-33	760	27	83:102437	83:102437	NUM
aji-33	760	28	.	.	PUNCT
aji-33	761	1	54	54	NUM
aji-33	761	2	.	.	PUNCT
aji-33	762	1	zheng	zheng	PROPN
aji-33	762	2	et	et	PROPN
aji-33	762	3	al	al	PROPN
aji-33	762	4	.	.	PUNCT
aji-33	763	1	functional	functional	ADJ
aji-33	763	2	exhaustion	exhaustion	NOUN
aji-33	763	3	of	of	ADP
aji-33	763	4	antiviral	antiviral	ADJ
aji-33	763	5	lymphocytes	lymphocyte	NOUN
aji-33	763	6	in	in	ADP
aji-33	763	7	covid-19	covid-19	PROPN
aji-33	763	8	patients	patient	NOUN
aji-33	763	9	.	.	PUNCT
aji-33	764	1	cellular	cellular	ADJ
aji-33	764	2	&	&	CCONJ
aji-33	764	3	molecular	molecular	ADJ
aji-33	764	4	immunology	immunology	NOUN
aji-33	764	5	;	;	PUNCT
aji-33	764	6	2020	2020	NUM
aji-33	764	7	.	.	PUNCT
aji-33	765	1	https://www.ahajournals.org/doi/10.1161/01.atv.0000134298.25489.92#r8-014928r	https://www.ahajournals.org/doi/10.1161/01.atv.0000134298.25489.92#r8-014928r	PROPN
aji-33	765	2	prasad	prasad	NOUN
aji-33	765	3	;	;	PUNCT
aji-33	765	4	aji	aji	NOUN
aji-33	765	5	,	,	PUNCT
aji-33	765	6	3(1	3(1	NUM
aji-33	765	7	):	):	PUNCT
aji-33	765	8	233	233	NUM
aji-33	765	9	-	-	SYM
aji-33	765	10	252	252	NUM
aji-33	765	11	,	,	PUNCT
aji-33	765	12	2020	2020	NUM
aji-33	765	13	;	;	PUNCT
aji-33	765	14	article	article	NOUN
aji-33	765	15	no.aji.58422	no.aji.58422	NOUN
aji-33	765	16	250	250	NUM
aji-33	765	17	appendix	appendix	ADJ
aji-33	765	18	1	1	NUM
aji-33	765	19	microbial	microbial	ADJ
aji-33	765	20	pattern	pattern	NOUN
aji-33	765	21	recognition	recognition	NOUN
aji-33	765	22	proteins	protein	NOUN
aji-33	765	23	---------------------------------------------------------------------	---------------------------------------------------------------------	X
aji-33	765	24	1	1	X
aji-33	765	25	.	.	PUNCT
aji-33	765	26	mannose	mannose	NOUN
aji-33	765	27	receptor	receptor	NOUN
aji-33	765	28	.	.	PUNCT
aji-33	766	1	2	2	X
aji-33	766	2	.	.	X
aji-33	766	3	complement	complement	NOUN
aji-33	766	4	receptors	receptor	NOUN
aji-33	766	5	.	.	PUNCT
aji-33	767	1	3	3	X
aji-33	767	2	.	.	X
aji-33	767	3	dc	dc	PROPN
aji-33	767	4	-	-	PUNCT
aji-33	767	5	sign	sign	NOUN
aji-33	767	6	.	.	PUNCT
aji-33	768	1	4.toll	4.toll	NUM
aji-33	768	2	-	-	PUNCT
aji-33	768	3	like	like	ADJ
aji-33	768	4	receptors(tlrs	receptors(tlrs	PROPN
aji-33	768	5	)	)	PUNCT
aji-33	768	6	.	.	PUNCT
aji-33	769	1	5	5	X
aji-33	769	2	.	.	X
aji-33	769	3	scavenger	scavenger	NOUN
aji-33	769	4	receptors	receptor	NOUN
aji-33	769	5	cd14	cd14	PROPN
aji-33	769	6	,	,	PUNCT
aji-33	769	7	and	and	CCONJ
aji-33	769	8	mac-1	mac-1	PUNCT
aji-33	769	9	the	the	DET
aji-33	769	10	prrs	prr	NOUN
aji-33	769	11	are	be	AUX
aji-33	769	12	divided	divide	VERB
aji-33	769	13	into	into	ADP
aji-33	769	14	four	four	NUM
aji-33	769	15	families	family	NOUN
aji-33	769	16	:	:	PUNCT
aji-33	769	17	1	1	X
aji-33	769	18	.	.	X
aji-33	769	19	toll	toll	NOUN
aji-33	769	20	-	-	PUNCT
aji-33	769	21	like	like	ADJ
aji-33	769	22	receptors	receptor	NOUN
aji-33	769	23	(	(	PUNCT
aji-33	769	24	tlr	tlr	PROPN
aji-33	769	25	)	)	PUNCT
aji-33	769	26	2	2	NUM
aji-33	769	27	.	.	X
aji-33	769	28	nucleotide	nucleotide	NOUN
aji-33	769	29	-	-	PUNCT
aji-33	769	30	binding	bind	VERB
aji-33	769	31	oligomerization	oligomerization	NOUN
aji-33	769	32	domain	domain	NOUN
aji-33	769	33	-	-	PUNCT
aji-33	769	34	like	like	ADJ
aji-33	769	35	receptors	receptor	NOUN
aji-33	769	36	(	(	PUNCT
aji-33	769	37	nlr	nlr	PROPN
aji-33	769	38	)	)	PUNCT
aji-33	769	39	3	3	NUM
aji-33	769	40	.	.	PUNCT
aji-33	769	41	rig-1	rig-1	X
aji-33	769	42	like	like	ADP
aji-33	769	43	receptors	receptor	NOUN
aji-33	769	44	(	(	PUNCT
aji-33	769	45	rlr	rlr	PROPN
aji-33	769	46	)	)	PUNCT
aji-33	769	47	4	4	NUM
aji-33	769	48	.	.	X
aji-33	770	1	c	c	X
aji-33	770	2	-	-	PUNCT
aji-33	770	3	type	type	NOUN
aji-33	770	4	lectin	lectin	NOUN
aji-33	770	5	receptors	receptor	NOUN
aji-33	770	6	(	(	PUNCT
aji-33	770	7	clr	clr	NOUN
aji-33	770	8	)	)	PUNCT
aji-33	770	9	pamps	pamp	NOUN
aji-33	770	10	1	1	NUM
aji-33	770	11	.	.	NUM
aji-33	770	12	glycans	glycan	NOUN
aji-33	770	13	lipoglycans	lipoglycan	VERB
aji-33	770	14	such	such	ADJ
aji-33	770	15	as	as	ADP
aji-33	770	16	lipopolysaccharide	lipopolysaccharide	ADJ
aji-33	770	17	,	,	PUNCT
aji-33	770	18	a	a	DET
aji-33	770	19	component	component	NOUN
aji-33	770	20	of	of	ADP
aji-33	770	21	the	the	DET
aji-33	770	22	grambacteria	grambacteria	ADJ
aji-33	770	23	outer	outer	ADJ
aji-33	770	24	membrane	membrane	NOUN
aji-33	770	25	peptidoglycans	peptidoglycan	NOUN
aji-33	770	26	such	such	ADJ
aji-33	770	27	as	as	ADP
aji-33	770	28	bacterial	bacterial	ADJ
aji-33	770	29	muramyl	muramyl	NOUN
aji-33	770	30	dipeptide	dipeptide	NOUN
aji-33	770	31	b-1,3	b-1,3	PROPN
aji-33	770	32	-	-	PUNCT
aji-33	770	33	glucans	glucan	NOUN
aji-33	770	34	from	from	ADP
aji-33	770	35	the	the	DET
aji-33	770	36	cell	cell	NOUN
aji-33	770	37	wall	wall	NOUN
aji-33	770	38	of	of	ADP
aji-33	770	39	various	various	ADJ
aji-33	770	40	fungi	fungus	NOUN
aji-33	770	41	species	specie	NOUN
aji-33	770	42	2	2	NUM
aji-33	770	43	.	.	PUNCT
aji-33	770	44	proteins	protein	NOUN
aji-33	770	45	bacteria	bacteria	NOUN
aji-33	770	46	flagellin	flagellin	NOUN
aji-33	770	47	--------------------------------------------------------------------------	--------------------------------------------------------------------------	PUNCT
aji-33	770	48	appendix	appendix	VERB
aji-33	770	49	2	2	NUM
aji-33	770	50	interaction	interaction	NOUN
aji-33	770	51	of	of	ADP
aji-33	770	52	prrs	prr	NOUN
aji-33	770	53	and	and	CCONJ
aji-33	770	54	pamps	pamp	NOUN
aji-33	770	55	:	:	PUNCT
aji-33	770	56	step	step	NOUN
aji-33	770	57	1	1	NUM
aji-33	770	58	.	.	PUNCT
aji-33	770	59	ligand	ligand	NOUN
aji-33	770	60	recognition/	recognition/	NUM
aji-33	770	61	binding	bind	VERB
aji-33	770	62	:	:	PUNCT
aji-33	770	63	pamps	pamp	NOUN
aji-33	770	64	are	be	AUX
aji-33	770	65	recognized	recognize	VERB
aji-33	770	66	and	and	CCONJ
aji-33	770	67	are	be	AUX
aji-33	770	68	attached	attach	VERB
aji-33	770	69	to	to	ADP
aji-33	770	70	prrs	prr	NOUN
aji-33	770	71	.	.	PUNCT
aji-33	771	1	step	step	NOUN
aji-33	771	2	2	2	NUM
aji-33	771	3	.	.	PUNCT
aji-33	771	4	activation	activation	NOUN
aji-33	771	5	of	of	ADP
aji-33	771	6	the	the	DET
aji-33	771	7	kinases	kinase	NOUN
aji-33	771	8	and	and	CCONJ
aji-33	771	9	antiviral	antiviral	ADJ
aji-33	771	10	signalling	signal	VERB
aji-33	771	11	cascades	cascade	NOUN
aji-33	771	12	:	:	PUNCT
aji-33	772	1	1	1	X
aji-33	772	2	.	.	X
aji-33	773	1	tbk1	tbk1	PROPN
aji-33	773	2	(	(	PUNCT
aji-33	773	3	tank	tank	NOUN
aji-33	773	4	-	-	PUNCT
aji-33	773	5	binding	bind	VERB
aji-33	773	6	kinase	kinase	NOUN
aji-33	773	7	1	1	NUM
aji-33	773	8	)	)	PUNCT
aji-33	773	9	2	2	NUM
aji-33	773	10	.	.	X
aji-33	773	11	mapk	mapk	NOUN
aji-33	773	12	(	(	PUNCT
aji-33	773	13	mitogen	mitogen	NOUN
aji-33	773	14	-	-	PUNCT
aji-33	773	15	activated	activate	VERB
aji-33	773	16	protein	protein	NOUN
aji-33	773	17	kinases	kinase	NOUN
aji-33	773	18	)	)	PUNCT
aji-33	773	19	3	3	NUM
aji-33	773	20	.	.	X
aji-33	773	21	ikkα	ikkα	PROPN
aji-33	773	22	and	and	CCONJ
aji-33	773	23	ikkβ	ikkβ	ADJ
aji-33	773	24	.	.	PUNCT
aji-33	774	1	κb	κb	INTJ
aji-33	774	2	kinase	kinase	PROPN
aji-33	774	3	α	α	PROPN
aji-33	774	4	and	and	CCONJ
aji-33	774	5	β	β	NOUN
aji-33	774	6	step	step	NOUN
aji-33	774	7	3	3	NUM
aji-33	774	8	.	.	PUNCT
aji-33	775	1	these	these	DET
aji-33	775	2	kinases	kinase	NOUN
aji-33	775	3	phosphorylate	phosphorylate	VERB
aji-33	775	4	and	and	CCONJ
aji-33	775	5	activate	activate	VERB
aji-33	775	6	interferon(ifn)-regulatory	interferon(ifn)-regulatory	ADJ
aji-33	775	7	factors	factor	NOUN
aji-33	775	8	3	3	NUM
aji-33	775	9	and	and	CCONJ
aji-33	775	10	7	7	NUM
aji-33	775	11	(	(	PUNCT
aji-33	775	12	irf3/7	irf3/7	PROPN
aji-33	775	13	)	)	PUNCT
aji-33	775	14	,	,	PUNCT
aji-33	775	15	ap-1	ap-1	ADV
aji-33	775	16	,	,	PUNCT
aji-33	775	17	nf	nf	PROPN
aji-33	775	18	-	-	PUNCT
aji-33	775	19	κb	κb	NOUN
aji-33	775	20	,	,	PUNCT
aji-33	775	21	step	step	VERB
aji-33	775	22	4.these	4.these	NUM
aji-33	775	23	proteins	protein	NOUN
aji-33	775	24	transcriptionally	transcriptionally	ADV
aji-33	775	25	induce	induce	VERB
aji-33	775	26	the	the	DET
aji-33	775	27	gene	gene	NOUN
aji-33	775	28	expression	expression	NOUN
aji-33	775	29	of	of	ADP
aji-33	775	30	1.type	1.type	NUM
aji-33	775	31	-	-	PUNCT
aji-33	775	32	i	i	PRON
aji-33	775	33	ifns	ifns	NOUN
aji-33	775	34	(	(	PUNCT
aji-33	775	35	mainly	mainly	ADV
aji-33	775	36	ifn	ifn	PROPN
aji-33	775	37	-	-	PUNCT
aji-33	775	38	α	α	NOUN
aji-33	775	39	subtypes	subtype	NOUN
aji-33	775	40	and	and	CCONJ
aji-33	775	41	ifn	ifn	PROPN
aji-33	775	42	-	-	PUNCT
aji-33	775	43	β	β	NOUN
aji-33	775	44	)	)	PUNCT
aji-33	775	45	,	,	PUNCT
aji-33	775	46	prasad	prasad	PROPN
aji-33	775	47	;	;	PUNCT
aji-33	775	48	aji	aji	NOUN
aji-33	775	49	,	,	PUNCT
aji-33	775	50	3(1	3(1	NUM
aji-33	775	51	):	):	PUNCT
aji-33	775	52	233	233	NUM
aji-33	775	53	-	-	SYM
aji-33	775	54	252	252	NUM
aji-33	775	55	,	,	PUNCT
aji-33	775	56	2020	2020	NUM
aji-33	775	57	;	;	PUNCT
aji-33	775	58	article	article	NOUN
aji-33	775	59	no.aji.58422	no.aji.58422	NOUN
aji-33	775	60	251	251	NUM
aji-33	775	61	appendix	appendix	NOUN
aji-33	775	62	3	3	NUM
aji-33	775	63	.	.	PUNCT
aji-33	775	64	laboratory	laboratory	NOUN
aji-33	775	65	tests	test	NOUN
aji-33	775	66	reported	report	VERB
aji-33	775	67	in	in	ADP
aji-33	775	68	covid	covid	PROPN
aji-33	775	69	19	19	NUM
aji-33	775	70	.	.	PUNCT
aji-33	776	1	their	their	PRON
aji-33	776	2	significance	significance	NOUN
aji-33	776	3	laboratory	laboratory	NOUN
aji-33	776	4	test	test	NOUN
aji-33	776	5	significance	significance	NOUN
aji-33	776	6	increased	increase	VERB
aji-33	776	7	esr	esr	PROPN
aji-33	776	8	crp	crp	PROPN
aji-33	776	9	(	(	PUNCT
aji-33	776	10	c	c	NOUN
aji-33	776	11	-	-	PUNCT
aji-33	776	12	reactive	reactive	ADJ
aji-33	776	13	protein	protein	NOUN
aji-33	776	14	)	)	PUNCT
aji-33	776	15	ferritin	ferritin	ADJ
aji-33	776	16	ac	ac	PROPN
aji-33	776	17	.	.	PROPN
aji-33	776	18	phase	phase	NOUN
aji-33	776	19	reactants	reactant	VERB
aji-33	776	20	/	/	SYM
aji-33	776	21	markers	marker	NOUN
aji-33	776	22	of	of	ADP
aji-33	776	23	ac	ac	PROPN
aji-33	776	24	inflammation	inflammation	PROPN
aji-33	776	25	ldh	ldh	PROPN
aji-33	776	26	.	.	PUNCT
aji-33	777	1	(	(	PUNCT
aji-33	777	2	lactic	lactic	ADJ
aji-33	777	3	dehydrogenase	dehydrogenase	NOUN
aji-33	777	4	)	)	PUNCT
aji-33	777	5	ast(aspartate	ast(aspartate	NOUN
aji-33	777	6	transaminase	transaminase	NOUN
aji-33	777	7	)	)	PUNCT
aji-33	777	8	fibrinogen	fibrinogen	NOUN
aji-33	777	9	prothrombin	prothrombin	NOUN
aji-33	777	10	liver	liver	NOUN
aji-33	777	11	cell	cell	NOUN
aji-33	777	12	dysfunction	dysfunction	NOUN
aji-33	777	13	hs	hs	ADJ
aji-33	777	14	-	-	ADJ
aji-33	777	15	ctnt(high	ctnt(high	ADJ
aji-33	777	16	sensitivity	sensitivity	NOUN
aji-33	777	17	cardiac	cardiac	ADJ
aji-33	777	18	troponin	troponin	ADJ
aji-33	777	19	)	)	PUNCT
aji-33	777	20	maker	maker	NOUN
aji-33	777	21	of	of	ADP
aji-33	777	22	cardiocyte	cardiocyte	NOUN
aji-33	777	23	damage	damage	NOUN
aji-33	777	24	.	.	PUNCT
aji-33	778	1	ac	ac	PROPN
aji-33	778	2	mi	mi	PROPN
aji-33	778	3	,	,	PUNCT
aji-33	778	4	myocarditis	myocarditis	ADJ
aji-33	778	5	pt(prothrombine	pt(prothrombine	ADJ
aji-33	778	6	time	time	NOUN
aji-33	778	7	)	)	PUNCT
aji-33	778	8	(	(	PUNCT
aji-33	778	9	both	both	PRON
aji-33	778	10	indicate	indicate	VERB
aji-33	778	11	clotting	clot	VERB
aji-33	778	12	disorder	disorder	NOUN
aji-33	778	13	causing	cause	VERB
aji-33	778	14	bleed	bleed	NOUN
aji-33	778	15	)	)	PUNCT
aji-33	778	16	extrinsic	extrinsic	ADJ
aji-33	778	17	coagulation	coagulation	NOUN
aji-33	778	18	pathway	pathway	NOUN
aji-33	778	19	involvement	involvement	NOUN
aji-33	778	20	.	.	PUNCT
aji-33	779	1	bu	bu	PROPN
aji-33	779	2	/	/	SYM
aji-33	779	3	bun	bun	PROPN
aji-33	779	4	(	(	PUNCT
aji-33	779	5	blood	blood	NOUN
aji-33	779	6	urea	urea	NOUN
aji-33	779	7	nitrogen	nitrogen	NOUN
aji-33	779	8	)	)	PUNCT
aji-33	779	9	creatinine	creatinine	NOUN
aji-33	779	10	renal	renal	ADJ
aji-33	779	11	function	function	NOUN
aji-33	779	12	impairment	impairment	NOUN
aji-33	779	13	.	.	PUNCT
aji-33	780	1	t8+/t4	t8+/t4	NOUN
aji-33	781	1	+	+	NUM
aji-33	781	2	cells	cell	NOUN
aji-33	781	3	immune	immune	ADJ
aji-33	781	4	reaction	reaction	NOUN
aji-33	781	5	.	.	PUNCT
aji-33	782	1	leucopenia	leucopenia	PROPN
aji-33	782	2	/lymphopenia	/lymphopenia	PUNCT
aji-33	783	1	thrombocytopenia	thrombocytopenia	PROPN
aji-33	783	2	neutrophilia	neutrophilia	PROPN
aji-33	783	3	leucoerythroblasticpicture	leucoerythroblasticpicture	PROPN
aji-33	783	4	.	.	PUNCT
aji-33	784	1	bone	bone	NOUN
aji-33	784	2	marrow	marrow	PROPN
aji-33	784	3	insult	insult	VERB
aji-33	784	4	purpura	purpura	NOUN
aji-33	784	5	secondary	secondary	ADJ
aji-33	784	6	infection	infection	NOUN
aji-33	784	7	or	or	CCONJ
aji-33	784	8	complication	complication	NOUN
aji-33	784	9	bone	bone	NOUN
aji-33	784	10	marrow	marrow	PROPN
aji-33	784	11	involvement	involvement	NOUN
aji-33	784	12	in	in	ADP
aji-33	784	13	covid	covid	PROPN
aji-33	784	14	19	19	NUM
aji-33	784	15	.	.	PUNCT
aji-33	784	16	appendix	appendix	VERB
aji-33	784	17	4	4	NUM
aji-33	784	18	role	role	NOUN
aji-33	784	19	of	of	ADP
aji-33	784	20	other	other	ADJ
aji-33	784	21	important	important	ADJ
aji-33	784	22	innate	innate	ADJ
aji-33	784	23	cellular	cellular	ADJ
aji-33	784	24	elements	element	NOUN
aji-33	784	25	1	1	NUM
aji-33	784	26	.	.	PUNCT
aji-33	784	27	natural	natural	ADJ
aji-33	784	28	killer	killer	NOUN
aji-33	784	29	cells	cell	NOUN
aji-33	784	30	:	:	PUNCT
aji-33	784	31	they	they	PRON
aji-33	784	32	are	be	AUX
aji-33	784	33	the	the	DET
aji-33	784	34	counterparts	counterpart	NOUN
aji-33	784	35	of	of	ADP
aji-33	784	36	cells	cell	NOUN
aji-33	784	37	of	of	ADP
aji-33	784	38	adaptive	adaptive	ADJ
aji-33	784	39	immunity	immunity	NOUN
aji-33	784	40	.	.	PUNCT
aji-33	785	1	functions	function	NOUN
aji-33	785	2	:	:	PUNCT
aji-33	785	3	they	they	PRON
aji-33	785	4	can	can	AUX
aji-33	785	5	directly	directly	ADV
aji-33	785	6	kill	kill	VERB
aji-33	785	7	the	the	DET
aji-33	785	8	pathogen	pathogen	NOUN
aji-33	785	9	or	or	CCONJ
aji-33	785	10	through	through	ADP
aji-33	785	11	the	the	DET
aji-33	785	12	antibody	antibody	NOUN
aji-33	785	13	mediated	mediate	VERB
aji-33	785	14	cell	cell	NOUN
aji-33	785	15	mediated	mediate	VERB
aji-33	785	16	cytotoxicity	cytotoxicity	NOUN
aji-33	785	17	.	.	PUNCT
aji-33	786	1	nk	nk	PROPN
aji-33	786	2	cell	cell	NOUN
aji-33	786	3	dependent	dependent	ADJ
aji-33	786	4	antibody	antibody	NOUN
aji-33	786	5	induced	induce	VERB
aji-33	786	6	cytotoxicity	cytotoxicity	NOUN
aji-33	786	7	:	:	PUNCT
aji-33	786	8	1	1	X
aji-33	786	9	.	.	X
aji-33	786	10	nk	nk	PROPN
aji-33	786	11	cell	cell	NOUN
aji-33	786	12	expresses	express	VERB
aji-33	786	13	fcγ	fcγ	NOUN
aji-33	786	14	receptors	receptor	NOUN
aji-33	786	15	cd16	cd16	PROPN
aji-33	786	16	or	or	CCONJ
aji-33	786	17	fcγriii	fcγriii	NOUN
aji-33	786	18	.	.	PUNCT
aji-33	787	1	2	2	X
aji-33	787	2	.	.	X
aji-33	787	3	these	these	DET
aji-33	787	4	receptors	receptor	NOUN
aji-33	787	5	recognize	recognize	VERB
aji-33	787	6	and	and	CCONJ
aji-33	787	7	bind	bind	VERB
aji-33	787	8	to	to	ADP
aji-33	787	9	the	the	DET
aji-33	787	10	reciprocal	reciprocal	ADJ
aji-33	787	11	portion	portion	NOUN
aji-33	787	12	of	of	ADP
aji-33	787	13	antibody	antibody	NOUN
aji-33	787	14	,	,	PUNCT
aji-33	787	15	(	(	PUNCT
aji-33	787	16	such	such	ADJ
aji-33	787	17	as	as	ADP
aji-33	787	18	igg	igg	PROPN
aji-33	787	19	,	,	PUNCT
aji-33	787	20	)	)	PUNCT
aji-33	787	21	which	which	PRON
aji-33	787	22	binds	bind	VERB
aji-33	787	23	to	to	ADP
aji-33	787	24	the	the	DET
aji-33	787	25	surface	surface	NOUN
aji-33	787	26	of	of	ADP
aji-33	787	27	a	a	DET
aji-33	787	28	pathogen	pathogen	NOUN
aji-33	787	29	-	-	PUNCT
aji-33	787	30	infected	infect	VERB
aji-33	787	31	target	target	NOUN
aji-33	787	32	cell	cell	NOUN
aji-33	787	33	.	.	PUNCT
aji-33	788	1	3	3	X
aji-33	788	2	.	.	X
aji-33	788	3	the	the	DET
aji-33	788	4	nk	nk	PROPN
aji-33	788	5	cell	cell	NOUN
aji-33	788	6	releases	release	VERB
aji-33	788	7	cytotoxic	cytotoxic	ADJ
aji-33	788	8	factors	factor	NOUN
aji-33	788	9	that	that	PRON
aji-33	788	10	cause	cause	VERB
aji-33	788	11	the	the	DET
aji-33	788	12	death	death	NOUN
aji-33	788	13	of	of	ADP
aji-33	788	14	the	the	DET
aji-33	788	15	target	target	NOUN
aji-33	788	16	cell	cell	NOUN
aji-33	788	17	through	through	ADP
aji-33	788	18	perforin	perforin	NOUN
aji-33	788	19	granzyme	granzyme	NOUN
aji-33	788	20	pathway	pathway	NOUN
aji-33	788	21	.	.	PUNCT
aji-33	789	1	2	2	X
aji-33	789	2	.	.	X
aji-33	789	3	mait	mait	PROPN
aji-33	789	4	cells	cell	NOUN
aji-33	789	5	(	(	PUNCT
aji-33	789	6	mucosal	mucosal	NOUN
aji-33	789	7	associated	associate	VERB
aji-33	789	8	invariant	invariant	PROPN
aji-33	789	9	t	t	NOUN
aji-33	789	10	cells	cell	NOUN
aji-33	789	11	)	)	PUNCT
aji-33	789	12	a	a	DET
aji-33	789	13	subset	subset	NOUN
aji-33	789	14	of	of	ADP
aji-33	789	15	t	t	NOUN
aji-33	789	16	cells	cell	NOUN
aji-33	789	17	they	they	PRON
aji-33	789	18	display	display	VERB
aji-33	789	19	innate	innate	NOUN
aji-33	789	20	,	,	PUNCT
aji-33	789	21	effector	effector	NOUN
aji-33	789	22	-	-	PUNCT
aji-33	789	23	like	like	ADJ
aji-33	789	24	qualities	quality	NOUN
aji-33	789	25	.	.	PUNCT
aji-33	790	1	ait	ait	NOUN
aji-33	790	2	cells	cell	NOUN
aji-33	790	3	secrete	secrete	VERB
aji-33	790	4	pro	pro	ADJ
aji-33	790	5	-	-	ADJ
aji-33	790	6	inflammatory	inflammatory	ADJ
aji-33	790	7	cytokines	cytokine	NOUN
aji-33	790	8	and	and	CCONJ
aji-33	790	9	alsolyse	alsolyse	VERB
aji-33	790	10	bacterially	bacterially	NOUN
aji-33	790	11	-	-	PUNCT
aji-33	790	12	infected	infect	VERB
aji-33	790	13	cells	cell	NOUN
aji-33	790	14	.	.	PUNCT
aji-33	791	1	supports	support	VERB
aji-33	791	2	the	the	DET
aji-33	791	3	adaptive	adaptive	ADJ
aji-33	791	4	immune	immune	ADJ
aji-33	791	5	response	response	NOUN
aji-33	791	6	.	.	PUNCT
aji-33	792	1	they	they	PRON
aji-33	792	2	have	have	VERB
aji-33	792	3	memory	memory	NOUN
aji-33	792	4	like	like	ADP
aji-33	792	5	phenotype	phenotype	NOUN
aji-33	792	6	.	.	PUNCT
aji-33	793	1	3	3	X
aji-33	793	2	.	.	X
aji-33	793	3	natural	natural	ADJ
aji-33	793	4	killer	killer	NOUN
aji-33	793	5	t	t	PROPN
aji-33	793	6	(	(	PUNCT
aji-33	793	7	nkt	nkt	PROPN
aji-33	793	8	)	)	PUNCT
aji-33	793	9	cells	cell	NOUN
aji-33	793	10	a	a	DET
aji-33	793	11	group	group	NOUN
aji-33	793	12	of	of	ADP
aji-33	793	13	t	t	PROPN
aji-33	793	14	cells	cell	NOUN
aji-33	793	15	that	that	PRON
aji-33	793	16	share	share	VERB
aji-33	793	17	properties	property	NOUN
aji-33	793	18	of	of	ADP
aji-33	793	19	both	both	DET
aji-33	793	20	t	t	NOUN
aji-33	793	21	cells	cell	NOUN
aji-33	793	22	and	and	CCONJ
aji-33	793	23	natural	natural	ADJ
aji-33	793	24	killer	killer	NOUN
aji-33	793	25	cells	cell	NOUN
aji-33	793	26	.	.	PUNCT
aji-33	794	1	.	.	PUNCT
aji-33	795	1	recognize	recognize	VERB
aji-33	795	2	foreign	foreign	ADJ
aji-33	795	3	lipids	lipid	NOUN
aji-33	795	4	and	and	CCONJ
aji-33	795	5	glycolipid	glycolipid	ADJ
aji-33	795	6	antigens	antigen	NOUN
aji-33	795	7	.	.	PUNCT
aji-33	796	1	4	4	X
aji-33	796	2	.	.	X
aji-33	796	3	gammadelta	gammadelta	PROPN
aji-33	796	4	t	t	PROPN
aji-33	796	5	cells	cell	NOUN
aji-33	796	6	(	(	PUNCT
aji-33	796	7	γδ	γδ	ADP
aji-33	796	8	t	t	PROPN
aji-33	796	9	cells	cell	NOUN
aji-33	796	10	)	)	PUNCT
aji-33	796	11	subset	subset	NOUN
aji-33	796	12	of	of	ADP
aji-33	796	13	t	t	PROPN
aji-33	796	14	cells	cell	NOUN
aji-33	796	15	-express	-express	VERB
aji-33	796	16	a	a	DET
aji-33	796	17	unique	unique	ADJ
aji-33	796	18	t	t	NOUN
aji-33	796	19	-	-	PUNCT
aji-33	796	20	cell	cell	NOUN
aji-33	796	21	receptor	receptor	NOUN
aji-33	796	22	(	(	PUNCT
aji-33	796	23	tcr	tcr	PROPN
aji-33	796	24	)	)	PUNCT
aji-33	796	25	-initiation	-initiation	PROPN
aji-33	796	26	and	and	CCONJ
aji-33	796	27	propagation	propagation	NOUN
aji-33	796	28	of	of	ADP
aji-33	796	29	immune	immune	ADJ
aji-33	796	30	responses	response	NOUN
aji-33	796	31	prasad	prasad	PROPN
aji-33	796	32	;	;	PUNCT
aji-33	796	33	aji	aji	NOUN
aji-33	796	34	,	,	PUNCT
aji-33	796	35	3(1	3(1	NUM
aji-33	796	36	):	):	PUNCT
aji-33	796	37	233	233	NUM
aji-33	796	38	-	-	SYM
aji-33	796	39	252	252	NUM
aji-33	796	40	,	,	PUNCT
aji-33	796	41	2020	2020	NUM
aji-33	796	42	;	;	PUNCT
aji-33	796	43	article	article	NOUN
aji-33	796	44	no.aji.58422	no.aji.58422	NOUN
aji-33	796	45	252	252	NUM
aji-33	796	46	5	5	NUM
aji-33	796	47	.	.	PUNCT
aji-33	797	1	innate	innate	ADJ
aji-33	797	2	lymphoid	lymphoid	ADJ
aji-33	797	3	cells	cell	NOUN
aji-33	797	4	(	(	PUNCT
aji-33	797	5	ilcs	ilcs	NOUN
aji-33	797	6	)	)	PUNCT
aji-33	797	7	1	1	NUM
aji-33	797	8	.	.	X
aji-33	797	9	lcs	lcs	PROPN
aji-33	797	10	contribute	contribute	VERB
aji-33	797	11	to	to	ADP
aji-33	797	12	immunity	immunity	NOUN
aji-33	797	13	via	via	ADP
aji-33	797	14	a.	a.	NOUN
aji-33	797	15	secretion	secretion	NOUN
aji-33	797	16	of	of	ADP
aji-33	797	17	signalling	signal	VERB
aji-33	797	18	molecules	molecule	NOUN
aji-33	797	19	,	,	PUNCT
aji-33	797	20	b.	b.	PROPN
aji-33	797	21	regulation	regulation	NOUN
aji-33	797	22	of	of	ADP
aji-33	797	23	both	both	DET
aji-33	797	24	innate	innate	ADJ
aji-33	797	25	and	and	CCONJ
aji-33	797	26	adaptive	adaptive	ADJ
aji-33	797	27	immune	immune	ADJ
aji-33	797	28	cells	cell	NOUN
aji-33	797	29	2	2	NUM
aji-33	797	30	)	)	PUNCT
aji-33	797	31	mucus	mucus	NOUN
aji-33	797	32	production	production	NOUN
aji-33	797	33	in	in	ADP
aji-33	797	34	the	the	DET
aji-33	797	35	respiratory	respiratory	ADJ
aji-33	797	36	tract	tract	NOUN
aji-33	797	37	.	.	PUNCT
aji-33	798	1	3	3	X
aji-33	798	2	)	)	PUNCT
aji-33	798	3	restoration	restoration	NOUN
aji-33	798	4	and	and	CCONJ
aji-33	798	5	maintenance	maintenance	NOUN
aji-33	798	6	of	of	ADP
aji-33	798	7	epithelial	epithelial	ADJ
aji-33	798	8	integrity	integrity	NOUN
aji-33	798	9	.	.	PUNCT
aji-33	799	1	4	4	X
aji-33	799	2	)	)	PUNCT
aji-33	799	3	secrete	secrete	NOUN
aji-33	799	4	ifn	ifn	PROPN
aji-33	799	5	-	-	PUNCT
aji-33	799	6	γ	γ	NOUN
aji-33	799	7	in	in	ADP
aji-33	799	8	response	response	NOUN
aji-33	799	9	to	to	ADP
aji-33	799	10	viral	viral	ADJ
aji-33	799	11	infection	infection	NOUN
aji-33	799	12	in	in	ADP
aji-33	799	13	the	the	DET
aji-33	799	14	lungs	lung	NOUN
aji-33	799	15	.	.	PUNCT
aji-33	800	1	6	6	X
aji-33	800	2	.	.	X
aji-33	800	3	dendritic	dendritic	ADJ
aji-33	800	4	cells	cell	NOUN
aji-33	800	5	:	:	PUNCT
aji-33	800	6	these	these	PRON
aji-33	800	7	are	be	AUX
aji-33	800	8	professional	professional	ADJ
aji-33	800	9	antigen	antigen	ADJ
aji-33	800	10	processing	processing	NOUN
aji-33	800	11	cells	cell	NOUN
aji-33	800	12	.	.	PUNCT
aji-33	801	1	present	present	ADJ
aji-33	801	2	antigens	antigen	NOUN
aji-33	801	3	to	to	ADP
aji-33	801	4	t	t	NOUN
aji-33	801	5	cells	cell	NOUN
aji-33	801	6	.	.	PUNCT
aji-33	802	1	mhc	mhc	PROPN
aji-33	802	2	class	class	PROPN
aji-33	802	3	ii	ii	PROPN
aji-33	802	4	molecules	molecule	NOUN
aji-33	802	5	thereby	thereby	ADV
aji-33	802	6	are	be	AUX
aji-33	802	7	critical	critical	ADJ
aji-33	802	8	for	for	ADP
aji-33	802	9	the	the	DET
aji-33	802	10	initiation	initiation	NOUN
aji-33	802	11	of	of	ADP
aji-33	802	12	the	the	DET
aji-33	802	13	antigen	antigen	NOUN
aji-33	802	14	-	-	PUNCT
aji-33	802	15	specific	specific	ADJ
aji-33	802	16	immune	immune	ADJ
aji-33	802	17	response.2	response.2	PROPN
aji-33	802	18	.	.	PUNCT
aji-33	802	19	role	role	NOUN
aji-33	802	20	of	of	ADP
aji-33	802	21	nab	nab	ADJ
aji-33	802	22	(	(	PUNCT
aji-33	802	23	natural	natural	ADJ
aji-33	802	24	antibodies	antibody	NOUN
aji-33	802	25	)	)	PUNCT
aji-33	802	26	1	1	NUM
aji-33	802	27	.	.	PUNCT
aji-33	802	28	opsonisation	opsonisation	NOUN
aji-33	802	29	2	2	NUM
aji-33	802	30	.	.	PUNCT
aji-33	802	31	activation	activation	NOUN
aji-33	802	32	of	of	ADP
aji-33	802	33	the	the	DET
aji-33	802	34	complement	complement	NOUN
aji-33	802	35	.	.	PUNCT
aji-33	803	1	mhc	mhc	PROPN
aji-33	803	2	class	class	PROPN
aji-33	803	3	ii	ii	PROPN
aji-33	803	4	molecules	molecule	NOUN
aji-33	803	5	:	:	PUNCT
aji-33	803	6	the	the	DET
aji-33	803	7	main	main	ADJ
aji-33	803	8	function	function	NOUN
aji-33	803	9	of	of	ADP
aji-33	803	10	major	major	ADJ
aji-33	803	11	histocompatibility	histocompatibility	NOUN
aji-33	803	12	complex	complex	NOUN
aji-33	803	13	(	(	PUNCT
aji-33	803	14	mhc	mhc	PROPN
aji-33	803	15	)	)	PUNCT
aji-33	803	16	class	class	NOUN
aji-33	803	17	ii	ii	NOUN
aji-33	803	18	molecules	molecule	NOUN
aji-33	803	19	is	be	AUX
aji-33	803	20	to	to	PART
aji-33	803	21	present	present	VERB
aji-33	803	22	processed	process	VERB
aji-33	803	23	antigens	antigen	NOUN
aji-33	803	24	,	,	PUNCT
aji-33	803	25	which	which	PRON
aji-33	803	26	are	be	AUX
aji-33	803	27	derived	derive	VERB
aji-33	803	28	primarily	primarily	ADV
aji-33	803	29	from	from	ADP
aji-33	803	30	exogenous	exogenous	ADJ
aji-33	803	31	sources	source	NOUN
aji-33	803	32	,	,	PUNCT
aji-33	803	33	to	to	ADP
aji-33	803	34	cd4(+)tlymphocytes	cd4(+)tlymphocyte	NOUN
aji-33	803	35	.	.	PUNCT
aji-33	804	1	_	_	PUNCT
aji-33	805	1	_	_	PUNCT
aji-33	806	1	_	_	PUNCT
aji-33	807	1	_	_	PUNCT
aji-33	808	1	_	_	PUNCT
aji-33	809	1	_	_	PUNCT
aji-33	810	1	_	_	PUNCT
aji-33	811	1	_	_	PUNCT
aji-33	812	1	_	_	PUNCT
aji-33	813	1	_	_	PUNCT
aji-33	814	1	_	_	PUNCT
aji-33	815	1	_	_	PUNCT
aji-33	816	1	_	_	PUNCT
aji-33	817	1	_	_	PUNCT
aji-33	818	1	_	_	PUNCT
aji-33	819	1	_	_	PUNCT
aji-33	820	1	_	_	PUNCT
aji-33	821	1	_	_	PUNCT
aji-33	822	1	_	_	PUNCT
aji-33	823	1	_	_	PUNCT
aji-33	824	1	_	_	PUNCT
aji-33	825	1	_	_	PUNCT
aji-33	826	1	_	_	PUNCT
aji-33	827	1	_	_	PUNCT
aji-33	828	1	_	_	PUNCT
aji-33	829	1	_	_	PUNCT
aji-33	830	1	_	_	PUNCT
aji-33	831	1	_	_	PUNCT
aji-33	832	1	_	_	PUNCT
aji-33	833	1	_	_	PUNCT
aji-33	834	1	_	_	PUNCT
aji-33	835	1	_	_	PUNCT
aji-33	836	1	_	_	PUNCT
aji-33	837	1	_	_	PUNCT
aji-33	838	1	_	_	PUNCT
aji-33	839	1	_	_	PUNCT
aji-33	840	1	_	_	PUNCT
aji-33	841	1	_	_	PUNCT
aji-33	842	1	_	_	PUNCT
aji-33	843	1	_	_	PUNCT
aji-33	844	1	_	_	PUNCT
aji-33	845	1	_	_	PUNCT
aji-33	846	1	_	_	PUNCT
aji-33	847	1	_	_	PUNCT
aji-33	848	1	_	_	PUNCT
aji-33	849	1	_	_	PUNCT
aji-33	850	1	_	_	PUNCT
aji-33	851	1	_	_	PUNCT
aji-33	852	1	_	_	PUNCT
aji-33	853	1	_	_	PUNCT
aji-33	854	1	_	_	PUNCT
aji-33	855	1	_	_	PUNCT
aji-33	856	1	_	_	PUNCT
aji-33	857	1	_	_	PUNCT
aji-33	858	1	_	_	PUNCT
aji-33	859	1	_	_	PUNCT
aji-33	860	1	_	_	PUNCT
aji-33	861	1	_	_	PUNCT
aji-33	862	1	_	_	PUNCT
aji-33	863	1	_	_	PUNCT
aji-33	864	1	_	_	PUNCT
aji-33	865	1	_	_	PUNCT
aji-33	866	1	_	_	PUNCT
aji-33	867	1	_	_	PUNCT
aji-33	868	1	_	_	PUNCT
aji-33	869	1	_	_	PUNCT
aji-33	870	1	_	_	PUNCT
aji-33	871	1	_	_	PUNCT
aji-33	872	1	_	_	PUNCT
aji-33	873	1	_	_	PUNCT
aji-33	874	1	_	_	PUNCT
aji-33	875	1	_	_	PUNCT
aji-33	876	1	_	_	PUNCT
aji-33	877	1	_	_	PUNCT
aji-33	878	1	_	_	PUNCT
aji-33	879	1	_	_	PUNCT
aji-33	880	1	_	_	PUNCT
aji-33	881	1	_	_	PUNCT
aji-33	882	1	_	_	PUNCT
aji-33	883	1	_	_	PUNCT
aji-33	884	1	_	_	PUNCT
aji-33	885	1	©	©	PROPN
aji-33	885	2	2020	2020	NUM
aji-33	885	3	prasad	prasad	NOUN
aji-33	885	4	;	;	PUNCT
aji-33	885	5	this	this	PRON
aji-33	885	6	is	be	AUX
aji-33	885	7	an	an	DET
aji-33	885	8	open	open	ADJ
aji-33	885	9	access	access	NOUN
aji-33	885	10	article	article	NOUN
aji-33	885	11	distributed	distribute	VERB
aji-33	885	12	under	under	ADP
aji-33	885	13	the	the	DET
aji-33	885	14	terms	term	NOUN
aji-33	885	15	of	of	ADP
aji-33	885	16	the	the	DET
aji-33	885	17	creative	creative	ADJ
aji-33	885	18	commons	common	NOUN
aji-33	885	19	attribution	attribution	NOUN
aji-33	885	20	license	license	NOUN
aji-33	885	21	(	(	PUNCT
aji-33	885	22	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-33	885	23	)	)	PUNCT
aji-33	885	24	,	,	PUNCT
aji-33	885	25	which	which	PRON
aji-33	885	26	permits	permit	VERB
aji-33	885	27	unrestricted	unrestricted	ADJ
aji-33	885	28	use	use	NOUN
aji-33	885	29	,	,	PUNCT
aji-33	885	30	distribution	distribution	NOUN
aji-33	885	31	,	,	PUNCT
aji-33	885	32	and	and	CCONJ
aji-33	885	33	reproduction	reproduction	NOUN
aji-33	885	34	in	in	ADP
aji-33	885	35	any	any	DET
aji-33	885	36	medium	medium	NOUN
aji-33	885	37	,	,	PUNCT
aji-33	885	38	provided	provide	VERB
aji-33	885	39	the	the	DET
aji-33	885	40	original	original	ADJ
aji-33	885	41	work	work	NOUN
aji-33	885	42	is	be	AUX
aji-33	885	43	properly	properly	ADV
aji-33	885	44	cited	cite	VERB
aji-33	885	45	.	.	PUNCT
aji-33	886	1	peer	peer	NOUN
aji-33	886	2	-	-	PUNCT
aji-33	886	3	review	review	NOUN
aji-33	886	4	history	history	NOUN
aji-33	886	5	:	:	PUNCT
aji-33	886	6	the	the	DET
aji-33	886	7	peer	peer	NOUN
aji-33	886	8	review	review	NOUN
aji-33	886	9	history	history	NOUN
aji-33	886	10	for	for	ADP
aji-33	886	11	this	this	DET
aji-33	886	12	paper	paper	NOUN
aji-33	886	13	can	can	AUX
aji-33	886	14	be	be	AUX
aji-33	886	15	accessed	access	VERB
aji-33	886	16	here	here	ADV
aji-33	886	17	:	:	PUNCT
aji-33	886	18	http://www.sdiarticle4.com/review-history/58422	http://www.sdiarticle4.com/review-history/58422	VERB
aji-33	886	19	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	X